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 I 
ABSTRACT 
Myofascial pain syndrome is characterized by sensory, motor and autonomic 
symptoms, and a myofascial trigger point (MTrP) is considered the principal 
clinical feature. Clinicians recognise myofascial pain syndrome as an 
important clinical entity but many basic and clinical issues need further 
research. Electrophysiological studies indicate that abnormal electrical activity 
is detectable near MTrPs. This phenomenon has been described as endplate 
noise and it has been purported to be associated MTrP pathophysiology. 
Authors also suggest that MTrPs are located in the innervation zone (IZ) of 
muscles. The aim of this thesis was to describe both the location of MTrP and 
the IZ’ locations in the upper trapezius muscle. The hypothesis was that 
distance between the IZ and the MTrP in upper trapezius muscle is equal to 
zero. 
This thesis includes two preliminary studies. The first one address the 
reliability of surface electromyography (EMG) in locating the IZ in upper 
trapezius muscle, and the second one address the reliability of a manual 
palpation protocol in locating the MTrP in upper trapezius muscle. The intra-
rater reliability of surface EMG in locating the IZ was almost perfect; with 
Kappa = 0.90 for operator A and Kappa = 0.92 for operator B. Also the inter-
rater reliability showed an almost perfect agreement, with Kappa = 0.82. Both 
the operators conducted 900 estimations of IZ’ location through visual 
analysis of the EMG signals. The reliability of an experienced physiotherapist 
using a manual palpation protocol in locating the MTrP in the upper trapezius 
was established. An anatomical landmark system was defined and MTrP’ 
location established using X and Y values. The ICC values were 0.62 for X 
and 0.81 for Y. Twenty-four subjects with MTrP in upper trapezius were 
enrolled for this latter study.  
MTrP’ and IZ’ locations were described in 48 subjects. MTrPs were located in 
well-defined areas of the upper trapezius, showing a typical location with a 
mean distance from the IZ of 10.4 ± 5.8 mm. MTrPs in the upper trapezius are 
proximally located to the IZ but not overlapped by it (p = 0.6). These results 
extend the body of knowledge regarding the phenomenon of MTrP 
iperalgesia.   
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GENERAL INTRODUCTION TO MYOFASCIAL 
TRIGGER POINTS 
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1.1 MUSCULOSKELETAL PAIN: THE WIDER PERSPECTIVE. 
 
Pain is a widespread negative experience involving different ages, races and 
cultures. It affects all individuals in their life and despite its common 
occurrence, it is difficult to understand, explain and treat. A simple, Cartesian 
model would postulate a direct link between the amount of pain experienced 
and the amount of pathology incurred by the tissues from which that pain 
emanates or which pain is referred to (Goldberg, 2008). However, research 
has shown that there isn’t always a direct relationship between the degree of 
tissue pathology and the pain experience, and modern medicine has replaced 
the old Cartesian model with more complex models (Goldberg, 2008). 
 
Musculoskeletal pain is a major medical problem and the related disorders are 
the leading cause of long-term disability in modern societies (Brooks, 2006, 
Woolf and Pfleger, 2003). Even if they are not life-threatening, they 
significantly affect the psychosocial status of the patients as well as their 
quality of life (Salaffi et al., 2005, Woolf and Akesson, 2001).  
 
Data from the General Research Database (GPRD), jointly funded by the 
NHS National Institute for Health Research (NIHR) and the Medicines and 
Healthcare Products Regulatory Agency (MHRA), reports that in 2001 the 
incidence of musculoskeletal conditions in the general population was 947 per 
10000. The data set was based on attendance in general practice and 
revealed that the largest group was tissue rheumatism and chronic 
widespread pain (figure 1.1). An additional data set from the same database, 
collected ten years previously, clearly shows a trend toward the increase in 
prevalence of musculoskeletal conditions, especially in subjects aged over 45 
(figure 1.2). Almost one third of people aged over 75 reports a 
musculoskeletal problem (Urwin et al., 1998) and the overall prevalence of 
musculoskeletal conditions rises in the aged population (Jordan et al., 2007). 
Notably, different general practice consultation databases report a higher 
female prevalence for musculoskeletal conditions with a ratio of 1:1.3 (figure 
1.3). 
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Figure 1.1: Epidemiological data for musculoskeletal pain from the General 
Practice Research Database (adapted from Parsons & Symmons, 2010). 
 
 
 
 
 
 
Figure 1.2: Prevalence of musculoskeletal pain in different aged groups. 
  
30% Soft tissue rheumatism and  
chronic widespread pain 
25% Arthralgia 
22% Back pain 
10% Osteoarthritis 
1% Rheumatoid arthritis 
1% Osteoporosis 
11% Other 
≥15,<25 75≥ 
3500 
3000 
2500 
2000 
1500 
1000 
  500 
GPRD 2001 
GPRD 1991 
Age group (years) 
P
re
v
a
le
n
c
e
 /
 1
0
0
0
0
 
≥25,<45 ≥45,<65 ≥65,<75 
 4 
 
 
 
 
Figure 1.3: Sex prevalence rates of musculoskeletal conditions from different 
consultation databases per 10000 people aged >15 years. 
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2010), and for most of them, pain is the main complaint. They include various 
types of degenerative joint and soft tissue disorders, osteoporosis, arthritis 
and systemic connective tissue diseases (Parsons and Symmons, 2010). 
 
In 2001, Mense proposed to classify these clinical disorders into two main 
groups, articular and nonarticluar (Mense et al., 2001). Articular disorders 
include joint diseases involving inflammation, varying degrees of trauma or 
degenerative process of the synovial joints. Two examples with a high 
epidemiological impact are osteoarthritis and rheumatoid arthritis. 
Osteoarthritis is uncommon among young subjects but in the elderly the 
prevalence approaches 70% (Cicuttini and Spector, 1995) while rheumatoid 
arthritis occurs in 1% of the general population (Parsons and Symmons, 
2010). Articular group also includes joint dysfunction usually characterized by 
mechanical pain arising from conditions such as hypomobility, hypermobility 
and instability. Conversely, nonarticular disorders affect periarticular tissue 
such as fascia, muscles, tendons, bursae, and nerves. Typical examples 
include plantar heel pain resulting from a non-inflammatory degenerative 
process of the plantar fascia (Lemont et al., 2003), achilles tendonitis 
(Enwemeka, 1989), myofascial pain syndromes (MPS)  (Giamberardino et al., 
2011), and fibromyalgia (Jafri, 2014, Chinn et al., 2016). 
 
The classification described above can give an insight into structures involved 
in nociception. It supports clinicians in their decision making both during the 
assessment and the treatment selection. Diagnostic tests or palpation 
procedures can be selected considering their diagnostic properties as well 
their capacity to induce a mechanical stress in a specific anatomical structure. 
With a similar approach, interventions should be selected by considering their 
underlying mechanism and the target tissue. Pain is a complex 
neurophysiological process where nociception from somatic structures is only 
part of the pain experience. Advances in pain science underlined the 
importance of other mechanisms involved in the pain elicitation (Gifford and 
Butler, 1997, Jones, 1995). Central sensitisation and peripheral neuropathic 
are two examples of mechanisms responsible for pain generation and/or 
maintenance (Smart et al., 2010, Smart et al., 2011, Smart et al., 2012a, 
 6 
Smart et al., 2012b, Smart et al., 2012c). Patients with central sensitization 
show pain hypersensitivity tactile allodynia, pressure hyperalgesia, and 
aftersensations. Central sensitization develops in the presence of long-lasting 
nociceptor inputs that increase the excitability and synaptic efficacy of 
neurons in central nociceptive pathways (Woolf, 2011). Peripheral 
sensitization is defined as a reduction in threshold and an amplification in the 
responsiveness of nociceptors (Latremoliere and Woolf, 2009). It occurs 
when, due to a tissue damage, primary sensory neurons are exposed to 
inflammatory mediators (Chen et al., 1999, Petho et al., 2001). Consequently, 
peripheral sensitization is restricted to the site of tissue injury while central 
sensitization is widespread phenomenon (Hucho and Levine, 2007). A 
growing body of experimental data has provided some evidence suggesting 
that central sensitisation may underline some commonly encountered clinical 
presentations of musculoskeletal pain including low back pain, neck pain, 
whiplash and MPS (Nijs et al., 2010, Woolf, 2011, Srbely et al., 2010). The 
diagnostic classification of patients with pain symptomatology could be 
challenging for clinicians. Widespread pain, long lasting pain, allodynia, 
hyperalgesia, and pain in the presence of cognitive or affective dysfunctions 
can be potentially associated with all the musculoskeletal disorders (Butler 
and Matheson, 2000, Nijs et al., 2010, Woolf, 2011). 
 
The need for a pain mechanisms-based approach has been suggested for 
both clinicians and researchers (Jones, 1995, Gifford and Butler, 1997) as it 
can turn into more appropriate evaluation of patients affected by 
musculoskeletal disorders. It is important to understand how subjects affected 
by the same pathology, may have a different presentation of pain symptoms. 
It can be local or widespread, moderate to intense, mechanical or 
spontaneous, aching or sharp. Smart and collaborators (2012) for example, 
with the aim of improving low back pain treatment, completed a series of 
studies to help clinicians to recognize different pain patterns in subjects with 
low back pain (Smart et al., 2012a, Smart et al., 2012b, Smart et al., 2012c). 
 
Future research should be aimed at improving the clinical evaluation of 
musculoskeletal pain, especially in cases of patients complaining of 
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widespread pain. It constitutes a major health issue and it is a big subgroup of 
the population with musculoskeletal pain. Widespread pain’ prevalence in 
Korean communities has been estimated around 12% (figure 1.4) (Cho et al., 
2012), which is essentially the same rate observed in Caucasians (Croft et al., 
1993). Considering the gender' difference, widespread pain in Koreans was 
respectively 5.5% in males and 16.2% in females, and for females, it rises to 
20% after the age of 60. 
 
 
 
 
 
 
Figure 1.4: Prevalence of musculoskeletal pain according to the number of 
painful regions (Adapted from Cho et al., 2012). 
 
 
A recent cross-sectional study, investigating the prevalence and the 
characteristics of multisite musculoskeletal pain, provided a detailed view on 
widespread pain among 3740 French workers. The extent of multisite pain 
during the past 12 months were noteworthy, 83.8% for males and 83.9% for 
females. The prevalence of multisite pain affecting more the one sites was 3 
to 12 times more frequent than prevalence of pain at only one site (figure 1.5 
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and 1.6). When considering musculoskeletal pain lasting at least 30 days, the 
prevalence dropped to 32.8% for males and 37.3% for females, and two-thirds 
complained of pain in more than one sites (Parot-Schinkel et al., 2012).   
 
Some questions that can be asked are: what are the clinical profiles and the 
determinants in these patients with widespread pain? Is it possible to ascribe 
them a specific diagnosis? If we exclude studies centred on fibromyalgia or 
other rheumatic disorders, there is paucity of epidemiological data aimed to 
provide a diagnosis for the patient with widespread or multisite pain. 
 
 
 
 
Figure 1.5: Distribution of multisite pain lasting at least 30 days among a 
selected population of male French workers (Adapted form Parot-Schinkel et 
al., 2012). 
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Figure 1.6: Distribution of multisite pain lasting at least 30 days among a 
selected population of female French workers (Adapted form Parot-Schinkel 
et al., 2012). 
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1.2 DEFINITION OF MYOFASCIAL PAIN SYNDROME AND MYOFASCIAL 
TRIGGER POINTS 
 
The original and the most commonly accepted definition of MPS has been 
formulated by Travell and Simons (1983) in the first volume of The Trigger 
point Manual edited in 1983. The authors defined the MPS as a regional pain 
characterized by the presence of one or more active myofascial trigger points 
(MTrPs). They recommend that it should be considered a specific diagnosis 
and clinicians should avoid using this term to refer to soft tissue pain in 
general or in other circumstances where a proper diagnostic category is not 
identified.  An active MTrP is a distinctive clinical characteristic of this painful 
syndrome and it is defined as a hyperirritable palpable nodule contained in the 
skeletal muscle fibres. It can produce referred pain, either on digital 
compression or spontaneously (figure 1.7). If stimulated with dry needling or 
snapping palpation, it may exhibit a typical muscle fasciculation or jump sign 
(a typical apprehension reaction to painful stimulus) (Simons, 1996). 
 
MTrPs can be classified as active or latent. A latent MTrP does not cause 
spontaneous pain but may restrict movement (Grieve et al., 2011, Trampas et 
al., 2010, Aguilera et al., 2009) or cause muscle weakness (Ge et al., 2012). 
Pain in this case only occurs with the application of vigorous digital pressure 
(Simons, 1996). Pain pressure threshold of latent MTrPs have been described 
only in a few clinical studies. For instance, Gemmell and Hilland (2011) 
(Gemmell and Hilland, 2011) reported a mean PPT value of 4 kg/cm2 for 
latent MTrPs in upper trapezius muscles, and Xu et al. (2010) reported a 
mean PPT values of 450 KPa for latent MTrP in the tibialis anterior muscles. 
The clinical relevance of latent MTrP has never been investigated deeply 
although a review published in 2013 on Current Pain Headache Reports 
stated that its treatment is important to prevent its “activation” (Celik and 
Mutlu, 2013). 
 
Conversely, an active trigger point is frequently responsible for the presenting 
complaint. Its PPT is lower than in latent MTrPs. For example, Llamas-Ramos 
et al. (2014) reported a mean PPT value of 188.1 KPa (i.e 1.9 kg/cm2) for 
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active MTrPs in upper trapezius muscles. With an active trigger point, manual 
palpation reproduces the patients’ pain symptoms and in some case also 
autonomic phenomena like skin redness (vasomotor response), sweating 
(sudomotor response), goose pimpling (pilomotor response), lacrimation and 
dizziness (Travell and Simons, 1983).  These possible reactions illustrate the 
dynamic nature of active MTrPs which can be limited to local muscle pain or 
can include complex referred pain (Mense and Gerwin, 2010). It is clear that 
“trigger” is an appropriate term to describe the clinical event of pain projection 
due to muscle palpation (referred pain). Especially in these cases, the digital 
compression stimulates pain at a location away from the stimulated site. It is 
important to note however, that a systematic investigation on MTrP 
symptomatology has never been performed. 
 
To further support clinicians, Travell and Simons published two seminal 
textbooks, one in 1983 for the upper extremities and one in 1992 for the lower 
extremities (Travell and Simons, 1983, Travell and Simons, 1992). In 1992, 
the textbook on the lower extremities was updated and a second edition is 
available (Simons et al., 1999). The textbooks include different body charts for 
several skeletal muscles. Common MTrPs locations and their referral zones 
are described for each muscle. The pain patterns illustrations were based on 
a previous experimental study, conducted by Janet Travell and Seymour 
Rinzler, including 32 muscles and a population of 1000 subjects diagnosed 
with MPS (Travell and Rinzler, 1952). The results of the study were published 
in a classic contribution to the field entitled “The Myofascial Genesis of Pain” 
(Travell and Rinzler, 1952). 
 
Over the past few decades, MPS have received greater attention in the 
scientific and clinical literature, and a survey by American pain specialists has 
revealed a general agreement that MPS is a legitimate medical diagnosis 
(Harden et al., 2000). Since 2005, the International Association for the Study 
of Pain has included MPS in the Core Curriculum for the Professional 
Education in Pain (Charlton, 2005).  
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Figure 1.7: Trigger point in the infraspinatus muscle refers pain to the 
ipsilateral arm, forearm and hand. The blue cross indicate the approximate 
location of a possible the trigger point while the red areas show the referred 
pain extent (Adapted from Travell and Simons, 1983). 
  
 
For effective management of patients with musculoskeletal disorders 
clinicians should be familiar with the clinical manifestations of MPS. Patients 
may complain of both an acute and chronic MPS. In both cases, the reported 
symptomatology is essentially muscle pain and it is described, as other 
somatic and visceral pain, like dull, aching and poorly localised (Mense, 2008, 
Bogduk, 2009). It is often reported as deep and when referred, it can mimic 
other pains such as radicular pain (Reynolds, 1981). It may occasionally be 
associated with a sensory component of paraesthesia (i.e. tingling, burning, 
prickling, tickling) or dysesthesia (i.e. abnormal sense of touch) (Mense et al., 
2001). MPS diagnosis can be challenging for clinicians especially because 
pain may be felt elsewhere than where it originates. Moreover, it can persist 
long after the initiating cause has resolved, similarly to whiplash injuries or 
chronic low back pain. In this case, additional comorbidities are frequently 
reported and the patient’s management becomes further complex. In such a 
complex clinical presentation, the MPS diagnosis is often underestimated 
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leading to frequent mistakes in diagnosis and in treatment of patients (Fricton, 
1994, Gerwin et al., 2004, Suleiman and Johnston, 2001).  
 
To assist practitioners in diagnosis of MPS, Simons (2004) remarked about 
the importance of accounting for the following history findings:  
 Regional pain 
 Onset with sudden muscle overload 
 Onset with sustained muscular contraction in shortened position  
 Onset with repetitive activity  
 
MTrPs should be considered the main distinguishing features of MPS, and 
clinicians are required to develop effective manual skills to palpate muscle 
and detect their presence. A MTrP shows an abnormal muscle structure (i.e 
the taut band) and a localised hyperalgesia. Moreover, MTrPs may exert 
influences upon motor function; typically, a reduction of range of motion 
(Grieve et al., 2011, Grieve et al., 2013b) but also muscle inhibition or muscle 
imbalances (Lucas et al., 2010a, Roach et al., 2013).  The taut band is a 
linear band of hardened muscle. It does not involve the entire muscle but just 
a limited numbers of fibres. Indeed, a muscle affected by a MTrP has a 
heterogeneous feel of hard and soft areas, rather than a homogeneous 
consistency (Mense and Gerwin, 2010). It is currently suggested that the taut 
band is composed of a limited number of contracted fibres that include some 
constantly shortened sarcomeres, thought to be located in the vicinity of the 
motor endplate zone (Mense, 2008). This localized muscle contraction is 
associated with the sensory phenomenon of spot tenderness. A gentle 
manual palpation along the taut band presents the opportunity to define the 
exact location of the spot tenderness. When pressure is applied on the spot 
tenderness, patients often recognize the pain as a familiar symptom and in 
the case of a hyper-irritable spot, react with an instinctive movement or 
exclamation. Simons named this apprehension sign “Jump sign” and 
suggested that it depends on the degree of MTrP irritability (Simons, 1996), 
but obviously depends also on the amount of pressure exerted by the 
examiner (Travell and Simons, 1983).  Another distinguishing feature of MTrP 
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is the referred pain that is usually elicited by specific patient activities or 
postures. Alternatively, the referred pain can be induced by stimulating the 
spot tenderness with manual compression or dry needling. It usually spreads 
into a wide area adjacent or at distance from the MTrP’ location, where 
original nociceptions are generated. Clinically, it is important to remember that 
the referred pain pattern is not dermatomal (Bogduk, 2009). Patients usually 
find it difficult to describe the boundaries of this area, but can define its centre. 
Interpretation of the referred pain can make the diagnostic process difficult, 
even if each muscle has its own specific pain pattern and those are quite 
consistent amongst subjects. MTrP charts including the pain maps, are a valid 
support during the history taking. 
 
A specific motor sign associated with MTrPs is the local twitch response; once 
this is evoked by the mechanical stimulation of the spot tenderness. It is a 
transient contraction of some fibres that probably includes the taut band and it 
is clearly visible on the skin. According to an experiment conducted with 
patients affected by cervical radiculopathy, this transmission depends on the 
central nervous system, with a possible minor degree of local transmission 
(Hong, 1994b).  Hong investigated the twitch response using EMG and 
defined it as high-amplitude, polyphasic electrical discharge. Clinicians elicit 
the local twitch response both in active and latent MTrPs by snapping 
palpation (i.e plucking of the muscle fascicle, like plucking of a violin) or dry 
needling (Hong and Simons, 1998). A schematic chart of MTrP and its clinical 
features, is illustrated in figure 1.14. 
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Figure 1.14: MTrPs’ clinical features. MTrP is characterized by the presence 
of a taut band including a spot tenderness. Additionally, manual palpation can 
elicit additional signs as the referred pain and the local twitch response. 
 
 
1.3 ADDITIONAL CLINICAL FEATURES 
 
Beside the main clinical features, patients with MPS may complain of some 
additional symptoms and signs. The most commonly observed are: muscle 
weakness, reduced range of motion, altered muscle recruitment, and 
autonomic signs. They should not be considered specific for MPS but more as 
correlated motor impairments. Indeed, they are frequently observed in 
musculoskeletal disorders with different underlying aetiologies. Clinicians 
should be aware of these impairments during both the examination and 
treatment. 
 
1.3.1 Muscle Weakness 
Patients affected by MPS can exhibit weakness in specific active tasks. 
During muscle strength testing, muscles harbouring active MTrPs frequently 
show a relevant loss of maximal strength or a reduced resistance during 
submaximal contraction. The loss of strength is often evident when involved 
and uninvolved muscles are compared (Simons, 1996). Additionally, Celik and 
Yeldan showed in a group of 50 healthy adults, that even latent MTrPs in 
shoulder muscles could decrease muscle strength (Celik and Yeldan, 2011).  
 T
a
u
t b
a
n
d
	
Spot tenderness	
• Local  twitch response 
• Referred pain	
 16 
 
1.3.2 Range of motion 
Muscles with MTrPs exhibit a limited extensibility and consequently, the 
involved joints may show a limited range of motion (Travell and Simons, 
1983). A recent study demonstrated this in patients with acute whiplash 
associated disorders (Fernandez-Perez et al., 2012). The cervical range of 
motion showed a greater reduction in patients with a greater number of MTrPs 
and a lower pressure pain threshold over the neck (Fernandez-Perez et al., 
2012). It would seem reasonable to expect that when a muscle with an active 
MTrP is stretched, pain is produced because the sensitized fibres of the taut 
band increase their tension. Also, two published case reports described 
patients with shoulder conditions and reduction of the shoulder range of 
motion     (Passigli et al., 2016, Clewley et al., 2014). In both the cases, the 
MTrPs of the shoulder girdle (i.e. infraspinatus, teres minor, posterior deltoid) 
were treated using dry needling and the shoulder mobility improved.  
Restriction of the range of motion in the ankle has also been demonstrated in 
heathy subjects, with MTrPs in the triceps surae and soleus muscle (Grieve et 
al., 2011, Grieve et al., 2013b). 
 
The reduction of motion due to MTrP is muscle specific and it varies from 
muscle to muscle. For example, the degree of movement limitation induced by 
MTrPs may be marked in the case of subscapularis muscle (Jankovic and van 
Zundert, 2006, Gupta and Singh, 2016, Shin et al., 2014). Conversely, the 
movement limitation may be difficult to be detected in a muscle like latissimus 
dorsi in which the muscle extensibility does not clearly affect its joint mobility 
(i.e. the shoulder). In such a case, electronic inclinometers can be used to 
accurately establish pre and post treatment improvements in patients with 
MPS (Shin et al., 2012, Brosseau et al., 1997). 
 
1.3.3 Altered muscle recruitment  
Alteration of muscle activation patterns occur due to pain in patients with neck 
and low back pain. Some muscles may show an inhibition and others on the 
contrary, a hyper-activation (Richardson et al., 2004). It is hypothesized by 
authors that similar motor control alterations can be associated with MTrPs.  
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Lucas and his collaborators investigated muscle activation patterns in 
scapular muscles harbouring latent MTrPs. They concluded that the presence 
of latent MTrP in upward scapular rotators (upper trapezius muscles, lower 
trapezius muscle and serratus anterior muscle) modifies the muscle activation 
pattern during scapular elevation (Lucas et al., 2010a), potentially increasing 
the risk of developing conditions like for example, rotator cuff injury, 
impingement syndromes and shoulder instability. 
 
Moreover, the experimental muscle pain induced by injection of hypertonic 
saline, that can be considered a nociception similar to MTrP, has been found 
to evoke a reorganization of the spatial distribution of muscle activity and 
prevents the adaptation of the muscle activity during fatigue (Falla et al., 
2010, Madeleine et al., 2006, Falla et al., 2009). This phenomenon has been 
described also in women with fibromyalgia (Falla et al., 2010).  It is 
reasonable to suppose that MTrPs will induce similar changes and this 
scenario fits with the early manifestation of fatigue reported by patients with 
MPS. In support of this Ge and his collaborators showed in an EMG study, 
that latent MTrPs are associated with an accelerated development of muscle 
fatigue (Ge et al., 2012). 
 
1.3.4 Autonomic component  
Disturbances of the autonomic functions can be present in patients with MPS 
and include vasoconstriction, vasodilatation, lacrimation (in case of MTrPs in 
the orofacial region), and goosebumps (i.e pilomotor activity) (Travell and 
Simons, 1983). In musculoskeletal rehabilitation, these dysfunctional 
phenomena are often un-noted, although they are very important for the 
patient management.  A systematic examination of patients with MPS is 
recommended to establish the degree of autonomic dysfunction and to avoid 
adverse effects during treatments. Vasoconstriction can be tested with the 
back of the examiner’s hand; the affected area will be cooler if compared with 
adjacent areas. Conversely, in the of case of vasodilatation, a pattern of 
sweating will be noted. A pilomotor reflex can be observed when the involved 
area is stimulated with manual palpation or dry needling. 
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1.4 A BRIEF HISTORICAL REVIEW. 
 
The current understanding of MPS and the related MTrP has been developed 
progressively during the past century. MTrPs are a common cause of 
muscular pain and authors from different countries have identified and 
described them innumerable times. They have been identified using different 
names, focusing mostly on the specific anatomical area and thus providing a 
limited interpretation of this clinical phenomenon (Travell and Simons, 1983).  
 
It was 1841 when Francoise Valleix, in his “Traité des Neuralgies; ou, 
affections douloureuses des nerfs” (Essay on neuropathic pain and nerve 
disorders) for the first time, carefully described “les points douloureux”(the 
painful spots) that emanate pain due to digital pressure (Valleix, 1841). He 
stated: “If, in the interval of the shooting pains, one asks a patient what is the 
seat of his pain, he replies then by designating limited points. It is only with 
the aid of pressure that one discovers exactly the extent of the painful points. 
They are found placed in four principal points of the trajectory of different 
nerves” (Valleix, 1841). This started a debate, which persisted for many years, 
as to whether pain arises from muscles or nerves. Walleix pointed out “… if 
the pain spreads into the muscles, the muscular contractions are principally 
painful. This is muscular rheumatism” (Valleix, 1841). 
 
The German physician Cornelius, in 1903, contributed to this hypothesis 
asserting that the nerve endings at these points, which he called 
“Nervenpunkte” (Neural point), are sensitized as a consequence of both 
physical and emotional stress (Cornelius, 1903).  
 
In the following years, other German authors again identified clinical 
phenomena characteristic of the MPS, as a muscular rheumatism (Llewellyn 
and Jones, 1915, Schmidt, 1918). Additionally, in 1931, Lange authored the 
first trigger point manual using the term “myogelosis”, where the term clearly 
referred to the palpation findings (Lange, 1931). 
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Hunter, a Canadian physician, in 1933 reported a few cases in which 
abdominal pain arose from points of tenderness in the abdominal muscles 
(Hunter, 1933). Similarly in 1936, Edeiken and Wolferth, at the University of 
Pennsylvania Medical School, noticed that patients with coronary thrombosis 
could develop shoulder pain that had been elicited by digital pressure to 
points of tenderness in muscle nearby the scapula (Edeiken, 1936). 
 
The physician who gave the greatest contribution to the knowledge of what is 
now called MPS was John Kellgren. He was Professor of Rheumatology at 
Manchester University but during the 1940s, he also conducted many 
research studies on muscle pain pathophysiology. His publication described 
the referred pain distributions evoked by injecting 0.1 to .03 c.c. of 6% saline 
into muscles and spinal ligaments (figure 1.8) (Kellgren, 1938). 
 
Kellgren moved his attention from the local pain, induced by the injection, to 
what he called the zone of pain referral and adopted this experimental 
observation directly to enhance the clinical evaluation of patients with muscle 
pain. He stated “The distribution of pain from normal muscles guided me to 
the muscles from which spontaneous pain may have arisen. Such muscles 
always presented tender spots on palpation and pressure on these spots 
reproduced the patient’s pain.”(Kellgren, 1938). 
 
He concluded in accordance with previous authors, that pain was a 
consequence of localized nerve hyperactivity in specific regions of the 
affected muscles. Additionally, he proved that pain can be reduced by 
injecting an anaesthetic solution at the tender sites. 
 
In line with Kellgren’ findings, Kelly (1941) during a cases-series on 200 
subjects with fibrositis, noticed both the palpable hardness of the “nodule” 
associated with the muscle tenderness and the distant referral of pain in the 
involved muscles. Kelly developed the concept that fibrositis was a functional 
neurologic disorder originating at the myalgic lesion (Kelly, 1941). Likewise, in 
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the same period, Good (1942) examined 500 cases of myalgia and described 
both the myalgic spots and the referred pain for 20 muscles (Good, 1942). 
It is at that time that Janet Travell, an American physician, undertook a 
systematic investigation of this disorder (Travell et al., 1942). She expanded 
the research’ line initiated by Kellgren and introduced, as proposed by an 
American orthopaedic surgeon, the term trigger point. A case series of 58 
subjects with musculoskeletal pain in the upper quadrant was used to widely 
describe the clinical findings related to MTrPs such as precipitating factors, 
number of MTrPs for each patient, and distribution of the referred pain. 
Interestingly, she noticed that apart from infraspinatus’ and serratus posterior’ 
MTrP the pain patterns did not clearly follow the somatic reference zones of 
the spinal segments (Travell et al., 1942). Ten years later together with 
Seymour Rinzler, she also determined the pain patterns of MTrPs in 32 
skeletal muscles and compiled anatomical charts of MTrPs (Travell and 
Rinzler, 1952).  
 
The medical terminology was subsequently improved by adding the term 
“myofascial” to point out that pain arises both from muscular and connective 
tissues, thus the related medical diagnosis was named MPS.  
Between 1942 and 1992, Travell published more than 15 scientific papers and 
four books. Together with her colleague David Simons, she described the 
clinical presentation of trigger points in many different muscles, and provided 
diagrams of both their locations and the referred pain’ patterns. All this 
information together with many treatment techniques, such as stretch and 
spray or injection, were included in the well-known publication: The Trigger 
point Manual (Travell and Simons, 1983). These books are still considered the 
most extensive and authoritative publications on MPS and introduced this 
diagnosis to the medical community (Tough et al., 2007). 
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Figure 1.8: Diagram of the distribution of referred pain after a saline injection 
of the multifidus muscle at L5 level (Adapted from Kellgren, 1938). 
 
 
More recently, other authors have contributed to further develop the 
understanding of MTrPs. During the 80s, Karel Lewit explored the manual 
treatment of MTrPs, as he was particularly interested in the interaction 
between joint dysfunctions and trigger points (Dostal et al., 1978, Janda et al., 
1979, Lewit and Simons, 1984). Chang-Zern Hong proposed the first animal 
model, contributed to several publications on animal pathophysiology and was 
also a pioneer of the dry needling technique (Hong, 1994b, Hong, 1996, 
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Hong, 2002, Hong and Hsueh, 1996, Hong and Simons, 1998, Hong, 1994a). 
After 2000, Hong-You Ge led several experimental investigations and 
provided important contributions to address the enigmatic MTrP’ 
pathophysiology (Ge et al., 2012, Ge et al., 2014, Ge et al., 2008a, Ge et al., 
2008b). Jan Dommerholt, who wrote several critical syntheses of the recent 
scientific literature provided an outstanding contribution for researchers in the 
field of myofascial pain (Bron and Dommerholt, 2012, Dommerholt, 2005, 
Dommerholt, 2008, Dommerholt, 2010, Dommerholt, 2011b, Dommerholt, 
2011a, Dommerholt et al., 2006, Dommerholt et al., 2016, Dommerholt and 
Gerwin, 2015, Dommerholt et al., 2015a, Dommerholt and Huijbregts, 2011, 
Dommerholt et al., 2015b, Fernandez-de-las-Penas and Dommerholt, 2014, 
Gerwin et al., 2004). Finally, Cesar Fernandez-de-las-Penas promoted 
several clinical trials to investigate the effectiveness of manual therapy and 
dry needling for MPS (Alonso-Blanco et al., 2012, Arias-Buria et al., 2015, 
Bodes-Pardo et al., 2013, Cantarero-Villanueva et al., 2012, Fernandez-
Carnero et al., 2010, Fernandez-Perez et al., 2012, Iglesias-Gonzalez et al., 
2013, Llamas-Ramos et al., 2014, Mejuto-Vazquez et al., 2014, Renan-Ordine 
et al., 2011). The international literature is still growing and contributing to the 
body of knowledge. However, despite the large volume of research, the 
methodological quality of the studies is frequently poor and the need for a 
validated pathway to diagnose MTrP is underestimated. 
 
 
1.4 EPIDEMIOLOGY 
 
The literature suggests that MTrPs are extremely common and can be 
considered both a primary cause of a MPS or a secondary pain generator in 
patients affected by a principal musculoskeletal disorder (Fricton, 1991, 
Giamberardino et al., 2011, Zuil-Escobar et al., 2016, Lluch et al., 2015, 
Roach et al., 2013). Unfortunately, accurate information on the prevalence of 
MTrPs and MPS is lacking. To properly address this epidemiological issue, it 
is important to investigate the MPS prevalence in general populations as well 
as the MTrPs’ prevalence in selected conditions. In the latter case, it may be 
important also to distinguish active and latent MTrPs. Considering the 
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variability of the criteria used to diagnose MPS and low reliability for the 
MTrPs’ diagnostic criteria, this should be considered a very complex and 
challenging goal (Lucas et al., 2009, Myburgh et al., 2008, Tough et al., 
2007). A few cross-sectional studies on musculoskeletal pain that selected 
healthy subjects according to their occupational/professional category, can be 
identified in the scientific literature but some of them do not conform properly 
to the MTrP's definition (Schiffman et al., 1990, Fröhlich and Fröhlich, 1995, 
Sola et al., 1955, Chaiamnuay et al., 1998, Fernandez-de-las-Penas et al., 
2012, Celik and Kaya Mutlu, 2012).  
 
A first attempt to investigate the presence of muscle tenderness was 
conducted in a study of 269 randomly selected female student nurses with or 
without pain symptoms (Schiffman et al., 1990). Muscle tenderness was 
identified in the craniocervical region, using a palpation protocol to identify 
tender points. In neck muscles, tender points were recognized in 35% of the 
right splenius capitis muscles and in 33% of the right upper trapezius 
muscles.  In masticatory muscles, tender points were recognized in 54% of 
the right masseter muscles, in 43% of right anterior temporalis muscles, and 
in 40% of right medial pterygoid muscles (Schiffman et al., 1990). Similarly, a 
population of 200 asymptomatic adults from Air Force Personnel were 
screened for a focal tenderness in the shoulder muscles. The focal 
tenderness (i.e. hypersensitive areas during manual palpation) was fully 
comparable to a latent MTrP and the authors reported a rate of 54% for 
females and 45% for males (Sola et al., 1955). Additionally, in 25% of the 
subjects, it was possible to elicit referred pain by palpation. Results of both 
studies should be considered with caution as MTrP’s diagnostic criteria was 
not reported.    
 
Two German physicians investigated the presence of latent MTrPs in the 
lumbo-gluteal region among 100 healthy subjects. They observed latent 
MTrPs in the following muscles: quadratus lumborum in 45% of the subjects, 
gluteus medius in 41%, iliopsoas in 24%, gluteus minimus in 11%, and 
piriformis in 5% (Fröhlich and Fröhlich, 1995). Again, a study about the 
musculoskeletal disorders in villagers from rural Thailand, has indicated MPS 
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in 6.3 % of 431 subjects reporting pain during the previous week 
(Chaiamnuay et al., 1998). 
 
In order to explore the relationship between MTrPs and work related activities, 
a recent study investigated the MTrPs prevalence in blue-collar and white-
collar workers. The authors hypothesized that different work activities or 
physical load can determine the MTrPs’ activation.  Although the sample was 
very small (n = 35), it was interesting to note that the two groups exhibited a 
similar number and distribution of active and latent MTrPs. The observed 
prevalence was high, with 6 ± 3 blue-collar and 6 ± 4 white-collar workers 
showing active MTrPs (table 1.1 and 1.2) (Fernandez-de-las-Penas et al., 
2012). 
Again in 2012, an original study conducted at the Istanbul University (School 
of Physical Therapy and Rehabilitation) observed for the first time, a close 
relationship between latent MTrPs in periscapular muscles and depression in 
healthy people (Celik and Kaya Mutlu, 2012). Given that latent MTrPs can 
develop into active MTrPs, it seems relevant to carefully assess muscles for 
MTrPs presence not only in patients with common musculoskeletal disorders. 
Finally, due to the paucity of data on the MTrP prevalence for lower limbs, a 
study on 220 healthy volunteers was conducted (Grieve et al., 2013a).  The 
principal aim was to establish the prevalence of latent MTrPs in triceps surae. 
Interestingly, to compare findings, the MTrP prevalence in upper trapezius 
muscles was also examined. Prevalence of latent MTrP in triceps surae was 
recorded in six different locations and its rate ranged from 13 % to 30%; the 
highest prevalence was recorded for the medial portion of the left 
gastrocnemius muscle. The MTrP prevalence of the left upper trapezius 
muscle was 23% while for the right, it was 20%. Latent MTrPs in the soleus 
muscle have been associated with a limitation of the dorsiflexion of the ankle 
and calf cramps (Grieve et al., 2011) (Kim et al., 2005, Ge et al., 2008b). 
Similarly, latent and active MTrP have been associated with several 
musculoskeletal conditions (Bron et al., 2011b, Calvo-Lobo et al., 2016, 
Roach et al., 2013, Fernandez-de-las-Penas et al., 2006a) or 
neurophysiological impairments (Ge et al., 2012, Ge et al., 2014). These 
results contribute to increased knowledge of the prevalence of MTrP in a 
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healthy population and suggest that clinicians should carefully examine the 
role of MTrPs in a clinical population as well as healthy subjects. Moreover, a 
few reports (Bron et al., 2011b, Fernandez-de-las-Penas et al., 2007, 
Schiffman et al., 1990, Roach et al., 2013) have been published on the 
prevalence of MTrPs among selected patient groups and once again, a high 
prevalence is reported, suggesting that the MTrP’s nature also as an 
associated phenomenon. Results from these studies are summarized in table 
1.3. 
 
In an internal medicine group practice, 54 out 174 patients complaining of 
pain were examined and in 30% of the cases, their painful symptoms were 
related to the presence of a MTrP (Skootsky et al., 1989). Notably, patients 
with upper body pain were more likely to have a MPS diagnosis. 
 
Again, among 164 patients with chronic head and neck pain, 55% had a 
primary diagnosis of MPS, and in 97 patients examined at an Orthopaedic 
clinic, 70% presented with an active or latent MTrP (Fricton et al., 1985, 
Fröhlich and Fröhlich, 1995). 
 
Fishbain and his collaborators (1986) reported a similar prevalence in 283 
patients presenting to a Comprehensive Pain Centre of the University of 
Miami School of Medicine. MPS was the primary condition in 85% of the 
patients (Fishbain et al., 1986), the diagnosis was established by two 
physicians that applied the diagnostic criteria proposed by Simons and Travell 
(Travell and Simons, 1983). Gerwin examined 96 patients at a Pain Medicine 
Centre. Surprisingly, he reported that MTrPs, in 93% of the subjects, were at 
least partially responsible for the pain symptomatology and were the primary 
cause of pain in 74% of the subjects (Gerwin, 1997) 
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Table 1.1: Number of blue-collar workers (n = 16) with active or latent MTrPs for 15 muscles on both sides (Adapted from 
Fernandez-de-las-Penas et al., 2012) 
 
 
Right side Left side 
 
Right side Left side 
 
Right side Left side 
         
 
Temporalis muscle 
 
Masseter Muscle 
 
Upper trapezius muscle 
 Active MTrPs (n) 1 1 
 
0 0 
 
11 9 
 Latent MTrPs (n) 4 2 
 
10 10 
 
2 4 
 No MTrPs (n) 11 13 
 
6 6 
 
3 3 
 
Sternocleidomastoid muscle 
 
Splenius capitis  muscle 
 
Oblique capitis inferior muscle 
 Active MTrPs (n) 1 3 
 
6 5 
 
4 2 
 Latent MTrPs (n) 7 9 
 
3 3 
 
5 6 
 No MTrPs (n) 8 4 
 
7 8 
 
7 8 
 
Levator scapulae muscle 
 
Scalene muscle 
 
Pectoralis major muscle 
 Active MTrPs (n) 2 4 
 
1 2 
 
3 3 
 Latent MTrPs (n) 3 3 
 
4 4 
 
7 6 
 No MTrPs (n) 11 9 
 
11 10 
 
6 7 
 
Deltoid muscle 
 
Infraspinatus 
 
Ext. carpi radialis brevis muscle 
 Active MTrPs (n) 2 3 
 
7 6 
 
4 2 
 Latent MTrPs (n) 3 4 
 
8 9 
 
5 7 
 No MTrPs (n) 11 9 
 
1 1 
 
7 7 
 
Ext. Car. radialis longus muscle 
 
Ext. digitorum communis muscle 
 
Supinator muscle 
 Active MTrPs (n) 4 2 
 
1 0 
 
2 1 
 Latent MTrPs (n) 5 4 
 
6 7 
 
8 9 
 No MTrPs (n) 7 9 
 
9 9 
 
6 6 
         
 27 
Table 1.2: Number of white-collar workers (n = 19) with active or latent MTrPs for 15 muscles on both sides. (Adapted from 
Fernandez-de-las-Penas et al., 2012) 
 
 
Right side Left side 
 
Right side Left side 
 
Right side Left side 
         
 
Temporalis muscle 
 
Masseter Muscle 
 
Upper trapezius muscle 
Active MTrPs (n) 1 1 
 
1 3 
 
12 12 
Latent MTrPs (n) 4 9 
 
10 11 
 
7 6 
No MTrPs (n) 14 9 
 
8 5 
 
0 1 
 
Sternocleidomastoid muscle 
 
Splenius capitis  muscle 
 
Oblique capitis inferior muscle 
Active MTrPs (n) 4 4 
 
4 3 
 
6 6 
Latent MTrPs (n) 10 10 
 
2 3 
 
6 5 
No MTrPs (n) 5 5 
 
13 13 
 
7 8 
 
Levator scapulae muscle 
 
Scalene muscle 
 
Pectoralis major muscle 
Active MTrPs (n) 7 6 
 
3 4 
 
1 1 
Latent MTrPs (n) 2 5 
 
6 6 
 
12 15 
No MTrPs (n) 10 8 
 
10 9 
 
6 3 
 
Deltoid muscle 
 
Infraspinatus 
 
Ext. carpi radialis brevis muscle 
Active MTrPs (n) 2 1 
 
4 6 
 
4 3 
Latent MTrPs (n) 4 5 
 
10 10 
 
7 9 
No MTrPs (n) 13 13 
 
5 3 
 
8 7 
 
Ext. Car. radialis longus muscle 
 
Ext. digitorum communis muscle 
 
Supinator muscle 
Active MTrPs (n) 5 3 
 
4 1 
 
6 3 
Latent MTrPs (n) 7 7 
 
7 9 
 
6 8 
No MTrPs (n) 7 9 
 
8 9 
 
7 8 
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Table 1.3: Prevalence of MTrPs among selected patient groups. 
 
Authors Practice Diagnosis Number studied % with MTrP 
      Skootsky et al.,1889  Medical n/a 172 30 
 Fricton et al., 1985 Head and Neck Pain Clinic n/a 164 55 
 Fishbain et al., 1986 Comprehensive Pain Center n/a 283 85 
 Frohlich and Frohlich, 1995 Orthopaedic Clinic n/a 97 93 
 Gerwin, 1997 Pain Medicine Center n/a 96 70 
 Fernandez-de-la-Penas et al., 2007 N/A Neck pain 20 100 
 Bron et al., 2011 Physiotherapy Shoulder pain 72 100 
 Roach et al., 2013 Physiotherapy Patellofemoral pain 52 97 
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Subsequently, in a blind controlled study including 20 neck pain patients and 
20 healthy subjects, at least three MTrPs were identified in patients. On the 
other hand, all the control healthy subjects exhibited latent MTrPs 
(Fernandez-de-las-Penas et al., 2007). Similarly, an observational study 
conducted at a primary care practice for physical therapy, revealed MTrPs in 
all patients with shoulder pain. The mean number of active MTrPs per 
subject was 6, and infraspinatus was the muscle most frequently involved 
(77%) (Bron et al., 2011b). The authors also pointed out a moderate 
correlation between the number of MTrPs and disability measured with a 
multidimensional scale (Disabilities of the Arm, Shoulder, and Hand scale). 
Also, in a selected group of patients with the patellofemoral pain, a high 
prevalence for MTrP was observed (Roach et al., 2013). Bilateral MTrPs 
were identified in gluteus medius and quadratus lumborum muscles and a 
related reduction of the hip abduction’ strength was also observed.   
 
Large-scale epidemiological studies in the general population for MPS are 
not available. Current data are from small, selected groups and the biggest 
sample investigated was from the study of Fishbain, who examined 283 
consecutive admissions to a pain centre. Additionally, in the aforementioned 
epidemiological studies, the diagnostic criteria for the MPS diagnosis were 
not clearly reported and an adequate training for the manual palpation of a 
MTrP was not provided to the assessors.  
 
The selected studies showed wide-ranging prevalences for active and latent 
MTrPs (30% to 100%). The observed variability for the prevalence can be 
partially explained by diversity of the selected groups.  In most of the studies, 
the main complaint was pain and for subjects with a confirmed MPS 
diagnosis, no information on comorbidity was considered. Thus, it is not 
possible to establish if MPS was the principal diagnosis or an associated 
disorder. This is an important issue when establishing the clinical relevance 
of a diagnosis and subsequently, for the planning of a proper treatment. Only 
a few researchers (Bron et al., 2011b, Fernandez-de-las-Penas et al., 2007, 
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Roach et al., 2013) selected groups of patients using a medical diagnosis as 
inclusion criteria.  They enrolled subjects with non-traumatic shoulder pain 
(Bron et al., 2011b), mechanical neck pain (Fernandez-de-las-Penas et al., 
2007) , and patellofemoral pain (Roach et al., 2013) using detailed exclusion 
criteria. Surprisingly in both of the studies, the prevalence approached 100% 
and each subject exhibited several MTrPs.  
 
This suggests that muscles are an important source of pain in the three 
conditions investigated and it is possible to speculate that active MTrPs are a 
very common cause of pain and dysfunction in many non-specific 
musculoskeletal disorders, like for example, low back pain.  On the other 
hand, a poor agreement on the diagnostic criteria and differences in training 
of examiners has been reported. Also, all the investigators during the 
experimental procedures were focused on only one medical diagnosis, which 
was indeed the MPS. These elements could lead to a significant number of 
false positives and thus, an overestimation of the MPS’ prevalence. There is 
a need, as already remarked upon by other authors (Simons, 2004, Shah et 
al., 2015), to improve reliability and validity of the MTrP' diagnostic criteria. 
 
1.5 AETIOLOGY AND PATHOPHYSIOLOGY 
 
Before the mid-1990s, key elements regarding the pathophysiology of MTrPs 
were unrecognized. Subsequently, research studies have made the 
pathophysiology of MPS much better understood. Three main hypotheses 
have been provided: energy crisis theory, muscle spindle concept and the 
motor endplate hypothesis (Simons, 1996). Each of them provides elements 
that can explain part of the symptoms and signs of MPS. Later Simons 
(1999) presented an integrated hypothesis that Gerwin (2004) subsequently 
developed further by the inclusion of new experimental data accounting for 
additional aspects of muscle pathophysiology. The integrated hypthesis 
combines several important electrophysiological and histopathological 
research findings. 
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1.5.1 Energy Crisis Theory 
Simons and Travell introduced the energy crisis theory for the first time in a 
paper published in the journal Pain in 1981 (Simons and Travell, 1981) and 
then it was updated with the inclusion of some experimental evidence, in 
1993 (Lindblom et al., 1993). It was developed with regard to a few aspects 
considered characteristic of the MTrP and with the the intention of providing 
a robust rationale for the MPS’ pathophysiology. The following elements 
were considered as starting points for the authors’ speculation. 
 
1. Subjects affected by MTrPs at rest do not show any motor units’ 
action potentials travelling along the taut band. 
2. It is well-known among clinicians that MTrPs are usually induced by 
muscle overload, especially low level sustained muscle activity 
3. the evident focal hyperalgesia of the MTrP 
4. the efficacy of treatments aimed to stretch or compress the MTrP taut 
band  
 
The proposed theory enclosed a vicious cycle (figure 1.9) that starts with a 
lesion of the sarcoplasmic reticulum or the sarcolemma and the release of 
calcium in the cytoplasm. The exact mechanism responsible for the 
described lesion was not reported and only mentioned as a generic trauma.  
 
The non-physiological delivery of calcium would activate the actin and 
myosin contractile activity in a limited number of fibres (i.e taut band). This 
sustained shortening of the fibres will induce at the same time an increase of 
the local metabolism and a compression of capillaries that supply oxygen 
and nutritional substances.  The simultaneous increased metabolism and the 
impaired metabolic intake could induce the so-called energy crisis, during 
which a release of sensitising substances is postulated. Finally in this 
dysfunctional context the calcium pump, that returns calcium into the 
sarcoplasmic reticulum, cannot work properly due to the lack of adenosine 
triphosphate (ATP). This completes the vicious cycle, where an abnormal 
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quantity of calcium remains in the muscle fibres cytoplasm promoting a 
further shortening of the fibres. The proposed hypothesis fits with the 
absence of motor unit action potentials as the described contracture should 
be considered endogenous and not nerve-initiated, the mechanical sensibility 
of the synaptic cleft region that release calcium due to a trauma, the release 
of sensitizing substances that explain the local hyperalgesia, and finally the 
efficacy of the stretching techniques in reducing pain.  
 
 
 
 
Figure 1.9: Energy crisis hypothesis and the vicious cycle of events that 
contribute to MTrP’ manifestation. 
 
 
1.5.2 - Muscle spindle concept and the motor endplate hypothesis. 
Electromyography investigations of different painful muscle syndromes have 
produced conflicting results and the concept of a pain-spasm-pain cycle is 
not fully supported by physiologic and clinical evidence. Two editorials in 
important scientific journals (Olesen and Jensen, 1991, Johnson, 1989) 
reviewed this issue and remarked that it was not clear that increased EMG 
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activity did not account for the muscle tenderness. Similarly, in 1957, Travell 
described a high-frequency firing (Travell, 1957) from MTrPs, but later the 
same author, together with Simons, published in The Trigger point Manual 
(Travell and Simons, 1983) that MTrPs did not show EMG resting activity.  
 
Hubbard and Berkoff (1993) attempted to clarify this issue by recording 
needle EMG signals simultaneously from the MTrP site and from an adjacent 
non-painful site of the same muscle (Hubbard and Berkoff, 1993). They 
included in their study, three groups of subjects with active or latent MTrPs: 
normal subjects, tension headache patients and fibromyalgia patients. 
Spontaneous EMG activity (SEA) was evident from the MTrPs of all normal 
subjects and patients, while no SEA was recorded from the control sites. In 
all subjects, the occurrence of the SEA corresponded to the manifestation of 
a painful symptomatology. MTrPs’ mean EMG amplitudes for normal 
subjects were significantly lower than for patients, but the EMGs were always 
higher at MTrP’ sites than in the control site, especially for the two patients’ 
groups. The authors concluded that the source of the EMG activity in the 
vicinity of the MTrPs were the dysfunctional muscle spindles (Hubbard, 1996, 
Hubbard and Berkoff, 1993). To support their hypothesis, the authors 
commented that the EMG activity was not localised enough to be generated 
in the endplate region. Even the waveform morphology was not considered 
typical for an endplate activity. Additionally, and by the fact that the electrical 
phenomenon showed a localized nature, it was possible to rule out a muscle 
spasm or a metabolic disorder. It was also speculated that the aetiology was 
related to prolonged spindle tension that becomes painful by distending or 
chemically sensitizing the spindle’ capsule. The sympathetic innervation of 
the intrafusal fibres was put forward as an explanation for the autonomic 
symptoms associated with MTrPs (Hubbard and Berkoff, 1993). 
 
These assertions opened a debate among researchers. Simons interpreted 
the experimental findings differently and came to opposite conclusions. The 
localizations of EMG activity reported in the study of Hubbard and Berkoff, 
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according to Simons, was thought to be similar to that previously observed in 
a scientific paper on the source of motor endplate potentials (Wiederholt, 
1970). Additionally, he also remarked that even the observed waveforms 
corresponded to atypical EMG records from the endplate region, defined as 
“Noise” (Buchthal and Rosenfalck, 1966). This convinced Simons to study in 
depth, the EMG signals from MTrPs and particularly, the waveforms of the 
SEA. Initially, Hubbard and Berkoff (1993) reported that a muscle affected by 
a MTrP has several sites (named active loci) where it was possible using the 
needle EMG, to record low voltage, continuous noise-like potentials and an 
intermittent spikes (i.e. SEA) for as long as the needle was not removed 
(Hubbard and Berkoff, 1993) . They focused their attention on mean EMG 
amplitude and spikes without going into more details of the signals. Surface 
EMG signals from a MTrP were recorded at slow speed and the general 
pattern of activity was appreciated but details were not available (figure 
1.10A).  
Many large spikes were clearly visible but the small-amplitude SEA cannot 
be distinguished clearly and the waveform of SEA remains hidden in the 
electromyographic path. Then Simons decided to record sEMG signals from 
MTrPs at higher speed and succeeded to show a marked difference between 
the SEA and the higher amplitude spikes (figure 1.10B) (Simons et al., 1999). 
The SEA looked like a low amplitude noise while the high amplitude spikes 
were sharp, initially-negative and diphasic (Simons et al., 1999).  
 
Simons commented that according to his experience, the SEA of MTrPs is 
located in the endplate region and not in the taut band outside of the 
endplate region (Simons et al., 1995c, Simons et al., 1995a). Again, he 
speculated that in accordance to a few old physiological studies, the SEA 
arises froma dysfunctional endplate. Indeed, Liley in 1956, observed that a 
mechanical stress (i.e. vibration at the endplates site, stretching the motor 
nerve, dimpling the muscle surface) applied to the endplate region, increases 
the frequency of the post-junctional membrane potentials and could start an 
abnormal EMG pattern, comparable to the SEA (Liley, 1956). Later, a 
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preliminary study on the effectiveness of botulinum A toxin to reduce pain in 
patients with MTrPs, further supported the endplate hypothesis (Yue, 1995). 
 
 
 
Figure 1.10: EMG signals at an MTrP’ site in the upper trapezius muscle. A) 
EMG signals recorded at slow speed, B) EMG signals recorded at high 
speed (Adapted from Hubbard & Berkoff, 1993). 
 
 
The nature of this localized atypical EMG activity remained partially 
unsolved. Although it seems improbable that muscle spindles were the site of 
the described electrical activity, it was not possible to exclude an important 
contribution of muscle spindles to the MTrPs’ phenomena. The issue of 
whether the SEA, finally recognized by electromyographers as a type of 
endplate noise, arose from normal or from dysfunctional endplates became 
critical to validate this hypothesis. As well as its correlation with the MTrP 
should be confirmed.  
A first attempt to solve this issue was in 1995 (Simons et al., 1995b), during a 
preliminary study, but final results were published subsequently, in March 
2002 (Simons et al., 2002). Investigators examined the SEA in different sites 
of muscle affected by MTrP, using needle EMG. Three different sites were 
considered for the SEA detection: in the MTrP, in the endplate zone outside 
of the MTrP, and in the taut band outside the endplate zone (figure 1.11).  
All sites were examined systematically by inserting an EMG needle in three 
divergent tracks (30, 45, 60 degrees to the skin surface). Needle 
A B 100 ms 10 ms 
ëSEAì 
Spike è 
40µV 
Spike è 
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advancement was slow and gentle, stopping whenever the SEA with or 
without spikes was observed and whenever the EMG needle had advanced 
1.5 mm. Eleven muscles in 10 subjects, showed SEA to be four times more 
frequent in the MTrP’ site than in the endplate zone outside of the MTrP’ site 
(table 1.4). Additionally, no SEA was observed outside the endplate’ zone 
further supporting the hypothesis that the SEA arises from the endplate’ 
zone.  
The validity of this finding was also supported by a similar animal’ study 
conducted on the biceps femoris muscle of rabbits (Simons et al., 1995d). A 
review of physiology’ literature also indicated that the waveform of the SEA 
was considerably different from normal endplate potentials and that the 
abnormal waveform pattern of the SEA was probably related to an increased 
release of ACh from the postjunctional membrane (Simons, 2001). 
 
Two possible mechanisms were considered as explanations of the SEA 
phenomenon and the abnormal release of ACh. The first assumes that the 
SEA’s sEMG’ pattern may appear due to the release of ACh packets 
because of the mechanical stress caused by the EMG needle. In this case, 
before the needle insertion, the endplate would have been producing normal 
endplate potentials. Thus, if this was the case, it was possible to speculate 
that some of the endplates associated with a MTrP, were more sensitive to 
mechanical stress by the needle than an endplate that was not associated 
with the MTrP (Simons et al., 2002). This rationale is well supported by 
previous experimental findings focusing on the effect of mechanical, 
chemical and immunological stimuli on the endplate physiology (DeBassio et 
al., 1971, Heuser and Miledi, 1971, Ito et al., 1974).  
 
 37 
 
 
Figure 1.11: The illustration indicates the sites selected to investigate the 
SEA presence in a muscle affected by a MTrP. The muscles were 
systematically explored inserting the needle in the MTrP, in the endplate 
zone 1-2 cm away from the MTrP, and in the taut band (Adapted from 
Simons, Hong, & Simons, 2002). 
 
 
The second possibility is obviously that the observed SEA could have been 
present as a result of a pathophysiologic condition that is related to the 
clinical manifestation of MTrP. Further research is needed to confirm this 
latter hypothesis as the results from the Simons et al study neither refuse nor 
prove this possibility. The SEA, currently named by experts in this field as 
endplate noise (EPN), should be demonstrated the absence of needle 
stimulation. As reported in table 4 the tenderness of the MTrP was commonly 
associated with the SEA with or without spikes but only exceptionally when 
only spikes were recorded. Moreover, the SEA was never detected in taut 
band sites.  
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Table 1.4: SEA recordings during 264 needle advances in 11 muscles. Number of observations of the SEA only, the SEA with 
spikes, and only spikes. Note that the SEA was not detected in the taut band sites considered. SEA, spontaneous electrical 
activities, (Adapted from Simons, Hong, & Simons, 2002). 
 
 
EMG activity detected MTrP sites Endplate site Taut band sites 
     SEA without spikes 21 7 0 
 Present* 10 4 0 
Absent° 1 7 11 
 SEA with spikes 14 2 0 
 Present*  7 2 0 
 Absent° 4 9 11 
Spikes only 1 12 2 
    * Number of muscles in which SEA only or SEA with spike was detected. °Number of muscles in which SEA only or SEA with spike was not detected. 
 
 39 
 
A few methodological limitations should be taken in to account when 
asserting a spatial relationship between the SEA and the MTrP. The 
alteration of pain perception in subjects due to the experimental procedures 
and the absence of standardized procedures to estimate pain during the 
needle advancement, are among these. Nevertheless, modifications of the 
motor endplate potentials in association with pain, have been already 
reported by previous investigators (Brown and Varkey, 1981, Wiederholt, 
1970, Jones et al., 1955).  
 
1.5.3 The integrated trigger point hypothesis and his expansion. 
The integrated trigger point hypothesis classifies the MTrP as a 
neuromuscular disease and postulates that the endplate dysfunction, and the 
excessive release of Ach, are central events (figure 1.13) (Simons, 2004). It 
was originally proposed in 1999 by Simons in the second edition of his 
textbook “Myofascial Pain and Dysfunction: The Trigger Point Manual” 
(Simons et al., 1999). It is essentially an original update of the “Energy Crisis 
Hypothesis” and combines electrodiagnostic and histopathological evidence 
(Simons and Travell, 1981). This hypothesis has been further developed 
according to some recent findings and it is now the most complete rationale 
for the MTrP pathophysiology (Gerwin et al., 2004). The hypothesis, named 
in a few papers as the expanded trigger point hypothesis, is a positive-
feedback cycle that includes a few activating events, and where the starting 
point is an acute or persistent muscle overload (figure 1.12). 
 
According to the authors, it can be an unaccustomed or excessive 
eccentric/concentric muscle activity that leads initially to ischemia and 
afterwards to the endplate dysfunction (Treaster et al., 2006, Huang et al., 
2013, Bron and Dommerholt, 2012). To explain the localized manifestation of 
MTrP, indeed it involves only a limited amount of contracted fibres within a 
muscle (i.e. taut band), the Cinderella Hypothesis has been suggested 
(Hagg, 1991). The Cinderella Hypothesis states that muscle pain can be 
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caused by selective overloading of type I muscle fibres, driven into a 
degenerative process as a consequence of long-standing activation, with a 
short recovery time. According to Hägg, who developed the Cinderella 
Hypothesis, low-level sustained contraction can engage a fraction of the 
motor units that show an inefficient process of motor units’ substitution and 
which is important to protect the muscle from excessive fatigue (Hagg, 1991). 
The overuse of a limited group fibres will lead initially, to energy depletion 
and subsequently, to tissue injuries with the release of sensitizing 
substances (Gerwin et al., 2004). 
 
 
 
 
Figure 1.12: A flow chart of the integrated trigger point hypothesis (Adapted 
from Gerwin et al., 2004).  
Motor nerve terminal	
Decrease AChE	
Local sarcomere contracture	
Increased AChR sensitivity	Abnormal ACh release 	
 Muscle overload	
Local Ischemia	 Increased metabolism	
Energy crisis	
Sensitizing substances	  Pain 	Autonomic stimulation	
Endplate	dysfunction 
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Additionally, according to some recent studies, a persistent mechanical 
stress (i.e. hypertonicity or stretching) may augment the ACh release 
(Grinnell et al., 2003, Chen and Grinnell, 1997). Chen and Grinnell showed 
that a 1% increase in muscle stretch at the motor endplate induced a 10% 
increase in ACh release.  This event has been related to a tension on the 
integrins (i.e. cell adhesion molecules) in the presynaptic membrane at the 
motor endplates, that can theoretically trigger an ACh release, which does 
not require Calcium (Kashani et al., 2001, Chen and Grinnell, 1997, Grinnell 
et al., 2003). The integrins are a family of cell adhesion receptors that 
mediate the attachment between a cell and its surroundings, such as other 
cells or the extracellular matrix.  In this context, the sodium channels of the 
sarcoplasmic reticulum are conditioned by the presence of ACh, and 
increase the intracellular calcium levels. This will further induce a local 
muscle contracture (i.e. taut band) in the absences of motor unit potentials.  
 
The proposed aetiology and the related mechanism is more convincing than 
the “Energy Crisis Theory”. Indeed, it was initially proposed in relation to a 
generic trauma, with no clear link to clinical practice, which suggests that 
MTrPs are induced by a long-lasting low intensity contraction or high intensity 
repeated contractions. As a consequence of this long-lasting local 
contracture, it is reasonable to think also that some myosin filaments of the 
taut band can be locked in the Z-band of the sarcomere. The regular 
physiology of muscle contraction that includes myosin sliding, become then 
altered, and some sarcomeres can not restore their resting length. Once 
again, the shortened sarcomeres will further contribute to the local circulation 
deficit (Dommerholt and Huijbregts, 2011, Dommerholt et al., 2006). The 
subsequent hypoxia will induce the release of sensitizing substances and 
activates the muscle nociceptors. The result will be a decrease of energy 
supply and a simultaneous increase of metabolic demand. This chronic 
energy deficit would also explain the described finding of ragged red fibres 
and swollen mitochondria, which are typically observed in the nerve terminal 
of patients with muscle pain (Larsson et al., 2000).  
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A few histological studies provide an additional support for the 
pathophysiology described above (Simons and Stolov, 1976, Windisch et al., 
1999, Mense et al., 2003, Reitinger et al., 1996).  A biopsy performed by 
Simons and Stolov (1976) in canine gracilis muscle, highlighted for the first 
time multiple contraction knots in several fibres, and it showed many 
shortened sarcomeres in the proximity of the MTrP, as well as many 
lengthened sarcomeres distally to the MTrP (Simons and Stolov, 1976).  
Also, Windisch and colleagues in post-mortem biopsies, described similar 
histological alterations (Windisch et al., 1999). In support of this 
pathophysiological process, a recent study also demonstrated that hypoxia 
can determine a spontaneous quantal and non-quantal release of ACh at 
mouse’ motor endplates (Bukharaeva et al., 2005). The mechanical and 
chemical stressful events can induce a sensitization of the peripheral nerve 
endings, autonomic nerves, and second order neurons. This will lead to a 
central sensitization and to the formation of new receptive fields that will 
explain the clinical manifestation of referred pain and hyperalgesia.  
 
The recent findings of Jay Shah (2008), a physiatrist at the Clinical Center of 
the National Institutes of Health (NIH) in Bethesda, have been considered a 
milestone in the understanding of the MTrP’ sensory component and also 
represented an important contribution for the development of the integrated 
trigger point hypothesis (Simons, 2008). His NIH project applied a notable 
technique of placing two tubes inside a 30-gauge acupuncture needle, with a 
microdialysis membrane between the ends of the open tubes and a 10 μm 
opening at the tip of the acupuncture needle (Shah et al., 2005, Shah et al., 
2008). The aim was to sample the unique biochemical milieu of substances 
related to pain and inflammation in muscle tissue, with and without MTrPs. 
The special needle was inserted into three different sites of the trapezius 
muscle: active MTrP of patients, latent MTrP in pain-free subjects, and 
normal muscle (MTrP-free) in healthy subjects. Samples were obtained 
before the needle movement, during the needle advancement involving local 
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twitch responses, and after the local twitch response. Samples of dialysate 
were analysed for electrolytes, pH, muscle metabolites, inflammatory 
mediators, arachidonic acid derivatives, cytokines, and neurotransmitters. 
The concentrations of neuropeptides substance P, calcitonin gene-related 
peptide, bradykinin, 5-hydroxytryptamin/serotonin (neurotransmitters), TNF-α 
and IL-1 (cytokines) were significantly higher in active MTrPs than in latent 
MTrPs and normal muscle (healthy subjects). Also, the pH levels were lower 
in the active MTrPs than in latent MTrPs and normal muscles. In addition, 
there were no overall differences between subjects with latent MTrPs and 
normal subjects (MTrP-free). Finally, after the local twitch response at the 
active MTrP, the europeptides substance P and the calcitonin gene-related 
peptide concentrations decreased significantly.  These results showed for the 
first time, significant biochemical differences between subjects with and 
without MTrPs, for a number of substances. A few interactions between the 
observed substances help to explain the local hyperalgesia, the endplate 
dysfunction, as well as the referred pain of MTrPs. First, the bradykinin is 
able to activate and sensitize muscle nociceptors, leading to a inflammatory 
hyperalgesia (Verri et al., 2006). Moreover, the bradykinin stimulates the 
release of TNF-α that activates the production of cytokines, especially the IL-
8 that can induce once again, hyperalgesia. The observed acid pH, probably 
a consequence of the hypoxia and the injured fibres, inhibit AChE’ activity 
and increased the   calcitonin gene-related peptide level, which can enhance 
the release of ACh from motor endplate and at the same time decrease the 
effectiveness of AChE (Fernandez and Hodges-Savola, 1996, Hodges-
Savola and Fernandez, 1995). Again, calcitonin gene-related peptide up-
regulates the ACh receptors, providing more binding opportunities for ACh. 
The state of the ACh receptors and the ACh concentration are considered 
critical to explain the EPN described by Simons and his collaborators 
(Simons et al., 1995d, Simons et al., 1995c, Simons, 2001). The Shah’ 
findings (2008) have provided an important contribution to the MTrP’ 
physiopathology but a few methodological limitations should be noted. The 
sample size was small (n = 9) and composed of healthy participants from a 
 44 
working population. Also, the reported alterations of the biochemical milieu 
are consistent with inflammation due either to muscular tissue damage or to 
dysfunctional peripheral nerve function (Mense, 2009, Chiu et al., 2012).  
 
More recently, Mense completed an interesting study by developing an 
experimental animal model to induce MTrP in rats (Mense et al., 2003). The 
study was undertaken to test if a local increase of ACh leads to an abnormal 
contraction that causes the formation of contraction knots. A small quantity of 
acetylcholinesterase inhibitor was injected into a limited area of 
gastrocnemius muscle of 22 rats. Subsequently, to simulate an intense 
muscle activity, the nerves of the muscle were electrically stimulated for 30-
60 minutes. The data supported the initial hypothesis and showed that an 
increase of ACh in the endplate zone, can determine morphological changes 
of muscle fibres that include longitudinal stripes, contraction disks and torn 
fibres. Visually, these morphological changes were very similar to the 
contraction’ knots of MTrPs described in pervious studies (Windisch et al., 
1999, Simons and Stolov, 1976) 
 
The available evidence indicates that MTrPs are a peripheral source of 
nociception (Shah et al., 2008, Shah et al., 2005, Arendt-Nielsen and 
Castaldo, 2015, Hsieh et al., 2012), where different types of endogenous 
substances like neuropeptides and inflammatory mediators, are implicated. 
Both hyperalgesia and allodynia have been observed at latent MTrPs 
indicating that MTrP can sensitize nociceptive and non-nociceptive nerve 
endings of muscles (Li et al., 2009). Moreover, an experimental investigation 
showed that an ischemic compression blockage of the large-diameter 
myelinated muscle afferents is associated with an increase of both pain 
pressure and referred pain thresholds at the MTrP’ site (Wang et al., 2010). 
The same phenomenon was not observed at control sites, suggesting a role 
for non-nociceptive large-diameter myelinated muscle afferents in MTrP’ 
symptomatology (Wang et al., 2010). These findings support the idea that the 
MTrP is characterized by a peripheral sensitization. Moreover, it has been 
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demonstrated that persistent nociceptive stimulation from MTrPs is 
associated with spatial pain propagation and that MTrP’ inactivation can 
prevent widespread pain (Wang et al., 2012). The ongoing nociceptive 
afferent’ activity can lead to abnormal function and structural changes in 
dorsal root ganglia and dorsal horn neurons (Camanho et al., 2011). In such 
conditions, an expansion of the receptive field of pain can occur (Shah et al., 
2008) and patients can show hyperalgesia, allodynia and temporal 
summation of pain. Similarly, central sensitization can be postulated 
(Fernandez-de-las-Penas and Dommerholt, 2014). This hypothesis is 
supported by two studies showing that MTrP’ stimulation alters the brain 
activity in regions processing stimulus intensity and pain affect (Niddam, 
2009, Niddam et al., 2008). Specifically, a functional magnetic resonance 
study revealed an abnormal hippocampal hypoactivity that was attributed to a 
stress-related change due to the presence of MTrPs (Niddam et al., 2008). 
Central sensitization was also demonstrated in healthy subjects with 
mechanical hyperalgesia, within extra-segmental tissues after sustained 
mechanical stimulation of latent MTrPs (Xu et al., 2010). The complex 
interlinked pathophysiology described, which finally constitutes an expansion 
of the MTrP integrated hypothesis, is schematically outlined for an easier 
comprehension in figure 1.13.  
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Figure 1.13.:  Flow chart of the expanded trigger point hypothesis (Adapted 
from R. D. Gerwin, Dommerholt, & Shah, 2004).  
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1.7 DIAGNOSIS 
 
Accurate history taking and physical examination are required in order to 
ensure a correct MPS’ diagnosis. Initially, it is important to lead an 
anamnestic interview focusing on pain symptomatology. The key elements 
regarding pain, are: quality, intensity, timing, location and extent. Patients 
with MPS usually describe their pain using the following terms: dull, steady, 
deep or aching. A visual analogue scale should be provided to patients to 
measure pain intensity, at a daily or weekly frequency, and any correlation 
with activities of daily life must be recorded.  Additionally, patients can use 
body charts to draw both pain’ location and extent. A comparison with the 
MTrPs’ reference maps will be helpful to hypothesize about which muscles 
have a MTrP. Nevertheless, as suggested by Simons in the second edition of 
his Trigger point manual (Simons et al., 1999), MTrP’ referred pain maps 
should be considered nonspecific and constitute only a cue for clinicians.  
Physical examination, which is essentially a manual palpation protocol, is 
then performed to confirm the presence of the MTrP diagnostic criteria. 
Simons and Travell proposed the following minimal criteria: 
1) Taut band palpable 
2) Focal spot tenderness of a nodule in the taut band  
3) Patient’s recognition of pain complaint by manual compression of the 
spot tenderness (identifies an active MTrP)  
4) Pain with stretching or contraction of the affected muscle 
Another two additional confirmatory signs (not mandatory) are also proposed: 
1) Local twitch response  
2) Referred pain with expected distribution (Travell and Simons, 1983)  
 
The minimal diagnostic criteria must be verified in the order proposed above, 
with manual palpation performed by drawing the fingertips of the examining 
hand forward and back, perpendicular to the muscle fibres (flat palpation 
technique) (figure 1.15). Alternatively, some muscle can be palpated 
between fingers and thumb using a pincer grip (figure. 1.15). Once the taut 
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band has been identified within the muscle, the spot tenderness should be 
located by gentle compression of contiguous spots along the taut band.  
 
 
 
 
Figure 1.15: Manual palpation techniques. Left side, pincer grip palpation of 
the medial gastrocnemius muscle. Right side, flat palpation of the paraspinal 
muscles.    
 
 
Beside palpation, clinicians must ask the following questions:  
1) “Which of the following spots is the most painful?” 
2) “Do you recognize this pain? Is it part of your usual complaints?” 
3) “Does the pain refer anywhere from the spot that I am compressing?” 
 
By definition, an affirmative reply to the first question will confirm the spot 
tenderness criteria. An affirmative reply to the second question will confirm 
the pain recognition criteria; and finally, the third question will confirm the 
referred pain’s presence. It is important to note that the physical examination 
of a subject with a possible MPS diagnosis, starts with the taut band 
investigation, which is, together with the local twitch response, the only 
objective sign among the MTrP criteria. All the other diagnostic criteria (i.e 
spot tenderness, pain recognition and referred pain) rely on pain elicitation, 
and therefore should be considered as subjective signs. To avoid 
misunderstanding, clinicians must provide patients with clear instructions and 
questions. 
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Finally, clinicians should consider different conditions other than MPS, that 
can potentially induce regional musculoskeletal pain. The following 
questions, proposed by Borg-Stein (Borg-Stein and Simons, 2002), may be 
useful in establishing the role of MTrP in generating the patient’s painful 
symptomatology and establish any differential diagnosis: 
 
. Is there regional myofascial pain, with MTrPs present? 
. Is the myofascial pain the primary pain generator or are there other 
coexisting or underlying structural diagnoses?  
. Is there a nutritional, metabolic, endocrinologic, psychologic, or 
inflammatory disorder that may be contributing to the regional pain?  
. Is there widespread pain and other associated symptoms? 
 
Specifically, the MPS’ differential diagnosis should consider the following 
disorders (Cummings and Baldry, 2007): 
 
• Joint disorders: zygapophyseal joint disorder, osteoarthritis, loss of 
normal joint range of motion. 
• Inflammatory disorders: polymyositis, polymyalgia rheumatica, 
rheumatoid arthritis. 
• Neurologic disorders: radiculopathy, entrapment neuropathy, 
metabolic myopathy. 
• Regional soft tissue disorders: bursitis, epicondylitis, tendinitis, and 
cumulative trauma. 
• Discogenic disorders: degenerative disk disease, annular tears, 
protrusion, and herniation. 
• Visceral referred pain: gastrointestinal, cardiac, pulmonary, and renal. 
• Endocrine: hypothyroidism. 
• Psychologic disorders: depression, anxiety, and disordered sleep. 
• Fibromyalgia or widespread chronic pain. 
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The MPS’ diagnostic criteria described above are the only ones available, 
and although there is variability in their application, they are accepted by 
researchers and clinicians (Tough et al. 2007).    
 
 
1.8 RELIABILITY OF DIAGNOSTIC CRITERIA 
 
An adequate treatment is possible only with an accurate diagnosis. In the 
case of incorrect diagnosis, the treatment approach may be not appropriate. 
Thus reliability and validity are critical in the development of any treatment 
approach and should be addressed prior to any clinical trials. Travell and 
Simons originally proposed diagnostic criteria for the MTrP diagnosis. The 
validity of the MPS’ diagnosis were considered reasonable and supported by 
some electrophysiological studies (Hong and Simons, 1998), while all the 
investigations depending on imaging techniques (Gerwin and Duranleau, 
1997), or biopsy and electromyography, were not accepted as a reference 
standard for the diagnosis. A general agreement on diagnostic criteria among 
clinicians has not been reached, although clinicians recognised the clinical 
entity of MTrPs and researcher-led studies on the effectiveness of MTrP’ 
treatments.     
In 2007, Elizabeth Tough and her collaborators led a systematic review on 
diagnostic criteria for MTrP (Tough et al., 2007). The purpose of the study 
was to investigate the criteria used by expert clinicians to diagnose MPS. 
Specifically, they were interested in the frequency and the combinations of 
different MTrP’ diagnostic criteria applied by researchers during their 
investigations. They selected 93 scientific papers including clinical 
intervention trials, diagnostic studies, and epidemiologic studies. The most 
frequently used criteria was “Tender spot in a taut band”, which had been 
explicitly reported or implied in 65% of the selected papers. “Patient pain 
recognition on tender spot palpation” and “Predicted pain referral pattern” 
were identified in 53% of the papers. As expected, to diagnose MPS, a 
combination of specific criteria was usually applied. Notably the combinations 
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of specific criteria used were inconsistent and additionally, fifteen studies 
indicated only one criterion. Publications by Travell and Simons were cited as 
the main authoritative references, although their recommendations regarding 
the diagnostic criteria were not always followed correctly. The observed lack 
of a consistent approach in MTrP’ diagnosis was probably due to the poor 
results reported in studies that investigated the reliability of manual palpation 
for MTrP’ examination. 
 
Several clinical studies on reproducibility of the diagnostic criteria for MTrP 
have been conducted and published in peer-reviewed journals between 1992 
and 2005 (table 1.5) (Sciotti et al., 2001, Njoo and Van der Does, 1994, Nice 
et al., 1992, Lew et al., 1997, Levoska et al., 1993, Hsieh et al., 2000, Gerwin 
et al., 1997, Bron et al., 2007, Al-Shenqiti and Oldham, 2005).  The study 
characteristics were different and included different populations, examiners, 
setting, muscles and variations regarding the diagnostic protocol.
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Table 1.5: Intra- and inter-examiner studies on MTrP manual palpation. 
 
Authors Title Year Journal 
Nice, et al. Intertester reliability of judgments of the presence of trigger points in 
patients with low back pain 
1992 Arch Phys Med 
Rehabil 
Levoska, et al. Repeatability of measurement of tenderness in the neck-shoulder region 
by a dolorimeter and manual palpation 
1993 Clin J Pain 
Njoo, et al. The occurrence and inter-rater reliability of myofascial trigger points in 
the quadratus lumborum and gluteus medius: a prospective study in 
non-specific low back pain patients and controls in general practice 
1994 Pain 
Gerwin, et al. Interrater reliability in myofascial trigger point examination 1997 Pain 
Lew, et al. Inter-therapist reliability in locating latent myofascial trigger points using 
palpation 
1997 Man Ther 
McKenzie, et al. Prevalence of muscle trigger points in children with celebral palsy 1997 Phy Occup Ther 
Pediatr 
Hsieh, et al. Interexaminer reliability of the palpation of trigger points in the trunk and 
lower limb muscles 
2000 Arch Phys Med 
Rehabil 
Sciotti, et al. Clinical precision of myofascial trigger point location in the trapezius 
muscle 
2001 Pain 
Bron, et al. Interrater reliability of palpation of myofascial trigger points in three 
shoulder muscles 
2007 J Man Manip 
Ther 
Al-shenqiti, et al. Test-retest reliability of myofascial trigger point detection in patients with 
rotator cuff tendonitis 
2005 Clin Rehabil 
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Notably, two systematic reviews have been conducted with the aim of 
determining the reliability of physical examination for MTrP (Lucas et al., 
2009, Myburgh et al., 2008). Both the reviews screened the literature using 
the most relevant electronic database and selected the studies using similar 
inclusion and exclusion criteria. Lucas and collaborators included 8 different 
studies, while Myburgh and collaborators only 6. All the selected studies 
investigated the reproducibility of manual palpation for MTrP identification 
using an appropriate repeated measures design, although several 
methodological biases were identified. The two reviews stated that an 
acceptable reliability was demonstrated only in a few studies and exclusively 
for some MTrP’ diagnostic criteria. The k values reported, varied widely, and 
ranged from excellent to less than chance for each diagnostic criterion and 
for each muscle. Reliability was higher for subjective criteria like spot 
tenderness and pain reproduction, and definitely lower for taut band and local 
twitch response. Spot tenderness criteria for upper trapezius, and pain 
reproduction criteria for gluteus medius and quadratus lumborum showed the 
highest K values. Considering the lack of evidence for the MPS diagnosis, 
the authors recommended extreme caution in considering the clinical entity 
of MTrP. Any treatment based primarily on the MTrPs, can be misleading 
and may not lead to the best treatment available (Lucas et al., 2009). 
 
A few important considerations can be drawn from the two systematic 
reviews.  First, it is clearly indicated that the reliability of each MTrP criteria 
depends on the muscle being considered. For example, in muscle that lies 
deep, for any manual examination aimed to identify the taut band, the local 
twitch response and the spot tenderness will be unfeasible. Secondly, when 
the MTrP has a high irritability (i.e. low pain pressure threshold) and 
manifests the referred pain phenomenon, its examination is most 
reproducible. Again, training for examiners and a rigorous standardization of 
the MTrP’ manual examination are fundamental for any future investigation. 
Finally, Myburgh suggested moving the MTrP examination from an individual 
criteria approach to a global assessment approach (Myburgh et al., 2011). 
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Gerwin adopted this approach and demonstrated a good reproducibility for 
the MTrP’ diagnosis in a few muscles (infraspinatus, latissimus dorsi, 
sternocleidomastoid, trapezius, extensor digitorum) (Gerwin et al., 1997).  In 
the global assessment, clinicians still consider the criteria originally proposed 
by Simons and Travell for the MTrP, but provide only an answer of whether 
or not a MTrP is present. This is in line with Tough et al. who reported in their 
review, that the number of MTrP criteria considered over the years has been 
progressively reduced (Tough et al., 2007). Indeed, the criteria not 
considered essential by the authorities have been abandoned and the 
diagnostic procedures refined over time. For example, predicted referral pain 
is now consider nonspecific and the local twitch response is no longer 
considered essential for the MPS’ diagnosis (Gerwin 1997, Lewis 1999). 
 
 
1.9 TREATMENT 
 
Effective treatment of a musculoskeletal disorder requires accurate 
identification of the pain source and correct management of perpetuating 
factors. The MPS is a clear example of a painful disorder where any 
proposed treatment implies a precise localization of the pain generator (i.e. 
MTrP), but also a coping strategy for the perpetuating factors. Specifically, 
authors suggest that any mechanical or stressing events should be 
considered. Mense and Gerwin provide a comprehensive description of 
perpetuating factors in their textbook (table 1.6) (Mense and Gerwin, 2010). 
Clinicians generally overlook them, reducing the efficacy of their treatment 
(Fricton, 1991, Fricton, 1989). In some patients, the complexity of 
perpetuating factors requires a multidisciplinary approach. Is it also important 
to point out, as confirmed by electromyographic investigations, that any 
emotional or mental stress may activate or perpetuate a MTrP (Hubbard and 
Berkoff, 1993, Celik and Kaya Mutlu, 2012). 
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Various methods of MTrP treatment are available but currently, no clinical 
guidelines are available and clinicians are required to balance the evidence, 
their clinical experience and the patient’s preferences.  
 
Treatment approaches can be considered as invasive and non-invasive 
(Mense and Gerwin, 2010, Rickards, 2006). Dry needling or intramuscular 
stimulation, is an invasive technique in which a filiform needle is used to 
penetrate the skin and stimulate the MTrP (Vulfsons et al., 2012). The 
expected therapeutic effect is to release the taut band and reduce the 
irritability of the spot tenderness (Chou et al., 2012). Together with injections 
(local anaesthetics, steroids, Botulinum toxin A), these are among the most 
common treatments for MPS. Non-invasive treatments include various 
manual techniques and modalities (Mense and Gerwin, 2010, Rickards, 
2006).  
 
Recently dry needling gained popularity among physiotherapists and four 
systematic reviews on the efficacy have been completed. Tough and 
collaborators led a literature search, selecting studies where at least one 
group of patients were treated by dry needling into the MTrP and where a 
control group were enrolled (Tough et al., 2009). Pain measured using the 
VAS was considered to be the principal outcome. A meta-analysis was 
conducted using 4 out 7 selected studies, and dry needling was not found to 
be significantly superior to sham treatments (standardised mean difference, 
14,9 [95%CI, -5,81 to 33.99]) (Itoh et al., 2007, Itoh et al., 2006, Ilbuldu et al., 
2004, Huguenin et al., 2005). Among the studies excluded from the meta-
analysis, one affirmed that dry needling was superior to no intervention 
(DiLorenzo et al., 2004), while the other comparing MTrP dry needling versus 
aspecific muscle needling (i.e. not in the MTrP), showed inconsistent results 
(Itoh et al., 2004, Chu, 1997).
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Table 1.6: Perpetuating factors divided into three main categories. 
 
Ergonomic factors 
 
Structural factors 
 
Medical factors 
 
Work related activities Scoliosis Hormonal 
Prolonged static postures Leg-length inequality hypothyroidism 
Repetitive activites Pelvis asymmetry testosterone deficiency 
Recreational activites Hyper-mobility nutritional 
Telephone use Hypo-mobility iron deficiency 
Computer use Forward neck posture Vitamin D deficiency 
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A more specific systematic review, aimed at verifying the efficacy of dry 
needling of MTrPs in patients with plantar heel pan, was completed in 2010 
(Cotchett et al., 2010). Only three quasi-experimental trials, each with a low 
quality score were included in the review. The investigators concluded that 
there is limited evidence to support the treatment of plantar heel pain using 
MTrPs’ dry needling. A systematic review with meta-analysis was able to 
support the use of MTrPs’ dry needling in clinical practice. It was published in 
the Journal of Orthopaedic and Sports Physical Therapy and aimed to 
explore the evidence for MTrPs’ dry needling in patients with MPS of the 
upper quarter (Kietrys et al., 2013). Twelve studies met the inclusion criteria 
and their quality score, according to the MacDermid Quality Checklist (scale 
range 0 to 48; maximal score 48), ranged from 23 to 40 points. Four different 
meta-analysis were completed: 1) immediate effect of dry needling versus 
sham or control, 2) efficacy at 4 weeks of dry needling versus sham or 
control, 3) immediate effect of dry needling versus a comparison treatment, 
4) efficacy at 4 weeks of dry needling versus a comparison treatment. With 
regards to the results of 3 randomized clinical trials, the authors provide a 
grade A recommendation for dry needling for immediate pain relief, when 
compared to placebo, in the selected population (Hsieh et al., 2007, Tsai et 
al., 2010, Tekin et al., 2013).  The effect size ranged from 1.2 to 4.9 points 
for the VAS score (maximum score, 10). Additionally, the results of two trials 
provided evidence that dry needling, in patients with upper quadrant MPS, 
can reduce pain at 4 weeks (Tekin et al., 2013, Itoh et al., 2007). It has to be 
noted that the overall effect was limited by a large confidence interval.  
Furthermore, many heterogeneous studies investigated the effect of dry 
needling in comparison to a variety of different treatments, with results 
ranging from no difference, to a difference favouring either dry needling or 
the comparison treatment (Cotchett et al., 2010). However, a recent 
systematic review without meta-analysis, on dry needling for MTrP in the 
upper trapezius muscle, found strong evidence on pain reduction (Cagnie et 
al., 2013). Eight clinical studies with low quality were examined (Hong, 
1994a, Itoh et al., 2007, Ma et al., 2010, Myburgh et al., 2012, Ay et al., 
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2010, Eroglu et al., 2013, Ga et al., 2007a, Ga et al., 2007b).  Also, this 
review, in agreement with Kietrys (2013), declared the need for a high-quality 
study design to provide more robust evidence on the dry needling’ efficacy. 
 
Many different manual therapy techniques to treat and manage MPS have 
been investigated in controlled studies: ischemic compression (Kim et al., 
2013, Martin-Pintado-Zugasti et al., 2015, Montenegro et al., 2015); MTrP’ 
pressure release  (Montenegro et al., 2015, Grieve et al., 2011, Grieve et al., 
2013b); myofascial induction technique (Saiz-Llamosas et al 2009); passive 
stretching (Hanten et al., 2000); muscle energy techniques (Yeganeh Lari et 
al., 2016, Oliveira-Campelo et al., 2013); strain counterstrain (Segura-Ortí et 
a 2016, Wong CK et al 20014, Ibáñez-García J et al 2009); and, high velocity 
low amplitude thrust (Srbely JZ et al 2013, Ruiz-Sáez et al 2007). In addition, 
many studies have been conducted for different modalities, such as 
ultrasound (Kavadar G et al 2015, Benjaboonyanupap D et al. Manca A et al 
2014, Kim Y et al. 2014), low level laser (Demirkol N et al 2015, Manca A et 
al 2014, Gur A et al 2004, Hakgüder A et al 2003) and transcutaneous 
electrical nerve stimulation (Gemmell H et al 2011, Rodríguez-Fernández 
AL et al 2011, Graff-Radford SB et al 1989, Salim M. et al 1992).  
   
Fernandez de las Penas (2005) selected for a systematic review, 7 trials that 
included at least one group receiving a manual therapy treatment 
(Fernandez-de-Las-Penas et al., 2005). Selection of the studies was limited 
by the lack of uniformity regarding the outcome measures and by the poor 
interval validity. Only 2 of the selected studies included a visual analogic 
scale, PPT and range of motion (Hou et al., 2002, Hanten et al., 2000); the 
remaining studies reported only a limited number of outcomes (Hanten et al., 
1997, Hong et al., 1993, Jaeger and Reeves, 1986) or selected non 
appropriate outcome measures such as tenderness or posture (Gam et al., 
1998, Dardzinski et al., 2000). Moreover, the PEDro score for internal validity 
reached 6 out of 10 only in two studies (Gam et al., 1998, Hong et al., 1993), 
and in 3 studies, was less than 4 out of 10 (Jaeger and Reeves, 1986, 
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Dardzinski et al., 2000, Hanten et al., 1997). Also, 4 of the selected studies 
included only one treatment session (Jaeger and Reeves, 1986, Hou et al., 
2002, Hong et al., 1993, Hanten et al., 1997). 
 
The review’s findings did not demonstrate any evidence in favour of manual 
therapy techniques, even when associated with other treatments such as 
ultrasound and massage.  The hypothesis that manual therapy for MTrP has 
a specific efficacy beyond placebo, was neither supported nor refuted. 
Nevertheless, some trials included in the review confirmed that MTrP’ 
treatment might reduce the pressure pain threshold of spot tenderness and 
the VAS score (Fernandez-de-Las-Penas et al., 2005). Notably, the author 
remarked upon the need to assess ROM in future clinical trials, as it is an 
important outcome measure in patients with MTrP.  
 
The efficacy of non-invasive treatments has been investigated also by 
Rickards (2006). The author conducted a systematic review including 23 
controlled or quasi-randomized trials. Only studies which clearly stated the 
MTrP diagnostic criteria and with concealed allocation, were included in the 
review. The selected trials were divided into 5 categories and the following 
treatments considered: laser therapies, electrotherapies, ultrasound, magnet 
therapies, and manual therapies. A short-term efficacy was confirmed for 
decreasing MTrP’ pain intensity by laser therapy and transcutaneous 
electrical nerve stimulation (Gur et al., 2004, Snyder-Mackler et al., 
1989, Hakguder et al., 2003, Ilbuldu et al., 2004, Ceccherelli et al., 
1989, Graff-Radford et al., 1989, Farina et al., 2004, Hsueh et al., 
1997). Moderate evidence supporting ultrasound was available from 
one high quality and two lower quality clinical studies, suggesting that 
ultrasound is not an effective MTrP’ treatment (Lee et al., 1997, Gam et 
al., 1998, Esenyel et al., 2000). Again, moderate evidence was also 
confirmed for magnet therapies (Smania et al., 2005, Smania et al., 
2003, Brown et al., 2002). Notably, 4 high quality studies on manual 
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therapy have been identified in which short-term efficacy was 
confirmed (Hanten et al., 2000, Gam et al., 1998, Chatchawan et al., 
2005, Fernandez-de-Las-Penas et al., 2006b). Overall, the evidence 
for effectiveness of the different non-invasive MTrP’ treatments was 
based on a limited number of studies and in a few cases, significant 
methodological biases were identified (i.e. unblinded assessors, low 
quality scoring system). 
 
In 2015, an original systematic review on the use of ischemic compression 
and dry needling for MTrPs was completed (Cagnie et al., 2013). Fifteen 
studies were selected, 80% were scored as level B studies (Ay et al., 2010, 
Eroglu et al., 2013, Ga et al., 2007a, Ga et al., 2007b, Ma et al., 2010, 
Aguilera et al., 2009, Hanten et al., 2000, Kannan, 2012, Oliveira-Campelo et 
al., 2013, Nagrale et al., 2010, Fernandez-de-Las-Penas et al., 2006b, 
Gemmell and Allen, 2008), and the remaining 20% were at level A2 (Hong, 
1994a, Itoh et al., 2007, Myburgh et al., 2012). Notably, the blinding of the 
operator and/or the patients was identified as a major limitation.  For all the 
selected studies, only short and medium term outcomes were considered. 
Seven studies investigated the efficacy of the ischemic compression and 8 
the efficacy of dry needling. Findings were in line with those reported in the 
previous reviews: moderate evidence was found in favour of ischemic 
compression and strong evidence was found for dry needling. According to 
the available systematic reviews dry needling should be considered the first 
choice treatment but due to the small number of high quality trials additional 
research requires to be undertaken. 
 
 
1.10 RESEARCH AGENDA. 
 
Myofascial pain research has increased since the publication of the first 
edition of “Travell and Simons’ Myofascial Pain and Dysfunction: Trigger 
Point Manual” (Travell and Simons, 1983) and many researchers are 
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currently leading both pure and clinical research. Simons, Mense, Gerwin 
and Hong did an extraordinary amount of work to address the MTrP enigma, 
and laid the foundations for further studies. It is now important to define 
priorities and develop a research agenda. In order to fulfill this aspiration a 
number of researchers have proposed areas for further MTrP research 
(Simons, 2004, Mense and Gerwin, 2010, Dommerholt and Huijbregts, 
2011).  
 
1.10.1 Aetiology 
Many theories regarding the development of MTrPs have been proposed but 
there is a lack of an officially recognised aetiology. It is postulated that a taut 
band and a latent MTrP are the first abnormalities, and that the active MTrP 
and the referred pain, are secondary stages of the MPS’ clinical course 
(Dommerholt and Huijbregts, 2011). It is not clear what the specific causes or 
risk factors are that trigger this sequence of events. Similarly, what is the 
relationship between active and latent MTrPs should be clarified. Finally, 
although evidence of endplate dysfunction in muscle harbouring a MTrP is 
available, the relationship between the MTrP and the endplate dysfunction 
should be further investigated. The integrated hypothesis (Simons et al., 
1999, Gerwin et al., 2004) defines the MTrP as a neuromuscular condition 
characterized by two components: a sensory locus and motor locus (Kuan, 
2009). 
The sensory component has been defined as the muscle site where 
pain (i.e. hyperalgesia and allodynia), referred pain, and a local twitch 
response can be evoked by manual compression or dry needling 
(Dommerholt et al., 2006). Referring to the manual palpation protocol, it is 
essentially the spot tenderness located within the taut band of muscle (see 
diagnostic criteria in Chapter 1).   The motor component has been defined as 
the muscle site where the SEA can be recorded using needle EMG, and 
according to the integrated hypothesis, this is an electromyographic signal 
that arises from dysfunctional endplates. 
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According to this definition of a MTrP and to the integrated hypothesis, 
it is reasonable to assume that the MTrP spot tenderness (i.e. the sensory 
locus) and the endplates are located in the same region, and are at least 
partially overlapped. Although no research studies have been conducted on 
this specific issue, authors indicate a close spatial relationship between the 
MTrP and the endplate region. Simons in 2002, during an investigation on 
the prevalence of the motor endplate potentials (i.e. SEA) in active MTrP, 
examined 11 muscles of 10 subjects using needle EMG. The SEA was 
recorded and detected within the MTrP region and also close to this, within 
the endplate zone (Simons et al., 2002).  This zone is also known as the  
innervation zone (IZ) in the literature (Buchthal and Rosenfalck, 1966). 
Buchthal & Rosenfalck published these results in this American Journal of 
Physical Medicne & Rehabilitation and clearly stated: “In this study, the 
MTrPs were consistently found within an endplate zone.” Later, Kuan (Kuan, 
2009) corroborated this finding in a literature review: “In skeletal muscle, a 
tender point can be an myofascial trigger point if it locates in the endplate 
zone with all characteristics of an MTrP, such as taut band, referred pain, 
and local twitch response”.  
The SEA is currently accepted to be an electromyographic signal that 
arises from a group of dysfunctional endplates and in the current literature, is 
named endplate noise (Simons, 2001, Simons et al., 2002, Kuan et al., 2002, 
Hong, 2002, Chou et al., 2009, Gerwin et al., 2004). The reported association 
between the endplate noise and the MTrP has led to the suggestion that the 
MTrP region is where the endplate zone is located (Kuan et al., 2007, Mense 
and Gerwin, 2010). 
Nevertheless, it is important to note that dysfunctional endplates in 
MTrP have never been demonstrated, and the accuracy of needle EMG in 
detecting and locating the IZ, has never been explored.  
As affirmed by Mense (2001) in his book on muscle pain: 
“Understanding the location of motor endplates is important for the clinical 
diagnosis and management of myofascial trigger points. Since the 
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pathophysiology of the myofascial trigger point is intimately associated with 
endplates, one expects to find TrPs only where are motor endplates.” 
 
 
1.10.2 Diagnostic gold standard 
 
Current diagnosis of MTrP relies on history taking and physical examination 
of patients, and strongly depends on clinical skill and experience. A few 
diagnostic procedures like electromyography (Simons et al., 2002), 
thermography (Wolf, 1989, Diakow, 1992), skin resistance, ultrasound 
(Gerwin and Duranleau, 1997), have been proposed, but none of these has 
been accepted as a diagnostic gold standard. A growing body of evidence 
indicates taut bands can be visualized during ultrasound-guided examination, 
especially using sonoelastography or multidimensional imaging (Thomas and 
Shankar, 2013, Shankar and Reddy, 2012, Sikdar et al., 2008). Using 
mechanical vibration during sonoelastography, Sikdar (2008) demonstrated 
abnormalities of muscle containing MTrPs. They described a nodular region 
characterized by hypoechogenicity. The examined MTrPs showed a 
diminished vibration amplitude consistent with the taut band site (Sikdar et 
al., 2008). It was suggested that active MTrPs are not necessarily associated 
with isolated nodular lesions, but that active MTrPs are associated with 
heterogeneity of the muscle (Ballyns et al., 2011, Sikdar et al., 2010). Forty-
four patients with acute cervical pain and one active MTrP were examined   
using sonoelastography, and the authors distinguished normal muscle from 
active MTrPs (Ballyns et al., 2011). Notably, no correlation between active 
MTrPs and the PPT was found, and the data regarding the MTrP size was 
not clearly reported. Moreover, a control group was not included in the study. 
However and notably, no correlation between an active MTrP and the PPT 
was found and the data regarding the MTrP size was not clearly reported. 
Moreover, a control group was not included in the study. However, the latest 
findings with ultrasound vibration elastography, confirmed the previous 
findings, and demonstrated how an effective dry needling treatment can 
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change the muscle tissue properties (Turo et al., 2015). These findings 
provide an important insight into the treatment of MTrPs, but it is important to 
note that the proposed ultrasound technique has never been fully validated, 
and its capability to assess the MTrP’ tissue properties requires further 
research. A preliminary attempt to identify and quantify the MTrP’ taut band 
using magnetic resonance elastography, has been undertaken on two 
subjects with chronic myofascial pain (Chen et al., 2008, Chen et al., 2007). 
The reported findings suggested that stiffness of the taut bands, in patients 
with myofascial pain, may be 50% greater than that of the surrounding 
muscle tissue. The authors did not provide any details about the diagnostic 
criteria for MTrP and did not describe the location of MTrP’ spot tenderness 
with respect to the taut band.  The same author concluded a study using the 
same magnetic resonance imaging technique on a convenience sample of 
65 subjects with myofascial pain (Chen et al., 2016). The intra- and inter-
reliabilities of the magnetic resonance imaging was excellent and the 
presence of the taut bands in upper trapezius confirmed. Unfortunately, the 
authors didn’t locate the position of the MTrP’ spot tenderness with respect to 
the taut band. Nevertheless, the agreement between physicians and the 
magnetic resonance imaging findings, was relatively poor. The taut band 
mean stiffness was 11.5  kPa while in the  control site was 5.8 KPa. The 
authors asserted that clinicians may overestimate the presence of the taut 
band, while the magnetic resonance imaging may underestimate its 
presence (Chen et al., 2016). These imaging techniques are promising and 
may assume an important role in the management of MPS. Future studies 
need to resolve which imaging techniques have the highest accuracy in 
detecting MTrPs, and which have the greatest applicability in clinical practice. 
 
1.10.3 Treatment 
It appears that MTrP inactivation can be achieved using different treatment 
approaches.  According to the available evidence, invasive treatments such 
as dry needling or substances injection, are considered more effective than 
non-invasive ones (Cagnie et al., 2013, Kietrys et al., 2013, Cotchett et al., 
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2010, Fernandez-de-Las-Penas et al., 2005, Rickards, 2006, Tough et al., 
2009). The efficacy of manual techniques or modalities has been explored in 
clinical trials with poor internal validity (Fernandez-de-Las-Penas et al., 2005, 
Rickards, 2006, Cagnie et al., 2013). Thus, high quality randomized clinical 
trials on the efficacy of non-invasive treatment are required. Moreover, it is 
important to define which manual therapy techniques are the most 
appropriate to treat MTrPs. Regarding this issue, Simons, after the 
publication of the motor endplate hypothesis (Simons et al., 1999), proposed 
an original manual approach named “trigger point pressure release”. The 
author suggested that the classic heavy ischaemic compression of MTrPs 
should be avoided, in order to avoid tissue hypoxia. As an alternative, he 
proposed a passive muscle lengthening until tissue resistance, with a slow 
and gentle MTrP compression. The hypothesis was that pressing and 
stretching the tissue uncouples myosin from actin in the MTrP region, a 
process that usually requires ATP. The described manual technique may 
also release the ”stuck” spring function of the titin connection to the Z bands 
of the sarcomeres (Dommerholt and Huijbregts, 2011). The theory described 
is very interesting, although based on anecdotal evidence, and needs basic 
physiological research to be confirmed.  
Moreover, preliminary results on low-level laser therapy has created much 
interest among researchers (Uemoto et al., 2013). Considering the potential 
complications and limitations of invasive (Brady et al., 2014) techniques, the 
availability of an effective non-invasive treatment will be relevant for 
clinicians.   
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CHAPTER 2  
 
 
 
 
RESEARCH QUESTION 
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2.1 - RESEARCH AIM, METHODOLOGICAL ASPECTS AND ETHICAL 
CONSIDERATIONS  
The integrated hypothesis suggests that abnormal depolarization of the post-
junction membrane of motor endplates induces a focal sarcomere 
contraction.  This would induce a hypoxic energy crisis of the involved fibres, 
associated with sensory and autonomic reflex arcs (Bron and Dommerholt, 
2012, Gerwin et al., 2004). The presence of the SEA at the endplate sites 
(Simons et al., 2002), and the clinical evidence that treating MTrPs 
significantly reduces the endplate noise, support the notion that MTrP are 
located in close proximity to dysfunctional motor endplates of the IZ (Ge et 
al., 2011, Kuan et al., 2007). The commonly encountered locations of MTrPs 
and their pain reference zones have been illustrated using standardized body 
charts, but there are no studies that describe the specific anatomical location 
of MTrPs. 
 
The aim of this work will be to describe the location of MTrPs and the IZ in 
the upper trapezius muscle. An accurate description of the location of both 
the IZ and the MTrP will provide data to unravel their spatial relationship and 
to significantly contribute to the body of knowledge, associated with the 
MTrP. In order to plan the research activities, it was fundamental to establish: 
- Which skeletal muscles might be best used to describe the MTrP’ 
location? 
- Which technique should be applied to optimally describe the IZ’ 
location? 
The upper trapezius muscle was selected for two main reasons. First, 
MTrPs in the upper trapezius are very common in subjects with mechanical 
neck pain, as well as in healthy subjects (Fernandez-de-las-Penas et al., 
2007). A high prevalence of a MTrP was considered important to reduce the 
effort in the enrolment phase. Secondly, a higher reliability in the upper 
trapezius, for most of the diagnostic criteria, has been reported in studies on 
MTrP palpation procedures (Lucas et al., 2010a, Myburgh et al., 2008). 
Alternative approaches to manual palpation that establish the presence and 
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location of MTrPs, were not available. Moreover, the manual palpation 
procedures and diagnostic criteria proposed by Simons, are considered a 
reference standard (Simons et al., 1999, Tough et al., 2007). Again, the 
upper trapezius muscle morphology was considered suitable. Its surface is 
wide enough while its thickness is reduced and, it is reasonably practicable 
to describe the spatial distribution of both the MTrPs and the IZs. To select 
an appropriate technique to detect the IZ’ location in the upper trapezius 
muscle, only non-invasive and painless procedures were considered. This 
approach was a priority due to ethical reasons, but also to avoid any increase 
of the MTrP’ irritability.  Needle EMG was excluded not only because it is an 
invasive tool, but also because the uptake area of a concentric needle 
electrode is approximately 2.5 mm (Merletti and Parker, 2004). 
A description of the IZ’ location, which is an anatomical structure and 
which involves a large portion of muscle, would be not feasible without 
sampling the EMG signals in many different regions of the upper trapezius. 
This approach, even though practicable, would give rise to many ethical 
concerns. Alternatively, the IZ’ location can be identified from surface EMG 
signals, detected using linear arrays of electrodes, placed along the direction 
of the muscle fibres. In such a configuration, the IZ appears as the area from 
where the electrical potential propagates in two opposite directions towards 
the tendon’ regions (Masuda et al., 1983b, Masuda et al., 1983a). This 
method has been originally proposed by Masuda and Sadoyama (1988), who 
also provided an appraisal of its validation.  A number of studies have 
investigated the use of surface electrode arrays to locate the IZ within 
specific muscles (Falla et al., 2002, Iwasaki et al., 1990, Masuda et al., 
1983b, Masuda et al., 1983a, Saitou et al., 2000). The IZ has been 
successfully identified in muscles having fibres running parallel to the skin 
(Saitou et al., 2000). This further supported the choice of the upper trapezius 
muscle as the experimental muscle. Indeed, it is composed of three different 
portions (i.e. upper, mid and lower), each with a different direction of fibres, 
but in which the fibres are always parallel to the skin surface (Johnson et al., 
1994). Surface EMG showed a few other advantages when compared to 
 69 
needle EMG. It is safe, and it is not necessary to penetrate the skin in order 
to record meaningful information regarding the motor units’ action potentials. 
Surface EMG’ application was considered an optimal technical solution to 
protect participants and to minimize their discomfort. Additionally, to generate 
EMG signals, it is enough to perform an isometric muscle contraction. Finally, 
it is technically easy to apply electrodes to the skin surface to detect EMG 
signals. 
 
 
2.2 - RESEARCH HYPOTHESIS 
 
 As previously mentioned, the aim of this work was to describe the 
location of both the IZ and the MTrP in the upper trapezius muscle. The 
research design involved a cross-sectional study in which experimental data 
(i.e. IZ’ and MTrP’ location) was collected in a given population, at the same 
point in time (Mann, 2003). The intention was to describe the spatial 
relationship between them, while acknowledging that some authors have 
proposed that MTrPs are located in the IZ (Mense et al., 2001, Kuan, 2009, 
Ge et al., 2011). In other words, this means that theoretically, the distance 
between them should approximate to zero, or that they share the same 
location. Then the following null hypothesis (H0) can be proposed: 
. H0: The distance between the IZ and the MTrP in upper trapezius 
muscle is equal to zero 
The proposed hypothesis characterised the subjects with MTrP in the upper 
trapezius as the independent variables, and the IZ’ location and the MTrP’ 
location as the dependent variables. The statistical analyses involved an 
appropriate, parametric, or non-parametric, difference test, aimed at retaining 
or rejecting statistically that the distance between the two dependent 
variables (i.e. the IZ’ location and the MTrP’ location) was significantly 
different from zero.  
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Errors in the hypothesis testing must be considered in all research studies. 
Two types of errors are possible: type I (rejecting a null hypothesis when it is 
true) and type II (not rejecting a null hypothesis when it is false).  In the case 
of type I error, the distance between the IZ’ location and the MTrP’ location is 
interpreted as being significantly different from zero, when in actual fact, it is 
zero. While in type II error, the distance between IZ and MTrP’ locations is 
interpreted as having been not significantly different from zero, when it had 
been zero in actuality. 
 
In the attempt to provide an answer to the research question, it was 
important to consider the risk for both the types of errors and to interpret the 
inferential statistic’ results with caution. For this reason, an investigation to 
define the reliability (relative and absolute) of the procedures to locate the IZ 
and the MTrP will be useful for discussing the results of the cross-sectional 
study. Then the following additional null hypothesis can be proposed: 
- H0: The reliability of surface EMG in locating the IZ in upper trapezius 
muscle is lower than 0.60 (K value) 
- H0: The reliability of manual palpation in locating MTrP in upper 
trapezius muscle is lower than 0.60 (Intraclass correlation coefficient) 
 
 
2.3 - RESEARCH PLANNING 
  
An effective research planning includes the selection of an adequate 
research strategy for producing the necessary evidence to answer the 
research questions. The selection of the appropriate research strategy 
depends mainly on the research hypothesis. In the study, as it has been 
proposed, the extent of the reliability associated with the selected 
measurement procedures had been critical, as IZ’ location and MTrP’ 
location were the dependent variables. In this context, reliability reflects the 
reproducibility of a measurement procedure or tool.  
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As previously mentioned, the IZ’ location in the upper trapezius muscle was 
inferred using measurements derived from surface EMG. Whereas, by 
contrast, the MTrP’ location in the upper trapezius muscle was measured by 
a trained operator, using manual palpation. Thus, it was important to 
complete an investigation for both procedures to quantify both absolute and 
relative reliability (Safrit and Wood, 1989).  Whereas relative reliability is the 
degree to which elements keep their position stable in a sample during 
repeated measurements. This kind of reliability is evaluated using correlation 
statistics. While absolute reliability is the degree to which repeated 
measurements change their values for the same elements (Safrit and Wood, 
1989). In this case, reliability is reported using units of measurement or 
proportion of measured values (Bruton et al., 2000). 
 
Single estimations of the reliability are not sufficient to define the reliability of 
a measurement procedure. The relative reliability of the measurement 
procedures will have to overcome some minimal correlation values.  These 
values are reported in the literature and depend on the selected statistics (i.e. 
correlation coefficients, Kappa values, intraclass correlation coefficient) 
(Landis and Koch, 1977, Cohen, 1960, Munro, 2005). While absolute 
reliability will have to define the size and range of the measurement 
differences and these will be discussed in terms of clinical acceptability. 
 
Findings of the cross-sectional study, aimed at describing IZ’ and MTrP’ 
locations, were to be discussed while considering the results of the two 
reliability studies.  The thesis included two reliability studies and one 
conclusive cross-sectional study. An optimal planning of the mentioned 
studies would have been as follows: first, the study aimed at establishing the 
reliability of IZ’ localization using surface EMG; second, the study aimed to 
establishing the reliability of MTrP’ localization in the upper trapezius muscle 
using manual palpation; finally, the cross-sectional study (figure 2.1). 
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Figure 2.1: Research planning chart including main features of the studies.  
 
 
2.4 – ACTUAL RESEARCH PLAN 
 
As regards to the research planning, it is important to note that the study on 
reliability of manual palpation in locating the MTrP, had been conducted after 
having been delayed (i.e. conducted in 2011) and specifically after the cross-
sectional study (i.e. completed in November 2008) (figure 2.2). The study on 
the reliability of surface EMG in locating the IZ had been conducted first, as 
planned. The implementation of the study on reliability of MTrP localization 
had been postponed necessarily due to the limited availability of the 
Laboratory of movement analysis of the Vita-Salute San Raffaele University 
(Milan, Italy). Research activities at the latter laboratory were prioritorised 
and supported according to an internal research agenda that wasn't 
controlled by the author. The deferral of the investigation on reliability of 
MTrP’ localization should be considered an amendment to the original 
research planning that hadn't directly impacted on the proposed research 
project.  Indeed, the research design and the experimental procedures of the 
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last study (i.e. the cross-sectional study) had not been constrained by the 
findings of the previous studies (i.e. the reliability studies). The selection of 
suitable outcome measures for use within the thesis had been extremely 
limited in practice (for the reasons mentioned previously). However, 
additional reliability-based clinometric criteria on which to appraise the 
selection of outcomes might have been compromised by the temporal re-
organisation of the studies' execution. Findings of the reliability studies have 
been used for an evidence based discussion of the cross-sectional study on 
the spatial relationship between MTrP and IZ, as had been planned 
originally. 
 
 
 
Figure 2.2: Chronological order of studies. 
 
 
2.5 - RELEVANCE OF THE PROJECT 
 
The relevance of a scientific investigation is gauged by the changes it 
introduces in the body of knowledge. In this thesis, the integrated hypothesis, 
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as suggested by current literature, had been accepted and the endplate 
dysfunction considered a central element of the MTrP’s pathophysiology. 
Research studies supported the presence of an abnormal EMG pattern (i.e. 
SEA) within the MTrP’s region. In spite of the criticisms raised by some 
experts, the abnormal EMG pattern has been attributed to the endplate and 
named endplate noise (Johnson, 2002). Moreover, the overlapping of the 
endplate noise and MTrP’s spot tenderness that had been proposed (Mense, 
1999, Simons et al., 2002, Kuan, 2009). Evidence that would support or 
refuse the overlapping spatially between the IZ and the MTrP will potentially 
provide insights into various fields of the MTrP research. 
 
Primarily, the research findings will contribute to the development of 
understanding of the MTrP physiopathology. An overlapping geometrically 
between the IZ and the MTrP will indeed reinforce the conceptual model for 
endplate dysfunction underpinning the phenomenon of MTrP. Otherwise, 
investigations of the geometric location will open new research perspectives 
to elucidate the nature of MTrP’ spot tenderness. The overlapping between 
IZ and MTrP will also support any therapy directed at muscle endplates (i.e. 
botox). Finally, if confirmed, the overlapping will also define the location of 
the MTrP according to an anatomical structure (i.e. IZ). Indeed, it is not 
clearly understood if a MTrP can be located anywhere within the belly of a 
muscle. The MTrP’ charts proposed by Simons (Simons et al., 1999), based 
on a previous study led by Janet Travell and Seymour Rinzler (1952), 
indicate a few possible locations for the MTrPs within various muscles, but 
these offer only approximate locations. During manual palpation, operators 
examine the entire muscle belly to locate both the spot tenderness and the 
taut band. If confirmed, a MTrP’ location anchored to the IZ, will facilitate the 
diagnostic procedure in several muscles, like for example, the bicep brachii 
muscle, where the IZ is constantly located in a well-defined region (mid 
portion of the belly) (Masuda et al., 1983a). Thus, in this muscle, it will be 
possible to reduce false positive findings by distinguishing nonspecific 
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hyperalgesia (i.e that can be located theoretically in any region of the muscle 
belly) and a MTrP. 
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CHAPTER 3  
 
 
 
 
RELIABILITY OF SURFACE EMG MATRIX IN 
LOCATING THE INNERVATION ZONE OF UPPER 
TRAPEZIUS MUSCLE 
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3.1 SUMMARY  
 
The identification of the motor unit IZ using surface EMG signals detected on 
the skin with a linear array or a matrix of electrodes has been recently 
proposed in the literature. However, an analysis of the reliability of this 
procedure and, therefore, of the suitability of the surface EMG signals for this 
purpose has not been reported. 
The purpose of this work is to describe the intra and inter-rater reliability and 
the suitability of surface EMG in locating the innervation zone of the upper 
trapezius muscle. 
Two operators were trained on electrode matrix positioning and sEMG signal 
analysis. Ten healthy subjects, instructed to perform a series of isometric 
contractions of the upper trapezius muscle participated in the study. The two 
operators collected sEMG signals and then independently estimated the IZ’ 
location through visual analysis. 
Results showed an almost perfect agreement for intra-rater and inter-rater 
reliability. The constancy of IZ’ location could be affected by the factors 
reflecting the population of active motor units and their IZs, including: the 
contraction intensity, the acquisition period analysed, the contraction 
repetition. In almost all cases the IZ’ location’ shift due to these factors did 
not exceed 4 mm. Results generalization to other muscles should be made 
with caution. 
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3.2 INTRODUCTION 
 
The motor unit is considered to be the basic functional unit of the 
neuromuscular system; it is composed of a group of muscle fibres and the 
somatic motor neuron. When the somatic neuron fires an action potential, all 
fibres included in the motor unit contract, converting an electrical stimulus to 
a mechanical response (Standring and Gray, 2008). The motor unit’s action 
potentials travel along the fibres of that motor unit with a conduction velocity 
ranging from 2.6 to 5.3 m/s (Andreassen and Arendt-Nielsen, 1987). 
 
Differently from the autonomic pathways (i.e. parasympathetic pathway, 
sympathetic pathways, and adrenal sympathetic pathway), the somatic motor 
pathways contain a single neuron. As with the other types of synapses, the 
neuromuscular junction includes three main components: 1) the motor 
neuron’s presynaptic axon terminal, that contains synaptic vesicles and 
mitochondria; 2) the synaptic cleft, that is a gap of approximately 30 nm 
between the presynaptic axon and the postsynaptic membrane; 3) the 
postsynaptic membrane of the muscle fibres (i.e. the motor end plate), that 
contains high concentrations of nicotinic acetylcholine receptors (Marieb and 
Hoehn, 2013). The synaptic cleft contains acetylcholinesterase, an enzyme 
that breaks down the neurotransmitter acetylcholine. The cleft is filled with a 
fibrous matrix containing collagen fibres that bind the axons of a motor nerve 
with the muscle fibres (figure 3.1) (Sine, 2012). 
 
The IZ (i.e. the motor endplate region) of a muscle is the site where axons of 
the motor nerve divide into a number of branches that end in a claw-like 
motor endplate. The IZ of a muscle has been described in the literature as a 
narrow band usually running perpendicular to the middle of the muscle fibres 
(Defreitas et al., 2008, Mense et al., 2001). Coërs and Woolf (1959) were the 
first authors to describe this principle in human, combing muscle biopsies 
and intravital staining with methylene-blue (Coërs and Woolf, 1959). The 
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same spatial arrangement of the IZ was also reported in several muscles of 
stillborn infants (Christensen, 1959).  
 
 
 
 
Figure 3.1: Neuromuscular junction and the innervation zone. 
 
 
The morphology of the IZ depends on the fibres’ orientation and thus, muscle 
architecture is important in understanding the IZ’ location within muscles, and 
therefore as previously debated, to estimate the possible MTrP’ locations.  
Fibre’ architecture falls into two major categories, parallel and pennate 
(Fukunaga et al., 1997). In parallel muscle, fibres are parallel to the length of 
the muscle and the IZ’ morphology can be described as a straight line, 
perpendicular to midfibres. Examples of this architecture type are the biceps 
brachii muscle and sternocleidomastoid muscle.  Differently, pennate 
muscles have one or more tendons that extent over the length of the muscle, 
and their fibres run obliquely to insert into tendons (Oatis, 2009). The IZ’ 
morphology in these muscles is an irregular curved line: upper trapezius 
muscle and deltoid muscle are two examples (figure 3.2). Nevertheless, the 
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principle of using a midfibres region for identifying the IZ' location, is not 
always applicable. 
 
 
 
Figure 3.2: Location of the innervation zone in human skeletal muscles with 
different architectures (Adapted from Mense, 1999)  
 
 
For example, sartorius and semitendinosus muscles showed motor 
endplates that supply parallel bundles of short fibres, distributed along the 
muscle’s belly, resulting in a scattering of the IZ throughout the muscle 
(Coërs and Woolf, 1959). Again, the gracilis muscle demonstrated two 
distinct transverse IZs (Christensen, 1959). The IZ’ morphology and its exact 
location within muscles in the general population, have not been studied 
systematically, and only limited experimental data are available. Moreover, 
non-invasive techniques to detect the IZ, were not available until a few years 
ago. 
 
Innervation zone
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A first attempt to overcome both the limitations has been made by Masuda in 
1983; he started successfully to investigate the IZ of the biceps brachii 
muscle during a voluntary muscular contraction, using myoelectric signals 
(Masuda et al., 1983a). Specifically, a multichannel EMG amplifier was used 
and signals were picked up with an electrode array consisting of several 
electrodes arranged along the muscle fibre direction. (Masuda et al., 1983b). 
Afterwards, a number of studies applied surface electrode arrays to locate 
the IZ within specific muscles (Masuda et al., 1985, Iwasaki et al., 1990, 
Saitou et al., 2000, Falla et al., 2002). A group of Japanese researchers led a 
study in 17 muscles and 8 muscle groups in both the upper and lower limbs. 
Unfortunately, the distribution of the IZ was reported only in 3 volunteers 
(Saitou et al., 2000). The IZ was easily identified in all muscles having fibres 
running parallel to the skin for example, biceps brachii, intrinsic hand 
muscles, vastus lateralis and medialis, tensor fasciae latae, peronei, 
soleus, tibialis anterior. While in muscle with a complicated structure 
including pennation fibres, in-series fibres, and aponeurotic digitations, 
identification was difficult. The muscles involved were: deltoid, flexors and 
extensors in the forearm, rectus femoris, sartorius, hamstrings and 
gastrocnemius. Also, Shiraishi pointed to a few limitations in the localization 
of the IZ in muscles with complex fibre’ orientations (Shiraishi et al., 1995). 
More recently, Rainoldi described the IZ’ location in lower limb muscles and 
provided a method to standardise the electrode placement for those muscles 
(Rainoldi et al., 2004). Additionally, the IZ’ shift due to different isometric 
contraction intensities and joint angle positions have been characterized and 
described in the literature (Defreitas et al., 2008, DeFreitas et al., 2010, 
Martin and MacIsaac, 2006, Piitulainen et al.,2009). Beck and his colleagues 
extensively studied the IZ’ influence on sEMG variables (Beck et al., 2008a, 
Beck et al., 2008b, Beck et al., 2008c, Beck et al., 2007a, Beck et al., 2007b, 
Malek et al., 2006). 
 
The IZ’ location can be identified from sEMG signals detected using linear 
arrays of electrodes placed along the direction of the muscle fibres (Merletti 
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et al., 2003). In such configurations, the IZ appears as the area from where 
the potential propagates in two opposite directions towards the tendon 
regions (Masuda et al., 1983b).  Therefore, it has been proposed that the IZ’ 
position could be established by analysis of single differential sEMG signals 
based on two criteria: minimum signal amplitude and/or phase reversal. 
These criteria can be applied only to the single differential surface EMG 
signals, and not to monopolar and double differential signals, which do not 
show phase inversion (Merletti et al., 1999, Merletti et al., 2003). 
 
The validity of the proposed EMG technique to identify the IZ’ location, has 
been proposed by Masuda and Sadoyama in 1988. In their publication in 
Transactions on Biomedical Engineering, they illustrated how a column of 
electrodes receive action potentials from many muscles’ fibres, and how the 
action potentials from a single fibre are received by several electrode 
columns located nearby to the fibre (Masuda and Sadoyama, 1988). The 
distribution of the action potential’ sources was used to represent the 
configuration of the IZ. Notably, it was identified that surface potentials are 
mainly caused by muscle fibres near the skin surface, and that these fibres 
are only a portion of the fibres activated in the motor unit, especially in 
muscles with a large thickness. Additionally, although the distribution of 
muscle fibres is usually uniform, a variability in the distribution of fibres near 
the skin surface, provoke scatter of a IZ' location.  These elements should be 
considered when applying surface EMG to describe the IZ’ location. On 
account of the recent technological advancements, it is now possible to cover 
large areas of the muscle using arrays of electrodes, or even using a matrix 
of electrodes (Merletti et al., 2003). Thus, it is currently possible to obtain a 
wide, bi-dimensional measurement of the IZ’ location for most skeletal 
muscles. To ensure an accurate application of the described technique and 
therefore, a valid measurement of the IZ’ location, it is critical to respect two 
experimental elements. Firstly, it is important to select muscles with fibres 
parallel to the skin surface. This is because in order, to identify the IZ’ 
location, the motor unit’ action potentials should travel parallel to the columns 
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of electrodes. Secondly, motor unit action potentials should be detected 
during isometric contractions. Indeed, the IZ’ location (i.e. the source of the 
motor unit action potentials) during a dynamic contraction, shifts under the 
skin according to the anatomy of the muscle under investigation, and 
according to the range of motion (Piitulainen et al., 2009). A shift of the motor 
unit action potentials’ source may introduce a bias in the estimation of the IZ’ 
location. 
 
Being able to reliably identify the IZ within muscles has several possible 
applications, ranging from the simple anatomical descriptions to the more 
complex interventions’ optimisation. Indeed, IZ localisation has been 
proposed in order to provide indications for botulinum toxin injection, motor 
point biopsy, and muscle incision during surgery (Enck et al., 2004, Merletti 
et al., 2003, Mesin et al., 2009, Saitou et al., 2000). 
 
Methodologically, an analysis of how reliably the IZ can be located, is 
therefore, a prerequisite for further investigations concerning muscles. Two 
distinct issues should be addressed: the agreement between ratings made 
by the same observer or between different observers, and the IZ’ location 
constancy’ according to variables related to neuromuscular activation. 
Whenever humans are involved in a measurement procedure, it is critical to 
ensure that the results are reliable (Rankin and Stokes, 1998).  
 
Reliability is related to the amount of random error in a measurement. The 
more reliable the measure, the less the random error in it. Estimation of the 
intra-observer variability is relevant when a researcher is interested in the 
‘true’ differences among the observations made by the same observer, on 
the same subject. Estimation of the inter-observer variability is relevant when 
a researcher is interested in the ‘true’ differences among observers reporting 
different values of the same entity (Munro, 2005). Observers can be 
distracted, can get tired, can apply the measurement’ technique in different 
ways, or can misinterpret the measurement’ technique. This may be the case 
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in relation to the procedure to identify the IZ’ location using EMG signals 
where operators are requested to conduct a visual inspection of several EMG 
signals, and apply two criteria (i.e. minimum signal amplitude and/or phase 
reversal). Moreover, during sustained isometric contractions, a few variables 
such as time, intensity and repetitions, may affect the pool of motor units 
recruited. This study conducted such an analysis within the context of a 
project, to determine the relationship between the IZ and myofascial trigger 
points in the upper trapezius muscle. 
 
The aims of this work were to evaluate: 
– The intra- and inter-rater reliability of two operators in locating the IZ in 
the upper trapezius muscle, using a sEMG matrix.  
– The constancy of the IZ’ location in relation to the contraction intensity, 
the acquisition period analysed, and the contraction repetition. 
– Finally, the precision of matrix’ repositioning by two operators, has 
been described. 
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3.3 MATERIALS AND METHODS 
 
All the experimental sessions were conducted between October and 
November 2007, at the Laboratory of Engineering of Neuromuscular System 
and Motor Rehabilitation of Politecnico of Torino (LiSIN), Italy. The ethical 
approval for this study was granted by the Research Ethics Committee of 
Queen Margaret University (Edinburgh), and the local Regional Ethical 
Committee (Regione Piemonte, Italy). All experiments were conducted in 
accordance with the Declaration of Helsinki, and all procedures were carried 
out with the adequate understanding of the subjects. Potential participants 
were informed fully about the goals, procedures and risks of the study before 
it commenced, using an information sheet. All subjects signed an informed 
consent form prior to participating in any experimental procedures. 
 
3.3.1 Participants 
A convenience sample of healthy adult volunteers was invited to participate 
in the study using poster placed at strategic locations within LiSIN. 
The following inclusion criteria were adopted to determine whether a person 
could participate in the study: 
– Adult aged between 18 and 40 years’ old 
– Sex: male or female 
– Body mass index below 25 Kg/m2 
– Free of neck and shoulder pain  
Further, the following exclusion criteria were applied: 
– Recent surgery of the upper quadrant 
– Pregnancy 
– Neck pain during the last 3 weeks 
– Positive history for neurological disorders 
– Positive history for rheumatic disorders 
– Positive history for psychiatric disorders 
Considering the aims of the study, it was important to enrol subjects who 
were able to fully activate their upper trapezius muscle during the shoulder 
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elevation task. Thus to avoid bias related to impaired activation of the upper 
trapezius muscle, only subjects who didn’t report pain in the neck and 
shoulder prior to the experiment, were included in it. For the same reason, 
subjects were excluded if they suffered from any disorders that may limit their 
capacity to perform a shoulder elevation task. 
 
For ethical reasons, the reported inclusion/exclusion criteria were necessary 
to protect subjects from physical or psychological harm. Individuals with pain 
or recent surgery in the neck and shoulder region, were excluded as in these 
subjects, upper trapezius’ contractions are usually provocative. Moreover, 
although rare, a submaximal muscle contraction may induce pain or injuries 
even in healthy subjects, and especially during unusual tasks, such as 
repeated and intense bilateral shoulder elevation tasks. To reduce this risk, it 
was decided to limit the age of enrolment to 40 years, as aging may be 
associated with significant reduction of neuromuscular performance or 
function (Gouveia et al., 2013, Charlier et al., 2015, Milanovic et al., 2013). 
Exclusion of subjects on account of a positive history for neurological or 
rheumatic disorders was necessary not only to protect them from physical 
harm but also to exclude confounding factors related to possible 
neuromuscular impairments. Exclusion on account of a positive history of 
psychiatric for psychiatric disorders was necessary to avoid adverse 
psychological reactions to the experimental procedures, and also because 
participants may show may show altered cognitive capacity that potentially 
could impact upon their ability to provide informed consent. A body mass 
index below 25 Kg/m2 (i.e. BMI higher the 25 generally indicates overweight 
or obesity) was utilised, as amplitude and the quality of myoelectric signals 
are significantly affected by the extent of subcutaneous fat (Hermens et al., 
2000). 
 
 
3.3.2 Equipment 
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Surface EMG signals were detected using a matrix of 64 electrodes, with 8 
mm interelectrode distance (IED) and with electrodes arranged in five 
columns and 13 rows (one column of 12 electrodes and four of 13 
electrodes, model ELSCH064, designed by LISiN at Politecnico di Torino and 
manufactured by OT Bioelectronica, Torino, Italy) (figure 3.3).  
 
The electrode matrix was held in place on the skin using a piece of 1 mm 
thick, double adhesive foam, which contained cavities for the insertion of 
electrode gel. These cavities corresponded with the electrode’ matrix. Each 
electrode cavity was injected with 20 μl of conductive gel, using a gel 
dispenser (Eppendorf AG-Multipette plus, Germany) to ensure proper 
electrode–skin contact (figure 3.3).  
 
Surface EMG signals were amplified within a bandwidth of 10 – 750 Hz and 
with a gain of 1000 or 2000, depending on the surface EMG amplitude during 
the isometric contraction. Signals were sampled at 2048 Hz and converted 
using a 12 bits A/D (analog-to-digital) converter. Samples were visualized 
during acquisition and then stored on a personal computer using customized 
software developed at LISiN (Acquisition V.1.62). Force generated by the 
upper trapezius muscle was measured during a shoulder elevation task, with 
subjects in sitting position. A metallic framework with two handles attached to 
bars set on rails, had been fixed under a chair’ seat to permit the correct 
subject’s positioning in order to perform the task (figure 3.5). The handle on 
the right side had been fixed to a load cell (Mod. UU-K100, CAP 100 Kgf).  
This special chair had been developed originally at the LISiN for a previous 
study on the trapezius muscle (Cescon et al., 2008), with a few minimal 
modifications of the handles needing to be done for this study.   
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Figure 3.3: Matrix electrodes and gel dispenser. Five columns x 13 rows, 
one column of 12 electrodes and four of 13 electrodes, 8 mm inter-electrode 
distance, model ELSCH064, designed by LISiN at Politecnico di Torino and 
manufactured by OT Bioelectronica, Torino, Italy. On the left side is the 
double adhesive foam with cavities. Below, is the gel dispenser produced by 
Eppendorf, Germany. 
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Figure 3.4: EMG-USB 128 channels surface EMG amplifier. EMG-USB was 
designed by LISiN at Politecnico di Torino and manufactured by OT 
Bioelectronica, Torino, Italy. 
 
 
 
 
Figure 3.5. The modified chair with the load cell. 
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The force signals was amplified (MISO II, LISiN, Torino, Italy, bandwidth 0-80 
HZ) and visualized using a bar of 50 green LEDs (100% MVC). An orange 
LED was used to pinpoint the target percentage of the MVC. 
 
In order to establish their maximum voluntary contraction (MVC) of upper 
trapezius muscle, subjects were asked to sit on a custom-designed chair and 
to hold the two chair’ handles. The handle on the right side was fixed to a 
load cell in order to measure the force exerted during shoulder elevation. 
Force signals were acquired and amplified (bandwidth 0 – 80 Hz) using a 
MISO II amplifier (LISiN, Torino, Italy). Feedback to subjects was provided by 
a bar of LEDs indicating the percentage of the MVC reached during each 
contraction (figure 3.6). 
 
 
 
 
Figure 3.6 Experimental setup. The custom made chair with a load cell 
connected to the right handle and a subject, with a matrix placed on the 
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upper trapezius, looking at the visual feedback device (MISO II, LISiN, 
Torino, Italy). 
 
3.3.3 Experimental design 
All the volunteers were asked to complete a case form that included the 
following information: age, gender, weight, height, presence of pain in the 
neck and shoulder region, recent surgery of the upper quadrant, pregnancy, 
diagnosis for neurological disorders, diagnosis for rheumatic disorders, and 
diagnosis for psychiatric disorders. Using the reported data, the researcher 
computed the body mass index (BMI) using the formula: weight in kilograms 
divided by the square of the height in meters (Mei et al., 2002). All of the 
information was self-reported; no measurements or tests were conducted to 
verify the anthropometric details, or the reported diagnosis. 
 
Surface EMG signals were collected from the right upper trapezius muscle of 
all subjects. For technical reasons, it had been decided to collect data on the 
right side of the body. The equipment (i.e. the modified chair with the load 
cell) included only one load cell. During the experimental sessions, it was 
technically complex and time consuming to move the load cell from one side 
to the other. Given that there had been a need to be considerate of the time 
that research participants were asked to commit to research projects, we 
decided to collect all the surface EMG signals from right upper trapezius 
muscle. This was considered acceptable because this study focused on the 
reliability of IZ localization using visual inspection of motor unit’ action 
potentials’ propagation. While a different IZ' location between left and right 
trapezius musculature, or between dominant and non-dominant upper limbs 
cannot be excluded, it had been outwith the scope of this investigation. 
Moreover, the planned clinical study was also focus on right upper trapezius 
muscle.  
 
Two physiotherapists, identified as operator A and operator B, conducted the 
experimental sessions. They were trained to use the described 
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instrumentation and to analyse the recorded data. Prior to undertaking the 
experimental protocol, both operators undertook a two-week training period 
on how to apply the criteria to locate the IZ.  This training consisted of 
instruction in the procedure and practice, with feedback on 100 screenshots 
of eleven single differential surface EMG signals (i.e. channel) from different 
skeletal muscles. Each screenshot included one EMG epoch of 0.25s and 
the operators had to score the IZ’ location according to the available 
channels. Both training and feedback were provided by a senior researcher 
(Lorenda Lo Conte), proficient in biomedical signal processing and employed 
for more than 10 years at the Laboratory of Engineering of Neuromuscular 
System and Motor Rehabilitation of Politecnico of Torino (LiSIN). The training 
was completed successfully and both the operators were able to correctly 
apply the criteria to identify the IZ’ location. 
 
Prior to collecting surface EMG data, in order to measure the MVC, each 
subject sat with the trunk against the chair back, arms by the side, hands 
grasping the two handles, and feet hanging in the air. The subject was 
instructed to perform a shoulder elevation task by pulling upwards on both 
handles simultaneously (to ensure trunk stability) and without moving the 
shoulder girdle, so that the activation of the trapezius muscle was indeed due 
to an isometric contraction. The co-activation of the levator scapulae muscle 
was considered to be not relevant due to its anatomical position with respect 
to the upper trapezius muscle (i.e. medial and ventral). Indeed, the peak 
potential amplitude of motor unit’ action potentials decays drastically within 
20 to 25 mm from the source (Farina et al., 2002). Considering that the upper 
trapezius’ thickness at the level T1 is about 15 mm (O'Sullivan et al., 2009), 
the distance of the levator scapula from the surface electrodes can be 20-30 
mm approximately. Moreover, the motor unit’ action potentials of the levator 
scapula muscle travel in a different direction with respect to the upper 
trapezius fibres (caudal-cranial for levator scapulae muscle and medial-
lateral for upper trapezius muscle), and can only minimally affect the 
amplitude of the EMG from the upper trapezius muscle. 
 93 
 
Before starting the experiment, each subject learnt how to use the force 
feedback tool to calibrate the force exerted, according to the level requested 
by the operator. The reference MVC force’ level for each subject was 
determined as the maximum of three contractions, with each contraction 
being followed by 2 minutes of rest. Subjects were verbally encouraged 
during the 3 MVCs. 
 
An important factor affecting the impedance of the electrode-gel-skin 
interface is skin. It has a large impendence to current flow due to the upper 
layer of the epidermis, the stratum corneum. According to a study published 
by Kim in 1989, a mild abrasion of the skin with fine sandpaper can reduce 
the skin resistance by a factor 100 to 1000 (Kim, 1989). The European 
Project on Surface EMG for Non Invasive Assessment of Muscles (SENIAM) 
recommends that the skin procedures consist of shaving, massaging with 
sandpaper or abrasive paste and rinsing the skin with isopropyl alcohol to 
remove the abrasion residuals (Hermens et al., 2000). Therefore, oils and 
flaky skin layers were removed from the skin of each of the participants in 
this study by abrasive paste (Spes Medica srl, Genoa, Italy). 
 
For each subject, a landmark system to place the electrode matrix according 
to the anatomical description of the upper trapezius muscle, had been 
agreed on by the two operators  (Hermens, 1999). Subsequently, one 
operator traced with a surgical pen, a first line joining the C7 vertebra and the 
acromial angle, and a second line perpendicular to the midway position of the 
first one. The so defined orthogonal system was used to place the center of 
the matrix on the intersection point of the two lines (figure 3.7). 
 
Following this, sEMG acquisition started. Each subject performed six 
contractions that was overseen by operator A and six contractions with 
operator B. The operator’s order was randomized. Randomization was 
performed using sealed opaque envelopes: 10 for the subjects, 2 for the 
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operators and 6 for the contraction’s order. Each contraction lasted 10 s. 
Three of these contractions were at 20% MVC and three were at 40% MVC. 
Again, the order of the contractions was randomized. 
 
After a session of six contractions, the electrode matrix was removed and 
repositioned by the second operator for the following session. The landmark 
system previously drawn on each subject was not erased between the 
matrix’ repositioning. 
 
 
 
 
 
 
Figure 3.7: Matrix’ position according to the anatomical landmark system, 
with columns oriented with respect to the direction of upper trapezius fibres. 
C7 indicates the spinous process of the seventh cervical vertebra. AA 
indicates the acromial angle of the scapula. 
 
C7 
AA	
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3.3.4 Data 
Overall 600 signals were available for the analysis (2 operators x 10 subjects 
x 6 contractions x 5 columns). Signals were acquired in single differential 
mode. 
 
In order to address the main questions of this work, we randomly extracted 
900 epochs of 0.25s of sEMG signals from each of the matrix columns. 
Epochs of 11 single differential surface EMG signals were presented to the 
two operators for visual analysis. Each file reported signals from 11 
numbered channels.   Each signal corresponded to the differences between 
the signals collected by two consecutive electrodes within the same column 
(figure 3.8 and 3.9). Using customized software, we created five epoch lists: 
 
List number 1 (L_Reliability) was used to assess the intra-rater and the inter-
rater reliability in locating the IZ’ position. One hundred epochs collected by 
operator A and 100 by operator B, including 100 at 20% MVC and 100 at 
40% MVC, were extracted. All the epochs were from 5.00s to 5.25s. The 
latter epochs were randomly extracted from among the 600 acquisitions 
(appendix I). 
 
List number 2 (L_Intensity) was used to assess if the intensity of the 
isometric contraction had an influence on the IZ’ location. One hundred 
epochs collected by operator A were paired together, and these included 50 
epochs at 20% MVC and 50 epochs at 40% MVC. These epochs were 
randomly extracted from the 600 acquisitions obtained from all the enrolled 
subjects, from 5.00s to 5.25s (appendix II). 
 
List number 3 (L_Time) was used to assess if the IZ’ location was stable over 
10s of isometric contraction. Two hundred epochs collected by the two 
operators were extracted randomly. Fifty signals were randomly selected and 
for each of the signals, four epochs were randomly extracted (appendix III). 
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Figure 3.8: Eleven SD sEMG signals over a 0.25 s epoch, collected from channel 40 to channel 50 of the array. Dotted lines 
represent motor unit action potential’ propagation. The circle indicates the IZ’ location estimated by the operator (channel 45) 
and scored as 45. 
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Figure 3.9. Eleven SD sEMG signals over a 0.25 s, collected from channel 14 to channel 24 of the array. Dotted lines 
represent motor unit action potential’ propagation. The circle indicates the IZ’ location identified by the operator between 
channel 18 and channel 19, and scored as 18.
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List number 4 (L_Repetition) was used to assess whether repetitive 
contractions had an effect on the IZ’ location. Three hundred epochs 
collected by operator B were extracted. Signals from the same columns in 
the 10 subjects, during the six contractions, were considered. All the epochs 
were extracted from 5.00 s to 5.25 s (appendix IV). 
 
Finally, list number 5 (L_Repositioning) was used to assess the precision of 
matrix’ repositioning by the two operators, using the same anatomical 
landmark system (ALS). One hundred epochs collected by operators A and B 
were extracted randomly. All of the first 20% MVC signals from the same 
column were considered (2 operators x 10 subjects x 5 columns) (appendix V 
and VI).  
 
Criteria applied by the customized software to extract the epochs from the 
five lists, are summarized in the table 3.1. All the above epoch’s lists were 
provided to the two operators for the visual analysis. Each operator repeated 
the procedures three weeks later. 
 
3.3.5 Localization of the innervation zone 
The two operators estimated the IZ’ location by visual analysis, 
independently from each other. Each selected epoch (a set of 11 SD signals) 
was visually analysed to identify the IZ’ area, as the one corresponding to the 
signal with minimum amplitude and/or phase reversal (Merletti et al., 1999). If 
the minimal amplitude channel was between two channels showing phase 
reversal (figure 3.8), the IZ was located in correspondence of that channel. If 
two channels showing phase reversal were adjacent (figure 3.9), the IZ was 
located as the middle area between these two channels. In this case, the 
operator actually had to interpolate between the two signals. 
 
Since the interelectrode distance was 8 mm, and given the interpolation, the 
resolution with which each operator estimated the IZ’ location was 4 mm, or 
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half the interelectrode distance. Possible scores for the IZ’ locations for each 
column, are reported in figure 3.10. 
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Table 3.1: Criteria to extract the epochs for the five lists. 
 
List Aim EMG Acquisitions 
Operator 
(A or B) 
MVC 
(20% or 40%) 
Time 
 (0 to 10 s) 
Repetitions 
(1 to 6) 
Number 1  
Intra and inter rater 
reliability 
40  EMG acq. RND 
selected ( 200 epochs) 
20 acq. Form A 
20 acq. From B 
10 acq. at 20% and 10 
acq. at 40%from A 
10 acq. at 20% and 10 
acq. at 40%from B 
Fixed RND 
Number 2  
Effect of isometric 
contraction intensity 
1 EMG acq. For each 
subject (100 epochs) 
A fixed 
50 epochs at 20% and 50 
epochs at 40% from the 
same session 
Fixed RND 
Number 3  
Effect of epoch;s 
time extraction 
10 EMG acq. RND 
selected (200 epochs) 
RND RND 
4 RND epochs 
for each column 
of the selected 
acq. 
RND 
Number 4  
Effect of contraction 
repetition 
All EMG acq. for each 
subject (300 epochs) 
B fixed 20% and 40% Fixed 
All the 6 
contractions 
for each 
subjects 
Number 5 
Effect of matrix 
repositioning 
1 EMG acq for each 
session (100 epochs) 
A and B 20% Fixed 
Fixed, first 
20% repetition 
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Figure 3.10: Score system for the IZ’ location according to the electrode’ 
matrix. Red numbers, which were not available as surface EMG signals, 
were detected in single differential mode. 
 
 
3.3.6 Statistical analysis 
The agreement among estimates in each list, was reported by absolute 
values and percentage. Intra-rater and inter-rater reliability (L_Reliability) 
were assessed using Cohen’s Kappa statistics (Cohen, 1960), as the IZ’ 
location, measured using surface EMG signals (detected with the linear 
array) should be considered a nominal variable. Indeed, IZ' location has been 
described considering two possible positions among the 11 channels: 
corresponding to the position of one channel or between two consecutive 
channels.  
 
The Kappa coefficient is more robust than the percent agreement calculation, 
since it takes into account the agreement occurring by chance. The 
constancy in IZ’ localization has been quantified as the number and entity of 
the disagreement regarding the IZ’ position, when considering variables 
related to neuromuscular activation. 
 
1 2 6 8 10 12 11 3 4 5 7 9
25 23 24 21 22 20 18 19 17 15 16 14 13 
26 28 27 30 29 31 33 32 34 36 35 37 38 
51 49 50 47 48 46 44 45 43 41 42 40 39 
52 54 53 56 55 57 59 58 60 62 61 63 64 
24.5 22.5 23.5 20.5 21.5 19.5 17.5 18.5 16.5 14.5 15.5 13.5 
26.5 28.5 27.5 30.5 29.5 31.5 33.5 32.5 34.5 36.5 35.5 37.5 
50.5 48.5 49.5 46.5 47.5 45.5 43.5 44.5 42.5 40.5 41.5 39.5 
52.5 54.5 53.5 56.5 55.5 57.5 59.5 58.5 60.5 62.5 61.5 63.5 
2.5 1.5 4.5 3.5 5.5 7.5 6.5 8.5 10.5 9.5 11.5 
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In order to run the Cohen’s Kappa statistics, the following assumptions were 
met: judgement made by the two raters must be measured on an ordinal or 
nominal scale; judgement data must be paired observations of the same 
phenomenon; each judgement variable must have the same number of 
categories; the two raters must be independent and fixed (Cohen, 1960). 
 
Prior to undertaking the study, sample size was obtained using a table based 
on a goodness-of-fit formula provided by Donner and Eliasziw (1992).  
Considering our 2-rater study, the minimum number of IZ’ estimates (i.e. 
epochs) required to detect a kappa coefficient as statistically significant (p < 
0.05), with 90% power, was 30. It was assumed a null hypothesis value of 
Kappa equal to .00 and a Kappa to detect, of 0.60 (appendix VII).  
 
 
3.4 RESULTS 
 
Ten volunteer subjects, seven males and three females, all right-handed, 
participated in this study. Subjects’ characteristics are summarized in table 
3.2. The operator’s order and contraction’s order was randomized prior to the 
data collection (appendix VIII).  Absolute frequency of IZ is reported for each 
possible location on the electrode’ matrix, is summarized in figure 3.11. 
 
Intra-rater reliability analysis (L_Reliability) indicated an ‘‘almost perfect 
agreement’’ (Interpretation of the Kappa coefficient: 0.01 – 0.20 slight 
agreement, 0.21 – 0.40 fair agreement, 0.41 – 0.60 moderate agreement, 
0.61 – 0.80 substantial agreement, 0.81 – 0.99 almost perfect agreement, for 
both operators) (Cohen, 1960); the percent agreement for operator A was 
91.5% (table 3.3), with Kappa = 0.90, and the percent agreement for operator 
B was 93% (table 3.4) with Kappa = 0.92. Inter-rater reliability analysis 
indicated an ‘almost perfect agreement’’ between the two operators. The 
percent agreement was 85% (table 3.5) of estimates, with Kappa = 0.82.  
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The variations on IZ’ localization for the remaining lists were as follows: no 
variation in 76% (38 out of 50 epochs) of the estimates in L_Intensity, no 
variation in 66% (33 out of 50) of the estimates in L_Time, no variation in 
50% (25 out 50 epochs) of the estimates in L_Repetition, and no variation in 
34% (17 out 50 epochs) of estimates in L_Repositioning. The results are 
summarized in table 3.6 and table 3.7. 
 
 
 
 
Figure 3.11: IZ’ locations estimated by the two raters using the proposed 
score system. Absolute frequency of IZ is reported for each possible location 
on the electrode’ matrix. Both the operators examined the same 900 epochs 
of 0.25 s. 
 
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
0 
20 
40 
60 
80 
100 
3 24 24 54 44 26 5 
23 50 69 34 3 1 
19 41 76 21 23 
23 6 49 38 52 2 10 
7 4 9 95 23 17 14 11 
  
32 20 61 43 22 1 1 
28 39 74 29 10 
26 39 68 24 21 2 
23 6 48 26 66 1 10 
8 3 4 108 16 18 6 17 
ç C7 
ç C7 
AA è  
AA è  
Rater A 
Rater B 
 104 
Table 3.2: Subjects’ characteristics. Values are expressed as mean ± SD except for gender.  F: female, M: male, BMI: body 
mass index, C7 to AA: distance between C7 vertebra and the acromial angle, MVC: maximal voluntary contraction. 
 
Subject_ID 
Age 
(years) 
Gender 
Height  
(m) 
Weight  
(Kg) 
BMI  
(Kg/m
2
) 
C7 to AA 
 (cm) 
MVC  
(N) 
1 37 F 1.63 55 20.7 18.5 412 
2 24 M 1.82 82 24.7 24 666 
3 23 M 1.85 73 21.3 24 735 
4 27 M 1.73 74 24.7 22 637 
5 27 M 1.78 78 24.6 23.5 676 
6 33 M 1.86 82 23.7 21.5 676 
7 21 M 1.75 69 22.5 20 490 
8 25 F 1.58 50 20 20 382 
9 27 M 1.75 68 22.2 22.7 666 
10 40 F 1.68 52 18.4 19 529 
 
28.4 ± 6.2 3F, 7M 1.7 ± 0.1 68.3 ± 12 22.3 ± 2.2 21.5 ± 2 586 ± 124 
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Table 3.3: Intra-rater percentage agreement for operator A during IZ’ 
estimations. 
Column Epochs Agreement Disagreement 
1 40 35 5 
2 40 37 3 
3 40 36 4 
4 40 38 2 
5 40 37 3 
Total 200 183 (91.5%) 17 (8.5%) 
 
 
Table 3.4: Intra-rater percentage agreement for operator B during IZ’ 
estimations. 
Column Epochs Agreement Disagreement 
1 40 39 1 
2 40 37 3 
3 40 37 3 
4 40 36 4 
5 40 37 3 
Total 200 186 (93%) 14 (7%) 
 
 
Table 3.5: Inter-rater percentage of agreement for operator A and B during 
IZ’ estimations. 
Column Epochs Agreement Disagreement 
1 40 32 8 
2 40 33 7 
3 40 34 6 
4 40 35 5 
5 40 36 4 
Tot 200 170 (85%) 30 (15%) 
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Table 3.6: Summary of the results, reliability analysis. IED: inter-electrode distance, IZ: innervation zone. (1 and 2):Intra-rater 
agreement and disagreement (number of cases and percentage) and K values, (3) inter-rater agreement and disagreement 
(number of cases and percentage) and K values.  
 
Row List’s name 
Estimates K statistics 
Agreement Disagreement K values 
1) 
L_Reliability, rater A 
(Epochs considered: 200, two estimates for each epoch) 
186 (93%) 14 (7%) 0.90 
2) 
L_Reliability, rater B 
(Epochs considered: 200, two estimates for each epoch) 
170 (85%) 30 (15%) 0.92 
3) 
L_Reliability rater A vs B 
(Epochs considered: 200, two estimates for each epoch) 
38 (76%) 12 (24%) 0.82 
4) 
L_Intensity 
(Epochs considered: 100, 50 at each level, one rater) 
33 (66%)* 17 (34%)** - 
5) 
L_Time 
(Epochs included: 200, 50 groups of 4 epochs, one rater) 
25 (50%)* 25 (50%)** - 
6) 
L_Repetition 
(Epochs included: 300, 50 groups of 6 epochs,one rater) 
17 (34%) 33 (66%) - 
7) 
L_Repositioning 
(Epochs included: 100, 50 for each of the two applications, one rater) 
183 (91.5%) 17 (8.5%) - 
       * No IZ’ shift observed within the epoch’s group . ** At least one IZ’ shift observed within the epoch’s group 
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Table 3.7: Summary of the results, disagreement and IZ’ shift analysis. IED: inter-electrode distance, IZ: innervation zone. 
 
Row  List’s name 
Extent of disagreement or  observed IZ’ shift  
(number of cases) 
0.5 
IED 
1 
IED 
1.5 
IED 
2 
IED 
1) 
L_Reliability, rater A 
(Epochs considered: 200, two estimates for each epoch) 
15 2 0 0 
2) 
L_Reliability, rater B 
(Epochs considered: 200, two estimates for each epoch) 
13 0 0 1 
3) 
L_Reliability rater A vs B 
(Epochs considered: 200, two estimates for each epoch) 
28 1 0 1 
4) 
L_Intensity 
(Epochs considered: 100, 50 at each level, one rater) 
10 2 0 0 
5) 
L_Time 
(Epochs included: 200, 50 groups of 4 epochs, one rater) 
16 1 0 0 
6) 
L_Repetition 
(Epochs included: 300, 50 groups of 6 epochs,one rater) 
20 4 0 1 
7) 
L_Repositioning 
(Epochs included: 100, 50 for each of the two applications, one rater) 
20 12 1 0 
 
Additional notes for table 3.7 and 3.8. 
(1 and 2) Intra-rater agreement and disagreement (number of cases and percentage), entity of disagreement expressed in number of cases showing disagreement of 0.5, 1, 1.5, and 2 IED, 
Kappa value (Cohen 1960). 
(3) Inter-rater agreement and disagreement, as above. 
(4) Agreement and disagreement between two estimates of the IZ’ location (by one rater) at two contraction intensities (20% MVC and 40% MVC). 
(5) Agreement and disagreement among four estimates of the IZ’ location (by one rater) using four epochs from the same signal. 
(6) Agreement and disagreement among six estimates of the IZ’ location (by one rater) using six epochs from six consecutive contractions. 
(7) Agreement and disagreement between two estimates of the IZ’ location (by one rater, for 10 subjects and for each column of the matrix) after two matrix applications on each subject (10 
subjects x 5 columns x 2 conditions).   
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3.5 DISCUSSION 
 
Recently, a few methods have been proposed to automatically estimate the 
IZ’ location (Beck et al., 2012, Enck et al., 2010, Mesin et al., 2009, Ostlund 
et al., 2007). A test set of sEMG signals for which the IZ has been located by 
expert raters, can be used as the ‘‘gold standard’’ against which to test 
automated methods. 
 
During this study, the raters successfully scored 900 epochs, providing IZ’ 
location for examined epochs. Prior to this IZ’ evaluation, the raters 
completed a specific training.  The results regarding intra- and inter-rater 
reliability showed that two trained operators exhibit a high rate of agreement 
in locating the IZ, using the information provided by single differential sEMG 
signals acquired with an electrode matrix. All the Kappa values were in the 
‘‘almost perfect agreement’’ range. There is only a slight difference between 
intra- and inter-rater reliability and, as expected, the chance of agreement is 
greater in the intra-rater reliability’ case. 
 
Considering the degree of disagreement, the intra-rater results show that, 
with the exception of three estimates out of 31 (two by operator A, one by 
operator B), the operators disagree by half a channel (15 estimates for 
operator A, 13 for operator B). Similarly, in 28 cases out of the 30 for which 
the two operators disagree (inter-rater disagreement), they do so by half a 
channel (table 3.7). Four millimeters (half IED) is the minimum disagreement 
that can be detected, given the experimental conditions. 
 
This half-channel disagreement points to the operator’s difficulty in 
discriminating between an IZ under a single channel or between two 
consecutive channels. A review using visual assessment showed that these 
half channel disagreements were usually present in epochs having more 
than one channel with reduced amplitude and with a phase that hadn't been 
discerned easily. An example of disagreement between raters is reported in 
figure 3.12. This condition makes the identification of a clear phase reversal 
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somewhat more difficult. This phenomenon could be due either to positions 
in which there is a high electrode–skin impedance, or to an IZ that had been 
wider than the IED. 
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Figure 3.12: Example of disagreement of half an IED between the raters.  
 
Rater A: 31.5 Rater B: 31 
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Once more, the results highlight the importance of proper skin treatment to 
reduce as much as possible, skin impedance prior to any sEMG’ acquisition 
(Merletti et al., 2009). 
 
The remaining lists (L_intensity, L_time, L_repetition, L_repositioning) clearly 
indicate an increased discordance between estimates with respect to intra-
rater and inter-rater reliability (L_reliability), in the range of 34 – 66% (table 
3.6). This suggests that variables affecting populations of active MUs (or 
related to the signal acquisition’ procedures) could affect the IZ’ location 
constancy’, determining a shift of the estimated location. 
 
The comparison between 20% MVC and 40% MVC epochs (L_intensity list) 
showed that force intensity could affect the IZ’ location, possibly because the 
newly recruited motor units have different IZs. The difference between 
estimates (table 3.7) is one channel in two cases, and in 10 cases half a 
channel. A minimal IZ’ shift due to the force levels and joint angle, has been 
already reported for the vastus lateralis, vastus medials, and the biceps 
brachii muscle (Martin and MacIsaac, 2006, Rainoldi et al., 2000), where the 
resolution of the IZ shift is determined by the IED of the used array. For 
example, the biceps brachii IZ’ shift, using a 15-channel array with 2.5 mm 
IED, has been quantified as varying between 4.5 and 7 mm with increases in 
isometric force and independently, with increasing joint angle (Defreitas et 
al., 2008). Our results show that the same phenomenon could also be 
observed in the upper trapezius, and be explained either by the shortening of 
the muscle fibres and lengthening of the tendons (Piitulainen et al., 2009), or 
by the recruiting of MUs with slightly different IZ’ locations (Gazzoni et al., 
2001). 
 
The level of disagreement (in percentage) for the L_time and L_repetition 
(row five and six of table 1) is higher than that reported in row one to four. 
This higher value accounts for the intra-rater reliability (rows one and two of 
table 1) that affects each of the comparisons between pairs of the four (six 
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pairs according to the combinatorics) or six epochs (15 pairs according to the 
combinatorics). Indeed, the expected intra-rater agreement using four or six 
epochs, should be lower. Considering four estimates (always the same 
epoch), the expected percentages of agreement for operator B will be 0.93 
(93%) to the power of six, which correspond to 0.64 (64%). The same 
calculations for six epochs result in 0.34 (34%). 
 
Therefore, it is not possible to simply conclude that the durations of the 
isometric contractions and their repetition, have an effect on the IZ’ location 
constancy, as these changes could well be due, at least in part, to human 
uncertainty in determining the IZ. 
 
The last list (L_positioning) shows a relatively high discordance level in IZ’ 
location after electrode matrix’ repositioning, with a difference between 
estimates of one or more IED in 13 out of 50 IZ’ location’ estimates (table 
3.11). This indicates that the matrix’ placement has been a difficult step of 
the experimental procedure, even though the landmark system was the 
same. Positioning should be performed with extreme attention, carefully 
centering and aligning the matrix with respect to the landmark system that 
had been drawn on the subject’s skin. This could be difficult in some 
subjects, as the upper trapezius area is not always a flat surface and the 
electrode matrix is only partially flexible. However, it should be noted that the 
positioning of the matrix does not influence the reliability of an operator in 
estimating the IZ’ location. 
 
 
3.6 LIMITATIONS OF THE STUDY 
 
As mentioned previously, the validity of surface EMG in locating the IZ was 
originally described in the eighties (Masuda and Sadoyama, 1988). 
Nevertheless, its validity can be limited by two factors: the ability to 
adequately cover the muscle belly and the execution of isometric contraction. 
The experimental procedures attempted to control both of these factors. The 
 113 
electrode matrix that was used was the largest available on the market, 
covering an area of 30.72 cm2 (9.6 cm x 3.2 cm). Given the anatomy of 
upper trapezius muscle, this should be sufficient, but it is acknowledged that 
a complete covering of trapezius muscle cannot be guaranteed and hence, a 
partial localization of the IZ cannot be excluded. Whilst consideration was 
given to ensuring that the IZ’ location was established during a shoulder’ 
elevation task that used a standardised positioning of subjects, it is 
recognised that small changes of posture may have occurred during the 
contractions, which may have induced an IZ’ shift during the EMG’ recording. 
However, an investigator carefully monitored the subjects’ posture to ensure 
a consistent starting posture and performance during the task. 
 
In this reliability study, the Kappa statistic had been used as the IZ’ position 
was considered to be a nominal scale with two possible values (i.e. on one 
channel, or between two channels) among the 11 channels. Additionally, the 
frequency, the size and the range of the disagreement were explored using 
descriptive statistics (Sim and Wright, 2005). The epoch’s sample (i.e. 200) 
largely exceeded the minimum required (i.e. 30) assuming a null hypothesis 
value of Kappa equal to .00, but epochs were randomly extracted from EMG’ 
measurements performed on 10 subjects. Their age ranged from 21 to 40 
years and their BMI from 18.4 to 24.7.  A sampling error cannot be excluded; 
a larger number of subjects with different characteristics may lead to a 
different epoch’s sample. The quality of EMG’ signals may be affected by 
aging or anthropometrics characteristics of the subjects; in particular, an 
increase of subcutaneous fat layer can induce a reduction of the signal’ 
amplitude an increase of the cross-talk’ effect (Merletti and Parker, 2004). 
This may lead to a difficulty in applying the visual analysis and thus, an 
increase of disagreements between operators.  
 
Signals were detected using a matrix of 64 electrodes (5 columns and 13 
rows) with 8 mm IED that covered an area of 30.72 cm2 (9.6 cm X 3.2 cm). 
Each matrix was carefully placed on a standardized ALS assuming that fibres 
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were parallel to the matrix’s columns.  An alternative method for the matrix’ 
placement can potentially ensure a better alignment between muscle fibres 
and matrix columns. This could facilitate the representation of the motor unit’ 
action potential’ propagation and thus, potentially improve the application of 
the visual analysis for the IZ’ detection.  
 
The 8 mm IED limited the accuracy of the IZ’ estimations to 4 mm (i.e. half 
IED). This level of accuracy was deemed suitable for this experiment's 
purpose but it could be inadequate for different applications, such as for 
example, surgical incisions or botulinum toxin injections. Matrices or arrays of 
electrodes with a lower IED (i.e. 5mm or 2.5 mm) are commercially available 
but generalization of results of this study to different methods in order to 
detect the EMG’ signal, should be made with caution.  
 
For a similar reason, the results cannot extend from the upper trapezius 
muscle to different muscles. The methodology can be applied to other 
muscles with an arrangement of parallel fibres but not to muscles with 
pennate fibres’ arrangements, in which motor units’ action potential 
propagation can be poorly visualized using surface EMG (Barbero et al., 
2012b, Beretta Piccoli et al., 2014). The upper trapezius muscle may be 
considered an optimal muscle to test the proposed method, but reliability 
could be lower in other muscles.   
 
 
3.7 CONCLUSIONS 
 
This study provides strong evidence that the visual estimation of the IZ’ 
location using sEMG’ signals, acquired by an electrode’ matrix, is a reliable 
procedure. This is a necessary prerequisite for a planned investigation on the 
spatial relationship between the IZ and myofascial trigger points in the upper 
trapezius muscle. This methodology could be also considered for use in 
other potential applications, such as determining the physiological 
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characteristics of muscles, optimising applications of functional electrical 
stimulation, and guiding botulinum toxin injection, motor point biopsy, or 
muscle incision during surgery. Moreover, manual annotations can be used 
to compare and validate the output of algorithms that determine the IZ’ 
location automatically. These results also show that the resolution in locating 
the IZ of the trapezius is half IED. This conclusion may or may not be 
generalized to other muscles with different innervations’ morphology. 
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CHAPTER 4  
 
 
 
 
INTRA-RATER RELIABILITY OF AN EXPERINCED 
PHYSIOTHERAPIST IN LOCATING MYOFASCIAL 
TRIGGER POINTS IN UPPER TRAPEZIUS MUSCLE 
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4.1 SUMMARY  
 
Myofascial trigger points (MTrPs) are considered the principal clinical feature 
of MPS. A MTrP consists of spot tenderness within a taut band of muscle’ 
fibres and its stimulation can produce both local and referred pain. The 
clinical diagnosis of MPS depends on correct history’ taking and a physical 
examination aimed at identifying the presence of a MTrP. The purpose of this 
study was to investigate the intra-rater reliability of a palpation protocol used 
for locating an MTrP in the upper trapezius muscle. 
 
Twenty-four subjects (23 female and 1 male; age 24 ± 3 years) with a MTrP 
in the upper trapezius muscle were examined by an experienced 
physiotherapist. During each of eight experimental sessions, subjects were 
examined twice in randomized order, using a palpation’ protocol. An 
anatomical landmark system was defined and the MTrP’ location established 
using X and Y values. 
The intraclass correlation coefficient, ICC(1,1),values were 0.62 (95% CI: 0.30 
–  0.81) for X and 0.81 (95% CI: 0.61 – 0.91) for Y. The Bland–Altman plots 
for X and Y showed a mean of difference of 0.04 and 20.2 mm, respectively. 
Limits of agreement for X ranged from 26.3 to 26.2 mm, and for Y from 27.0 
to 26.4 mm. 
The ICC(1,1) for the observed values revealed a moderate to high correlation, 
and the Bland–Altman analysis showed means of difference that were very 
close to zero, with narrow limits of agreement. An experienced 
physiotherapist can reliably identify MTrP’ locations in upper trapezius 
muscle using a palpation protocol. 
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4.2 INTRODUCTION 
 
Pain is a ubiquitous and mutable symptom for patients in all the branches of 
medicine. Musculoskeletal pain perceived in different regions (neck pain, 
shoulder pain, knee pain, low back pain, joint pain, chronic widespread pain) 
is a major reason for consultation in primary care (Main, 2005). Its 
assessment is a complex step of the patient’s examination and clinicians 
need a solid clinical reasoning to understand its nature, characteristics, and 
sources. Once they have completed the history’ taking, clinicians usually 
apply self-report questionnaires to quantify the patient’s disability, to the test 
fro kinesiophobia, or to measure the patient’s quality of life.  Additionally, 
physical examination (i.e. orthopaedic tests, neurological tests, manual 
palpation) may be performed to identify specific impairments or to diagnose 
medical conditions. Despite the recent technological advances in diagnostic 
procedures, manual examination still remains a core competency for 
physiotherapists and health care’ practitioners.  Manual palpation skills if 
applied correctly, provide relevant information including the bony location, 
tissue temperature, and texture. Again, these competences are also 
important for clinical reasoning and manual therapy treatments (Smart and 
Doody, 2007). 
 
Physical examination is generally manually-applied and the test’s positivity is 
mainly the painful response. It can be a pain from a specific anatomical 
region or the pain usually complained by the patient. Table 4.1 reports a few 
examples of pain provocation’ tests for the upper limb, together with criteria 
for positivity (O'Brien et al., 1998, Lozman et al., 1995, Cordasco et al., 1993, 
Bhargava et al., 2010, Hegedus et al., 2008). All of the tests underwent 
specific investigations aimed at confirming their validity and reliability. The 
standard methodological approach for validity is to explore the correlation 
between the pain provocation and the presence of the pathological 
conditions (Farber et al., 2006, Ben Kibler et al., 2009). By contrast, reliability 
studies focus on the pain provocation consistency of the manoeuvres (Marx 
et al., 1999, Cadogan et al., 2011, Kelly et al., 2010). The rationale of the 
 119 
provocative manoeuvres (i.e. the manual procedures) is constructed by 
considering the target condition, especially its anatomical location and its 
pathophysiology. The underling mechanism is usually a mechanical stress 
(i.e. compression or strain), directed to the anatomical structures affected by    
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Table 4.1: Orthopaedic tests. All the reported tests are considered pain provocation tests as their positivity rely on pain 
provocation.  
 
Name Name Purpose Positivity 
O’Brien 1998 Active Compression test Test the integrity of the glenoid labrum of 
the shoulder 
 
Painful clicking  “inside” the 
shoulder 
Lozman 1995 Cross Over Test Test lesion or dysfunction at the 
acromioclavicular joint 
 
Reproduction of the patient’s 
painful symptoms 
Bhargava 2010 Cozen’s Test To assess the lateral elbow for 
tendinopathy 
 
Reproduction of the patient’s 
painful symptoms 
Cordasco 1993 Anterior Apprehension Test To diagnose the glenohumeral joint 
instability 
 
Patient complains of pain or 
instability 
Hegedus 2008 Hawkins Test To diagnose shoulder impingement 
syndromes 
Shoulder Pain 
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the pathological condition. In line with the rationale described above, the 
manual palpation procedures to diagnose the MPS, are aimed at evoking 
painful symptoms from a MTrP, which is indeed considered a pathognomonic 
sign of the MPS. 
 
MTrPs have been described as discrete areas of muscle tenderness, 
presenting in taut bands of muscle, with a diagnosis dependent on a correct 
history’ taking, and confirmed by a physical examination. Three minimum 
clinical diagnostic criteria have been proposed: indurated bundle of fibres 
within a muscle, known as taut band; focal hypersensitivity and a painful 
point in the taut band, called spot tenderness; and a referred pain sensation 
with mechanical stimulation of the spot tenderness, known as referred pain 
(Simons et al., 1999, Mense et al., 2001). An additional six confirmatory 
features may be present: local twitch response with snapping palpation of the 
taut band, jump sign, patient recognition of the elicited, predicted referred 
pain’ patterns, muscle weakness or muscle tightness, and pain with 
stretching or contraction of the affected muscle (Simons, 2004, Cummings 
and Baldry, 2007, Bennett, 2007). 
  
A physical examination is used to confirm a MTrP diagnosis, which consists 
of a palpation protocol that includes manual palpation, and the patient’s 
replies to specific questions about elicited painful symptoms.  
Numerous research studies and two systematic reviews (Lucas et al., 2009, 
Myburgh et al., 2008) have been conducted to investigate the reproducibility 
of the MTrPs’ examination for several muscles (Nice et al., 1992, Njoo and 
Van der Does, 1994, Lew et al., 1997, Gerwin, 1997, Hsieh et al., 2000, Bron 
et al., 2007, Al-Shenqiti and Oldham, 2005, Wolfe et al., 1992). These 
studies have focused on the reliability of the MTrPs’ diagnostic criteria, with 
no attention given to the reliability of palpation protocols in identifying the 
MTrPs’ exact location. Indeed, all the reliability studies included in the 
systematic reviews assumed that the operators had applied the diagnostic 
criteria to the same MTrP (i.e. with the same location), but this condition was 
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not controlled. Overall, the best reproducibility of the MTrP diagnostic’ criteria 
has been reported in the upper trapezius muscle, which is frequently affected 
by MTrPs, as observed in patients with neck pain and chronic tension-type 
headaches (Fernandez-de-las-Penas et al., 2007, Unalan et al., 2011, 
Fernandez-de-las-Penas et al., 2006a). These should be considered 
important elements for any investigation on the accuracy of manual palpation 
in locating MTrPs, and for the feasibility of the proposed project. Indeed, the 
final aim of this project will include an accurate localization of both the IZ and 
MTrP in upper trapezius muscle. The relevance of this investigation could be 
also extended to MTrP’ treatment that requires the same MTrP to be located 
and treated over repeated sessions. The aim of this study was to investigate 
the intra-rater reliability of a palpation protocol, performed by an experienced 
physiotherapist, in locating a MTrP in the upper trapezius muscle. 
 
 
4.3 MATERIALS AND METHODS 
 
Experimental sessions were conducted between November and December 
2011, in the laboratory of movement analysis at Vita-Salute San Raffaele 
University, Milan, Italy. The ethical approval was granted by the Research 
Ethics Committee of Queen Margaret University (Edinburgh) and, by the 
Internal Ethics Committee of the San Raffaele Hospital of Milan (Italy). All 
experiments were conducted in accordance with the Declaration of Helsinki, 
and all procedures were carried out with the adequate understanding of the 
subjects.  The study respected the Ethical Guidelines for Pain Research in 
Humans (Charlton, 2005). Potential participants were informed fully about the 
goals, procedures and risks of the study, before the study, using an 
information sheet. All subjects, prior to participating in any experimental 
procedures, signed an informed consent form. 
 
Two junior physiotherapists and one senior physiotherapist, participated in 
the study. The experienced physiotherapist had 10 years of clinical 
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experience and a specialism in the management of MPS. Additionally, he 
had attended postgraduate courses on MTrP’ diagnosis and treatment.  
Before the study, the junior physiotherapists completed a training period in 
MTrP’ palpation under the supervision of the experienced physiotherapist. 
Specifically, the training focused on the flat palpation technique for upper 
trapezius muscle, and on the ability to identify both the taut band and spot 
tenderness.  Pincer palpation is also possible for locating the MTrP in the 
upper trapezius muscle, but considering the experimental setup of this study 
(i.e. blinding of the operator and sitting position), the operator was asked to 
apply only the flat palpation technique.  The Trigger Point Manual was used 
as the main reference for both palpation techniques and MTrP’ diagnostic 
criteria (Simons et al., 1999).  
 
A consensus on MTrP’ diagnostic criteria and palpation procedures was 
established prior to the study. As proposed by Myburgh (Myburgh et al., 
2011), a clinically relevant MTrP was defined as a taut band of muscle fibres, 
which when palpated, elicited either one or a combination of spot tenderness, 
pain recognition, or referred pain. 
 
The methodology proposed for this study was developed according to the 
Quality Appraisal of Reliability Studies Checklist, proposed by Lucas et al. 
(Lucas et al., 2010b). It includes 11 items that cover seven different domains: 
the spectrum of subjects, the spectrum of examiners, examiner’ blinding, the 
order’ effects of examination, the suitability of the time interval between 
repeated measurements, appropriate test’ application and interpretation, and 
finally, and appropriate statistical analysis (appendix IX).   
 
4.3.1 Participants 
A total of 33 volunteers who suffered from neck/shoulder pain, were enrolled 
for the screening phase, and they'd been derived from amongst students and 
employees of the San Raffaele Scientific Institute. Finally, 24 volunteers (23 
female and 1 male; age 24 ± 3 years) with a least one MTrP in the upper 
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trapezius (left or right), participated in the study. Public announcements were 
posted on a few message boards at San Raffaele institute to identify the 
potential participants. During the enrolment phase, information regarding the 
study was provided. All subjects signed a written informed consent form 
before participating in the screening phase. 
 
 Volunteers were requested to fill a case form, including the following 
information: age, gender, weight, height, presence of pain in the neck and 
shoulder region, diagnosis for neurological disorders, diagnosis for rheumatic 
disorders, diagnosis for psychiatric disorders, and previous whiplash 
associated disorders. Body mass index (BMI) was computed as weight in 
kilograms divided by height in meters squared (Mei et al., 2002). All the 
information was self-reported; no measurements or tests were conducted to 
verify the anthropometric details, or the reported diagnosis. 
 
The inclusion’ criteria listed at least one painful active movement of the 
cervical spine, and at least one painful neck/shoulder event, in the last 4 
weeks. The exclusion criteria included the following: (1) history of 
neurological or rheumatic disorders; (2) whiplash in the previous 6 months; 
(3) the presence of scars or moles in the area of the upper trapezius 
muscles; (4) pregnancy; (5) clinical depression; and (6), a body mass index 
of 30 or higher. The proposed exclusion criteria were applied to avoid minor 
and major adverse events due to MTrP palpation’ procedures. A body mass 
index of lower then 30 (i.e. the threshold beyond which people are 
considered obese) was necessary, as the reliability and accuracy of MTrP’ 
palpation is affected by the amount of the subcutaneous tissue. 
 
In order to ensure unbiased enrolment, two physiotherapists carried out a 
screening procedure one day before the collection of data. The purpose of 
the screening procedure was to ensure the presence of at least one clinically 
relevant MTrP in either the left or right upper trapezius. To test the accuracy 
of the MTrP’ palpation, the presence of at least one MTrP was assumed.  
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The two physiotherapists performed the palpatory assessment in two 
separate rooms, and without the possibility of knowing each other's judgment 
as to the presence of a MTrP. Subject’ enrolment was confirmed when there 
was agreement between the two physiotherapists. 
 
4.3.2 Procedures 
All the enrolled subjects (n = 24), one day after the screening, met the 
experienced physiotherapist (the examiner) that had performed the palpation 
protocol, to locate the MTrPs. The study consisted of eight experimental 
sessions, with three subjects taking part in each one. Four sessions included 
subjects with MTrPs in the left, and four in the right upper trapezius. 
Sessions were arranged in two separate rooms, in order to avoid the 
subject’s voice being recognised by the examiner. In the first room, one 
physiotherapist explained the experimental protocol and drew an anatomical 
landmark system (ALS) on the subject’s shoulder using a surgical pen (figure 
4.1).  
 
The ALS consisted of a line between the acromial angle (AA) and the 
spinous process of the seventh cervical vertebra (C7). The distance between 
AA and C7 (ALS_d) was recorded for all of the subjects. In the second room, 
subjects were seated in front of the examiner, who was blindfolded and not 
allowed to speak. A sheet with pre-set answers was given to each subject 
and used to reply to the examiner’s questions. This was considered 
necessary to ensure that the examiner didn’t recognise subjects by their 
voice.  Each subject was examined twice, and the MTrP detected during the 
first palpatory examination, was called MTrP_1, while the second MTrP, 
detected during the second session, was called MTrP_2. The subjects were 
allowed to rest for 10 minutes between the two consecutive examinations, 
which had been conducted in a randomized order. Before starting the 
palpation’ procedures, the physiotherapist adjusted the sitting posture of the 
volunteers. The following aspects were checked: feet flat on the floor, knees 
bent at 90 degrees, lumbar spine and pelvis in neutral position, shoulders 
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back and relaxed, head in line with the chest, chin in, and back relaxed 
against the back of the chair. 
 
 
 
 
Figure 4.1: Anatomical landmark system. A graphical representation of the 
anatomical landmark system and the two variables, X and Y, used to define 
the MTrP’ location on the upper trapezius. AA indicates the acromial angle of 
the scapula and C7 the spinal process of the seventh cervical vertebra. 
ALS_d is the distance between C7 and AA. MTrP, myofascial trigger point; 
AA, acriomial angle; C7, spinous process of the seventh vertebrae; ALS_d, 
distance between AA and C7. 
 
 
4.3.3 Myofascial trigger point palpation protocol 
Before each session, the examiner marked a point on the skin of the pad of 
his middle finger, using a surgical pen. The MTrPs were identified through a 
flat palpation technique using the index, the middle, and the ring finger of the 
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right hand. The spot tenderness identified on the taut band was used to 
define the location of the MTrPs on the upper trapezius muscle. Once the 
examiner confirmed the MTrP, location under the middle finger pad, the 
operator rolled the examiner’s middle finger and marked on the skin, the 
contact between the point on the pad and the skin. 
 
The palpation protocol was conducted according to the following steps: 
 1. Palpation over the upper trapezius region to identify one or more 
 taut bands and their extension along the muscle fibres; 
2. Gentle compression of contiguous spots along the detected taut 
band, in order to elicit pain and to locate accurately the spot 
tenderness. A positive reply from the subject to the question “Is this 
spot unusually  painful?” was used  to confirm the presence of 
spot tenderness. In  case of more than one painful spot, the question “I 
will compress two  spots, a first one and second one. Please tell me 
which is the most  painful” was asked; 
 3. Perpendicular progressive and gentle compression on spot 
 tenderness to elicit pain and verify the presence of pain recognition. A 
 positive reply to the question “ Do you recognize this pain as a familiar 
 complaint?” was requested to confirm the presence of pain 
recognition; 
4. Sustained painful compression (approximately 6 seconds) (Bennett, 
2007) on spot tenderness was performed to elicit pain and verify the 
 presence of referred pain. A positive reply to the question “Does the 
 pain occur away from the spot that I am compressing? If yes, 
 indicate where according to the anatomical regions reported on the 
 sheet” was requested to confirm the presence of referred pain. 
 
During all the palpation sessions, the examiner was seated and blindfolded.  
To answer the examiner’s questions, the subjects were asked to point to the 
sheet with the pre-set answers (appendix X). The construction of the 
questions and potential answers had been agreed before the experimental 
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phase.  The operator communicated the answers to the examiner. This 
indirect communication was necessary to prevent the subjects’ recognition by 
the tone of their voice. A taut band, with at least one of the following, spot 
tenderness, pain recognition, or referred pain, was requested to confirm the 
MTrP’ presence. If more than one spot tenderness was detected within the 
examined muscle, only the one that had elicited a familiar pain was 
considered (i.e. pain recognition). If a patient was not able to distinguish 
between two MTrPs in relation to his/her familiar pain, the examiner asked 
the subject to indicate which was the most painful. To avoid adverse effects 
due to tissue irritation, spot tenderness was compressed using the minimal 
force necessary to elicit pain in the subject. 
 
4.3.4 Statistical analysis 
The statistical analysis considered X and Y values in the two examinations, 
performed on the same subject. Intra-rater reliability was examined using 
intraclass correlation coefficients (ICC) (Chinn, 1990) and Bland–Altman 
plots (Bland and Altman, 1986, Bland and Altman, 1999), as they have been 
advocated to be the statistical methods of choice in reliability studies (Rankin 
and Stokes, 1998).  
 
For the intra-rater reliability, considering two replicates of MTrP examination, 
a minimum sample size of 11 subjects was computed as being required, 
according to the method by Walter and collaborators (Walter et al., 1998). It 
was assumed an ICC value of at least 0.9, and it was determined that ICC 
values higher than 0.6 would be acceptable (α = 0.05, β = .020) (Walter et 
al., 1998) (appendix XI). Since reliability of one examiner was analysed, a 
single measure ICC(1,1) model was applied  (Rankin and Stokes, 1998). For 
the variables under consideration, the 95% confidence interval of the ICC 
values was computed. X and Y values were normally distributed, as 
assessed by Shapiro-Wilk's test (p > 0.05). 
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The criteria used for the interpretation of the ICCs were as follows: 0.00 – 
0.25 indicated little or no correlation; 0.26 – 0.49 indicated low correlation; 
0.50 –0.69 indicated moderate correlation; 0.70 – 0.89 indicated high 
correlation; and 0.90 – 1.00 indicated very high correlation (Munro, 2005). 
ICC values were not considered clinically useful if under 0.6 (Chinn, 1990). 
Bland–Altman plots were provided to give a visual representation of the size 
and range’ differences between X and Y values.  
 
Moreover, the distance between MTrP_1 and MTrP_2 was estimated 
(MTrPs_d) (figure 4.2). MTrP_d values were normally distributed for both left 
and right sides, as assessed by Shapiro-Wilk's test (p > 0.05). An 
Independent t-test was used to compare the MTrP_d in the left and right 
upper trapezius muscles. X scores, considering only the first MTrP 
examination (i.e. X1), were normally distributed for both left and right sides, 
as assessed by Shapiro-Wilk's test (p > 0.05); while Y values, considering 
only the first MTrP examination (i.e. Y2), were not normally distributedfor 
both left and right side, as assessed by Shapiro-Wilk's test (p < 0.05). A 
Mann-Whitney U test was used to determine if there were differences in X 
and Y values between left and right sides. Tests for normality are 
summarized in appendix XII. Statistical analyses were performed using 
SPSS Version 12.0 (SPSS Inc, Chicago, IL, USA).  The significance level 
was set to p < 0.05 and CI was calculated at a confidence level of 95%.  
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Figure 4.2: Formula to compute the distance between MTrP_1 and MTrP_2 
(i.e. Pythagoras's theorem). MTrP_1, myofascial trigger point detected during 
the first palpatory examination; MTrP_2, myofascial trigger point detected 
during the second palpatory examination. 
 
 
4.4 RESULTS 
 
Characteristics of the enrolled volunteers are summarized in table 4.2. All 
study participants completed the palpation procedures, and the locations of 
MTrP_1 and MTrP_2 were recorded (table 4.3). Taut band, spot tenderness 
and pain recognition were identified in all subjects, while the referred pain 
was reported in nine subjects (appendix XIII). The referral zone was recorded 
according to the following anatomical region: head, neck, trunk, shoulder, 
arm, elbow, forearm and hand. 
 
The ICC(1,1) values were 0.62 (95% CI: 0.30 – 0.81) for X, and 0.81 (95% 
CI: 0.61 – 0.91) for Y. The Bland–Altman plots are shown in figure 4.3 and 
figure 4.4. The values for mean difference were 0.04 mm for X, and -0.20 
C7 è ç AA 
A
R
S
 m
id
p
o
in
t 
MTrP_1 
MTrP_2 
(X1;Y1)	
(X2;Y2)	
MTrP _ d = (X1 - X2 )
2 + (Y1 -Y2
2 )2
 131 
mm for Y. The standard deviation (SD) of the X value’s differences was 13.4 
mm and the 95% limits of agreement were -26.2 – 26.3 mm. The SD of Y 
value’s differences was 13.6 mm and the 95% limits of agreement were -27.0 
– 26.4 mm.  
 
The mean MTrPs_d was 15 ± 11.0 mm, and, in 19 out of 24 cases, it was 
less than 20.0 mm (table 4.3 and appendix XIV). No statistically significant 
difference was found between the values of MTrP_d (p = 0.52) and between 
the X1 values (p = 0.33) of the left and right upper trapezius. However, a 
statistically significant difference was found for the Y1 values between the left 
and right upper trapezius (P < 0.05). 
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Table 4.2: Characteristics of the enrolled volunteers. 
 
Subjects Age(y) 
Laterality 
VAS 
Pain frequency 
Provocative movement 
L R <1 week 1 week >1 week 
1 24 
 
x 7 
  
x Flexion and left lateral bending 
2 23 
 
x 5 
  
x Flexion and left lateral bending 
3 22 
 
x 6 x 
  
Left rotation + left lateral bending 
4 22 
 
x 3 
 
x 
 
Flexion + left lateral bending 
5 22 
 
x 5 x 
  
Flexion + right rotation 
6 22 
 
x 3 x 
  
Flexion + right lateral bending 
7 22 
 
x 6 
  
x Left lateral bending 
8 23 x 
 
6 
  
x Left lateral bending 
9 30 
 
x 5 
  
x Left rotation + left lateral bending 
10 22 
 
x 4 
 
x 
 
Extension and right rotation 
11 22 
 
x 3 x 
  
Right lateral bending 
12 23 
 
x 3 x 
  
Flexion 
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Table 4.2: Characteristics of the enrolled volunteers (continued). 
 
13 22 
 
x 6 
 
x 
 
Left rotation 
14 26 
 
x 6 x 
  
Right rotation + right lateral bending 
15 22 
 
x 7 x 
  
Flexion and right lateral bending 
16 35 
 
x 7 
  
x Left rotation 
17 21 
 
x 4 
  
x Right rotation 
18 23 
 
x 2 
 
x 
 
Flexion and right lateral bending 
19 23 
 
x 2 
 
x 
 
Flexion + right lateral bending 
20 31 
 
x 4 
  
x Left or right rotation and extension 
21 25 
 
x 6 
  
x Flexion and right lateral bending 
22 22 
 
x 4 x 
  
Flexion + left lateral bending 
23 22 
 
x 4 x 
  
Left lateral bending 
24 25 
 
x 4 
 
x 
 
Left rotation and left lateral bending 
Mean(SD) 24(3) 1 23 4.7(1.5) 9 6 9 … 
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Table 4.3: MTrP’ location (MTrP_1 and MTrP_2), with respect to the ALS, in the two examinations for each subject. Mean and 
standard deviation of the distance between MTrP_1 and MTrP_2 is reported in the last column (MTrPs_d). ALS_d indicates 
the distance between C7and the acromial angle. Abbreviations: MTrP, myofascial trigger point; ALS_d, distance between 
acromial angle and the spinous process of the seventh vertebrae; MTrP_1, myofascial trigger point detected during the first 
palpatory examination; MTrP_2, myofascial trigger point detected during the second palpatory examination; MTrPs_d, 
distance between MTrP_1 and MTrP_2. 
 
Subjects MTrP side Session ALS_d (mm) 
MTrP_1 MTrP_2 
MTrPs_d (mm)  
X (mm) Y (mm) X (mm) Y (mm) 
1 
R 
1 
214 
64 75 51 62 
18 
2 
R 210 
69 70 70 70 
1 
3 
R 216 
89 32 86 34 
4 
4 
L 
2 
210 
90 8 78 22 
18 
5 
L 192 
62 74 67 90 
17 
6 
L 195 
75 7 80 9 
5 
7 
R 
3 
185 
95 32 76 32 
19 
8 
R 205 
75 35 81 40 
8 
9 
R 195 
60 56 76 25 
35 
10 
R 
4 
220 
115 35 80 68 
48 
11 
R 215 
78 57 75 65 
9 
12 
R 215 
96 39 94 40 
2 
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Table 4.3: MTrP’ location (MTrP_1 and MTrP_2), with respect to the ALS, in the two examinations for each subject. Mean and 
standard deviation of distance between MTrP_1 and MTrP_2 is reported in the last column (MTrPs_d). ALS_d indicates the 
distance between C7and the acromial angle. Abbreviations: MTrP, myofascial trigger point; ALS_d, distance between acromial 
angle and the spinous process of the seventh vertebrae; MTrP_1, myofascial trigger point detected during the first palpatory 
examination; MTrP_2, myofascial trigger point detected during the second palpatory examination; MTrPs_d, distance between 
MTrP_1 and MTrP_2 (Continued). 
 
13 
L 
5 
197 
76 22 80 15 
8 
14 
L 203 
66 39 77 42 
11 
15 
L 195 
91 10 85 11 
6 
16 
L 
6 
220 
98 31 122 12 
31 
17 
L 218 
57 5 64 5 
7 
18 
L 193 
64 24 65 12 
12 
19 
L 
7 
205 
77 31 88 17 
18 
20 
L 217 
70 25 91 26 
21 
21 
L 195 
102 13 92 15 
10 
22 
R 
8 
187 
103 56 105 45 
11 
23 
R 200 
87 31 94 56 
26 
24 
R 208 
86 35 67 36 
11 
Mean(SD) - - 205(11) 81(16) 35(21) 81(15) 35(23) 
15(11) 
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Figure 4.3: Bland-Altman plots showing the intra-rater reliability of the 
palpation protocol for locating MTrPs in the upper trapezius muscle. X is a 
variable used to define the MTrP’ location according to the ALS. The 
difference of values is plotted against the mean values for each subject. The 
middle dotted line shows the mean of difference. The two lines above and 
below the mean of difference represent the 95% upper and lower limits ( 1.96 
standard deviations). X1, X value measured during the first palpatory 
examination; X2, X value measured during the second palpatory 
examination. 
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Figure 4.4: Bland-Altman plots showing the intra-rater reliability of the 
palpation protocol for locating MTrPs in the upper trapezius muscle. Y is a 
variable used to define the MTrP’ location according to the ALS. The 
difference between values is plotted against the mean values for each 
subject. The middle dotted line shows the mean of difference. The two lines 
above and below the mean of difference represent the 95% upper and lower 
limits (1.96 standard deviations). Y1, Y value measured during the first 
palpatory examination; Y2, Y value measured during the second palpatory 
examination. 
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4.5 DISCUSSION 
 
During the eight experimental sessions, 24 subjects with MTrPs were 
examined; 12 MTrPs were located in the left upper trapezius and 12 in the 
right upper trapezius. All subjects complained of at least one active painful 
movement of the cervical spine, and their VAS was 4.7 ± 1.5.  Subjects were 
examined twice in the same session, and the MTrPs locations were defined 
by an operator measuring X and Y, according to ALS. No statistically 
significant difference was observed for the MTrP_d (p = 0.52) in the left or 
right upper trapezius, indicating that the particular side (left or right), does not 
affect the reliability of the palpation protocol. 
 
The study’ cohort showed that the MTrPs that had been located medially with 
respect to the ALS midpoint (figure 4.5), resulted in no statistically significant 
differences between the X values of the left and right upper trapezius 
muscles (p = 0.32). Interestingly, the Y values of the MTrPs showed a 
statistically significant difference between the left and right sides (p < 0.05). 
The MTrPs in the right upper trapezius were clearly located, as shown by the 
ALS, in the more caudal areas (figure 4.5). It is possible to speculate that this 
finding could be related to different muscular activities between the left and 
right upper limbs, as all the study subjects, except one, were right-handed. 
However, caution should be used in discussing the observed location 
asymmetry among the MTrPs, as morphological differences between left and 
right hemibody are frequently observed, and this can affect the comparability 
of the left and right ALS. This study’ results showed a well-defined area for 
the MTrP’ location in the upper trapezius region that had been similar to that 
described by Travell and Simons (1983) in their maps. 
 
The ICC for the X and Y values did not fall under 0.6, suggesting a potential 
clinical application for the palpation protocol (Chinn, 1990). The reliability 
analysis showed a high correlation for Y (ICC(1,1) = 0.81) and a moderate 
correlation for X (ICC(1,1) = 0.62) (Munro, 2005). 
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Figure 4.5: Locations of MTrP_1 and MTrP_2 for each subject according to 
the ALS. X and Y values are normalized with respect to ALS. Coloured 
circles are used to distinguish subjects in left and right ALS. The dotted line 
joining MTrP_1 and MTrP_2 represent the normalized MTrP_d. MTrPs are 
located in well-defined area medially to the ALS’ midpoint, and right MTrPs 
are located in more caudal area (p < 0.001). ALS, anatomical landmark 
system; MTrP_1, myofascial trigger point detected during the first palpatory 
examination; MTrP_2, myofascial trigger point detected during the second 
palpatory examination; AA, acriomial angle; C7, spinous process of the 
seventh vertebrae; ALS, anatomical landmark system. 
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Considering the potential use of the palpation protocol in a clinical setting, 
further discussion is required concerning the difference that was found in the 
X and Y correlations. The Y values, according to the ALS, describe the 
vertical position of the MTrP, and are the first to be identified in accordance 
with the palpation protocol. The Y value can be used to detect the taut band 
in the upper trapezius muscle. The taut band is considered the only specific 
feature of the MTrP, and it is an objective sign. With regard to the muscle 
fibres direction, the indurated muscle bundles are palpated by snapping the 
bundles vertically. In the upper trapezius muscle, this procedure can be 
applied in optimal conditions, as the muscle fibres run approximately 
horizontal and parallel to the skin’ surface (Johnson et al., 1994). A recent 
study (Sikdar et al., 2009), using an innovative ultrasound imaging technique, 
described the taut band in upper trapezius as an elliptical shape with a size 
of 0.16 ± 0.11 cm2; thus, it can be reasonably palpated using fingers. A 
recent systematic review on the reliability of a physical examination for MTrP’ 
diagnosis, reported kappa scores for the taut band ranging from -0.08 to 0.75 
(Lucas et al., 2009). This inconsistent reliability was attributed to the anatomy 
of the different muscles and to the lack of appropriate training for the 
examiners. On the contrary, Myburgh and his collaborators stated the the 
spot tenderness, which has defined the MTrP’ location, had a moderate 
evidence supporting its reliability within the upper trapezius (Myburgh 2008). 
Two studies (Gerwin et al 1997 and Lewoska et al.) that were included in a 
systematic review, reported kappa values reaching 0.6. It noted that Gerwin 
and his collaborators (Gerwin et al. 1997) had highlighted that the influence 
of a trained examiner has a critical role in increasing the reliability of the 
assessment of the location of the MTrP, during any examination. 
 
The ICC scores for the X values, which indicate the horizontal location of the 
MTrPs, were considerably lower. The X values were defined by detecting the 
spot tenderness along the taut band, and they should be considered as a 
subjective sign that is related to the pain provocation of the palpation 
procedure. The spot tenderness of an MTrP is described as a highly 
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localized hyperalgesia on the taut band, but no investigations have been 
conducted to describe how pain threshold changes nearby to MTrP. Indeed, 
the question of whether hyperalgesia is localised, has never been addressed 
within a muscle harbouring a MTrP. It might be reasonable to speculate that 
a secondary hyperalgesia is presented nearby to MTrP, especially along the 
taut band, and that this makes difficult the manual localization of the spot 
tenderness.   In addition, it was located by eliciting pain using the middle 
finger, which had a fingerprint on skin of approximately 1.5 cm2. However, 
this potential error is limited by the palpation protocol that explicitly requires 
the examiner to elicit pain only by increasing pressure on the taut bands. 
Finally, the greater range of the X axis compared with that of the Y, could 
potentially result in a lower reliability. These factors could explain the 
difference in the reliability between the X and Y values. 
 
The Bland–Altman plots support the reliability of the MTrP’ palpation protocol 
by showing that the mean of the difference was close to zero for both X and 
Y. The limits of agreement were from 26.0 to -23.2 mm for X (figure 4.3) and 
from 26.2 to -29.6 mm for Y (figure 4.4). They indicated that both offered an 
acceptable error range and error size for the 24 MTrP’ palpation procedures, 
especially if the area explored by the examiner is considered, an area that 
extended horizontality for 205 ± 11 mm. 
 
In the examples where the results of Y are high, the Bland-Altman plot shows 
a lower reliability (figure 4.4). This suggests that palpation’ reliability in the 
upper trapezius region decreases when compared with the inferiorly located 
MTrPs, though this remains speculative due to the small number of cases in 
this study. The clinical relevance of the observed error is limited, and the 
extent of error should not influence the use of standard treatment techniques 
that require the MTrP’ location, such as ischemic compression, pressure 
release, strain counterstrain, ultrasound, or dry needling (Unalan et al., 2011, 
Montanez-Aguilera et al., 2010, Hsieh et al., 2007, Grieve et al., 2011). 
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The present study is the first to look at the intra-rater reliability of a palpation’ 
protocol for locating an active MTrP in the upper trapezius region, and the 
only known study to follow the Quality Appraisal of Reliability Studies 
Checklist guidelines. The seven domains included in the checklist, were 
evaluated by considering the context for, and the aim of the current study. 
The coherence of the study's design was assured by the examiner being 
blinded to the clinical information and to any additional cues that could have 
influenced the outcomes. The spectrum of subjects for this study was 
intentionally limited to volunteers with MTrP in the upper trapezius who were 
without additional comorbidities. Moreover, only one examiner was included. 
The rationale for the latter was because this study has been designed 
specifically to estimate the reliability of the protocols delivered by the 
operator included within the scheduled cross-sectional study. It is 
acknowledged that this decision reduces the external validity of this study 
and limits the generalizability of the results. Nevertheless, similar results 
have been reported in a study focusing on the clinical precision among four 
clinicians, in detecting a latent MTrP in the trapezius muscle (Sciotti et al., 
2001). The MTrP’ location was estimated using a 3D optoelectronic system 
(OptoTRAK/320) and the overall magnitudes of the errors were 6.6 cm for 
the examiner 1, 4.6 cm for examiner 2, 3.8 cm for examiner 3 and 3.0 cm for 
the examiner 4. The precision was approximately 5 mm in the mediolateral, 
superoinferior, and anteroposterior directions. Generalizability of the results 
for this study's data was confirmed by the statistical analysis, although the 
reliability of the MTrP’ location increased when the PPT was lower.   
 
Finally, it is important to consider that the reliability of the palpation’ protocol 
that has been investigatedl could be improved if applied in a clinical setting, 
where the examiner can benefit from visual contact, and be in direct verbal 
communication, with the patient. In order to prevent bias, this was not the 
case in current study.  
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4.6 LIMITATIONS OF THE STUDY 
 
In the study on MTrP’ palpation protocol, the relative reliability, defined as the 
degree of consistency to which measurements maintain their position over 
repeated measurements (Bruton et al., 2000), was computed using intra-
class correlation coefficients (ICC). The absolute reliability, defined as 
degree to which repeated measurements vary for subjects, was analysed 
using the Bland-Altman plots (Bland and Altman, 1999, Bland and Altman, 
1986).   
 
For the ICC statistics, a threshold of 0.6 for clinical applicability (Chinn, 1990) 
was adopted, although ICC values between 0.50 and 0.69 indicate moderate 
correlation between measurements (Munro, 2005). This assumption can be 
questionable, especially when considering that the ICC value for X slightly 
exceeded the 0.6 threshold. Moreover, the 95% confidence interval ranged 
from 0.30 to 0.91.  The upper and lower limits of agreement of the Bland-
Altman plots were approximately 2.5 mm for both X and Y.  
 
Moreover, a few methodological limitations need to be acknowledged. First, it 
is acknowledged that the pressure applied by the examiner on the spot 
tenderness of the taut band eliciting pain, was not measured. Thus, it was 
not possible to confirm that the subjects’ responses to the painful stimuli, 
were due to the pressure on the spot tenderness, rather than to overpressure 
on a taut band point. Also, it cannot be excluded that the first palpatory 
examination of the MTrP may have influenced the sensitivity of the MTrP 
during the second examination. Although advisable, a PPT measurement of 
the spot tenderness was not feasible due to limitations within the 
experimental setup: the handling of an algometer was not possible as the 
examiner was blinded. Even in the case of having an additional operator, the 
PPT assessment, which includes three consecutive measurements, may 
increase the MTrP’ sensibility due to the nociceptive repeated stimulation of 
the spot tenderness. PPT assessment could have been performed however 
with a single measurement (Grieve et al 2011; 2013). 
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Second, the possibility of a selection bias cannot be completely ruled out due 
to the procedure used for enrolling and screening of the study’ subjects. 
Subjects were selected from volunteers with neck/shoulder complaints, and 
both operators had to agree on the presence of an MTrP before a patient 
could be enrolled. This procedure could have selected subjects with MTrPs 
showing a lower pain threshold; thus, it is not possible to compare this study’ 
results with those from subjects having MTrPs with a higher pain threshold, 
such as that found with latent MTrPs. It was noticed that, on a few occasions, 
subjects reported a difficulty in comparing pain elicited by pressure applied to 
contiguous spots on the taut band. Also, this study’s findings cannot be 
extended to subjects with different ages, or with a higher BMI. Similarly, it 
should be noted that most of the enrolled volunteers were female. Since 
females have lower pain thresholds and greater accuracy in discriminating 
pain sensations (Vallerand and Polomano, 2000, Mogil and Bailey, 2010), 
the same palpation’ protocol used with a predominantly male population, on 
predominantly male population may yield different results. As for the IZ’ 
reliability study, the upper trapezius muscle should be considered an optimal 
muscle to investigate the reliability for locating MTrPs. Indeed, its anatomical 
characteristics facilitate the manual palpation; it is a superficial muscle, it has 
parallel fibres, and usually it has a reduced thickness. Moreover, the criteria 
to diagnose the MTrP’ presence in the upper trapezius muscle, showed an 
acceptable level of reliability when compared to other muscles (Lucas et al., 
2009), and this is a critical requirement for investigating the reliability of 
locating MTrPs. 
 
Furthermore, the results cannot be generalized to inexperienced 
physiotherapists and also the inter-rater reliability was not explored. Even in 
case of standardized training on MTrP’ manual palpation, as it had been 
done in the current study, proper reliability cannot be assured.  
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4.7 CONCLUSIONS 
 
The findings of this study suggest that an experienced physiotherapist, using 
the MTrP’ palpation protocol, can reliably locate a MTrP in the upper 
trapezius muscle. Further research is required to investigate the inter-rater 
reliability of the protocol for MTrP’ location, and to associate the current 
study’ results both to different muscles and to physiotherapists with less 
experience. 
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CHAPTER 5  
 
 
 
 
MYOFASCIAL TRIGGER POINTS AND INNERVATION 
ZONE LOCATIONS IN UPPER TRAPEZIUS MUSCLES 
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5.1 SUMMARY  
 
Background: Myofascial trigger points (MTrPs) are hyperirritable spots 
located in taut bands of muscle fibres. Electrophysiological studies indicate 
that abnormal electrical activity is detectable near MTrPs. This phenomenon 
has been described as endplate noise and it has been purported to be 
associated MTrP pathophysiology. Thus, it is suggested that MTrPs may 
overlap the innervation zone (IZ). The purpose of this work was to describe 
the location of MTrPs and the IZ in the right upper trapezius. 
Methods: Seventy-one individuals were screened and eventually, 24 subjects 
with neck pain and active MTrPs, and 24 subjects who were neck pain-free, 
with latent MTrPs, were enrolled. Surface electromyography (EMG) signals 
were detected using an electrode’ matrix during isometric contraction of the 
upper trapezius. A physiotherapist examined the subject’s trapezius to 
confirm the presence of MTrPs and to establish their location. The IZ’ 
locations were identified by visual analysis of surface EMG signals. IZ’ and 
MTrPs’ locations were described using an anatomical landmark system 
(ALS), with the skin’ area covered by the matrix, divided into four quadrants. 
Results: No significant difference was observed between active and latent 
MTrPs’ locations (p = 0.6). Forty-five MTrPs were in the third quadrant of the 
ALS, and 3 were included in the second quadrant. IZs were located 
approximately midway between the seventh cervical vertebrae and the 
acromial angle within a limited area between the second and third quadrants. 
The mean distance between the MTrP and the IZ was 10.4 ± 5.8 mm. 
Conclusions: According to the these results, it was concluded that the IZ and 
the MTrPs are located in well-defined areas within the upper trapezius 
muscle. Moreover, MTrPs in upper trapezius are proximally located to the IZ 
but are not overlapping its location.  
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5.2 INTRODUCTION 
 
MTrP’ pathophysiology appears to be associated with the motor endplate 
zone  (Hong and Simons, 1998, Kuan, 2009, Simons, 2001, Simons et al., 
2002, Simons, 2008). This region, also known as the innervation zone (IZ), is 
where the α-motor neuron divides into a number of branches and synapses 
onto target muscle fibres. The IZ is usually described as being in the middle 
region of the muscle belly (Coërs and Woolf, 1959), but more complex IZ’ 
spatial distributions have been reported in muscles with unipennate or 
multipennate fibre’ arrangements (e.g. gastrocnemius and soleus) (Kim et al., 
2005, Parratte et al., 2002, Prodanov et al., 2005). Needle electromyography 
(EMG)’ studies have demonstrated that MTrPs contain minute loci producing 
characteristic low-amplitude electrical activity (Simons et al., 2002, Hubbard 
and Berkoff, 1993, Kuan et al., 2007) (i.e. active locus), and which is 
described in the literature as spontaneous electrical activity (SEA). 
 
The origin of SEA has been extensively debated by experts. Initially, 
Hubbard and Berkoff attributed the source of SEA’ action potentials to 
intrafusal muscle spindles located near MTrPs (Hubbard and Berkoff, 1993). 
Later, Simons considered previous work by Liley (Liley 1956), hypothesising 
that SEA originates from motor endplates and defined the latter as endplate 
noise (Simons, 2001). In support of the latter hypothesis, a needle EMG 
study showed that endplate noise was more prevalent in MTrPs than in 
adjacent sites (Simons et al., 2002). 
 
This “motor endplate” hypothesis was also tested by Kuan et al., who 
injected MTrPs with botulinum toxin type A, to block acetylcholine release 
into the synaptic cleft, and found that the injection diminished SEA in MTrPs 
(Kuan et al., 2002). 
 
Finally, the reported electrophysiological findings have been correlated with 
histological changes (Mense et al., 2003, Simons and Stolov, 1976) and local 
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biochemical alterations (Shah et al., 2008, Shah et al., 2005) (e.g. 
inflammatory mediators, neuropeptides, catecholamines, and cyokines) to 
support MTrP pathophysiology. 
 
The reported experimental findings associated with MTrPs suggest that they 
are located close to the IZ (Mense et al., 2001, Kuan et al., 2007). In a 
research context aimed at clarifying the MTrP’ aetiology, a confirmation of 
the overlapping between a MTrP and an IZ will help to clarify their interaction 
(i.e. the active locus and the sensitive locus) (Simons, 2004). Furthermore, 
manual identification of MTrPs could become useful to optimise treatments 
addressing to the IZ, such as botulinum injections for both cervical dystonia 
and myofascial pain (Soares et al., 2012, Delnooz and van de Warrenburg, 
2012). 
 
A technology, based on EMG’ signals, and useful for detecting the IZ in vivo, 
has recently been proposed (Barbero et al., 2011, Masuda et al., 1983a, 
Merletti et al., 2003, Saitou et al., 2000), and to-date, no study has assessed 
both MTrP’ and IZ’ locations. Therefore, the purpose of this work was to 
describe MTrP’ and IZ’ locations in the upper trapezius muscle. The following 
hypothesis was tested in a clinical study: the distance between the IZ and the 
MTrPs in theupper trapezius, is different from zero.  
 
 
5.3 METHODS 
 
All experimental sessions were conducted between July and November 
2008, at the laboratory of movement analysis of the San Raffaele Scientific 
Institute in Milan, Italy. The Internal Ethical Committee of the San Raffaele 
Scientific Institute and Research Ethics Committee of Queen Margaret 
University (Edinburgh) approved the protocol. All experiments were 
conducted in accordance with the Declaration of Helsinki, and all procedures 
were carried out with the adequate understanding of the subjects.  The study 
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respected the Ethical Guidelines for Pain Research in Humans (Charlton, 
2005). 
  
Before commencement of the study, potential participants were fully informed 
about the goals, procedures and risks of the study, using an information 
sheet. All participants signed an informed consent form before enrolling in 
the study. 
 
5.3.1 Participants 
Twenty-nine patients with chronic mechanical neck pain, and 42 pain-free 
subjects with negative histories for neck and shoulder pain, were screened 
for participation in the study, according to the inclusion and exclusion criteria. 
Patients were recruited through the Rehabilitation Service of San Raffaele 
Hospital, and pain-free subjects consisted of San Raffaele Scientific Institute’ 
employees. The healthy volunteers were recruited using a public 
announcement, posted at the DIBIT (Dipartimento di Biotecnologie). A 
convenience sampling was used to select the volunteers, due to fact that no 
previous studies were available on the primary outcome measure (i.e. the 
distance between the IZ and the MTrPs). This study should be considered a 
descriptive study, including a continuous variable, and the sample calculation 
(n = 4Z2S2/W2, Z = 1.96) required three parameters: the confidence level 
(usually 95%), the desired width of the confidence interval (W) and the 
standard deviation of the investigated variables (S) (Hulley, 2001). Even 
assuming a width of the confidence interval, the standard deviation of the 
distance between the IZ and the MTrPs was not available. 
  
Mechanical neck pain was defined as pain elicited by active cervical spine 
movements and perceived anywhere in the posterior region of the cervical 
spine, from the superior nuchal line to the first thoracic spinous process 
(Bogduk and McGuirk, 2006). Subjects with neck pain were screened, as 
they usually show MTrPs in the upper and mid trapezius muscles (Travell 
and Simons, 1983) . 
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Patients had to meet the following inclusion criteria: mechanical neck pain, 
neck pain’ history lasting more than 3 months, and an active or latent MTrP 
in the right upper trapezius. Exclusion criteria were: positive history for 
neurological or rheumatic disorders, radiculopathy, fibromyalgia, joint 
disorders, whiplash in the previous 6 months, pregnancy, clinical depression 
and a body mass index ≥30. Concomitant painful disorders and psycho 
emotional distress were ruled out to avoid adverse effects and confounding 
factors during the MTrP’ palpation procedure. This was done by a self-
certification. Subjects with a BMI lower than 30, were excluded because an 
excessive subcutaneous fat layer thickness can limit the MTrP’ palpation. 
 
Fifty-two subjects were enrolled and eventually, 48 subjects were analysed: 
18 patients with chronic neck pain and active MTrPs, 6 patients with chronic 
neck pain and latent MTrPs, and 24 pain-free subjects with latent MTrPs. 
The following subjects were excluded from the study:  
 16 subjects didn’t show any latent or active MTrPs in the right upper 
trapezius muscle. Two out of 29 subjects with chronic mechanical 
neck pain, were negative to painful spot and taut band criteria. 
Fourteen out of 42 healthy subjects were negative to painful spot and 
taut band criteria. 
 3 subjects were excluded due to a positive history for neurological 
disorders 
 4 subjects showed an MTrP located outside the area covered by the 
electrode’ matrix. Three out of 27 subjects were chronic neck pain with 
active MTrPs. One out of 24, was a healthy subject with a latent MTrP 
(figure 5.1). 
 
During the screening phase, MTrPs were detected by a physiotherapist with 
10 years of clinical experience specialising in myofascial pain syndrome’ 
diagnosis and management. The physiotherapist explored the upper 
trapezius area using a flat palpation technique (Travell and Simons, 1983).  
Only neck pain patients with an active or latent MTrP, and pain-free subjects 
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with latent MTrPs, were considered for further analysis. Diagnostic criteria for 
an active MTrP were: the presence of a taut band within the upper trapezius 
muscle and at least one of the following clinical signs; the presence of a spot 
tenderness within the taut band, the reproduction of pain during mechanical 
stimulation of the spot tenderness, and the reproduction of a referred pain 
with mechanical stimulation of the spot tenderness (Myburgh et al., 2008). 
The presence of a local twitch response, which may occur during snapping 
palpation of the taut band, was not considered as one of the diagnostic 
criteria. Researchers have proposed the local twitch response as a 
confirmatory sign but its elicitation may require a vigorous palpation that is 
usually very painful (Simons, 1996). As its diagnostic values is not clearly 
defined, and it is not considered mandatory to diagnose the MTrP’ presence, 
the assessor didn't elicit it specifically. This was also done to protect 
volunteers from harmful situations. Diagnostic criteria for latent MTrPs were 
the presence of both a taut band and spot tenderness. 
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Figure 5.1: Flow diagram of volunteers' progress throughout the course of the study. Abbreviations: CNP, chronic neck pain; 
MTrP, myofascial trigger point.  
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5.3.2 Equipment 
Surface electromyographic signals (sEMG) were detected using a matrix 
(model ELSCH064) composed by 4 columns of 13 electrodes and 1 column 
of 12, with 8 mm interelectrode distance (IED), designed by LISiN at 
Politecnico di Torino and manufactured by OT Bioelettronica, Torino, Italy.  
The skin at the matrix site was shaved, lightly abraded using abrasive paste 
(Spes Medica srl, Genoa, Italy), and cleansed with isopropyl alcohol prior to 
the matrix application. The matrix was fixed on to the skin with double 
adhesive tape. The cavities corresponding with the electrodes, were filled 
with 20 μl conductive paste (TEN20, Weaver and Company, Aurora, 
Colorado, USA) using a spatula to ensure proper electrode–skin contact. 
Surface EMG signals were amplified with an EMG-USB amplifier (LISiN - OT 
Bioelettronica, Torino, Italy - bandwidth 10 – 750 Hz; adjustable gain 
between 500 and 10,000; sampling frequency 2048 Hz; 16 bits A/D 
converter). Samples were visualised on a laptop’ screen during acquisition 
and stored on a personal computer OTBiolab software (OT Bioelettronica, 
Torino, Italy). During EMG experiments, the visualization of signals is 
important to exclude power-line’ interference and artefacts. 
 
In order to measure the torque exerted by the upper trapezius muscle, 
subjects were asked to sit on a custom designed chair and hold both chair 
handles (figure 5.2). The handle on the right side was fixed to a load cell in 
order to measure the force exerted during the shoulder elevation task. 
Subjects were asked to pull the handle toward the ceiling, without flexing 
their elbows and using 20% of their MVC. This contraction intensity was 
demonstrated to be appropriate to describe the IZ’ location using surface 
EMG signals. Higher contraction intensity doesn’t improve the estimation of 
the IZ’ location, and is potentially painful if patients are involved (Barbero et 
al., 2011). 
 
Force signals were acquired and amplified (band- width 0 – 80 Hz) using an 
MISOII amplifier (LISiN - OT Bioelettronica, Torino, Italy). Subject’ feedback 
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was provided by a bar of light-emitting diodes indicating the percentage of 
the maximum voluntary contraction (MVC) that had been reached during 
each shoulder elevation. MTrP’ pain pressure threshold (PPT) was assessed 
with a mechanical pressure algometer (Wagner Instruments, Greenwich, CT, 
USA). The application’ rate was approximately 1 kg/s and the algometer was 
held perpendicular to the skin. The algometer had a rubber tip with a 1 cm2 
contact’ area.  PPT, defined as the minimum force applied at the MTrP’ site 
which induces pain (Fischer, 1987), was measured three times on each site, 
and the average was recorded. The investigator instructed the subjects to 
stop the measurement by saying “ouch” as soon as a discernible sensation 
of pain was felt. The algometric measurement was performed while the 
subjects were seated on a chair with both the arms relaxed by the side. 
 
 
 
Figure 5.2: Experimental setup. Subjects sat in a custom made chair with a 
load cell connected to the right handle and were connected to an electrode’ 
matrix (model ELSCH064, designed by LISiN at Politecnico di Torino and 
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manufactured by OT Bioelectronica, Torino, Italy), placed on the upper 
trapezius. They viewed the visual feedback device (MISO II, LISiN, OT 
Bioelettronica, Torino, Italy) during the experiment.  
 
 
5.3.3 Procedures 
The day after enrolment and immediately prior to the experimental 
procedure, patients with neck pain completed a Neck Disability Index (NDI) 
and a visual analogue scale (VAS). The NDI is a questionnaire, developed by 
Vernon and Mior, to assess self-rated disability in neck pain patients. It 
includes 10 items concerning pain and activities of daily living, including 
personal care, lifting, reading, headaches, concentration, work status, 
driving, sleeping and recreation.  Its reliability and validity have been 
confirmed, and an Italian version (appendix XV) was validated recently 
(Monticone et al., 2012). 
 
Scoring intervals for interpretation of the NDI were as follows: 0-4, no 
disability; 5-14, mild; 14-24, moderate; 25-34, severe; above 34, complete 
disability (Vernon and Mior, 1991). VAS is pain scale used to quantify pain’ 
intensity. It consists of a 10 cm line drawn on a paper. It includes two written 
anchors, “the worst imaginable pain” and “no pain”. The use of VAS has 
been validated for both chronic and experimental pain (Price et al., 1983). 
 
In the current study, subjects reported their mean pain experienced in the 
last week was reported. Pain-free subjects started the experimental 
procedures immediately. Prior to each experimental session, the same 
operator used a surgical pen to draw a standardised anatomical landmark 
system (ALS) on the right shoulder of subjects, while they were seated on 
the data acquisition’ chair. The ALS consisted of a line between the spinal 
process of the seventh vertebrae and the acromial angle (X-axis), and a 
second line perpendicular to the first one and passing through its midpoint 
(Y-axis). The centre of the electrode’ matrix was placed on the intersection 
between the axes’ with the matrix’ columns parallel to the X-axis line, so that 
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the skin area covered by the matrix was divided into four quadrants (first, 
second, third and fourth). 
 
To measure MVC, subjects were instructed to perform a shoulder elevation 
task by pulling the chair’s handles upwards. The MVC’ force level was 
determined as the maximum of three isometric contractions. Two minutes of 
rest were provided between the maximum exertions. Each subject was given 
instructions and allowed to practice for 5 minutes in order to learn the ability 
to keep the force level at 20% of MVC, using the feedback provided. 
Following this, surface EMG signals were acquired for 20 seconds at 20% 
MVC isometric contraction. After the electrode’ matrix was removed, the 
expert physiotherapist performed an examination of the upper trapezius 
muscle using flat palpation techniques, in order to locate the MTrP according 
to the established diagnostic criteria (Myburgh et al., 2008). The latter’s 
location was marked on the skin using a custom designed stamp (a 1cm2 
circle with a dot in the centre). The dot in the centre was overlapped by the 
spot tenderness on the taut band, and its distance from the X- and Y-axes of 
the ALS was measured with a ruler. An operator blinded to the MTrP’ 
location, performed IZ’ visual analysis. The IZ was identified for each of the 
five columns of the bi-dimensional electrode’ matrix by means of visual 
analysis of the single differential surface EMG signals (Merletti et al., 1999). 
The blinding of the operator was achieved by performing the visual analysis 
outwith the experimental session (i.e. offline), and while using signals that 
had records of the subject' and the experimental session' details purposely 
removed before analysis. The criteria to detect the MTrPs’ location on each 
column were minimal amplitude and/or phase reversal of signals  (Merletti et 
al., 2003, Masuda et al., 1983b). Subsequently, IZ’ locations were described 
according to the ALS. To complete the IZ’ location over the upper trapezius 
muscle IZs detected on matrix’ columns were linked (linear interpolation) 
(figure 5.3). 
The PPT over the stamp was assessed for each MTrP using a pressure 
algometer. PPT was measured three times while the subjects were seated 
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with the arms relaxed and positioned by the side of the subject's body. 
Measurements were promptly stopped by the subject saying " ouch". A 
pressure algometer has been suggested for the objective assessment of the 
MTrP, and its ability to measure MTrP with reliability and sensitivity, 
confirmed (Fischer, 1987, Reeves et al., 1986, Jaeger and Reeves, 1986). 
PPT, NDI (scale range, 0 to 50) and VAS (scale range, 0 to 100) provided 
detailed descriptions of the population that had been investigated. 
 
 
 
 
 
 
Figure 5.3: Electrode’ matrix placement. The red dot indicates an MTrP in 
the upper trapezius and the blue line shows the IZ’ location over the area 
covered by the electrode’ matrix. The IZ was typically located medially to the 
Y-axis. TrP-IZ is the distance between spot tenderness in the MTrP’ region 
and the IZ line. For each of the five columns of the matrix, EMG signals are 
reported and IZ’ locations indicated using a blue arrow. The IZ’ location was 
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detected where EMG signals showed minimal amplitude and/or phase 
reversal. AC, acromial angle; C7, spinous process of the seventh vertebrae 
 
5.3.4 Statistical analysis 
The distribution of the dependent variables was explored by using a 
histogram for each outcome measure. The sample size was small (< 50 
samples), thus data were tested for Gaussian distribution using a Shapiro-
Wilk test. The mean and standard deviation of NDI, VAS and MTrPs’ PPTs 
were calculated in order to describe the subjects’ clinical parameters. IZ’ and 
MTrP’ locations were described in accordance with the four quadrants that 
had been defined by the ALS. The distance between the spot tenderness 
and the IZ (TrP- IZ) was computed by tracing pathway parallel to the X-axis, 
reflecting the upper trapezius’ fibre’ direction (Johnson et al., 1994), and 
described as mean and SD. The TrP-IZ was measured along the X-axis 
because the intention was to intercept the IZs located in the same fibres that 
included the MTrP (figure 5.3). The correlations among variables (NDI, 
MTrPs’ PPT, VAS, X, Y, TrP-IZ) were examined using Pearson' product-
moment correlation coefficients. An independent t-test was used to compare 
the values of X, Y and TrP-IZ in active and latent MTrPs, and finally, to verify 
that the TrP-IZ was significantly different from zero. SPSS version 19 (SPSS 
Inc., IBM Company, New York, NY, USA) was used to perform the statistical 
analysis and the level of significance was set at 0.05, and each CI was 
calculated at a confidence level of 95%.  
 
 
5.4 RESULTS 
 
Variables’ distribution was assessed by visual inspection of histograms 
(appendix XVI). All the variables showed a normal distribution, as assessed 
by Shapiro-Wilk's test (p > 0.05) (X, p = 0.9; Y, p = 01; TrP_IZ , p = 0.68; 
PTT, p = 0.28; NDI, p = 0.07; VAS, p = 0.28). Details of statistics for 
normality are summarized in the appendix XVI.  The neck pain patients 
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showed a mean VAS score of 37.3 ± 15.2 and a mean NDI score of 11 ± 5 
out 50. The overall mean PPT of the MTrPs was 2.6 ± 0.9 kg/cm2 (table 5.1), 
while for healthy subjects showed a mean of 2.8 ± 0.8 kg/cm2 and for neck 
pain patients showed a mean of 2.4 ± 0.9 kg/cm2. No significant correlations 
were found among variables except between X and TrP-IZ (p < 0.01). 
According to the ALS, 45 subjects showed an MTrP which was medially 
located with respect to the Y-axis, and all the MTrPs were located in the third 
quadrant, except 3 that were located in second quadrant (figure 5.3).  No 
statistically significant difference was found for X (p = 0.6) or Y (p = 0.1) 
values between active and latent MTrPs.  
 
The IZ was successfully detected in all subjects, for each of the matrix’ 
columns, and was not larger than 8 mm (i.e., the IED) (appendix XVII). 
Typically, the IZ was located medially with respect to the Y-axis and not 
further than 2.4 cm from the Y-axis (i.e., 3 IED) and for the most part, in an 
area that extended from the second to the third quadrant. It was occasionally 
included partially in the first and fourth quadrants (7 out of 48 subjects) 
(figure 5.4). 
 
The mean TrP-IZ was 10.4 ± 5.8 mm, with no statistically significant 
difference between active and latent MTrPs (p = 0.6). TrP-IZ was significantly 
different from zero (p <0.01). figure 5.4 shows both MTrPs’ and IZ’ locations, 
according to the ALS.  
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Table 5.1: Summarised results. Column two indicates patient group: H, healthy group; NP, neck pain group. Column three 
indicates MTrP’ status: A, active MTrP; L, latent MTrP. Neck disability index (NDI) was not requested (n/r) from healthy 
subjects. 
 
 
Subjects 
 
Group MTrPs VAS score NDI score PPT (Kg/cm
2)
 X (mm) Y (mm) TrP-IZ (mm) 
1 H L 0 n/r 2.9 -1 -1 10 
2 NP A 51 21 1.3 -1 -1.5 2 
3 NP L 21 8 2.1 -0.6 -1.5 10.5 
4 NP A 30 7 3.9 -2.4 -1.6 4 
5 H L 0 n/r 5.2 -1.2 0 0 
6 NP A 49 18 2 -1.8 -1.3 14 
7 H L 0 n/r 2.5 -1.9 -0.8 3 
8 H L 0 n/r 3.7 -2 -0.6 16 
9 H L 0 n/r 1.9 -1.7 -0.3 14.5 
10 NP A 19 5 1.6 -2.5 -0.7 17.5 
11 NP A 41 8 1.5 -2.3 -1.2 11 
12 NP A 49 18 2.9 -1.3 -1.3 1 
13 NP A 39 15 1.8 -1.6 -0.6 9 
14 NP A 30 8 1 -2.7 -1.4 10 
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Table 5.1: Summarised results. Column two indicates patient group: H, healthy group; NP, neck pain group. Column three 
indicates MTrP’ status: A, active MTrP; L, latent MTrP. (Continued) 
 
 
15 NP A 55 6 1.7 -1.4 -1.4 12 
16 NP A 21 10 2.4 -2.2 -0.3 18 
17 H L  0  n/r 2.4 -2.1 -0.5 19.5 
18* NP A - - - -0.9 -2.1 - 
19 H L  0  n/r 3.1 -0.1 -1.5 6.5 
20 NP L 75 8 2.3 -1.8 -1.3 6 
21 H L  0  n/r 2.9 -2.9 -1.4 9 
22 H L  0  n/r 2.5 -1.6 -0.3 9 
23 H L  0  n/r 2.8 -3.1 0 7 
24 NP L 46 7 3.4 -1.7 -0.1 16.5 
25 H L  0  n/r 2.7 -1.5 0 11 
26 H L  0  n/r 1.8 -2.7 -0.6 16 
27 H L  0  n/r 1.6 -1.1 -0.6 3 
28 H L  0  n/r 2.7 -2 -0.4 14 
   * Subjects who showed an MTrP located outside the matrix, were excluded from the analysis  
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Table 5.1: Summarised results. Column two indicates patient group: H, healthy group; NP, neck pain group. Column three 
indicates MTrP’ status: A, active MTrP; L, latent MTrP. (Continued) 
 
 
29 H L  0  n/r 4.8 -2.7 -0.7 19 
30 H L  0  n/r 2.6 -2.9 -1 20 
31 H L  0  n/r 2.5 -0.7 -0.5 0.5 
32 NP A 27 11 2.7 -2.2 0 10 
33* H L - - - -1.4 -1.7 - 
34 H L  0  n/r 3.2 -1.4 -0.6 10 
35 H L  0  n/r 2.3 -1.4 -0.7 2.5 
36 H L  0  n/r 1.9 -2.7 -0.5 12.5 
37 H L  0  n/r 3.6 -2.1 0 13 
38 H L  0  n/r 2.1 -2 0.1 8 
39 NP A 20 4 3.2 -2.9 -0.7 17 
40 H L  0  n/r 2.3 -2.6 0 14 
41 H L  0  n/r 3.4 -1.5 -1.4 12 
42 NP A 67 16 2 -2.3 0.5 11 
   * Subjects who showed an MTrP located outside the matrix, were excluded from the analysis  
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Table 5.1: Summarised results. Column two indicates patient group: H, healthy group; NP, neck pain group. Column three 
indicates MTrP’ status: A, active MTrP; L, latent MTrP. (Continued) 
 
43 NP A 39 16 1.7 -2.2 -0.6 15 
44 NP L 47 13 2.7 -1.4 -1.5 10.5 
45 NP A 34 9 2.2 -1.9 -1.5 8 
46 NP A 23 4 3.5 -0.5 0 1 
47 NP L 33 13 4 -1.5 -0.4 1 
48 NP A 34 11 3.8 -2.1 -0.6 16 
49 NP L 25 9 2.1 -2.7 0.5 20 
50 NP A 21 14 3 -1 -0.9 6 
51* NP A - - - -2 -1.9 - 
52* NP A - - - -1.8 -1.9 - 
Mean ± SD     37.3 ± 15.2 11 ± 5 2.6 ± 0.9     10.4 ± 5.8 
 
   * Subjects who showed an MTrP located outside the matrix, were excluded from the analysis  
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Figure 5.4: Graphical representation of MTrPs’ and IZ’ location in the upper 
trapezius according to the ALS in 48 subjects. A) Active MTrPs are 
represented as green circles and latent ones as white circles, and the colours 
indicate MTrP’ spatial densities (a dark red spot indicates high trigger point’ 
density). B) IZ’ distribution, colour represents IZ’ density (a dark blue area 
indicates high IZ’ density). C) Each IZ' loction that is represented by a 
different colour, shows a linked IZ that had been detected within the columns 
of the matrix. AA, acromial angle; C7, spinous process of the seventh 
cervical vertebrae.  
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5.5 DISCUSSION 
 
The purpose of this work was to describe the location of MTrPs and IZs in 
the upper trapezius muscle. Previous studies have reported that it is unclear 
whether the locations of the MTrPs and the IZs are closely related (Mense et 
al., 2001, Simons, 2004, Kuan et al., 2007). A study that investigates both 
these locations in the same subjects has not previously been undertaken. 
Previous studies have shown that the MTrP’ region includes active loci, 
where it is possible to identify low-amplitude electrical activity (i.e., SEA), that 
had been attributed to motor endplate dysfunction, termed endplate noise. 
Additionally, high correlation between MTrP’ site irritability and endplate 
noise’ prevalence has been demonstrated by inserting an EMG needle (Kuan 
et al., 2007). The procedure for searching for endplate noise included the 
insertion of an intramuscular needle at the MTrP’ region that had been 
identified during palpation (Simons et al., 2002). As stated by the authors, 
this suggests an immediate proximity between the MTrP and the IZ (Mense 
et al., 2001, Kuan et al., 2002, Kuan et al., 2007). 
 
Results indicated that MTrPs were located in a well-defined area of the upper 
trapezius, with a PPT that was clearly lower than in normal muscles of 
healthy subjects (Fischer, 1987). For the upper trapezius muscle in healthy 
subjects without MTrPs, Fischer reported a mean PPT of 3.7 ± 1.9 kg/cm2 for 
females, and 5.4 ± 2.8 kg/cm2 for males. Moreover, the reported values are 
similar to those reported in previous studies including those for subjects with 
latent or active MTrPs (Sciotti et al., 2001, Simons et al., 2002, Kuan et al., 
2002). In the current study, the area under investigation was the inferior part 
of upper trapezius and a portion of the upper part of the mid trapezius where 
fibres were described as being horizontally oriented (Johnson et al., 1994). 
This anatomical region is where patients with neck pain, typically report 
tenderness, and where both active and latent MTrPs are frequently observed 
(Fernandez-de-las-Penas et al., 2007). The data from the current study 
described an area for the MTrP’ location in upper trapezius that is similar to 
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the MTrP’ chart proposed by Simons and Travell (Travell and Simons, 1983). 
The latter approach produces results that match the results of the manual 
palpation study of this thesis, and which had used the same ALS (Barbero et 
al., 2012a). MTrPs in the upper trapezius appear to have a stereotyped 
location, and clinicians could use our ALS to guide their palpatory 
examinations. 
 
No significant correlations were found among the variables, with the 
exception of those between X and TrP-IZ, which is an obvious finding 
considering how TrP-IZ had been computed. Additionally, no significant 
differences were observed for either X or Y values between active and latent 
MTrPs. A similar location for active and latent MTrPs would support, as 
described by Simons, a natural course for myofascial pain that includes a 
subclinical stage in which the MTrPs are not spontaneously painful (i.e., 
latent) (Simons, 1996). Forty-two neck pain-free subjects with a negative 
history for arm/shoulder complaints were screened, and just 16 of them were 
negative for taut bands with spot tenderness. The common presence of taut 
bands in pain-free subjects (Fernandez-de-las-Penas et al., 2007, Wolfe et 
al., 1992, Njoo and Van der Does, 1994) and the similar location for active 
and latent MTrPs, seem to suggest that taut bands could be considered as a 
necessary precursor to the development of a MTrP. It is likely that stress’ 
factors (e.g. muscle overload or emotional distress) could be involved in the 
progression from latent to active (Simons, 1996). This was recently 
confirmed by Shah et al., who demonstrated that active and latent MTrPs 
contain the same biochemical substances (Shah et al., 2005) (bradykinin, 
substance P and serotonin), and that latters’ concentration is lower in latent 
MTrPs compared with active MTrPs. In the current study, spot tenderness 
compression failed to evoke complaints (i.e. a negative pain recognition 
criterion) in just 6 of 24 subjects with neck pain, suggesting that MTrPs in the 
upper trapezius frequently contribute to neck pain. The presence of MTrPs 
should not be overlooked when examining subjects with painful conditions; 
moreover, high MTrP’ prevalence has been reported in several selected 
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patient populations (Bron et al., 2011a, Alonso-Blanco et al., 2012, Itza et al., 
2010, Skootsky et al., 1989) . 
The electrode’ matrix covered a 30.72 cm2 area (9.6 cm × 3.2 cm), and the IZ 
can be approximately drawn on the skin as a straight line that runs 
orthogonally to the upper trapezius fibres and tends to curve medially to- 
wards the spine in its caudal part. A similar distribution for the IZ in the upper 
trapezius had been previously reported by Saito el al. in three healthy 
subjects (Saitou et al., 2000). However, this is the first time that the IZ’ 
location was investigated in a large group of subjects, focusing on the area 
that extends over the muscle’ surface. The same experimental setting was 
applied in a previous study that did not focus on the IZ’ morphology (Barbero 
et al., 2011). It should be noted that there was limited variability for the IZ’ 
location in the upper trapezius, and the current study's results support the 
generally accepted principle that muscles with parallel fibres contain IZs in 
the midbelly (Coërs and Woolf, 1959). 
 
The current study's findings confirm that the MTrPs in the upper trapezius are 
located in the proximity of the IZ but do not overlap with it; rather, their 
locations are about 10 mm apart. In contrast with previous investigations 
distinct locations for IZs and MTrPs were observed, but it is important to note 
that this study had investigated investigated a different region of the upper 
trapezius, compared to those of previous studies. Interestingly, MTrPs were 
not equally distributed along the IZ and only affected specific groups of fibres 
in the upper trapezius muscle. 
 
The close spatial relationship between IZ and MTrPs can be potentially 
useful to guide treatments targeting the IZ. As for example, the procedures 
for botulinum toxin injections in various pain conditions, including muscle 
spasticity, cervical dystonia, headache and myofascial pain (Soares et al., 
2012, Delnooz and van de Warrenburg, 2012). A few limitations need to be 
taken into account when interpreting the results of this study. MTrP’ locations 
were identified using spot tenderness located on taut bands by means of 
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palpation, in a similar way to previous studies (Simons et al., 2002, Kuan et 
al., 2007). Although this method has been shown to reliably locate MTrPs in 
the upper trapezius, it had been appreciated that this only provides an 
approximation of its location, ranging from a few millimetres to 1.5 
centimetres (Sciotti et al., 2001).  
 
 
5.6 LIMITATIONS OF THE STUDY  
 
With respect to the cross-sectional study that reflects the analysis of data 
collected at one specific point in time, two aspects of the research design 
should be considered specifically. Firstly, the current study was carried out at 
one point in time and assessments at a different point in time may have 
provided different results. While it is not reasonable to expect a modification 
of the IZ’ location, at least in the short or medium term, it is possible to 
speculate that the MTrP’ spot tenderness varies its location during the clinical 
course of a MPS (Levin, 2006). Perpetuating factors or muscle’ activations 
may have a role in this phenomenon. Thus, a prospective study may help not 
only in addressing the clinical course of a MTrP, but also to confirm its spatial 
relationship with the IZ. Secondly, in cross-sectional studies, it is hard to 
make causal inference for the observed variables (Levin, 2006). Any 
discussion, based on these results, on the underlying mechanism for the 
close spatial relationship between IZ and MTrP, will remain speculative.  
 
Again, as for the reliability studies, the spatial relationship between IZ and 
MTrP was explored with reference to one muscle. The upper trapezius 
muscle has a unique fibre architecture and IZ’ morphology, which can also 
heterogeneous amongst various peoples' trapezius muscles (Saitou et al., 
2000). In muscles like the gastrocnemius (Kim et al., 2005), the IZ is 
scattered throughout the muscle, so the spatial relationship with hypothetical 
MTrPs could give different results. 
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Similarly, the possibility that MTrP’ location in the upper trapezius depends 
on how its motor units are activated during functional activities, cannot be 
excluded. In muscles with a different spatial recruitment of motor units, the 
MTrPs’ location may vary and thus, the spatial relationship between the 
MTrP and the IZ may be different. 
 
A portion of the enrolled population (24 out of 48) were diagnosed to have 
had neck pain; which is a condition characterized by painful symptoms over 
the neck and shoulder region. In these patients, primary and secondary 
hyperalgesia may involve muscles, joints, and ligaments of this region; and 
manual palpation can elicit a painful response. This should be considered a 
potential confounding factor during the patient’ manual examination aimed at 
identify MTrPs. Additionally, the possibility cannot be excluded that the MTrP’ 
location is influenced or determined by the presence of the neck pain. 
Different medical conditions, which are prevalent in this anatomical region, 
may influence the MTrP’ development, as well as modifying the MTrP’s 
location within muscles. 
 
Finally, it is important to note that the detection methodology for the IZs and 
MTrPs gives bi-dimensional locations on the skin, rather than a 3-
dimensional location. Both the IZ and the MTrP are physically located within 
muscles by 3 dimensional coordinates. Alternative approaches, able to locate 
the IZ and the MTrP on a 3 dimensional coordinates system, may describe 
their spatial relationship better. The development of new imaging techniques 
will probably support these investigations.   
 
 
5.7 CONCLUSIONS  
 
MTrP’ and IZ’ locations were described according to the ALS in all enrolled 
subjects. MTrPs were located in well-defined areas of the upper trapezius, 
showing a typical location involving a mean TrP-IZ distance of 10 mm. MTrPs 
in the upper trapezius are proximally located to the IZ, but not overlapped by 
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it. These results provide an interesting insight for future research regarding 
the mechanism underlying the MTrP’ iperalgesia. Moreover, the anatomical 
landmark system proposed in this study may help clinicians identify these 
areas. 
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THESIS CONCLUSIONS 
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6.1 THESIS CONCLUSIONS 
 
Muscle pain and tenderness in the absence of a clear diagnosis is a common 
clinical scenario for physiotherapists. Muscle pain can be localized or 
widespread, constant or intermittent, mild to severe and may reduce the 
patient’s health-related quality of life (Fernandez-Perez et al., 2012, 
Cummings and Baldry, 2007). In these clinical circumstances, during the past 
century, as reported in chapter 1, several authors have described 
systematically what is now accepted as the MTrP (Harden et al., 2000). 
Clinicians of different medical disciplines are currently educated/trained to 
confirm the MPS diagnosis after the identification of at least one active MTrP 
(Charlton, 2005). Within the published literature, a precise set of diagnostic 
criteria has been recommended and the procedures for the manual 
examination of muscles, described (Tough et al., 2007). A narrative review 
published in 2015, stated that the gold standard for the MPS’ diagnosis is the 
physical examination and the following criteria must be met: (1) palpation of 
the taut band; (2) identification of an exquisitely tender nodule in the taut 
band; and reproduction of the patient’s symptomatic pain with sustained 
pressure (Shah et al., 2015). Nevertheless, a few limitations of the proposed 
physical examination should be acknowledged: training and palpation skills 
are critical, it is not applicable to all muscles, the characteristics of the 
physical examination's sensitivity and specificity are not available (Lucas et 
al., 2009). Moreover, there is a lack of consensus among clinicians regarding 
the physical findings associated with the MPS’ diagnosis (Shah et al., 2015).  
 
Estimates from the epidemiological studies, although generally of poor 
quality, suggest that MTrP is a common clinical feature; and it is frequently 
associated with the major musculoskeletal conditions such as for example, 
spinal conditions and shoulder pain (Lluch et al., 2015, Chiarotto et al., 2016, 
Fernandez-de-las-Penas et al., 2007, Iglesias-Gonzalez et al., 2013, Roach 
et al., 2013, Bron et al., 2011b). A search on the Physiotherapy Evidence 
Database (PEDro, http://www.pedro.org.au) using specific keywords for 
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MPS, clearly showed an increase of clinical studies for physiotherapy MTrP’ 
treatment in the last decade (Figure 6.1) (Schneebeli et al., 2015). Clinical 
trials indicate a positive clinical response to different types of MTrP’ 
treatments ranging from invasive to non-invasive, but recommendations from 
clinical guidelines are not available. However, according to the latest 
evidence from the literature, both dry needling and ischemic compression 
can be recommended for short and medium term pain relief (Cagnie et al., 
2013, Kietrys et al., 2013). 
 
 
Figure 6.1: Cumulative number of randomized clinical trials and clinical 
studies on physiotherapy interventions for MTrP indexed in the 
Physiotherapy Evidence database (PEDro) by year, from 1978 to 2014. A 
total of 557 hits were retrieved, after screening for duplicates and inclusion 
criteria, 170 studies were included (Schneebeli et al. 2015). 
 
A notable number of scientific papers have been published since 1942, when 
the first publication on MTrP by Janet Travell (1942) was accepted in Journal 
of the American Medical Association. Overall, three main research lines can 
be identified in the literature. MTrP aetiology; aimed at associating 
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pathophysiological elements like the endplate dysfunction, inflammatory 
mediators, or abnormal tissue properties, with the MTrP’ presence. MTrP 
diagnostic procedures; aimed aimed at proposing a reliable and valid method 
to detect MTrPs. In this case, the final goal is to overcome the well-known 
limitations of the MTrP’ physical examination based on manual palpation 
(Myburgh et al., 2011, Myburgh et al., 2008, Lucas et al., 2009). Lastly, 
MTrP’ treatments; aimed at identifying the most effective treatments for the 
MTrPs.  In this context, the priority is to provide evidence-based 
recommendations for invasive and non-invasive MTrP’ treatment. Among the 
latter research’ lines,  
a high priority can be afforded towards investigating the aetiology of a MTrP.  
Investigating the contributions of end plate dysfunction to the latter would be 
particularly appropriate, since it is considered a central pathophysiological 
element of the integrated trigger point hypothesis, proposed by Simon et al 
(1999). The face validity of MTrPs is high and practitioners recognise its 
clinical relevance, but the validity of the MPS’ diagnosis is discussed in the 
scientific community and controversies still exist (Johnson, 2002, Quintner et 
al., 2014, Quintner and Cohen, 1994). Quinter and his collaborators (2014) 
asserted that the MPS’ construct should be considered a conjecture and that 
the derived hypothesis must be dismissed. Alternatively, they suggested that 
the MTrP’ phenomena can be explained as secondary hyperalgesia of 
peripheral neural origin (Quintner et al., 2014). It has been argued that 
MTrPs are located nearby to the peripheral nerves, and their cause involves 
a focal inflammation of the nerve axons leading to ectopic impulse generation 
(Dilley and Bove, 2008, Dilley et al., 2005). 
 
There is a need for further investigations focusing on specific 
pathophysiological elements regarding the MTrP. It is important to define 
what is the exact nature of this “enigmatic” clinical phenomenon (Simons, 
2004). To strengthen the validity of the MPS’ diagnosis, the MTrPs should be 
recognised as specific pain generators and the underlying 
pathophysiological features should be clearly defined. Nonspecific 
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symptoms like hyperalgesia or referred pain are not enough to distinguish 
MTrPs from other common musculoskeletal conditions. Any advances in this 
direction will help to establish the content validity of a MPS’ diagnosis and 
thereafter, its relevance for clinical practice within the musculoskeletal field.  
 
For this reason, the spatial relationship between MTrP and IZ was 
investigated. A central role of the endplates within MTrP’ pathophysiology 
has been proposed (Mense et al., 2001).  MTrP’ location within muscles and 
its relation with respect to other anatomical structures, has been 
underestimated, although authors, as already discussed in previous 
chapters, advocated its proximity with the IZ. Interestingly, and also during 
clinical practice with patients complaining of muscle pain of the neck and 
shoulder region, it is noticeable that that MTrPs in certain muscles (i.e. upper 
trapezius, sternocleidomastoid muscle, teres major muscle, infraspinatus 
muscle) can be identified in a quite a defined location, within the muscle’ 
belly.  
 
This thesis involved the application of two procedures to conduct the 
experimental measurements. A first one was used to detect the IZ’ location 
using surface EMG signals, and a second one to locate the MTrP using a 
manual palpation’ procedure. Both the procedures were applied to the upper 
trapezius muscle.  
 
The principal goal was to address the spatial relationship between IZ and 
MTrP, while acknowledging that the authors have proposed that MTrPs are 
located in the IZ (Kuan, 2009, Mense et al., 2001). Thus, evidence regarding 
the relative and the absolute reliability of the applied experimental 
procedures were considered important for meaningful discussion of the 
findings of the cross-sectional study investigating the IZ’ and MTrP’ locations. 
When the current evidence had been considered carefully, the proposed null 
hypothesis for the cross-sectional study was that the distance between the IZ 
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and the MTrP in the upper trapezius would not have been significantly 
different from zero. 
 
The intra- and inter-rater reliability statistics indicated a high degree of 
agreement between repeated IZ’ estimations. Kappa values ranged from 
0.82 to 0.92, indicating that any trained operators can confidently apply the 
visual analysis of surface EMG to locate the IZ. Even in cases of uncertainty 
in the application of the visual analysis, the measurement' error in the 
estimation of the IZ’ location did not exceed 4 mm (i.e. half IED). In the same 
study, the effect on IZ localization of the following factors: contraction’ 
intensity, the selected EMG’ epochs (i.e. acquisition period), the contraction’ 
repetition and the matrix’ repositioning.  This was done to ensure that the IZ 
estimation was not affected by variables related to the EMG procedures for 
the acquisition of EMG signals. The measurement error corresponding to the 
disagreement between operators and expressed as a percentage, was 
higher in this case than that observed previously in the literature.  However, 
in general, it again translated to a disagreement that was mostly within an 
error of 4 mm. This accuracy of 4 mm was considered suitable for the cross-
sectional study. The reported results supported both relative and absolute 
reliability for the procedure to locate the IZ. In relation to the planned 
enrolment of neck pain patients, the low intensity contraction (i.e. 20% MVC) 
was considered optimal to define the IZ’ location and to avoid painful 
contractions of the upper trapezius. It is well known that the number and size 
of motor units activated during a muscle contraction depends on the force 
magnitude (Henneman et al., 1965), but no information was available about 
the IZ’ spatial distribution with respect to contraction intensity. In the upper 
trapezius muscle, the EMG signals collected during higher contraction’ 
intensities indicated essentially the same IZ’ location. 
 
Subsequently in the cross-sectional study, IZ’ locations were successfully 
identified using surface EMG. The analysis involved 48 subjects and included 
a total of 30 latent MTrPs and 18 active MTrPs. Both IZ’ and MTrP’ locations 
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were detected for all the enrolled subjects, and no statistically different 
location was detected for latent and active MTrPs. Interestingly, they were 
located in a well-defined area of the ALS (i.e. the third quadrant) that can be 
approximately described as the midfibre’ region of the upper part of the mid 
trapezius muscle, or alternatively, of the inferior part of upper trapezius 
muscle (figure 5.4). A similar MTrP’ distribution was also observed in the last 
intra-rater study on manual palpation. Although it is not possible to clearly 
define this anatomical area, the findings indicate the MTrPs were not 
uniformly distributed along the IZ of the upper trapezius. Their mean distance 
to the position of IZ was 10.4 ± 5.8 mm, with the IZ always medially located 
with respect to MTrP’ spot tenderness. The distance between IZ and MTrP 
was significantly different from zero (p < 0.01), which means that the testing 
null hypothesis was rejected. According to the finding, it is not possible to 
assert a clear overlapping between the MTrP and the IZ, even though it was 
evident that MTrPs were proximally located to the IZ. Indeed, considering the 
two anatomical elements, it is not easy to define clearly what would be an 
overlapping; the IZ is a narrow band that runs vertically through the mid-belly 
region of the upper trapezius, and the MTrP isn't a well-defined area of 
hyperalgesia within a muscle. Moreover, the MTrP’ entity has been located 
using the spot tenderness, which is an element that does not directly 
represent the physical dimension of MTrPs, and no investigation has been 
proposed on their relationship. The only preliminary evidence available on 
the physical dimension of the MTrP reported a cross sectional area of less 
than a square centimetre (Ballyns et al., 2011). The spot tenderness, that 
may be considered the peak of the MTrP’ hyperalgesia, was located 
approximately one centimetre medial to the IZ. It is possible to affirm that the 
MTrP hyperalgesia, which is not limited to the spot tenderness, extended 
through the IZ’ location. In support of our IZ' localization using sEMG, 
evidence that comes from a gross anatomical study on 22 cadavers 
described the IZ localization of trapezius muscle using a Sihler’s Neural 
staining technique (Xie et al., 2015). Although the thesis' study of IZ’ 
investigations were limited to the upper muscle, a visual analysis of the 
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findings from Xie et al. (2015) indicate very similar results to those of the 
current study (figure 6.2). 
 
The reliability of the MTrP’ palpation protocol was confirmed in the latter 
study (Barbero et al., 2012a), strengthening the findings of the cross-
sectional study.  
 
 
Figure 6.2: Two schematic diagrams of IZ’ location of the upper trapezius 
muscle. The blue colour indicates the IZ. On the left side the IZ’ location 
according to Xie et al. (2015), on right side, the IZ’ location according to 
Barbero et al.  (2013).  
 
 
Specifically, the study was planned with the intention of producing evidence 
on the absolute and relative reliability of the manual procedures to locate 
MTrPs in the upper trapezius muscle. The ICC values showed from 
moderate to high correlation for the relevant outcome measures. Two 
variables, X and Y, expressed in millimetres, defined the MTrP, location. The 
mean distance between the MTrP’ locations estimated in the two consecutive 
sessions, was 15.0 ±11.0 mm, with no difference between left and right 
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upper trapezius muscles. MTrPs in the left and the right upper trapezius 
muscles were located according to the ALS previously used for the study 
investigating IZ' reliability. MTrPs in the upper trapezius muscles on both 
sides of the body were located in well-defined area, medially to the ALS_d 
midpoint, and caudally with respect to line between acromial angle and the 
seventh cervical vertebra. This MTrP’ spatial distribution in the upper 
trapezius was very similar to the one observed in the previous cross-
sectional study.  ICC values were 0.62 for the horizontal direction (x axis of 
the ALS) and 0.81 for the vertical direction (y axis of the ALS).  Both the 
values reached the ICC threshold of 0.6, suggested as offering acceptable 
reliability for any clinical procedure or tool (Chinn, 1990). Nevertheless, the 
lower ICC value for the horizontal direction was noted.  A difficulty in locating 
the spot tenderness along the taut band using palpation, was also reported 
by the examiner. Two elements were taken in account to explain low ICC 
values for the horizontal direction: firstly, the spot tenderness, which is a 
focal hyperalgesia, may involve an extended area and not just a discrete 
point on the ALS; secondly, the fingerprint used to explore the taut band has 
an area of approximately 1.5 cm2, again relatively bigger than a discrete point 
on the ALS. However, the Bland-Altman plots showed that in both the 
directions a clinically acceptable error range, and additionally, the mean of 
the difference for repeated X and Y outcome measures were close to zero. 
  
In summary, the results support the statements of a few leading researchers 
in suggesting that MTrPs are always located in the endplate zone. 
Interestingly, two recent papers (Fernandez-de-las-Penas and Dommerholt, 
2014, Dommerholt and Gerwin, 2015), aimed at reviewing the MTrP’ 
physiopathology and supporting the integrated trigger point hypothesis, cited 
our findings, to provide evidence that MTrPs are located proximal to the 
innervation zone (Barbero et al., 2013), and to refute an alternative 
pathophysiological hypothesis that had been formulated by Quinter al 
(Quintner and Cohen, 1994). The latter author claimed that the MTrP’ 
construct lacks internal validity and is a tautological concept based on 
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empirical treatments of MPS (Quintner et al., 2014). Quinter suggested that 
myofascial pain is actually a nerve trunk pain, which is indeed, a specific kind 
of somatic referred pain (Quintner and Cohen, 1994). Local inflammation of 
the peripheral nerves associated with axonal mechanical sensitivity and 
spontaneous discharge of the nociceptors, was proposed as the alternative 
underlying pathophysiology (Quintner et al., 2014). Such a theory would 
imply a spatial localization of the MTrP, nearby to the nerve branches. If the 
anatomy of the upper trapezius was considered, many anastomosing 
branches can be found in all the muscle bellies, with a different distribution 
relative to the IZ. They originate from the spinal accessory nerve and from 
the trapezius branches of the cervical plexus, and form an S-shaped IZ 
throughout the muscle (figure 5.6) (Xie et al., 2015). This would imply 
theoretically, that MTrPs can be located anywhere in the muscle. The 
findings of the cross-sectional study and of the manual palpation’ study, do 
not support such a spatial distribution and conversely, indicate for MTrPs a 
well-defined location within the upper trapezius muscle. 
 
Finally, it is important to remark that the cross-sectional study explored the 
location of the IZ and of the MTrP at one specific point in time, without 
investigating directly the MTrP’ physiopathology. An underling mechanism for 
the observed close spatial relationship between MTrP and IZ cannot be 
proposed, although the endplates’ dysfunction remains a reasonable element 
of the integrated trigger point hypothesis (Mense et al., 2001).  
 
Limitations associated with each of the thesis' studies have been detailed 
within the previous chapters. However, in order to avoid potential 
misinterpretations or generalizations of the findings, it may be useful to 
summarize here, the most important constraints, and to add a few more 
general considerations about the whole of the research project. Both IZ and 
MTrP have been examined only in upper trapezius muscle, and MTrPs have 
been identified only in subjects with neck pain. Thus, it is not possible to 
exclude the possibility that the spatial relationship between IZ and MTrP 
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might differ from that observed in the upper trapezius, when other muscles 
are considered. IZ’ spatial distribution, as well as MTrP’ spatial distribution, 
may have different features among different muscles. IZ’ location and shape 
can vary substantially among muscles, according to their architecture 
(Beretta Piccoli et al., 2014). Similarly, it can be speculated that the observed 
stereotypical location of MTrPs in the upper trapezius may differ according to 
different muscle’ functions (i.e. muscle activation patterns). Also, it is 
plausible that the MTrP’ locations depend on the pathophysiology of the 
associated clinical conditions. For example, painful conditions of the cervical 
spine, such as chronic neck pain, whiplash associated disorders or cervical 
radiculopathy, can be characterized by different pain mechanisms or by 
different anatomical impairments (Bogduk, 2011b, Bogduk, 2009, Bogduk, 
2011a). Currently, no information is available on how a MTrP in a specific 
muscle, is located according to different clinical conditions, but involving the 
same anatomical region.  
 
The possibility that conditioning of the principal investigator might have 
influenced the thesis' findings exists; researcher bias that may limit the 
internal validity of the studies should be considered. During the three 
experimental studies, IZ’ and MTrP’ localization had been performed by the 
same investigator. The experimental procedures and data analysis 
conducted during the first study (i.e. the reliability of sEMG in locating the IZ) 
may have influenced the investigator during the second one (i.e. the cross-
sectional study on the spatial relationship between IZ and MTrP). For the 
same reason, the second study may have influenced the investigator during 
the third study (i.e. the reliability of manual palpation in locating the MTrP in 
the upper trapezius muscle). Even though the investigator was blind to the 
subject during both IZ’ and MTrP’ localization, the possibility of an 
experimenter’ bias can’t be excluded. Lastly, as already mentioned in chapter 
2, the original research’ planning had been modified out of necessity. The 
study on the reliability of manual palpation in locating the MTrP was 
conducted after the cross-sectional study. This amendment to the original 
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research planning hasn't directly impacted on the research project because 
the research design and the experimental procedures of the cross-sectional 
study had not been constrained by the findings of the previous studies. 
Nevertheless, it should be acknowledged that the manual palpation protocol 
had been applied within the cross-sectional study, without information about 
its reliability having been available. Additionally, the investigator didn’t have 
the possibility of having performed the palpation protocol in an experimental 
context before the cross-sectional study had been initiated. The original 
planning should be considered optimal because in turn, it would have 
facilitated optimisation of the palpation protocol. The studies in the thesis had 
focused attention on experimental designs that had been group-based.  
Nevertheless, when focusing on clinical applications involving single-patient 
care, in the case of low reliability for the MTrP’ palpation protocol, it would 
not have been possible to either confirm the results of the cross-sectional 
study, or to have modified its experimental procedures to properly 
incorporate alterations to measurement' precision for use in case-study' 
applications. It is plausible experimentally that if the original planning for the 
studies' sequencing had been respected, different results could have been 
obtained. 
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7.1 AREAS OF FUTURE RESEARCH 
 
The findings of this thesis contribute to extending the body of knowledge 
regarding MTrPs. A close spatial relationship between MTrP and IZ was 
supported in the upper trapezius muscle as previously proposed (Kuan et al., 
2007, Simons, 2001, Simons et al., 2002). However, generalization to other 
muscles should be avoided. Experimental observations from the current 
thesis' studies, as well as those from previous studies in the literature, should 
be limited to the upper trapezius muscle (Simons et al., 2002, Kuan et al., 
2007). Future studies on this topic should include more than one muscle and 
especially, muscles with different fibres’ architecture. Investigations such as 
these, will also clarify if MTrPs have a stereotypical location within the 
muscles, and will permit enhancement of the MTrP’ charts proposed by 
Simons and Travell (Simons et al., 1999), in which the MTrP’ location had not 
been systematically investigated. This information would be of help to 
clinicians during the manual examination of patients. The use of ALS for 
each muscle could also provide a useful guide for the palpation’ procedures 
during clinical practice. Importantly, new research questions can be 
formulated in relation to our results, and other original studies may be 
proposed.  
 
In the reliability study, and also in the study cross-sectional study, MTrPs 
were observed within a well-defined area of the upper trapezius. This region 
includes a limited number of fibres and a specific population of motor units of 
upper trapezius muscle. A study that had evaluated people with latent MTrPs 
in the upper trapezius muscle, documented early myoelectric manifestations 
of fatigue of the upper trapezius during sustained isometric contractions, but 
notably the muscle fibres close to the latent MTrP exhibited an anticipated 
and significant increase in surface EMG’ amplitude (Ge et al., 2012). An 
increase of the intramuscular EMG’ amplitude of the trapezius muscle has 
also been observed in subjects with latent MTrPs during synergistic muscle 
activation (Ge et al., 2014). The influences of MTrPs on motor function need 
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to be clarified. It may excite or inhibit normal motor control in their muscle of 
origin, or in functionally-related muscle. 
 
Based on these observations, it may be suspected that the location of the 
peak myoelectrical activity of the upper trapezius muscle would be different 
in people with MTrPs, and that the peak activity would be located at the site 
of the MTrP. During a task, localized amplitude peaks correspond to activity 
of a motor unit pool whose territory is limited to region of the muscle (Vieira 
et al., 2011) and a spatial modification of this phenomenon may reflect an 
adaptation’ strategy of the motor control system.  
 
Novel high-density, two-dimensional surface EMG provides a measure of the 
electric potential distribution over a large surface area during muscle 
contraction (Gallina et al., 2013, Zwarts and Stegeman, 2003).  Unlike classic 
bipolar EMG applications, this method provides a topographical 
representation of EMG amplitude, and can identify relative adaptations in the 
intensity of activity within regions of a muscle, and the location of the peak 
EMG amplitude across a large region of the muscle. High-density EMG 
studies have confirmed that either acute experimental muscle pain (Falla et 
al., 2009) or chronic clinical pain (Falla et al., 2010) may alter the distribution 
of muscle activity, and may cause a shift of the peak muscle activity. 
Considering these findings, it may be speculated that a long-lasting 
nociceptive irritant, such as a MTrP, could induce a spatial reorganization of 
muscle activity, although this prospect hasn't yet been investigated. 
  
A study to extract topographical maps of surface EMG’ amplitude to evaluate 
the location of peak muscle activity, may be proposed in subjects with and 
without MTrPs in the upper trapezius. Moreover, the relationship between the 
location of the MTrPs (i.e spot tenderness site) and the location of the peak 
EMG amplitude could be examined within this type of study. Investigations 
such as these, will help to unravel if MTrPs have an influence on motor 
control, at least at the level of the involved muscle. Additionally, this type of 
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study could provide evidence on the location of potential physiological 
impairments in relation to MTrP’ spot tenderness. 
 
The accuracy and the reliability of sEMG in locating the IZ, although limited 
to muscles with parallel fibres, has been demonstrated in the study. sEMG 
investigations are inexpensive and non-invasive, and no adverse events 
been reported during their applications. IZ’ identification is a fast procedure 
and can be easily performed in a clinical setting.  On the contrary, manual 
palpation to detect MTrPs showed a few limitations; its reliability is muscle 
dependent, it is operator-dependent, and it can’t be considered a fully 
objective approach to measurement (Myburgh et al., 2008, Lucas et al., 
2009, Tough et al., 2007). For these reasons, some research groups during 
the last few decades, have attempted to identify MTrPs using objective 
imaging techniques. Both ultrasound and magnetic resonance imaging have 
been proposed, and different imaging processing explored (Turo et al., 2015, 
Sikdar et al., 2009, Shankar and Reddy, 2012, Thomas and Shankar, 2013, 
Chen et al., 2007, Chen et al., 2008). Theoretical advantages can be 
attributed to the proposed imaging techniques: 1) they can be applied to all 
the muscles, 2) the MTrP can be objectively located within the muscle belly, 
3) the MTrP’ position can be established using a 3 dimensional approach.  
Moreover, in the case of  magnetic resonance imaging, the taut band’ 
stiffness may be estimated (Chen et al., 2007, Chen et al., 2008). 
 
These imaging techniques can be proposed to further explore the spatial 
relationship between the IZ and the MTrP. For example, the combined 
applications of sEMG and ultrasound in locating MTrPs and IZs, would have 
overcome some constraints related to the MTrP’ manual palpation. 
Additionally, in such a study, there would be the possibility to assess more 
than one muscle.  Unfortunately, a comprehensive review of the literature on 
the use of ultrasound imaging to measure and characterize MTrPs didn’t fully 
support the clinical application (Kumbhare et al., 2016). More research is 
needed to confirm the validity of both magnetic resonance imaging and 
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ultrasound in detecting MTrPs. Nevertheless, the combination of sEMG and 
imaging is a promising approach to explore the spatial relationship between 
the IZ and the MTrP. 
  
A clinical study published in Pain Physician investigated the efficacy of IZ’ 
lidocaine injection for the treatment of MTrPs in patients with chronic neck 
pain (Xie et al., 2015). The authors acknowledged the motor endplate’ 
dysfunction as the most reasonable explanation for the MTrP’ 
pathophysiology (Kuan, 2009), but quoted details of study on the spatial 
relationship between the MTrP and the IZ (Barbero et al., 2013) to speculate 
that two elements may not overlap.  
 
The study design of Xie et al.'s research (2015) was developed test whether 
any injection site for MTrPs would have a clinical effect on patients' 
perceptions of the intensity of pain on a visual analogue scale and on their 
perceptions of painful days per month. Thus, 120 patients with a MTrP in the 
upper trapezius were randomly divided into 5 experimental groups: (1) 
injection of saline at the MTrP’ location (n = 24), (2) injection of lidocaine at 
the MTrP’ location (n = 24), (3) injection of saline at a mid-upper trapezius IZ’ 
location (n = 24), (4) injection of lidocaine at the mid-upper trapezius IZ’ 
location (n = 24), and (5) combined injection of lidocaine at mid-upper and 
lower trapezius IZ’ locations (n = 24). The study confirmed that a lidocaine 
injection performed in the IZ’ location, when compared with the effects of a 
MTrP’ injection, significantly reduces the intensity and frequency of neck pain 
at 6 months post-intervention.  
 
The internal validity of the study was fairly good; inclusion/exclusion criteria 
for patients had been detailed, a random allocation had been adopted and 
blinding of assessors had been applied. Two weakness in the statistical 
analysis should be noted, however a sample-size’ computation had not been 
performed and the authors hadn't provided a between-group statistical 
comparison for the outcomes measures. Overall, both the rationale and the 
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results of study were interesting and represent possible implications for the 
IZ within clinical interventions. Notably, the distribution pattern of the IZ in the 
upper trapezius had been determined during a preliminary time-consuming 
and complex anatomical study. The authors had examined 44 pieces of 
trapezius muscle from 22 cadavers and identified the IZ using an 
intramuscular Sihler’s neural staining’ technique. Finally, a schematic 
diagram of the trunk including the distribution pattern of the IZ was obtained 
to guide IZ’ injections. The proposed method to guide an injection into an IZ 
may be at least questionable, when considering that sEMG can be used to 
precisely locate the IZ in each patient (Barbero et al., 2011). Similar clinical 
studies may further explore the efficacy of MTrP-related interventions 
targeting the IZ by using sEMG. The use of sEMG and an electrodes’ array 
have already been explored for Botulinum toxin injections (Guzman-Venegas 
et al., 2011). Preliminary results have been promising and have suggested 
that the proposed methods can be useful in optimising the injection site and 
to reducing the Botulinum toxin’ dosage (Guzman-Venegas et al., 2014, 
Lapatki et al., 2011).  
 
 
 
  
 191 
REFERENCES 
 
AGUILERA, F. J., MARTIN, D. P., MASANET, R. A., BOTELLA, A. C., SOLER, L. B. 
& MORELL, F. B. 2009. Immediate effect of ultrasound and ischemic 
compression techniques for the treatment of trapezius latent myofascial 
trigger points in healthy subjects: a randomized controlled study. J 
Manipulative Physiol Ther, 32, 515-20. 
AL-SHENQITI, A. M. & OLDHAM, J. A. 2005. Test-retest reliability of myofascial 
trigger point detection in patients with rotator cuff tendonitis. Clin Rehabil, 19, 
482-7. 
ALONSO-BLANCO, C., DE-LA-LLAVE-RINCON, A. I. & FERNANDEZ-DE-LAS-
PENAS, C. 2012. Muscle trigger point therapy in tension-type headache. 
Expert Rev Neurother, 12, 315-22. 
ANDREASSEN, S. & ARENDT-NIELSEN, L. 1987. Muscle fibre conduction velocity 
in motor units of the human anterior tibial muscle: a new size principle 
parameter. J Physiol, 391, 561-71. 
ARENDT-NIELSEN, L. & CASTALDO, M. 2015. MTPs are a peripheral source of 
nociception. Pain Med, 16, 625-7. 
ARIAS-BURIA, J. L., VALERO-ALCAIDE, R., CLELAND, J. A., SALOM-MORENO, 
J., ORTEGA-SANTIAGO, R., ATIN-ARRATIBEL, M. A. & FERNANDEZ-DE-
LAS-PENAS, C. 2015. Inclusion of trigger point dry needling in a multimodal 
physical therapy program for postoperative shoulder pain: a randomized 
clinical trial. J Manipulative Physiol Ther, 38, 179-87. 
AY, S., EVCIK, D. & TUR, B. S. 2010. Comparison of injection methods in 
myofascial pain syndrome: a randomized controlled trial. Clin Rheumatol, 29, 
19-23. 
BALLYNS, J. J., SHAH, J. P., HAMMOND, J., GEBREAB, T., GERBER, L. H. & 
SIKDAR, S. 2011. Objective sonographic measures for characterizing 
myofascial trigger points associated with cervical pain. J Ultrasound Med, 
30, 1331-40. 
BARBERO, M., BERTOLI, P., CESCON, C., MACMILLAN, F., COUTTS, F. & 
GATTI, R. 2012a. Intra-rater reliability of an experienced physiotherapist in 
locating myofascial trigger points in upper trapezius muscle. J Man Manip 
Ther, 20, 171-7. 
BARBERO, M., CESCON, C., TETTAMANTI, A., LEGGERO, V., MACMILLAN, F., 
COUTTS, F. & GATTI, R. 2013. Myofascial trigger points and innervation 
zone locations in upper trapezius muscles. BMC Musculoskelet Disord, 14, 
179. 
BARBERO, M., GATTI, R., LO CONTE, L., MACMILLAN, F., COUTTS, F. & 
MERLETTI, R. 2011. Reliability of surface EMG matrix in locating the 
innervation zone of upper trapezius muscle. J Electromyogr Kinesiol, 21, 
827-33. 
BARBERO, M., MERLETTI, R. & RAINOLDI, A. 2012b. Atlas of muscle innervation 
zones : understanding surface electromyography and its applications, Milan; 
New York, Springer. 
BECK, T. W., DEFREITAS, J. M. & STOCK, M. S. 2012. Accuracy of three different 
techniques for automatically estimating innervation zone location. Comput 
Methods Programs Biomed, 105, 13-21. 
BECK, T. W., HOUSH, T. J., CRAMER, J. T., MALEK, M. H., MIELKE, M. & 
HENDRIX, R. 2008a. The effects of the innervation zone and interelectrode 
distance on the patterns of responses for electromyographic amplitude and 
mean power frequency versus isometric torque for the vastus lateralis 
muscle. Electromyogr Clin Neurophysiol, 48, 13-25. 
 192 
BECK, T. W., HOUSH, T. J., CRAMER, J. T., MALEK, M. H., MIELKE, M., 
HENDRIX, R. & WEIR, J. P. 2008b. Electrode shift and normalization reduce 
the innervation zone's influence on EMG. Med Sci Sports Exerc, 40, 1314-
22. 
BECK, T. W., HOUSH, T. J., CRAMER, J. T., MIELKE, M. & HENDRIX, R. 2008c. 
The influence of electrode shift over the innervation zone and normalization 
on the electromyographic amplitude and mean power frequency versus 
isometric torque relationships for the vastus medialis muscle. J Neurosci 
Methods, 169, 100-8. 
BECK, T. W., HOUSH, T. J., CRAMER, J. T. & WEIR, J. P. 2007a. The effect of the 
estimated innervation zone on EMG amplitude and center frequency. Med 
Sci Sports Exerc, 39, 1282-90. 
BECK, T. W., HOUSH, T. J., MIELKE, M., CRAMER, J. T., WEIR, J. P., MALEK, M. 
H. & JOHNSON, G. O. 2007b. The influence of electrode placement over the 
innervation zone on electromyographic amplitude and mean power 
frequency versus isokinetic torque relationships. J Neurosci Methods, 162, 
72-83. 
BEN KIBLER, W., SCIASCIA, A. D., HESTER, P., DOME, D. & JACOBS, C. 2009. 
Clinical utility of traditional and new tests in the diagnosis of biceps tendon 
injuries and superior labrum anterior and posterior lesions in the shoulder. 
Am J Sports Med, 37, 1840-7. 
BENNETT, R. 2007. Myofascial pain syndromes and their evaluation. Best Pract 
Res Clin Rheumatol, 21, 427-45. 
BERETTA PICCOLI, M., RAINOLDI, A., HEITZ, C., WUTHRICH, M., BOCCIA, G., 
TOMASONI, E., SPIROLAZZI, C., EGLOFF, M. & BARBERO, M. 2014. 
Innervation zone locations in 43 superficial muscles: toward a 
standardization of electrode positioning. Muscle Nerve, 49, 413-21. 
BHARGAVA, A. S., EAPEN, C. & KUMAR, S. P. 2010. Grip strength measurements 
at two different wrist extension positions in chronic lateral epicondylitis-
comparison of involved vs. uninvolved side in athletes and non athletes: a 
case-control study. Sports Med Arthrosc Rehabil Ther Technol, 2, 22. 
BLAND, J. M. & ALTMAN, D. G. 1986. Statistical methods for assessing agreement 
between two methods of clinical measurement. Lancet, 1, 307-10. 
BLAND, J. M. & ALTMAN, D. G. 1999. Measuring agreement in method comparison 
studies. Stat Methods Med Res, 8, 135-60. 
BODES-PARDO, G., PECOS-MARTIN, D., GALLEGO-IZQUIERDO, T., SALOM-
MORENO, J., FERNANDEZ-DE-LAS-PENAS, C. & ORTEGA-SANTIAGO, 
R. 2013. Manual treatment for cervicogenic headache and active trigger 
point in the sternocleidomastoid muscle: a pilot randomized clinical trial. J 
Manipulative Physiol Ther, 36, 403-11. 
BOGDUK, N. 2009. On the definitions and physiology of back pain, referred pain, 
and radicular pain. Pain, 147, 17-9. 
BOGDUK, N. 2011a. The anatomy and pathophysiology of neck pain. Phys Med 
Rehabil Clin N Am, 22, 367-82, vii. 
BOGDUK, N. 2011b. On cervical zygapophysial joint pain after whiplash. Spine 
(Phila Pa 1976), 36, S194-9. 
BOGDUK, N. & MCGUIRK, B. 2006. Management of acute and chronic neck pain : 
an evidence-based approach, Edinburgh; New York, Elsevier. 
BORG-STEIN, J. & SIMONS, D. G. 2002. Focused review: myofascial pain. Arch 
Phys Med Rehabil, 83, S40-7, S48-9. 
BRADY, S., MCEVOY, J., DOMMERHOLT, J. & DOODY, C. 2014. Adverse events 
following trigger point dry needling: a prospective survey of chartered 
physiotherapists. J Man Manip Ther, 22, 134-40. 
 193 
BRON, C., DE GAST, A., DOMMERHOLT, J., STEGENGA, B., WENSING, M. & 
OOSTENDORP, R. A. 2011a. Treatment of myofascial trigger points in 
patients with chronic shoulder pain: a randomized, controlled trial. BMC Med, 
9, 8. 
BRON, C., DOMMERHOLT, J., STEGENGA, B., WENSING, M. & OOSTENDORP, 
R. A. 2011b. High prevalence of shoulder girdle muscles with myofascial 
trigger points in patients with shoulder pain. BMC Musculoskelet Disord, 12, 
139. 
BRON, C. & DOMMERHOLT, J. D. 2012. Etiology of Myofascial Trigger Points. 
Current Pain and Headache Reports, 16, 439-444. 
BRON, C., FRANSSEN, J., WENSING, M. & OOSTENDORP, R. A. 2007. Interrater 
reliability of palpation of myofascial trigger points in three shoulder muscles. 
J Man Manip Ther, 15, 203-15. 
BROOKS, P. M. 2006. The burden of musculoskeletal disease--a global 
perspective. Clin Rheumatol, 25, 778-81. 
BROSSEAU, L., TOUSIGNANT, M., BUDD, J., CHARTIER, N., DUCIAUME, L., 
PLAMONDON, S., O'SULLIVAN, J. P., O'DONOGHUE, S. & BALMER, S. 
1997. Intratester and intertester reliability and criterion validity of the 
parallelogram and universal goniometers for active knee flexion in healthy 
subjects. Physiother Res Int, 2, 150-66. 
BROWN, C. S., LING, F. W., WAN, J. Y. & PILLA, A. A. 2002. Efficacy of static 
magnetic field therapy in chronic pelvic pain: a double-blind pilot study. Am J 
Obstet Gynecol, 187, 1581-7. 
BROWN, W. F. & VARKEY, G. P. 1981. The origin of spontaneous electrical activity 
at the end-plate zone. Ann Neurol, 10, 557-60. 
BRUTON, A., CONWAY, J. H. & HOLGATE, S. T. 2000. Reliability: What is it, and 
how is it measured? Physiotherapy, 86, 94-99. 
BUCHTHAL, F. & ROSENFALCK, P. 1966. Spontaneous electrical activity of human 
muscle. Electroencephalogr Clin Neurophysiol, 20, 321-36. 
BUKHARAEVA, E. A., SALAKHUTDINOV, R. I., VYSKOCIL, F. & NIKOLSKY, E. E. 
2005. Spontaneous quantal and non-quantal release of acetylcholine at 
mouse endplate during onset of hypoxia. Physiol Res, 54, 251-5. 
BUTLER, D. S. & MATHESON, J. 2000. The sensitive nervous system, Adelaide, 
Noigroup. 
CADOGAN, A., LASLETT, M., HING, W., MCNAIR, P. & WILLIAMS, M. 2011. 
Interexaminer reliability of orthopaedic special tests used in the assessment 
of shoulder pain. Man Ther, 16, 131-5. 
CAGNIE, B., DEWITTE, V., COPPIETERS, I., VAN OOSTERWIJCK, J., COOLS, A. 
& DANNEELS, L. 2013. Effect of ischemic compression on trigger points in 
the neck and shoulder muscles in office workers: a cohort study. J 
Manipulative Physiol Ther, 36, 482-9. 
CALVO-LOBO, C., PACHECO-DA-COSTA, S., MARTINEZ-MARTINEZ, J., 
RODRIGUEZ-SANZ, D., CUESTA-ALVARO, P. & LOPEZ-LOPEZ, D. 2016. 
Dry Needling on the Infraspinatus Latent and Active Myofascial Trigger 
Points in Older Adults With Nonspecific Shoulder Pain: A Randomized 
Clinical Trial. J Geriatr Phys Ther. 
CAMANHO, G. L., IMAMURA, M. & ARENDT-NIELSEN, L. 2011. Genesis of Pain in 
Arthrosis. Rev Bras Ortop, 46, 14-7. 
CANTARERO-VILLANUEVA, I., FERNANDEZ-LAO, C., FERNANDEZ-DE-LAS-
PENAS, C., LOPEZ-BARAJAS, I. B., DEL-MORAL-AVILA, R., DE LA-
LLAVE-RINCON, A. I. & ARROYO-MORALES, M. 2012. Effectiveness of 
water physical therapy on pain, pressure pain sensitivity, and myofascial 
 194 
trigger points in breast cancer survivors: a randomized, controlled clinical 
trial. Pain Med, 13, 1509-19. 
CECCHERELLI, F., ALTAFINI, L., LO CASTRO, G., AVILA, A., AMBROSIO, F. & 
GIRON, G. P. 1989. Diode laser in cervical myofascial pain: a double-blind 
study versus placebo. Clin J Pain, 5, 301-4. 
CELIK, D. & KAYA MUTLU, E. 2012. The relationship between latent trigger points 
and depression levels in healthy subjects. Clin Rheumatol, 31, 907-11. 
CELIK, D. & MUTLU, E. K. 2013. Clinical implication of latent myofascial trigger 
point. Curr Pain Headache Rep, 17, 353. 
CELIK, D. & YELDAN, I. 2011. The relationship between latent trigger point and 
muscle strength in healthy subjects: a double-blind study. J Back 
Musculoskelet Rehabil, 24, 251-6. 
CESCON, C., REBECCHI, P. & MERLETTI, R. 2008. Effect of electrode array 
position and subcutaneous tissue thickness on conduction velocity 
estimation in upper trapezius muscle. J Electromyogr Kinesiol, 18, 628-36. 
CHAIAMNUAY, P., DARMAWAN, J., MUIRDEN, K. D. & ASSAWATANABODEE, P. 
1998. Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR 
COPCORD study. Community Oriented Programme for the Control of 
Rheumatic Disease. J Rheumatol, 25, 1382-7. 
CHARLIER, R., MERTENS, E., LEFEVRE, J. & THOMIS, M. 2015. Muscle mass 
and muscle function over the adult life span: a cross-sectional study in 
Flemish adults. Arch Gerontol Geriatr, 61, 161-7. 
CHARLTON, J. E. 2005. Core curriculum for professional education in pain, Seattle, 
IASP Press. 
CHATCHAWAN, U., THINKHAMROP, B., KHARMWAN, S., KNOWLES, J. & 
EUNGPINICHPONG, W. 2005. Effectiveness of traditional Thai massage 
ver- sus Swedish massage among patients with back pain associated with 
myofascial trigger points. J Bodyw Mov Ther, 298-309. 
CHEN, B. M. & GRINNELL, A. D. 1997. Kinetics, Ca2+ dependence, and 
biophysical properties of integrin-mediated mechanical modulation of 
transmitter release from frog motor nerve terminals. J Neurosci, 17, 904-16. 
CHEN, Q., BASFORD, J. & AN, K. N. 2008. Ability of magnetic resonance 
elastography to assess taut bands. Clin Biomech (Bristol, Avon), 23, 623-9. 
CHEN, Q., BENSAMOUN, S., BASFORD, J. R., THOMPSON, J. M. & AN, K. N. 
2007. Identification and quantification of myofascial taut bands with magnetic 
resonance elastography. Arch Phys Med Rehabil, 88, 1658-61. 
CHEN, Q., WANG, H. J., GAY, R. E., THOMPSON, J. M., MANDUCA, A., AN, K. N., 
EHMAN, R. E. & BASFORD, J. R. 2016. Quantification of Myofascial Taut 
Bands. Arch Phys Med Rehabil, 97, 67-73. 
CHEN, X., TANNER, K. & LEVINE, J. D. 1999. Mechanical sensitization of 
cutaneous C-fibre nociceptors by prostaglandin E2 in the rat. Neurosci Lett, 
267, 105-8. 
CHIAROTTO, A., CLIJSEN, R., FERNANDEZ-DE-LAS-PENAS, C. & BARBERO, M. 
2016. Prevalence of Myofascial Trigger Points in Spinal Disorders: A 
Systematic Review and Meta-Analysis. Arch Phys Med Rehabil, 97, 316-37. 
CHINN, S. 1990. The assessment of methods of measurement. Stat Med, 9, 351-
62. 
CHINN, S., CALDWELL, W. & GRITSENKO, K. 2016. Fibromyalgia Pathogenesis 
and Treatment Options Update. Curr Pain Headache Rep, 20, 25. 
CHIU, I. M., VON HEHN, C. A. & WOOLF, C. J. 2012. Neurogenic inflammation and 
the peripheral nervous system in host defense and immunopathology. Nat 
Neurosci, 15, 1063-7. 
 195 
CHO, N. H., KIM, I., LIM, S. H. & KIM, H. A. 2012. Prevalence of widespread pain 
and its influence on quality of life: population study in Korea. J Korean Med 
Sci, 27, 16-21. 
CHOU, L. W., HSIEH, Y. L., KAO, M. J. & HONG, C. Z. 2009. Remote influences of 
acupuncture on the pain intensity and the amplitude changes of endplate 
noise in the myofascial trigger point of the upper trapezius muscle. Arch 
Phys Med Rehabil, 90, 905-12. 
CHOU, L. W., KAO, M. J. & LIN, J. G. 2012. Probable mechanisms of needling 
therapies for myofascial pain control. Evid Based Complement Alternat Med, 
2012, 705327. 
CHRISTENSEN, E. 1959. Topography of terminal motor innervation in striated 
muscles from stillborn infants. Am J Phys Med, 38, 65-78. 
CHU, J. 1997. Does EMG (dry needling) reduce myofascial pain symptoms due to 
cervical nerve root irritation? Electromyogr Clin Neurophysiol, 37, 259-72. 
CICUTTINI, F. M. & SPECTOR, T. D. 1995. Osteoarthritis in the aged. 
Epidemiological issues and optimal management. Drugs Aging, 6, 409-20. 
CLEWLEY, D., FLYNN, T. W. & KOPPENHAVER, S. 2014. Trigger point dry 
needling as an adjunct treatment for a patient with adhesive capsulitis of the 
shoulder. J Orthop Sports Phys Ther, 44, 92-101. 
COËRS, C. E. F. O. & WOOLF, A. L. 1959. The innervation of muscle: a biopsy 
study, Oxford, Blackwell Scientific Publications. 
COHEN, J. 1960. Coefficient of agreement for nominal scales. Educ Psychol Meas, 
20, 37-46. 
CORDASCO, F. A., STEINMANN, S., FLATOW, E. L. & BIGLIANI, L. U. 1993. 
Arthroscopic treatment of glenoid labral tears. Am J Sports Med, 21, 425-30; 
discussion 430-1. 
CORNELIUS, A. 1903. Narben und Nerven. Deutsche Militartzlische Zeitschrift, 32, 
657-673. 
COTCHETT, M. P., LANDORF, K. B. & MUNTEANU, S. E. 2010. Effectiveness of 
dry needling and injections of myofascial trigger points associated with 
plantar heel pain: a systematic review. J Foot Ankle Res, 3, 18. 
CROFT, P., RIGBY, A. S., BOSWELL, R., SCHOLLUM, J. & SILMAN, A. 1993. The 
prevalence of chronic widespread pain in the general population. J 
Rheumatol, 20, 710-3. 
CUMMINGS, M. & BALDRY, P. 2007. Regional myofascial pain: diagnosis and 
management. Best Pract Res Clin Rheumatol, 21, 367-87. 
DARDZINSKI, J. A., OSTROV, B. E. & HAMANN, L. S. 2000. Myofascial pain 
unresponsive to standard treatment: successful use of a strain and 
counterstrain technique with physical therapy. J Clin Rheumatol, 6, 169-74. 
DEBASSIO, W. A., SCHNITZLER, R. M. & PARSONS, R. L. 1971. Influence of 
lanthanum on transmitter release at the neuromuscular junction. J Neurobiol, 
2, 263-78. 
DEFREITAS, J. M., COSTA, P. B., RYAN, E. D., HERDA, T. J., CRAMER, J. T. & 
BECK, T. W. 2008. An examination of innervation zone movement with 
increases in isometric torque production. Clin Neurophysiol, 119, 2795-9. 
DEFREITAS, J. M., COSTA, P. B., RYAN, E. D., HERDA, T. J., CRAMER, J. T. & 
BECK, T. W. 2010. Innervation zone location of the biceps brachii, a 
comparison between genders and correlation with anthropometric 
measurements. J Electromyogr Kinesiol, 20, 76-80. 
DELNOOZ, C. C. & VAN DE WARRENBURG, B. P. 2012. Current and future 
medical treatment in primary dystonia. Ther Adv Neurol Disord, 5, 221-40. 
DIAKOW, P. R. 1992. Differentiation of active and latent trigger points by 
thermography. J Manipulative Physiol Ther, 15, 439-41. 
 196 
DILLEY, A. & BOVE, G. M. 2008. Resolution of inflammation-induced axonal 
mechanical sensitivity and conduction slowing in C-fibre nociceptors. J Pain, 
9, 185-92. 
DILLEY, A., LYNN, B. & PANG, S. J. 2005. Pressure and stretch mechanosensitivity 
of peripheral nerve fibres following local inflammation of the nerve trunk. 
Pain, 117, 462-72. 
DILORENZO, L., TRABALLESI, M., MORELLI, D., POMPA, A., BRUNELLI, S., 
BUZZI, M. G. & FORMISANO, R. 2004. Hemiparetic Shoulder Pain 
Syndrome Treated with Deep Dry Needling During Early Rehabilitation: A 
Prospective, Open-Label, Randomized Investigation. J Musculoskel Pain, 
12, 25-34. 
DOMMERHOLT, J. 2005. Persistent myalgia following whiplash. Curr Pain 
Headache Rep, 9, 326-30. 
DOMMERHOLT, J. 2008. Myofascial Pain Syndrome-Trigger Points Literature 
Review: Comment on Dorsher Study Reply. Journal of Musculoskeletal Pain, 
16, 349-351. 
DOMMERHOLT, J. 2010. Performing arts medicine - instrumentalist musicians: part 
III - case histories. J Bodyw Mov Ther, 14, 127-38. 
DOMMERHOLT, J. 2011a. Dry needling - peripheral and central considerations. J 
Man Manip Ther, 19, 223-7. 
DOMMERHOLT, J. 2011b. Myofascial Pain Syndrome: Trigger Points. Journal of 
Musculoskeletal Pain, 19, 171-177. 
DOMMERHOLT, J., BRON, C. & FRANSSEN, J. 2006. Myofascial Trigger Points: 
An Evidence-Informed Review. J Man Manip Ther, 14, 203-221. 
DOMMERHOLT, J., FINNEGAN, M., GRIEVE, R. & HOOKS, T. 2016. A critical 
overview of the current myofascial pain literature - January 2016. J Bodyw 
Mov Ther, 20, 156-67. 
DOMMERHOLT, J. & GERWIN, R. 2015. A Critical Evaluation of Quintner et al: 
Missing the Point. J Bodyw Mov Ther. 
DOMMERHOLT, J., GRIEVE, R., HOOKS, T. & LAYTON, M. 2015a. A critical 
overview of the current myofascial pain literature - October 2015. J Bodyw 
Mov Ther, 19, 736-46. 
DOMMERHOLT, J. & HUIJBREGTS, P. 2011. Myofascial trigger points: 
pathophysiology and evidence-informed diagnosis and management, 
Sudbury, Mass., Jones and Bartlett Publishers. 
DOMMERHOLT, J., LAYTON, M., HOOKS, T. & GRIEVE, R. 2015b. A critical 
overview of current myofascial pain literature - March 2015. J Bodyw Mov 
Ther, 19, 337-49. 
DONNER, A. & ELIASZIW, M. 1992. A goodness-of-fit approach to inference 
procedures for the kappa statistic: confidence interval construction, 
significance-testing and sample size estimation. Stat Med, 11, 1511-9. 
DOSTAL, C., PAVELKA, K. & LEWIT, K. 1978. [Ibuprofen in the treatment of the 
cervicocranial syndrome in combination with manipulative therapy]. Fysiatr 
Revmatol Vestn, 56, 258-63. 
EDEIKEN, J. W., CC. 1936. Persistent pain in the shoulder region following 
myocardial infarction. American Journal of the Medical Sciences, 191, 201-
210. 
ENCK, P., FRANZ, H., AZPIROZ, F., FERNANDEZ-FRAGA, X., HINNINGHOFEN, 
H., KASKE-BRETAG, K., BOTTIN, A., MARTINA, S. & MERLETTI, R. 2004. 
Innervation zones of the external anal sphincter in healthy male and female 
subjects. Preliminary results. Digestion, 69, 123-30. 
 197 
ENCK, P., FRANZ, H., DAVICO, E., MASTRANGELO, F., MESIN, L. & MERLETTI, 
R. 2010. Repeatability of innervation zone identification in the external anal 
sphincter muscle. Neurourol Urodyn, 29, 449-57. 
ENWEMEKA, C. S. 1989. The effects of therapeutic ultrasound on tendon healing. 
A biomechanical study. Am J Phys Med Rehabil, 68, 283-7. 
EROGLU, P. K., YILMAZ, O., BODUR, H. & ATES, C. 2013. A Comparison of the 
Efficacy of Dry Needling, Lidocaine Injection, and Oral Flurbiprofen 
Treatments in Patients with Myofascial Pain Syndrome: A Double-Blind (For 
Injection, Groups Only), Randomized Clinical Trial. Turkish Journal of 
Rheumatology, 28, 38-46. 
ESENYEL, M., CAGLAR, N. & ALDEMIR, T. 2000. Treatment of myofascial pain. 
Am J Phys Med Rehabil, 79, 48-52. 
FALLA, D., ANDERSEN, H., DANNESKIOLD-SAMSOE, B., ARENDT-NIELSEN, L. 
& FARINA, D. 2010. Adaptations of upper trapezius muscle activity during 
sustained contractions in women with fibromyalgia. J Electromyogr Kinesiol, 
20, 457-64. 
FALLA, D., ARENDT-NIELSEN, L. & FARINA, D. 2009. The pain-induced change in 
relative activation of upper trapezius muscle regions is independent of the 
site of noxious stimulation. Clin Neurophysiol, 120, 150-7. 
FALLA, D., DALL'ALBA, P., RAINOLDI, A., MERLETTI, R. & JULL, G. 2002. 
Location of innervation zones of sternocleidomastoid and scalene muscles - 
a basis for clinical and research electromyography applications. Clin 
Neurophysiol, 113, 57-63. 
FARBER, A. J., CASTILLO, R., CLOUGH, M., BAHK, M. & MCFARLAND, E. G. 
2006. Clinical assessment of three common tests for traumatic anterior 
shoulder instability. J Bone Joint Surg Am, 88, 1467-74. 
FARINA, D., CESCON, C. & MERLETTI, R. 2002. Influence of anatomical, physical, 
and detection-system parameters on surface EMG. Biol Cybern, 86, 445-56. 
FARINA, S., CASAROTTO, M., BENELLE, M., TINAZZI, M., FIASCHI, A., 
GOLDONI, M. & SMANIA, N. 2004. A randomized controlled study on the 
effect of two different treatments (FREMS AND TENS) in myofascial pain 
syndrome. Eura Medicophys, 40, 293-301. 
FERNANDEZ, H. L. & HODGES-SAVOLA, C. A. 1996. Physiological regulation of 
G4 AChe in fast-twitch muscle: effects of exercise and CGRP. J Appl 
Physiol, 80, 357-62. 
FERNANDEZ-CARNERO, J., LA TOUCHE, R., ORTEGA-SANTIAGO, R., GALAN-
DEL-RIO, F., PESQUERA, J., GE, H. Y. & FERNANDEZ-DE-LAS-PENAS, 
C. 2010. Short-term effects of dry needling of active myofascial trigger points 
in the masseter muscle in patients with temporomandibular disorders. J 
Orofac Pain, 24, 106-12. 
FERNANDEZ-DE-LAS-PENAS, C., ALONSO-BLANCO, C., CUADRADO, M. L., 
GERWIN, R. D. & PAREJA, J. A. 2006a. Trigger points in the suboccipital 
muscles and forward head posture in tension-type headache. Headache, 46, 
454-60. 
FERNANDEZ-DE-LAS-PENAS, C., ALONSO-BLANCO, C., FERNANDEZ 
CARNERO, J. & MIANGOLARRA PAGE, J. C. 2006b. The immediate effect 
of ischemic compression technique and transverse friction on tenderness of 
active and latent myofascial trigger points: a pilot study. J Bodyw Mov Ther, 
3-9. 
FERNANDEZ-DE-LAS-PENAS, C., ALONSO-BLANCO, C. & MIANGOLARRA, J. C. 
2007. Myofascial trigger points in subjects presenting with mechanical neck 
pain: a blinded, controlled study. Man Ther, 12, 29-33. 
 198 
FERNANDEZ-DE-LAS-PENAS, C. & DOMMERHOLT, J. 2014. Myofascial trigger 
points: peripheral or central phenomenon? Curr Rheumatol Rep, 16, 395. 
FERNANDEZ-DE-LAS-PENAS, C., GROBLI, C., ORTEGA-SANTIAGO, R., 
FISCHER, C. S., BOESCH, D., FROIDEVAUX, P., STOCKER, L., 
WEISSMANN, R. & GONZALEZ-IGLESIAS, J. 2012. Referred pain from 
myofascial trigger points in head, neck, shoulder, and arm muscles 
reproduces pain symptoms in blue-collar (manual) and white-collar (office) 
workers. Clin J Pain, 28, 511-8. 
FERNANDEZ-DE-LAS-PENAS, C., SOHRBECK CAMPO, M., FERNANDEZ 
CARNERO, J. & MIANGOLARRA PAGE, J. C. 2005. Manual therapies in 
myofascial trigger point treatment: a systematic review. J Bodyw Mov Ther, 
9, 27-34. 
FERNANDEZ-PEREZ, A. M., VILLAVERDE-GUTIERREZ, C., MORA-SANCHEZ, 
A., ALONSO-BLANCO, C., STERLING, M. & FERNANDEZ-DE-LAS-
PENAS, C. 2012. Muscle trigger points, pressure pain threshold, and 
cervical range of motion in patients with high level of disability related to 
acute whiplash injury. J Orthop Sports Phys Ther, 42, 634-41. 
FISCHER, A. A. 1987. Reliability of the pressure algometer as a measure of 
myofascial trigger point sensitivity. Pain, 28, 411-4. 
FISHBAIN, D. A., GOLDBERG, M., MEAGHER, B. R., STEELE, R. & ROSOMOFF, 
H. 1986. Male and female chronic pain patients categorized by DSM-III 
psychiatric diagnostic criteria. Pain, 26, 181-97. 
FRICTON, J. R. 1989. Myofascial pain syndrome. Neurol Clin, 7, 413-27. 
FRICTON, J. R. 1991. Clinical care for myofascial pain. Dent Clin North Am, 35, 1-
28. 
FRICTON, J. R. 1994. Myofascial pain. Baillieres Clin Rheumatol, 8, 857-80. 
FRICTON, J. R., KROENING, R., HALEY, D. & SIEGERT, R. 1985. Myofascial pain 
syndrome of the head and neck: a review of clinical characteristics of 164 
patients. Oral Surg Oral Med Oral Pathol, 60, 615-23. 
FRÖHLICH, D. & FRÖHLICH, R. 1995. Das Piriformissyndrom: eine häufige 
Differentialdiagnose des lumboglutäalen Schmerzes. Manuelle Medizin, 33, 
7-10. 
FUKUNAGA, T., KAWAKAMI, Y., KUNO, S., FUNATO, K. & FUKASHIRO, S. 1997. 
Muscle architecture and function in humans. J Biomech, 30, 457-63. 
GA, H., CHOI, J. H., PARK, C. H. & YOON, H. J. 2007a. Dry needling of trigger 
points with and without paraspinal needling in myofascial pain syndromes in 
elderly patients. J Altern Complement Med, 13, 617-24. 
GA, H., KOH, H. J., CHOI, J. H. & KIM, C. H. 2007b. Intramuscular and nerve root 
stimulation vs lidocaine injection to trigger points in myofascial pain 
syndrome. J Rehabil Med, 39, 374-8. 
GALLINA, A., MERLETTI, R. & GAZZONI, M. 2013. Uneven spatial distribution of 
surface EMG: what does it mean? Eur J Appl Physiol, 113, 887-94. 
GAM, A. N., WARMING, S., LARSEN, L. H., JENSEN, B., HOYDALSMO, O., 
ALLON, I., ANDERSEN, B., GOTZSCHE, N. E., PETERSEN, M. & 
MATHIESEN, B. 1998. Treatment of myofascial trigger-points with 
ultrasound combined with massage and exercise--a randomised controlled 
trial. Pain, 77, 73-9. 
GAZZONI, M., FARINA, D. & MERLETTI, R. 2001. Motor unit recruitment during 
constant low force and long duration muscle contractions investigated with 
surface electromyography. Acta Physiol Pharmacol Bulg, 26, 67-71. 
GE, H. Y., ARENDT-NIELSEN, L. & MADELEINE, P. 2012. Accelerated muscle 
fatigability of latent myofascial trigger points in humans. Pain Med, 13, 957-
64. 
 199 
GE, H. Y., FERNANDEZ-DE-LAS-PENAS, C., MADELEINE, P. & ARENDT-
NIELSEN, L. 2008a. Topographical mapping and mechanical pain sensitivity 
of myofascial trigger points in the infraspinatus muscle. Eur J Pain, 12, 859-
65. 
GE, H. Y., FERNANDEZ-DE-LAS-PENAS, C. & YUE, S. W. 2011. Myofascial trigger 
points: spontaneous electrical activity and its consequences for pain 
induction and propagation. Chin Med, 6, 13. 
GE, H. Y., MONTERDE, S., GRAVEN-NIELSEN, T. & ARENDT-NIELSEN, L. 2014. 
Latent myofascial trigger points are associated with an increased 
intramuscular electromyographic activity during synergistic muscle 
activation. J Pain, 15, 181-7. 
GE, H. Y., ZHANG, Y., BOUDREAU, S., YUE, S. W. & ARENDT-NIELSEN, L. 
2008b. Induction of muscle cramps by nociceptive stimulation of latent 
myofascial trigger points. Exp Brain Res, 187, 623-9. 
GEMMELL, H. & ALLEN, A. 2008. Relative Immediate Effect of Ischaemic 
Compression and Activator Trigger Point Therapy on Active Upper Trapezius 
Trigger Points: A Randomized Trial. Clin Chiropr, 11, 175-81. 
GEMMELL, H. & HILLAND, A. 2011. Immediate effect of electric point stimulation 
(TENS) in treating latent upper trapezius trigger points: a double blind 
randomised placebo-controlled trial. J Bodyw Mov Ther, 15, 348-54. 
GERWIN, R. 1997. A study of 96 subjects examined both for fibromyalgia and 
myofascial pain (abstract). J Musculoskel Pain, 3, 121. 
GERWIN, R. D., DOMMERHOLT, J. & SHAH, J. P. 2004. An expansion of Simons' 
integrated hypothesis of trigger point formation. Curr Pain Headache Rep, 8, 
468-75. 
GERWIN, R. D. & DURANLEAU, D. 1997. Ultrasound identification of the myofacial 
trigger point. Muscle Nerve, 20, 767-8. 
GERWIN, R. D., SHANNON, S., HONG, C. Z., HUBBARD, D. & GEVIRTZ, R. 1997. 
Interrater reliability in myofascial trigger point examination. Pain, 69, 65-73. 
GIAMBERARDINO, M. A., AFFAITATI, G., FABRIZIO, A. & COSTANTINI, R. 2011. 
Myofascial pain syndromes and their evaluation. Best Pract Res Clin 
Rheumatol, 25, 185-98. 
GIFFORD, L. S. & BUTLER, D. S. 1997. The integration of pain sciences into 
clinical practice. J Hand Ther, 10, 86-95. 
GOLDBERG, J. S. 2008. Revisiting the Cartesian model of pain. Med Hypotheses, 
70, 1029-33. 
GOOD, M. 1942. Five Hundred Cases of Myalgia in the British Army. Ann Rheum 
Dis, 3, 118-38. 
GOUVEIA, E. R., MAIA, J. A., BEUNEN, G. P., BLIMKIE, C. J., FENA, E. M. & 
FREITAS, D. L. 2013. Functional fitness and physical activity of Portuguese 
community-residing older adults. J Aging Phys Act, 21, 1-19. 
GRAFF-RADFORD, S. B., REEVES, J. L., BAKER, R. L. & CHIU, D. 1989. Effects 
of transcutaneous electrical nerve stimulation on myofascial pain and trigger 
point sensitivity. Pain, 37, 1-5. 
GRIEVE, R., BARNETT, S., COGHILL, N. & CRAMP, F. 2013a. The prevalence of 
latent myofascial trigger points and diagnostic criteria of the triceps surae 
and upper trapezius: a cross sectional study. Physiotherapy, 99, 278-84. 
GRIEVE, R., CLARK, J., PEARSON, E., BULLOCK, S., BOYER, C. & JARRETT, A. 
2011. The immediate effect of soleus trigger point pressure release on 
restricted ankle joint dorsiflexion: A pilot randomised controlled trial. J Bodyw 
Mov Ther, 15, 42-9. 
GRIEVE, R., CRANSTON, A., HENDERSON, A., JOHN, R., MALONE, G. & 
MAYALL, C. 2013b. The immediate effect of triceps surae myofascial trigger 
 200 
point therapy on restricted active ankle joint dorsiflexion in recreational 
runners: a crossover randomised controlled trial. J Bodyw Mov Ther, 17, 
453-61. 
GRINNELL, A. D., CHEN, B. M., KASHANI, A., LIN, J., SUZUKI, K. & KIDOKORO, 
Y. 2003. The role of integrins in the modulation of neurotransmitter release 
from motor nerve terminals by stretch and hypertonicity. J Neurocytol, 32, 
489-503. 
GUPTA, L. & SINGH, S. P. 2016. Ultrasound-Guided Trigger Point Injection for 
Myofascial Trigger Points in the Subscapularis and Pectoralis Muscles. 
Yonsei Med J, 57, 538. 
GUR, A., SARAC, A. J., CEVIK, R., ALTINDAG, O. & SARAC, S. 2004. Efficacy of 
904 nm gallium arsenide low level laser therapy in the management of 
chronic myofascial pain in the neck: a double-blind and randomize-controlled 
trial. Lasers Surg Med, 35, 229-35. 
GUZMAN-VENEGAS, R. A., ARANEDA, O. F. & SILVESTRE, R. A. 2014. 
Differences between motor point and innervation zone locations in the 
biceps brachii. An exploratory consideration for the treatment of spasticity 
with botulinum toxin. J Electromyogr Kinesiol, 24, 923-7. 
GUZMAN-VENEGAS, R. A., SILVESTRE, R. A. & ARRIAGADA, D. A. 2011. Biceps 
brachii muscle innervation zone location in healthy subjects using high-
density surface electromyography. Int J Morphol, 29, 347-352. 
HAGG, G. M. 1991. Static Work Loads and Occupational Myalgia - a New 
Explanation Model. Electromyographical Kinesiology, 949, 141-144. 
HAKGUDER, A., BIRTANE, M., GURCAN, S., KOKINO, S. & TURAN, F. N. 2003. 
Efficacy of low level laser therapy in myofascial pain syndrome: an 
algometric and thermographic evaluation. Lasers Surg Med, 33, 339-43. 
HANTEN, W. P., BARRET, M., GILLESPIE-PLESKO, M., JUMP, K. A. & OLSON, S. 
L. 1997. Effects of active head retraction with retraction/extension and 
occipital release on the pressure pain threshold of cervical and scapular 
trigger points. Physiother Theory Pract, 13, 285-291. 
HANTEN, W. P., OLSON, S. L., BUTTS, N. L. & NOWICKI, A. L. 2000. 
Effectiveness of a home program of ischemic pressure followed by sustained 
stretch for treatment of myofascial trigger points. Phys Ther, 80, 997-1003. 
HARDEN, R. N., BRUEHL, S. P., GASS, S., NIEMIEC, C. & BARBICK, B. 2000. 
Signs and symptoms of the myofascial pain syndrome: a national survey of 
pain management providers. Clin J Pain, 16, 64-72. 
HEGEDUS, E. J., GOODE, A., CAMPBELL, S., MORIN, A., TAMADDONI, M., 
MOORMAN, C. T., 3RD & COOK, C. 2008. Physical examination tests of the 
shoulder: a systematic review with meta-analysis of individual tests. Br J 
Sports Med, 42, 80-92; discussion 92. 
HENNEMAN, E., SOMJEN, G. & CARPENTER, D. O. 1965. Functional Significance 
of Cell Size in Spinal Motoneurons. J Neurophysiol, 28, 560-80. 
HERMENS, H. J. 1999. European recommendations for surface electromyography : 
results of the SENIAM project, Enschede, Roessingh Research and 
Development. 
HERMENS, H. J., FRERIKS, B., DISSELHORST-KLUG, C. & RAU, G. 2000. 
Development of recommendations for SEMG sensors and sensor placement 
procedures. J Electromyogr Kinesiol, 10, 361-74. 
HEUSER, J. & MILEDI, R. 1971. Effects of lanthanum ions on function and structure 
of frog neuromuscular junctions. Proc R Soc Lond B Biol Sci, 179, 247-60. 
HODGES-SAVOLA, C. A. & FERNANDEZ, H. L. 1995. A role for calcitonin gene-
related peptide in the regulation of rat skeletal muscle G4 
acetylcholinesterase. Neurosci Lett, 190, 117-20. 
 201 
HONG, C. Z. 1994a. Lidocaine injection versus dry needling to myofascial trigger 
point. The importance of the local twitch response. Am J Phys Med Rehabil, 
73, 256-63. 
HONG, C. Z. 1994b. Persistence of local twitch response with loss of conduction to 
and from the spinal cord. Arch Phys Med Rehabil, 75, 12-6. 
HONG, C. Z. 1996. Pathophysiology of myofascial trigger point. J Formos Med 
Assoc, 95, 93-104. 
HONG, C. Z. 2002. New trends in myofascial pain syndrome. Zhonghua Yi Xue Za 
Zhi (Taipei), 65, 501-12. 
HONG, C. Z., CHEN, Y. C., PON, C. H. & YU, J. 1993. Immediate effects of various 
physical medicine modalities on pain threshold of an active myofascial 
trigger point. J Musculoskelet Pain, 1, 37-53. 
HONG, C. Z. & HSUEH, T. C. 1996. Difference in pain relief after trigger point 
injections in myofascial pain patients with and without fibromyalgia. Arch 
Phys Med Rehabil, 77, 1161-6. 
HONG, C. Z. & SIMONS, D. G. 1998. Pathophysiologic and electrophysiologic 
mechanisms of myofascial trigger points. Arch Phys Med Rehabil, 79, 863-
72. 
HOU, C. R., TSAI, L. C., CHENG, K. F., CHUNG, K. C. & HONG, C. Z. 2002. 
Immediate effects of various physical therapeutic modalities on cervical 
myofascial pain and trigger-point sensitivity. Arch Phys Med Rehabil, 83, 
1406-14. 
HSIEH, C. Y., HONG, C. Z., ADAMS, A. H., PLATT, K. J., DANIELSON, C. D., 
HOEHLER, F. K. & TOBIS, J. S. 2000. Interexaminer reliability of the 
palpation of trigger points in the trunk and lower limb muscles. Arch Phys 
Med Rehabil, 81, 258-64. 
HSIEH, Y. L., KAO, M. J., KUAN, T. S., CHEN, S. M., CHEN, J. T. & HONG, C. Z. 
2007. Dry needling to a key myofascial trigger point may reduce the 
irritability of satellite MTrPs. Am J Phys Med Rehabil, 86, 397-403. 
HSIEH, Y. L., YANG, S. A., YANG, C. C. & CHOU, L. W. 2012. Dry needling at 
myofascial trigger spots of rabbit skeletal muscles modulates the 
biochemicals associated with pain, inflammation, and hypoxia. Evid Based 
Complement Alternat Med, 2012, 342165. 
HSUEH, T. C., CHENG, P. T., KUAN, T. S. & HONG, C. Z. 1997. The immediate 
effectiveness of electrical nerve stimulation and electrical muscle stimulation 
on myofascial trigger points. Am J Phys Med Rehabil, 76, 471-6. 
HUANG, Q. M., YE, G., ZHAO, Z. Y., LV, J. J. & TANG, L. 2013. Myoelectrical 
activity and muscle morphology in a rat model of myofascial trigger points 
induced by blunt trauma to the vastus medialis. Acupunct Med, 31, 65-73. 
HUBBARD, D. R. 1996. Chronic and recurrent muscle pain: pathophysiology and 
treatment, and review of pharmacologic studies. J Musculoskel Pain, 4(1/2), 
124-143. 
HUBBARD, D. R. & BERKOFF, G. M. 1993. Myofascial trigger points show 
spontaneous needle EMG activity. Spine (Phila Pa 1976), 18, 1803-7. 
HUCHO, T. & LEVINE, J. D. 2007. Signaling pathways in sensitization: toward a 
nociceptor cell biology. Neuron, 55, 365-76. 
HUGUENIN, L., BRUKNER, P. D., MCCRORY, P., SMITH, P., WAJSWELNER, H. 
& BENNELL, K. 2005. Effect of dry needling of gluteal muscles on straight 
leg raise: a randomised, placebo controlled, double blind trial. Br J Sports 
Med, 39, 84-90. 
HULLEY, S. B. 2001. Designing clinical research : an epidemiologic approach, 
Philadelphia, Pa. ; London, Lippincott Williams & Wilkins. 
HUNTER, C. 1933. Myalgia of the Abdominal Wall. Can Med Assoc J, 28, 157-61. 
 202 
IGLESIAS-GONZALEZ, J. J., MUNOZ-GARCIA, M. T., RODRIGUES-DE-SOUZA, 
D. P., ALBURQUERQUE-SENDIN, F. & FERNANDEZ-DE-LAS-PENAS, C. 
2013. Myofascial trigger points, pain, disability, and sleep quality in patients 
with chronic nonspecific low back pain. Pain Med, 14, 1964-70. 
ILBULDU, E., CAKMAK, A., DISCI, R. & AYDIN, R. 2004. Comparison of laser, dry 
needling, and placebo laser treatments in myofascial pain syndrome. 
Photomed Laser Surg, 22, 306-11. 
ITO, Y., MILEDI, R. & VINCENT, A. 1974. Transmitter release induced by a 'factor' 
in rabbit serum. Proc R Soc Lond B Biol Sci, 187, 235-41. 
ITOH, K., KATSUMI, Y., HIROTA, S. & KITAKOJI, H. 2006. Effects of trigger point 
acupuncture on chronic low back pain in elderly patients--a sham-controlled 
randomised trial. Acupunct Med, 24, 5-12. 
ITOH, K., KATSUMI, Y., HIROTA, S. & KITAKOJI, H. 2007. Randomised trial of 
trigger point acupuncture compared with other acupuncture for treatment of 
chronic neck pain. Complement Ther Med, 15, 172-9. 
ITOH, K., KATSUMI, Y. & KITAKOJI, H. 2004. Trigger point acupuncture treatment 
of chronic low back pain in elderly patients--a blinded RCT. Acupunct Med, 
22, 170-7. 
ITZA, F., ZARZA, D., SERRA, L., GOMEZ-SANCHA, F., SALINAS, J. & ALLONA-
ALMAGRO, A. 2010. [Myofascial pain syndrome in the pelvic floor: a 
common urological condition]. Actas Urol Esp, 34, 318-26. 
IWASAKI, S., TOKUNAGA, T., BABA, S., TANAKA, M. & KAWAZOE, T. 1990. 
Noninvasive estimation of the location of the end plate in the human 
masseter muscle using surface electromyograms with an electrode array. J 
Osaka Dent Univ, 24, 135-40. 
JAEGER, B. & REEVES, J. L. 1986. Quantification of changes in myofascial trigger 
point sensitivity with the pressure algometer following passive stretch. Pain, 
27, 203-10. 
JAFRI, M. S. 2014. Mechanisms of Myofascial Pain. Int Sch Res Notices, 2014. 
JANDA, V., LEWIT, K., HORYNOVA, M., CHALUPA, J. & TUTZKY, V. 1979. 
[Modern schools of thought and developmental trends in manual medicine 
(author's transl)]. Cas Lek Cesk, 118, 545-9. 
JANKOVIC, D. & VAN ZUNDERT, A. 2006. The frozen shoulder syndrome. 
Description of a new technique and five case reports using the subscapular 
nerve block and subscapularis trigger point infiltration. Acta Anaesthesiol 
Belg, 57, 137-43. 
JOHNSON, E. W. 1989. The myth of skeletal muscle spasm. Am J Phys Med 
Rehabil, 68, 1. 
JOHNSON, E. W. 2002. More on endplate noise. Am J Phys Med Rehabil, 81, 161. 
JOHNSON, G., BOGDUK, N., NOWITZKE, A. & HOUSE, D. 1994. Anatomy and 
actions of the trapezius muscle. Clin Biomech (Bristol, Avon), 9, 44-50. 
JONES, M. 1995. Clinical reasoning and pain. Man Ther, 1, 17-24. 
JONES, R. V., JR., LAMBERT, E. H. & SAYRE, G. P. 1955. Source of a type of 
insertion activity in electromyography with evaluation of a histologic method 
of localization. Arch Phys Med Rehabil, 36, 301-10. 
JORDAN, K., CLARKE, A. M., SYMMONS, D. P., FLEMING, D., PORCHERET, M., 
KADAM, U. T. & CROFT, P. 2007. Measuring disease prevalence: a 
comparison of musculoskeletal disease using four general practice 
consultation databases. Br J Gen Pract, 57, 7-14. 
KANNAN, P. 2012. Management of myofascial pain of upper trapezius: a three 
group comparison study. Glob J Health Sci, 4, 46-52. 
 203 
KASHANI, A. H., CHEN, B. M. & GRINNELL, A. D. 2001. Hypertonic enhancement 
of transmitter release from frog motor nerve terminals: Ca2+ independence 
and role of integrins. J Physiol, 530, 243-52. 
KELLGREN, J. H. 1938. Referred Pains from Muscle. Br Med J, 1, 325-7. 
KELLY, M. 1941. The treatment of fibrositis and allied disorders by local 
anaesthesia. Medical Journal of Australia, 1, 294-298. 
KELLY, S. M., BRITTLE, N. & ALLEN, G. M. 2010. The value of physical tests for 
subacromial impingement syndrome: a study of diagnostic accuracy. Clin 
Rehabil, 24, 149-58. 
KIETRYS, D. M., PALOMBARO, K. M., AZZARETTO, E., HUBLER, R., SCHALLER, 
B., SCHLUSSEL, J. M. & TUCKER, M. 2013. Effectiveness of Dry Needling 
for Upper Quarter Myofascial Pain: A Systematic Review and Meta-analysis. 
J Orthop Sports Phys Ther. 
KIM, D. W. 1989. Detection of physiological events by impedance. Yonsei Med J, 
30, 1-11. 
KIM, M. W., KIM, J. H., YANG, Y. J. & KO, Y. J. 2005. Anatomic localization of 
motor points in gastrocnemius and soleus muscles. Am J Phys Med Rehabil, 
84, 680-3. 
KIM, S. A., OH, K. Y., CHOI, W. H. & KIM, I. K. 2013. Ischemic compression after 
trigger point injection affect the treatment of myofascial trigger points. Ann 
Rehabil Med, 37, 541-6. 
KUAN, T. S. 2009. Current studies on myofascial pain syndrome. Curr Pain 
Headache Rep, 13, 365-9. 
KUAN, T. S., CHEN, J. T., CHEN, S. M., CHIEN, C. H. & HONG, C. Z. 2002. Effect 
of botulinum toxin on endplate noise in myofascial trigger spots of rabbit 
skeletal muscle. Am J Phys Med Rehabil, 81, 512-20; quiz 521-3. 
KUAN, T. S., HSIEH, Y. L., CHEN, S. M., CHEN, J. T., YEN, W. C. & HONG, C. Z. 
2007. The myofascial trigger point region: correlation between the degree of 
irritability and the prevalence of endplate noise. Am J Phys Med Rehabil, 86, 
183-9. 
KUMBHARE, D. A., ELZIBAK, A. H. & NOSEWORTHY, M. D. 2016. Assessment of 
Myofascial Trigger Points Using Ultrasound. Am J Phys Med Rehabil, 95, 
72-80. 
LANDIS, J. R. & KOCH, G. G. 1977. The measurement of observer agreement for 
categorical data. Biometrics, 33, 159-74. 
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Appendix I: List number 1. Epochs’ list extracted using customized software. 
IZ’ location estimated by operators A and B is included. Each epoch is 
identified by a code containing the following details: date of acquisition, 
subject ID, contraction number, operator code, signal epoch, matrix column.  
A1, 1st estimate by operator A; A2, 2nd estimate by operator A; B1, 1st 
estimate by operator B; B2, 2nd estimare by operator B. 
 
 
n Epochs_ID A1 A2 B1 B2 
1 20071019_00002_002_mb_00010241_00010752_0001_0011 6 6 6 6 
2 20071019_00002_004_rg_00010241_00010752_0001_0011 5.5 5.5 5.5 5.5 
3 20071019_00002_005_rg_00010241_00010752_0001_0011 6 5.5 5.5 5.5 
4 20071019_00003_002_mb_00010241_00010752_0001_0011 6 6 6 6 
5 20071019_00003_005_mb_00010241_00010752_0001_0011 6 6 6 6 
6 20071019_00003_006_rg_00010241_00010752_0001_0011 5 5 5 5 
7 20071025_00004_002_rg_00010241_00010752_0001_0011 5 5 5 5 
8 20071025_00004_003_mb_00010241_00010752_0001_0011 4.5 4.5 4.5 4.5 
9 20071025_00004_003_rg_00010241_00010752_0001_0011 5 5 5 5 
10 20071025_00004_004_rg_00010241_00010752_0001_0011 5 5 5 5 
11 20071025_00004_006_rg_00010241_00010752_0001_0011 5 5 5 5 
12 20071026_00005_001_rg_00010241_00010752_0001_0011 4.5 4.5 4.5 4.5 
13 20071026_00005_003_mb_00010241_00010752_0001_0011 5 5 5 5 
14 20071026_00005_004_mb_00010241_00010752_0001_0011 5 5 5 5 
15 20071026_00005_005_mb_00010241_00010752_0001_0011 5.5 5 5 5 
16 20071026_00005_005_rg_00010241_00010752_0001_0011 4 4 4 4 
17 20071026_00006_002_rg_00010241_00010752_0001_0011 5 5 5 5 
18 20071026_00006_004_mb_00010241_00010752_0001_0011 5 5 5 5 
19 20071026_00006_006_rg_00010241_00010752_0001_0011 5 5 5 5 
20 20071026_00007_001_rg_00010241_00010752_0001_0011 4 4 4 4 
21 20071026_00007_002_mb_00010241_00010752_0001_0011 4 4 4 4 
22 20071026_00007_003_rg_00010241_00010752_0001_0011 4 3.5 4 4 
23 20071026_00007_004_mb_00010241_00010752_0001_0011 4.5 4.5 4.5 4.5 
24 20071026_00007_005_mb_00010241_00010752_0001_0011 4.5 4 4 4 
25 20071026_00007_006_rg_00010241_00010752_0001_0011 4 4 4 4 
26 20071026_00008_001_mb_00010241_00010752_0001_0011 5 5 5 5 
27 20071026_00008_002_rg_00010241_00010752_0001_0011 5.5 5.5 5.5 5.5 
28 20071026_00008_004_mb_00010241_00010752_0001_0011 5 5 5 5 
29 20071026_00008_004_rg_00010241_00010752_0001_0011 5.5 5.5 5.5 5.5 
30 20071026_00008_005_rg_00010241_00010752_0001_0011 5 5 5 5 
31 20071026_00008_006_mb_00010241_00010752_0001_0011 5 5 5 5 
32 20071026_00009_001_rg_00010241_00010752_0001_0011 5.5 5.5 5.5 5.5 
33 20071026_00009_002_mb_00010241_00010752_0001_0011 6.5 5.5 6 6 
34 20071026_00009_003_mb_00010241_00010752_0001_0011 6.5 6.5 6 6 
35 20071026_00009_004_mb_00010241_00010752_0001_0011 6.5 6.5 6.5 6.5 
36 20071026_00009_005_rg_00010241_00010752_0001_0011 5.5 5.5 5.5 5.5 
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37 20071026_00009_006_mb_00010241_00010752_0001_0011 6.5 6.5 7 6.5 
38 20071112_00010_002_mb_00010241_00010752_0001_0011 4.5 4.5 4.5 4.5 
39 20071112_00011_002_rg_00010241_00010752_0001_0011 5.5 5.5 5.5 5.5 
40 20071112_00011_004_mb_00010241_00010752_0001_0011 5.5 5.5 5.5 5.5 
41 20071019_00002_002_mb_00010241_00010752_0024_0014 18 18 18 18 
42 20071019_00002_004_rg_00010241_00010752_0024_0014 18.5 18.5 18.5 18.5 
43 20071019_00002_005_rg_00010241_00010752_0024_0014 18.5 18.5 18.5 18.5 
44 20071019_00003_002_mb_00010241_00010752_0024_0014 18 18 18 18 
45 20071019_00003_005_mb_00010241_00010752_0024_0014 18 18 18 18 
46 20071019_00003_006_rg_00010241_00010752_0024_0014 19 19 19 19 
47 20071025_00004_002_rg_00010241_00010752_0024_0014 18.5 18.5 18 18.5 
48 20071025_00004_003_mb_00010241_00010752_0024_0014 19 19 19 19 
49 20071025_00004_003_rg_00010241_00010752_0024_0014 18.5 18.5 18 18 
50 20071025_00004_004_rg_00010241_00010752_0024_0014 18 18 18 18 
51 20071025_00004_006_rg_00010241_00010752_0024_0014 18.5 18.5 18.5 18.5 
52 20071026_00005_001_rg_00010241_00010752_0024_0014 19.5 19.5 19.5 19.5 
53 20071026_00005_003_mb_00010241_00010752_0024_0014 18.5 18.5 18.5 18.5 
54 20071026_00005_004_mb_00010241_00010752_0024_0014 18.5 18.5 19 19 
55 20071026_00005_005_mb_00010241_00010752_0024_0014 18.5 18.5 18.5 18.5 
56 20071026_00005_005_rg_00010241_00010752_0024_0014 19.5 19.5 19.5 19.5 
57 20071026_00006_002_rg_00010241_00010752_0024_0014 19 19 19 19 
58 20071026_00006_004_mb_00010241_00010752_0024_0014 19 19 19 19 
59 20071026_00006_006_rg_00010241_00010752_0024_0014 19 19 19 19 
60 20071026_00007_001_rg_00010241_00010752_0024_0014 20 19.5 20 19.5 
61 20071026_00007_002_mb_00010241_00010752_0024_0014 19.5 19.5 19.5 19.5 
62 20071026_00007_003_rg_00010241_00010752_0024_0014 19.5 19.5 19.5 19.5 
63 20071026_00007_004_mb_00010241_00010752_0024_0014 19.5 19.5 19.5 19.5 
64 20071026_00007_005_mb_00010241_00010752_0024_0014 19.5 19.5 19.5 19.5 
65 20071026_00007_006_rg_00010241_00010752_0024_0014 19.5 19.5 20 20 
66 20071026_00008_001_mb_00010241_00010752_0024_0014 19.5 19.5 19 19 
67 20071026_00008_002_rg_00010241_00010752_0024_0014 18.5 18.5 18.5 18.5 
68 20071026_00008_004_mb_00010241_00010752_0024_0014 19 19 19 19 
69 20071026_00008_004_rg_00010241_00010752_0024_0014 18.5 18.5 18.5 18.5 
70 20071026_00008_005_rg_00010241_00010752_0024_0014 19 19 19 19 
71 20071026_00008_006_mb_00010241_00010752_0024_0014 19.5 19 19 19 
72 20071026_00009_001_rg_00010241_00010752_0024_0014 19 19 19 19 
73 20071026_00009_002_mb_00010241_00010752_0024_0014 18 18 18 18 
74 20071026_00009_003_mb_00010241_00010752_0024_0014 18 18 18 18 
75 20071026_00009_004_mb_00010241_00010752_0024_0014 18 17.5 18 18 
76 20071026_00009_005_rg_00010241_00010752_0024_0014 19 19 19 19 
77 20071026_00009_006_mb_00010241_00010752_0024_0014 18 18 18 18 
78 20071112_00010_002_mb_00010241_00010752_0024_0014 19.5 19.5 19.5 19.5 
79 20071112_00011_002_rg_00010241_00010752_0024_0014 18.5 18.5 19 18.5 
80 20071112_00011_004_mb_00010241_00010752_0024_0014 18.5 18.5 18.5 18.5 
81 20071019_00002_002_mb_00010241_00010752_0027_0037 31.5 31.5 31.5 31.5 
82 20071019_00002_004_rg_00010241_00010752_0027_0037 31 31 31 31 
83 20071019_00002_005_rg_00010241_00010752_0027_0037 31 31 33 31 
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84 20071019_00003_002_mb_00010241_00010752_0027_0037 31.5 31.5 31 31.5 
85 20071019_00003_005_mb_00010241_00010752_0027_0037 31 31 31 31 
86 20071019_00003_006_rg_00010241_00010752_0027_0037 31 31 31 31 
87 20071025_00004_002_rg_00010241_00010752_0027_0037 32 32 32 32 
88 20071025_00004_003_mb_00010241_00010752_0027_0037 31.5 31.5 31.5 31.5 
89 20071025_00004_003_rg_00010241_00010752_0027_0037 32 32 32 32 
90 20071025_00004_004_rg_00010241_00010752_0027_0037 32 32 32 32 
91 20071025_00004_006_rg_00010241_00010752_0027_0037 32 32 32 32 
92 20071026_00005_001_rg_00010241_00010752_0027_0037 30.5 30.5 30 30 
93 20071026_00005_003_mb_00010241_00010752_0027_0037 31.5 31.5 31.5 31.5 
94 20071026_00005_004_mb_00010241_00010752_0027_0037 31.5 31.5 31.5 31.5 
95 20071026_00005_005_mb_00010241_00010752_0027_0037 31.5 31.5 31.5 31.5 
96 20071026_00005_005_rg_00010241_00010752_0027_0037 30.5 30.5 30.5 30.5 
97 20071026_00006_002_rg_00010241_00010752_0027_0037 31 30.5 30.5 30.5 
98 20071026_00006_004_mb_00010241_00010752_0027_0037 30.5 30.5 30.5 30.5 
99 20071026_00006_006_rg_00010241_00010752_0027_0037 30.5 30.5 30.5 30.5 
100 20071026_00007_001_rg_00010241_00010752_0027_0037 30 30 30 30 
101 20071026_00007_002_mb_00010241_00010752_0027_0037 30.5 31.5 31.5 31.5 
102 20071026_00007_003_rg_00010241_00010752_0027_0037 30.5 30.5 30.5 30.5 
103 20071026_00007_004_mb_00010241_00010752_0027_0037 31 31 30.5 31 
104 20071026_00007_005_mb_00010241_00010752_0027_0037 30.5 30.5 30.5 30.5 
105 20071026_00007_006_rg_00010241_00010752_0027_0037 30.5 30.5 30 30 
106 20071026_00008_001_mb_00010241_00010752_0027_0037 30 30.5 30 30 
107 20071026_00008_002_rg_00010241_00010752_0027_0037 31 31 31 31 
108 20071026_00008_004_mb_00010241_00010752_0027_0037 30.5 30.5 30.5 30.5 
109 20071026_00008_004_rg_00010241_00010752_0027_0037 31 31 31 31 
110 20071026_00008_005_rg_00010241_00010752_0027_0037 31 31 31 31 
111 20071026_00008_006_mb_00010241_00010752_0027_0037 30 30 30 30 
112 20071026_00009_001_rg_00010241_00010752_0027_0037 30.5 30.5 31 31 
113 20071026_00009_002_mb_00010241_00010752_0027_0037 32 32 32 32 
114 20071026_00009_003_mb_00010241_00010752_0027_0037 32 32 32 32 
115 20071026_00009_004_mb_00010241_00010752_0027_0037 32 32 32 32 
116 20071026_00009_005_rg_00010241_00010752_0027_0037 31 31 31 31 
117 20071026_00009_006_mb_00010241_00010752_0027_0037 31.5 32 31.5 31.5 
118 20071112_00010_002_mb_00010241_00010752_0027_0037 30.5 30.5 30.5 30.5 
119 20071112_00011_002_rg_00010241_00010752_0027_0037 31 31 31 31 
120 20071112_00011_004_mb_00010241_00010752_0027_0037 31 31 31 31 
121 20071019_00002_002_mb_00010241_00010752_0050_0040 45 45 45 45 
122 20071019_00002_004_rg_00010241_00010752_0050_0040 45 45 45 45 
123 20071019_00002_005_rg_00010241_00010752_0050_0040 45 45 45 45 
124 20071019_00003_002_mb_00010241_00010752_0050_0040 45.5 45.5 46 46 
125 20071019_00003_005_mb_00010241_00010752_0050_0040 45.5 45.5 46 45.5 
126 20071019_00003_006_rg_00010241_00010752_0050_0040 45 45 45 45 
127 20071025_00004_002_rg_00010241_00010752_0050_0040 44 44 44 44 
128 20071025_00004_003_mb_00010241_00010752_0050_0040 44 44 44 44 
129 20071025_00004_003_rg_00010241_00010752_0050_0040 44 44 44 44 
130 20071025_00004_004_rg_00010241_00010752_0050_0040 44 44 44 44 
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131 20071025_00004_006_rg_00010241_00010752_0050_0040 44 44 44 44 
132 20071026_00005_001_rg_00010241_00010752_0050_0040 46 46 46 46 
133 20071026_00005_003_mb_00010241_00010752_0050_0040 45 45 45 45 
134 20071026_00005_004_mb_00010241_00010752_0050_0040 44.5 44.5 44.5 44.5 
135 20071026_00005_005_mb_00010241_00010752_0050_0040 45 45 45 45 
136 20071026_00005_005_rg_00010241_00010752_0050_0040 46 46 46 46 
137 20071026_00006_002_rg_00010241_00010752_0050_0040 46 46 46 46 
138 20071026_00006_004_mb_00010241_00010752_0050_0040 45.5 45.5 46 46 
139 20071026_00006_006_rg_00010241_00010752_0050_0040 45.5 45.5 46 45.5 
140 20071026_00007_001_rg_00010241_00010752_0050_0040 46 46 46 46 
141 20071026_00007_002_mb_00010241_00010752_0050_0040 46 46 46 46 
142 20071026_00007_003_rg_00010241_00010752_0050_0040 46 46 46 46 
143 20071026_00007_004_mb_00010241_00010752_0050_0040 45.5 45.5 45.5 46 
144 20071026_00007_005_mb_00010241_00010752_0050_0040 45.5 46 45.5 45.5 
145 20071026_00007_006_rg_00010241_00010752_0050_0040 46 46 46 46 
146 20071026_00008_001_mb_00010241_00010752_0050_0040 46 46 46 46 
147 20071026_00008_002_rg_00010241_00010752_0050_0040 45 45 45 45 
148 20071026_00008_004_mb_00010241_00010752_0050_0040 46 45.5 46 46 
149 20071026_00008_004_rg_00010241_00010752_0050_0040 45 45 45 45 
150 20071026_00008_005_rg_00010241_00010752_0050_0040 45 45 45 45 
151 20071026_00008_006_mb_00010241_00010752_0050_0040 46 46 46 46 
152 20071026_00009_001_rg_00010241_00010752_0050_0040 46 46 46 46 
153 20071026_00009_002_mb_00010241_00010752_0050_0040 44.5 44.5 44.5 45 
154 20071026_00009_003_mb_00010241_00010752_0050_0040 44.5 44.5 44.5 44.5 
155 20071026_00009_004_mb_00010241_00010752_0050_0040 44.5 44.5 44.5 44.5 
156 20071026_00009_005_rg_00010241_00010752_0050_0040 46 46 46 46 
157 20071026_00009_006_mb_00010241_00010752_0050_0040 44.5 44.5 44.5 44.5 
158 20071112_00010_002_mb_00010241_00010752_0050_0040 47 47 47 47 
159 20071112_00011_002_rg_00010241_00010752_0050_0040 45.5 45.5 45.5 45.5 
160 20071112_00011_004_mb_00010241_00010752_0050_0040 45.5 45.5 45.5 45.5 
161 20071019_00002_002_mb_00010241_00010752_0053_0063 57 57 57 57 
162 20071019_00002_004_rg_00010241_00010752_0053_0063 55.5 55.5 56 56 
163 20071019_00002_005_rg_00010241_00010752_0053_0063 56 56 56 56 
164 20071019_00003_002_mb_00010241_00010752_0053_0063 56 56 56 56 
165 20071019_00003_005_mb_00010241_00010752_0053_0063 56 56 56 56 
166 20071019_00003_006_rg_00010241_00010752_0053_0063 56 56 56 56 
167 20071025_00004_002_rg_00010241_00010752_0053_0063 58 58 58 58 
168 20071025_00004_003_mb_00010241_00010752_0053_0063 57.5 57.5 58 58 
169 20071025_00004_003_rg_00010241_00010752_0053_0063 58 58 58 58 
170 20071025_00004_004_rg_00010241_00010752_0053_0063 58 58 58 58 
171 20071025_00004_006_rg_00010241_00010752_0053_0063 57.5 57.5 58 58 
172 20071026_00005_001_rg_00010241_00010752_0053_0063 55.5 56 56 56 
173 20071026_00005_003_mb_00010241_00010752_0053_0063 57 57 57 56.5 
174 20071026_00005_004_mb_00010241_00010752_0053_0063 57 57 57 57 
175 20071026_00005_005_mb_00010241_00010752_0053_0063 57 57 57 57 
176 20071026_00005_005_rg_00010241_00010752_0053_0063 55.5 55.5 56 55.5 
177 20071026_00006_002_rg_00010241_00010752_0053_0063 56 56 56 56 
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178 20071026_00006_004_mb_00010241_00010752_0053_0063 56 56 56 56 
179 20071026_00006_006_rg_00010241_00010752_0053_0063 56 56 56 56 
180 20071026_00007_001_rg_00010241_00010752_0053_0063 56 56.5 56 56 
181 20071026_00007_002_mb_00010241_00010752_0053_0063 56 56 56 56 
182 20071026_00007_003_rg_00010241_00010752_0053_0063 56 56 56 56 
183 20071026_00007_004_mb_00010241_00010752_0053_0063 56 56 56 56 
184 20071026_00007_005_mb_00010241_00010752_0053_0063 56.5 56 56.5 56.5 
185 20071026_00007_006_rg_00010241_00010752_0053_0063 56 56 56 56 
186 20071026_00008_001_mb_00010241_00010752_0053_0063 56 56 56 56 
187 20071026_00008_002_rg_00010241_00010752_0053_0063 56.5 56.5 56.5 56.5 
188 20071026_00008_004_mb_00010241_00010752_0053_0063 56 56 56 56 
189 20071026_00008_004_rg_00010241_00010752_0053_0063 56.5 56.5 56.5 56 
190 20071026_00008_005_rg_00010241_00010752_0053_0063 56.5 56.5 56.5 56.5 
191 20071026_00008_006_mb_00010241_00010752_0053_0063 56 56 56 56 
192 20071026_00009_001_rg_00010241_00010752_0053_0063 56 56 56 56 
193 20071026_00009_002_mb_00010241_00010752_0053_0063 57 57 57 57 
194 20071026_00009_003_mb_00010241_00010752_0053_0063 57 57 57 57 
195 20071026_00009_004_mb_00010241_00010752_0053_0063 57 57 57 57 
196 20071026_00009_005_rg_00010241_00010752_0053_0063 56 56 56 56 
197 20071026_00009_006_mb_00010241_00010752_0053_0063 57 57 57 57 
198 20071112_00010_002_mb_00010241_00010752_0053_0063 55 55 55 55 
199 20071112_00011_002_rg_00010241_00010752_0053_0063 56 56 56 56 
200 20071112_00011_004_mb_00010241_00010752_0053_0063 56 56 56 56 
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Appendix II: List number 2. Epochs’ list extracted using customized software. 
IZ’ location estimated by operators A is included. Each epoch is identified by 
a code containing the following details: date of acquisition, subject ID, 
contraction number, operator code, signal epoch, matrix column. A1, 1st 
estimate by operator A. 
 
 
n Epochs_ID A1 
1 20071019_00002_001_mb_00010241_00010752_0001_0011 6 
2 20071019_00002_003_mb_00010241_00010752_0001_0011 6 
3 20071019_00003_002_mb_00010241_00010752_0001_0011 6 
4 20071019_00003_006_mb_00010241_00010752_0001_0011 6 
5 20071025_00004_003_mb_00010241_00010752_0001_0011 4.5 
6 20071025_00004_006_mb_00010241_00010752_0001_0011 4.5 
7 20071026_00005_001_mb_00010241_00010752_0001_0011 5 
8 20071026_00005_003_mb_00010241_00010752_0001_0011 5 
9 20071026_00006_001_mb_00010241_00010752_0001_0011 5 
10 20071026_00006_005_mb_00010241_00010752_0001_0011 5 
11 20071026_00007_003_mb_00010241_00010752_0001_0011 4 
12 20071026_00007_006_mb_00010241_00010752_0001_0011 4 
13 20071026_00008_004_mb_00010241_00010752_0001_0011 5 
14 20071026_00008_006_mb_00010241_00010752_0001_0011 5 
15 20071026_00009_001_mb_00010241_00010752_0001_0011 6 
16 20071026_00009_002_mb_00010241_00010752_0001_0011 6 
17 20071112_00010_001_mb_00010241_00010752_0001_0011 4.5 
18 20071112_00010_005_mb_00010241_00010752_0001_0011 4.5 
19 20071112_00011_002_mb_00010241_00010752_0001_0011 5.5 
20 20071112_00011_005_mb_00010241_00010752_0001_0011 5.5 
21 20071019_00002_001_mb_00010241_00010752_0024_0014 18 
22 20071019_00002_003_mb_00010241_00010752_0024_0014 18 
23 20071019_00003_002_mb_00010241_00010752_0024_0014 18 
24 20071019_00003_006_mb_00010241_00010752_0024_0014 18 
25 20071025_00004_003_mb_00010241_00010752_0024_0014 19 
26 20071025_00004_006_mb_00010241_00010752_0024_0014 19 
27 20071026_00005_001_mb_00010241_00010752_0024_0014 18.5 
28 20071026_00005_003_mb_00010241_00010752_0024_0014 18.5 
29 20071026_00006_001_mb_00010241_00010752_0024_0014 19 
30 20071026_00006_005_mb_00010241_00010752_0024_0014 19 
31 20071026_00007_003_mb_00010241_00010752_0024_0014 20 
32 20071026_00007_006_mb_00010241_00010752_0024_0014 19 
33 20071026_00008_004_mb_00010241_00010752_0024_0014 19 
34 20071026_00008_006_mb_00010241_00010752_0024_0014 19 
35 20071026_00009_001_mb_00010241_00010752_0024_0014 18 
36 20071026_00009_002_mb_00010241_00010752_0024_0014 18 
37 20071112_00010_001_mb_00010241_00010752_0024_0014 19.5 
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38 20071112_00010_005_mb_00010241_00010752_0024_0014 19.5 
39 20071112_00011_002_mb_00010241_00010752_0024_0014 19 
40 20071112_00011_005_mb_00010241_00010752_0024_0014 18.5 
41 20071019_00002_001_mb_00010241_00010752_0027_0037 31.5 
42 20071019_00002_003_mb_00010241_00010752_0027_0037 31.5 
43 20071019_00003_002_mb_00010241_00010752_0027_0037 31 
44 20071019_00003_006_mb_00010241_00010752_0027_0037 31 
45 20071025_00004_003_mb_00010241_00010752_0027_0037 31.5 
46 20071025_00004_006_mb_00010241_00010752_0027_0037 31.5 
47 20071026_00005_001_mb_00010241_00010752_0027_0037 31.5 
48 20071026_00005_003_mb_00010241_00010752_0027_0037 31.5 
49 20071026_00006_001_mb_00010241_00010752_0027_0037 30.5 
50 20071026_00006_005_mb_00010241_00010752_0027_0037 30.5 
51 20071026_00007_003_mb_00010241_00010752_0027_0037 30 
52 20071026_00007_006_mb_00010241_00010752_0027_0037 30.5 
53 20071026_00008_004_mb_00010241_00010752_0027_0037 30.5 
54 20071026_00008_006_mb_00010241_00010752_0027_0037 30 
55 20071026_00009_001_mb_00010241_00010752_0027_0037 32 
56 20071026_00009_002_mb_00010241_00010752_0027_0037 32 
57 20071112_00010_001_mb_00010241_00010752_0027_0037 30 
58 20071112_00010_005_mb_00010241_00010752_0027_0037 30 
59 20071112_00011_002_mb_00010241_00010752_0027_0037 31 
60 20071112_00011_005_mb_00010241_00010752_0027_0037 31.5 
61 20071019_00002_001_mb_00010241_00010752_0050_0040 45 
62 20071019_00002_003_mb_00010241_00010752_0050_0040 45 
63 20071019_00003_002_mb_00010241_00010752_0050_0040 46 
64 20071019_00003_006_mb_00010241_00010752_0050_0040 45 
65 20071025_00004_003_mb_00010241_00010752_0050_0040 44 
66 20071025_00004_006_mb_00010241_00010752_0050_0040 44 
67 20071026_00005_001_mb_00010241_00010752_0050_0040 45 
68 20071026_00005_003_mb_00010241_00010752_0050_0040 45 
69 20071026_00006_001_mb_00010241_00010752_0050_0040 45.5 
70 20071026_00006_005_mb_00010241_00010752_0050_0040 46 
71 20071026_00007_003_mb_00010241_00010752_0050_0040 46 
72 20071026_00007_006_mb_00010241_00010752_0050_0040 46 
73 20071026_00008_004_mb_00010241_00010752_0050_0040 46 
74 20071026_00008_006_mb_00010241_00010752_0050_0040 46 
75 20071026_00009_001_mb_00010241_00010752_0050_0040 45 
76 20071026_00009_002_mb_00010241_00010752_0050_0040 44.5 
77 20071112_00010_001_mb_00010241_00010752_0050_0040 46.5 
78 20071112_00010_005_mb_00010241_00010752_0050_0040 47 
79 20071112_00011_002_mb_00010241_00010752_0050_0040 45.5 
80 20071112_00011_005_mb_00010241_00010752_0050_0040 45 
81 20071019_00002_001_mb_00010241_00010752_0053_0063 57 
82 20071019_00002_003_mb_00010241_00010752_0053_0063 57 
83 20071019_00003_002_mb_00010241_00010752_0053_0063 56 
84 20071019_00003_006_mb_00010241_00010752_0053_0063 56 
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85 20071025_00004_003_mb_00010241_00010752_0053_0063 58 
86 20071025_00004_006_mb_00010241_00010752_0053_0063 58 
87 20071026_00005_001_mb_00010241_00010752_0053_0063 57 
88 20071026_00005_003_mb_00010241_00010752_0053_0063 57 
89 20071026_00006_001_mb_00010241_00010752_0053_0063 56 
90 20071026_00006_005_mb_00010241_00010752_0053_0063 56 
91 20071026_00007_003_mb_00010241_00010752_0053_0063 56 
92 20071026_00007_006_mb_00010241_00010752_0053_0063 56 
93 20071026_00008_004_mb_00010241_00010752_0053_0063 56 
94 20071026_00008_006_mb_00010241_00010752_0053_0063 56 
95 20071026_00009_001_mb_00010241_00010752_0053_0063 57 
96 20071026_00009_002_mb_00010241_00010752_0053_0063 57 
97 20071112_00010_001_mb_00010241_00010752_0053_0063 55 
98 20071112_00010_005_mb_00010241_00010752_0053_0063 54.5 
99 20071112_00011_002_mb_00010241_00010752_0053_0063 56 
100 20071112_00011_005_mb_00010241_00010752_0053_0063 56.5 
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Appendix III: List number 3.  Epochs’ list extracted using customized 
software. IZ’ location estimated by operators A is included. Each epoch is 
identified by a code containing the following details: date of acquisition. 
subject ID, contraction number, operator code, signal epoch, matrix column. 
A1, 1st estimate by operator A. 
 
n Epochs_ID A1 
1 20071019_00002_005_rg_00000001_00000512_0001_0011 5.5 
2 20071019_00002_005_rg_00000513_00001024_0001_0011 5.5 
3 20071019_00002_005_rg_00010753_00011264_0001_0011 6 
4 20071019_00002_005_rg_00015361_00015872_0001_0011 5.5 
5 20071019_00003_003_rg_00004609_00005120_0001_0011 5 
6 20071019_00003_003_rg_00007681_00008192_0001_0011 5 
7 20071019_00003_003_rg_00015873_00016384_0001_0011 5 
8 20071019_00003_003_rg_00019969_00020480_0001_0011 5 
9 20071019_00003_006_mb_00003073_00003584_0001_0011 6 
10 20071019_00003_006_mb_00005121_00005632_0001_0011 6 
11 20071019_00003_006_mb_00007681_00008192_0001_0011 6 
12 20071019_00003_006_mb_00011265_00011776_0001_0011 6 
13 20071025_00004_005_mb_00007681_00008192_0001_0011 4.5 
14 20071025_00004_005_mb_00009217_00009728_0001_0011 4.5 
15 20071025_00004_005_mb_00010753_00011264_0001_0011 4.5 
16 20071025_00004_005_mb_00011777_00012288_0001_0011 4.5 
17 20071025_00004_006_rg_00003585_00004096_0001_0011 5 
18 20071025_00004_006_rg_00008193_00008704_0001_0011 5 
19 20071025_00004_006_rg_00016385_00016896_0001_0011 5 
20 20071025_00004_006_rg_00017409_00017920_0001_0011 5.5 
21 20071026_00006_002_rg_00000513_00001024_0001_0011 5 
22 20071026_00006_002_rg_00006145_00006656_0001_0011 5 
23 20071026_00006_002_rg_00010241_00010752_0001_0011 5 
24 20071026_00006_002_rg_00018433_00018944_0001_0011 5 
25 20071026_00007_004_mb_00001025_00001536_0001_0011 4 
26 20071026_00007_004_mb_00001537_00002048_0001_0011 4 
27 20071026_00007_004_mb_00002049_00002560_0001_0011 4 
28 20071026_00007_004_mb_00006145_00006656_0001_0011 4 
29 20071026_00007_006_mb_00001025_00001536_0001_0011 4 
30 20071026_00007_006_mb_00003585_00004096_0001_0011 4 
31 20071026_00007_006_mb_00005633_00006144_0001_0011 4 
32 20071026_00007_006_mb_00009217_00009728_0001_0011 4 
33 20071026_00009_005_rg_00009217_00009728_0001_0011 5.5 
34 20071026_00009_005_rg_00009729_00010240_0001_0011 5.5 
35 20071026_00009_005_rg_00018945_00019456_0001_0011 5.5 
36 20071026_00009_005_rg_00019969_00020480_0001_0011 5.5 
37 20071112_00011_004_rg_00007681_00008192_0001_0011 5.5 
38 20071112_00011_004_rg_00014337_00014848_0001_0011 5.5 
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39 20071112_00011_004_rg_00016897_00017408_0001_0011 5.5 
40 20071112_00011_004_rg_00017921_00018432_0001_0011 5.5 
41 20071019_00002_005_rg_00000001_00000512_0024_0014 18.5 
42 20071019_00002_005_rg_00000513_00001024_0024_0014 18.5 
43 20071019_00002_005_rg_00010753_00011264_0024_0014 18.5 
44 20071019_00002_005_rg_00015361_00015872_0024_0014 18.5 
45 20071019_00003_003_rg_00004609_00005120_0024_0014 19 
46 20071019_00003_003_rg_00007681_00008192_0024_0014 19 
47 20071019_00003_003_rg_00015873_00016384_0024_0014 19 
48 20071019_00003_003_rg_00019969_00020480_0024_0014 19 
49 20071019_00003_006_mb_00003073_00003584_0024_0014 18 
50 20071019_00003_006_mb_00005121_00005632_0024_0014 18 
51 20071019_00003_006_mb_00007681_00008192_0024_0014 18 
52 20071019_00003_006_mb_00011265_00011776_0024_0014 18 
53 20071025_00004_005_mb_00007681_00008192_0024_0014 19 
54 20071025_00004_005_mb_00009217_00009728_0024_0014 19 
55 20071025_00004_005_mb_00010753_00011264_0024_0014 19 
56 20071025_00004_005_mb_00011777_00012288_0024_0014 19 
57 20071025_00004_006_rg_00003585_00004096_0024_0014 18.5 
58 20071025_00004_006_rg_00008193_00008704_0024_0014 18.5 
59 20071025_00004_006_rg_00016385_00016896_0024_0014 18.5 
60 20071025_00004_006_rg_00017409_00017920_0024_0014 18.5 
61 20071026_00006_002_rg_00000513_00001024_0024_0014 19 
62 20071026_00006_002_rg_00006145_00006656_0024_0014 19 
63 20071026_00006_002_rg_00010241_00010752_0024_0014 19 
64 20071026_00006_002_rg_00018433_00018944_0024_0014 19 
65 20071026_00007_004_mb_00001025_00001536_0024_0014 19 
66 20071026_00007_004_mb_00001537_00002048_0024_0014 19.5 
67 20071026_00007_004_mb_00002049_00002560_0024_0014 19 
68 20071026_00007_004_mb_00006145_00006656_0024_0014 19 
69 20071026_00007_006_mb_00001025_00001536_0024_0014 19 
70 20071026_00007_006_mb_00003585_00004096_0024_0014 19.5 
71 20071026_00007_006_mb_00005633_00006144_0024_0014 19.5 
72 20071026_00007_006_mb_00009217_00009728_0024_0014 19.5 
73 20071026_00009_005_rg_00009217_00009728_0024_0014 19 
74 20071026_00009_005_rg_00009729_00010240_0024_0014 19 
75 20071026_00009_005_rg_00018945_00019456_0024_0014 19 
76 20071026_00009_005_rg_00019969_00020480_0024_0014 19 
77 20071112_00011_004_rg_00007681_00008192_0024_0014 19 
78 20071112_00011_004_rg_00014337_00014848_0024_0014 19 
79 20071112_00011_004_rg_00016897_00017408_0024_0014 19 
80 20071112_00011_004_rg_00017921_00018432_0024_0014 19 
81 20071019_00002_005_rg_00000001_00000512_0027_0037 31 
82 20071019_00002_005_rg_00000513_00001024_0027_0037 31 
83 20071019_00002_005_rg_00010753_00011264_0027_0037 31 
84 20071019_00002_005_rg_00015361_00015872_0027_0037 31 
85 20071019_00003_003_rg_00004609_00005120_0027_0037 31 
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86 20071019_00003_003_rg_00007681_00008192_0027_0037 31 
87 20071019_00003_003_rg_00015873_00016384_0027_0037 31 
88 20071019_00003_003_rg_00019969_00020480_0027_0037 31 
89 20071019_00003_006_mb_00003073_00003584_0027_0037 31 
90 20071019_00003_006_mb_00005121_00005632_0027_0037 31.5 
91 20071019_00003_006_mb_00007681_00008192_0027_0037 31 
92 20071019_00003_006_mb_00011265_00011776_0027_0037 31.5 
93 20071025_00004_005_mb_00007681_00008192_0027_0037 31.5 
94 20071025_00004_005_mb_00009217_00009728_0027_0037 31.5 
95 20071025_00004_005_mb_00010753_00011264_0027_0037 31.5 
96 20071025_00004_005_mb_00011777_00012288_0027_0037 31.5 
97 20071025_00004_006_rg_00003585_00004096_0027_0037 32 
98 20071025_00004_006_rg_00008193_00008704_0027_0037 32 
99 20071025_00004_006_rg_00016385_00016896_0027_0037 32 
100 20071025_00004_006_rg_00017409_00017920_0027_0037 32 
101 20071026_00006_002_rg_00000513_00001024_0027_0037 30.5 
102 20071026_00006_002_rg_00006145_00006656_0027_0037 31 
103 20071026_00006_002_rg_00010241_00010752_0027_0037 30.5 
104 20071026_00006_002_rg_00018433_00018944_0027_0037 31 
105 20071026_00007_004_mb_00001025_00001536_0027_0037 30.5 
106 20071026_00007_004_mb_00001537_00002048_0027_0037 30.5 
107 20071026_00007_004_mb_00002049_00002560_0027_0037 31 
108 20071026_00007_004_mb_00006145_00006656_0027_0037 30.5 
109 20071026_00007_006_mb_00001025_00001536_0027_0037 30.5 
110 20071026_00007_006_mb_00003585_00004096_0027_0037 30.5 
111 20071026_00007_006_mb_00005633_00006144_0027_0037 30.5 
112 20071026_00007_006_mb_00009217_00009728_0027_0037 30.5 
113 20071026_00009_005_rg_00009217_00009728_0027_0037 31 
114 20071026_00009_005_rg_00009729_00010240_0027_0037 30.5 
115 20071026_00009_005_rg_00018945_00019456_0027_0037 31 
116 20071026_00009_005_rg_00019969_00020480_0027_0037 30.5 
117 20071112_00011_004_rg_00007681_00008192_0027_0037 31 
118 20071112_00011_004_rg_00014337_00014848_0027_0037 31 
119 20071112_00011_004_rg_00016897_00017408_0027_0037 31 
120 20071112_00011_004_rg_00017921_00018432_0027_0037 31 
121 20071019_00002_005_rg_00000001_00000512_0050_0040 45 
122 20071019_00002_005_rg_00000513_00001024_0050_0040 45 
123 20071019_00002_005_rg_00010753_00011264_0050_0040 45.5 
124 20071019_00002_005_rg_00015361_00015872_0050_0040 45 
125 20071019_00003_003_rg_00004609_00005120_0050_0040 45.5 
126 20071019_00003_003_rg_00007681_00008192_0050_0040 46 
127 20071019_00003_003_rg_00015873_00016384_0050_0040 45 
128 20071019_00003_003_rg_00019969_00020480_0050_0040 45.5 
129 20071019_00003_006_mb_00003073_00003584_0050_0040 45 
130 20071019_00003_006_mb_00005121_00005632_0050_0040 45 
131 20071019_00003_006_mb_00007681_00008192_0050_0040 45 
132 20071019_00003_006_mb_00011265_00011776_0050_0040 45.5 
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133 20071025_00004_005_mb_00007681_00008192_0050_0040 44 
134 20071025_00004_005_mb_00009217_00009728_0050_0040 44 
135 20071025_00004_005_mb_00010753_00011264_0050_0040 44 
136 20071025_00004_005_mb_00011777_00012288_0050_0040 44 
137 20071025_00004_006_rg_00003585_00004096_0050_0040 44 
138 20071025_00004_006_rg_00008193_00008704_0050_0040 44 
139 20071025_00004_006_rg_00016385_00016896_0050_0040 44 
140 20071025_00004_006_rg_00017409_00017920_0050_0040 44 
141 20071026_00006_002_rg_00000513_00001024_0050_0040 46 
142 20071026_00006_002_rg_00006145_00006656_0050_0040 46 
143 20071026_00006_002_rg_00010241_00010752_0050_0040 46 
144 20071026_00006_002_rg_00018433_00018944_0050_0040 46 
145 20071026_00007_004_mb_00001025_00001536_0050_0040 45.5 
146 20071026_00007_004_mb_00001537_00002048_0050_0040 45.5 
147 20071026_00007_004_mb_00002049_00002560_0050_0040 45.5 
148 20071026_00007_004_mb_00006145_00006656_0050_0040 46 
149 20071026_00007_006_mb_00001025_00001536_0050_0040 45.5 
150 20071026_00007_006_mb_00003585_00004096_0050_0040 45.5 
151 20071026_00007_006_mb_00005633_00006144_0050_0040 46 
152 20071026_00007_006_mb_00009217_00009728_0050_0040 46 
153 20071026_00009_005_rg_00009217_00009728_0050_0040 46 
154 20071026_00009_005_rg_00009729_00010240_0050_0040 46 
155 20071026_00009_005_rg_00018945_00019456_0050_0040 46 
156 20071026_00009_005_rg_00019969_00020480_0050_0040 46 
157 20071112_00011_004_rg_00007681_00008192_0050_0040 46 
158 20071112_00011_004_rg_00014337_00014848_0050_0040 45.5 
159 20071112_00011_004_rg_00016897_00017408_0050_0040 46 
160 20071112_00011_004_rg_00017921_00018432_0050_0040 45.5 
161 20071019_00002_005_rg_00000001_00000512_0053_0063 56 
162 20071019_00002_005_rg_00000513_00001024_0053_0063 56 
163 20071019_00002_005_rg_00010753_00011264_0053_0063 55.5 
164 20071019_00002_005_rg_00015361_00015872_0053_0063 56 
165 20071019_00003_003_rg_00004609_00005120_0053_0063 56 
166 20071019_00003_003_rg_00007681_00008192_0053_0063 56 
167 20071019_00003_003_rg_00015873_00016384_0053_0063 56.5 
168 20071019_00003_003_rg_00019969_00020480_0053_0063 56 
169 20071019_00003_006_mb_00003073_00003584_0053_0063 56 
170 20071019_00003_006_mb_00005121_00005632_0053_0063 56 
171 20071019_00003_006_mb_00007681_00008192_0053_0063 56 
172 20071019_00003_006_mb_00011265_00011776_0053_0063 56 
173 20071025_00004_005_mb_00007681_00008192_0053_0063 57.5 
174 20071025_00004_005_mb_00009217_00009728_0053_0063 57.5 
175 20071025_00004_005_mb_00010753_00011264_0053_0063 57.5 
176 20071025_00004_005_mb_00011777_00012288_0053_0063 57.5 
177 20071025_00004_006_rg_00003585_00004096_0053_0063 57.5 
178 20071025_00004_006_rg_00008193_00008704_0053_0063 58 
179 20071025_00004_006_rg_00016385_00016896_0053_0063 58 
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180 20071025_00004_006_rg_00017409_00017920_0053_0063 58 
181 20071026_00006_002_rg_00000513_00001024_0053_0063 56 
182 20071026_00006_002_rg_00006145_00006656_0053_0063 56 
183 20071026_00006_002_rg_00010241_00010752_0053_0063 56 
184 20071026_00006_002_rg_00018433_00018944_0053_0063 56 
185 20071026_00007_004_mb_00001025_00001536_0053_0063 56 
186 20071026_00007_004_mb_00001537_00002048_0053_0063 56 
187 20071026_00007_004_mb_00002049_00002560_0053_0063 56 
188 20071026_00007_004_mb_00006145_00006656_0053_0063 56 
189 20071026_00007_006_mb_00001025_00001536_0053_0063 56 
190 20071026_00007_006_mb_00003585_00004096_0053_0063 56 
191 20071026_00007_006_mb_00005633_00006144_0053_0063 56 
192 20071026_00007_006_mb_00009217_00009728_0053_0063 56 
193 20071026_00009_005_rg_00009217_00009728_0053_0063 56 
194 20071026_00009_005_rg_00009729_00010240_0053_0063 56 
195 20071026_00009_005_rg_00018945_00019456_0053_0063 56 
196 20071026_00009_005_rg_00019969_00020480_0053_0063 56 
197 20071112_00011_004_rg_00007681_00008192_0053_0063 56 
198 20071112_00011_004_rg_00014337_00014848_0053_0063 56 
199 20071112_00011_004_rg_00016897_00017408_0053_0063 56 
200 20071112_00011_004_rg_00017921_00018432_0053_0063 56 
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Appendix IV: List number 4. Epochs’ list extracted using customized 
software. IZ’ location estimated by operators A is included. Each epoch is 
identified by a code containing the following details: date of acquisition. 
subject ID. contraction number, operator code, signal epoch, matrix column. 
A1, 1st estimate by operator A. 
 
n Epochs_ID A 
1 20071019_00002_001_rg_00010241_00010752_0001_0011 5.5 
2 20071019_00002_002_rg_00010241_00010752_0001_0011 5.5 
3 20071019_00002_003_rg_00010241_00010752_0001_0011 6 
4 20071019_00002_004_rg_00010241_00010752_0001_0011 5.5 
5 20071019_00002_005_rg_00010241_00010752_0001_0011 5.5 
6 20071019_00002_006_rg_00010241_00010752_0001_0011 5.5 
7 20071019_00003_001_rg_00010241_00010752_0001_0011 5 
8 20071019_00003_002_rg_00010241_00010752_0001_0011 5 
9 20071019_00003_003_rg_00010241_00010752_0001_0011 5 
10 20071019_00003_004_rg_00010241_00010752_0001_0011 5 
11 20071019_00003_005_rg_00010241_00010752_0001_0011 5 
12 20071019_00003_006_rg_00010241_00010752_0001_0011 5 
13 20071025_00004_001_rg_00010241_00010752_0001_0011 5 
14 20071025_00004_002_rg_00010241_00010752_0001_0011 5 
15 20071025_00004_003_rg_00010241_00010752_0001_0011 5 
16 20071025_00004_004_rg_00010241_00010752_0001_0011 5 
17 20071025_00004_005_rg_00010241_00010752_0001_0011 5 
18 20071025_00004_006_rg_00010241_00010752_0001_0011 5 
19 20071026_00005_001_rg_00010241_00010752_0001_0011 4.5 
20 20071026_00005_002_rg_00010241_00010752_0001_0011 4 
21 20071026_00005_003_rg_00010241_00010752_0001_0011 4 
22 20071026_00005_004_rg_00010241_00010752_0001_0011 4 
23 20071026_00005_005_rg_00010241_00010752_0001_0011 4 
24 20071026_00005_006_rg_00010241_00010752_0001_0011 4 
25 20071026_00006_001_rg_00010241_00010752_0001_0011 5 
26 20071026_00006_002_rg_00010241_00010752_0001_0011 5 
27 20071026_00006_003_rg_00010241_00010752_0001_0011 5 
28 20071026_00006_004_rg_00010241_00010752_0001_0011 5 
29 20071026_00006_005_rg_00010241_00010752_0001_0011 5 
30 20071026_00006_006_rg_00010241_00010752_0001_0011 5 
31 20071026_00007_001_rg_00010241_00010752_0001_0011 4 
32 20071026_00007_002_rg_00010241_00010752_0001_0011 4 
33 20071026_00007_003_rg_00010241_00010752_0001_0011 4 
34 20071026_00007_004_rg_00010241_00010752_0001_0011 4 
35 20071026_00007_005_rg_00010241_00010752_0001_0011 4 
36 20071026_00007_006_rg_00010241_00010752_0001_0011 4 
37 20071026_00008_001_rg_00010241_00010752_0001_0011 5.5 
38 20071026_00008_002_rg_00010241_00010752_0001_0011 5.5 
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39 20071026_00008_003_rg_00010241_00010752_0001_0011 6 
40 20071026_00008_004_rg_00010241_00010752_0001_0011 5.5 
41 20071026_00008_005_rg_00010241_00010752_0001_0011 5 
42 20071026_00008_006_rg_00010241_00010752_0001_0011 5.5 
43 20071026_00009_001_rg_00010241_00010752_0001_0011 5.5 
44 20071026_00009_002_rg_00010241_00010752_0001_0011 5.5 
45 20071026_00009_003_rg_00010241_00010752_0001_0011 5.5 
46 20071026_00009_004_rg_00010241_00010752_0001_0011 5.5 
47 20071026_00009_005_rg_00010241_00010752_0001_0011 5.5 
48 20071026_00009_006_rg_00010241_00010752_0001_0011 5.5 
49 20071112_00010_001_rg_00010241_00010752_0001_0011 4 
50 20071112_00010_002_rg_00010241_00010752_0001_0011 4 
51 20071112_00010_003_rg_00010241_00010752_0001_0011 4.5 
52 20071112_00010_004_rg_00010241_00010752_0001_0011 4.5 
53 20071112_00010_005_rg_00010241_00010752_0001_0011 4.5 
54 20071112_00010_006_rg_00010241_00010752_0001_0011 4.5 
55 20071112_00011_001_rg_00010241_00010752_0001_0011 6 
56 20071112_00011_002_rg_00010241_00010752_0001_0011 5.5 
57 20071112_00011_003_rg_00010241_00010752_0001_0011 5 
58 20071112_00011_004_rg_00010241_00010752_0001_0011 5 
59 20071112_00011_005_rg_00010241_00010752_0001_0011 5.5 
60 20071112_00011_006_rg_00010241_00010752_0001_0011 5 
61 20071019_00002_001_rg_00010241_00010752_0024_0014 18.5 
62 20071019_00002_002_rg_00010241_00010752_0024_0014 18.5 
63 20071019_00002_003_rg_00010241_00010752_0024_0014 18.5 
64 20071019_00002_004_rg_00010241_00010752_0024_0014 18.5 
65 20071019_00002_005_rg_00010241_00010752_0024_0014 18.5 
66 20071019_00002_006_rg_00010241_00010752_0024_0014 18.5 
67 20071019_00003_001_rg_00010241_00010752_0024_0014 19 
68 20071019_00003_002_rg_00010241_00010752_0024_0014 18.5 
69 20071019_00003_003_rg_00010241_00010752_0024_0014 19 
70 20071019_00003_004_rg_00010241_00010752_0024_0014 19 
71 20071019_00003_005_rg_00010241_00010752_0024_0014 19 
72 20071019_00003_006_rg_00010241_00010752_0024_0014 19 
73 20071025_00004_001_rg_00010241_00010752_0024_0014 18 
74 20071025_00004_002_rg_00010241_00010752_0024_0014 18 
75 20071025_00004_003_rg_00010241_00010752_0024_0014 18 
76 20071025_00004_004_rg_00010241_00010752_0024_0014 18 
77 20071025_00004_005_rg_00010241_00010752_0024_0014 18 
78 20071025_00004_006_rg_00010241_00010752_0024_0014 18.5 
79 20071026_00005_001_rg_00010241_00010752_0024_0014 19.5 
80 20071026_00005_002_rg_00010241_00010752_0024_0014 19.5 
81 20071026_00005_003_rg_00010241_00010752_0024_0014 19.5 
82 20071026_00005_004_rg_00010241_00010752_0024_0014 19.5 
83 20071026_00005_005_rg_00010241_00010752_0024_0014 19.5 
84 20071026_00005_006_rg_00010241_00010752_0024_0014 19.5 
85 20071026_00006_001_rg_00010241_00010752_0024_0014 19 
 229 
86 20071026_00006_002_rg_00010241_00010752_0024_0014 19 
87 20071026_00006_003_rg_00010241_00010752_0024_0014 19 
88 20071026_00006_004_rg_00010241_00010752_0024_0014 19 
89 20071026_00006_005_rg_00010241_00010752_0024_0014 19 
90 20071026_00006_006_rg_00010241_00010752_0024_0014 19 
91 20071026_00007_001_rg_00010241_00010752_0024_0014 20 
92 20071026_00007_002_rg_00010241_00010752_0024_0014 20 
93 20071026_00007_003_rg_00010241_00010752_0024_0014 19.5 
94 20071026_00007_004_rg_00010241_00010752_0024_0014 20 
95 20071026_00007_005_rg_00010241_00010752_0024_0014 20 
96 20071026_00007_006_rg_00010241_00010752_0024_0014 20 
97 20071026_00008_001_rg_00010241_00010752_0024_0014 18.5 
98 20071026_00008_002_rg_00010241_00010752_0024_0014 18.5 
99 20071026_00008_003_rg_00010241_00010752_0024_0014 18.5 
100 20071026_00008_004_rg_00010241_00010752_0024_0014 18.5 
101 20071026_00008_005_rg_00010241_00010752_0024_0014 19 
102 20071026_00008_006_rg_00010241_00010752_0024_0014 18.5 
103 20071026_00009_001_rg_00010241_00010752_0024_0014 19 
104 20071026_00009_002_rg_00010241_00010752_0024_0014 19 
105 20071026_00009_003_rg_00010241_00010752_0024_0014 19 
106 20071026_00009_004_rg_00010241_00010752_0024_0014 19 
107 20071026_00009_005_rg_00010241_00010752_0024_0014 19 
108 20071026_00009_006_rg_00010241_00010752_0024_0014 19 
109 20071112_00010_001_rg_00010241_00010752_0024_0014 19.5 
110 20071112_00010_002_rg_00010241_00010752_0024_0014 20 
111 20071112_00010_003_rg_00010241_00010752_0024_0014 19.5 
112 20071112_00010_004_rg_00010241_00010752_0024_0014 19.5 
113 20071112_00010_005_rg_00010241_00010752_0024_0014 19.5 
114 20071112_00010_006_rg_00010241_00010752_0024_0014 19.5 
115 20071112_00011_001_rg_00010241_00010752_0024_0014 18.5 
116 20071112_00011_002_rg_00010241_00010752_0024_0014 19 
117 20071112_00011_003_rg_00010241_00010752_0024_0014 19 
118 20071112_00011_004_rg_00010241_00010752_0024_0014 19 
119 20071112_00011_005_rg_00010241_00010752_0024_0014 18.5 
120 20071112_00011_006_rg_00010241_00010752_0024_0014 18.5 
121 20071019_00002_001_rg_00010241_00010752_0027_0037 31 
122 20071019_00002_002_rg_00010241_00010752_0027_0037 31 
123 20071019_00002_003_rg_00010241_00010752_0027_0037 31 
124 20071019_00002_004_rg_00010241_00010752_0027_0037 31 
125 20071019_00002_005_rg_00010241_00010752_0027_0037 33 
126 20071019_00002_006_rg_00010241_00010752_0027_0037 31 
127 20071019_00003_001_rg_00010241_00010752_0027_0037 31 
128 20071019_00003_002_rg_00010241_00010752_0027_0037 31.5 
129 20071019_00003_003_rg_00010241_00010752_0027_0037 31 
130 20071019_00003_004_rg_00010241_00010752_0027_0037 31 
131 20071019_00003_005_rg_00010241_00010752_0027_0037 31 
132 20071019_00003_006_rg_00010241_00010752_0027_0037 31 
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133 20071025_00004_001_rg_00010241_00010752_0027_0037 32 
134 20071025_00004_002_rg_00010241_00010752_0027_0037 32 
135 20071025_00004_003_rg_00010241_00010752_0027_0037 32 
136 20071025_00004_004_rg_00010241_00010752_0027_0037 32 
137 20071025_00004_005_rg_00010241_00010752_0027_0037 32 
138 20071025_00004_006_rg_00010241_00010752_0027_0037 32 
139 20071026_00005_001_rg_00010241_00010752_0027_0037 30 
140 20071026_00005_002_rg_00010241_00010752_0027_0037 31 
141 20071026_00005_003_rg_00010241_00010752_0027_0037 30.5 
142 20071026_00005_004_rg_00010241_00010752_0027_0037 30.5 
143 20071026_00005_005_rg_00010241_00010752_0027_0037 30.5 
144 20071026_00005_006_rg_00010241_00010752_0027_0037 30.5 
145 20071026_00006_001_rg_00010241_00010752_0027_0037 31 
146 20071026_00006_002_rg_00010241_00010752_0027_0037 30.5 
147 20071026_00006_003_rg_00010241_00010752_0027_0037 30.5 
148 20071026_00006_004_rg_00010241_00010752_0027_0037 31 
149 20071026_00006_005_rg_00010241_00010752_0027_0037 30.5 
150 20071026_00006_006_rg_00010241_00010752_0027_0037 30.5 
151 20071026_00007_001_rg_00010241_00010752_0027_0037 30 
152 20071026_00007_002_rg_00010241_00010752_0027_0037 30 
153 20071026_00007_003_rg_00010241_00010752_0027_0037 30.5 
154 20071026_00007_004_rg_00010241_00010752_0027_0037 30 
155 20071026_00007_005_rg_00010241_00010752_0027_0037 30 
156 20071026_00007_006_rg_00010241_00010752_0027_0037 30 
157 20071026_00008_001_rg_00010241_00010752_0027_0037 31 
158 20071026_00008_002_rg_00010241_00010752_0027_0037 31 
159 20071026_00008_003_rg_00010241_00010752_0027_0037 31 
160 20071026_00008_004_rg_00010241_00010752_0027_0037 31 
161 20071026_00008_005_rg_00010241_00010752_0027_0037 31 
162 20071026_00008_006_rg_00010241_00010752_0027_0037 31 
163 20071026_00009_001_rg_00010241_00010752_0027_0037 31 
164 20071026_00009_002_rg_00010241_00010752_0027_0037 30.5 
165 20071026_00009_003_rg_00010241_00010752_0027_0037 31 
166 20071026_00009_004_rg_00010241_00010752_0027_0037 30.5 
167 20071026_00009_005_rg_00010241_00010752_0027_0037 31 
168 20071026_00009_006_rg_00010241_00010752_0027_0037 30.5 
169 20071112_00010_001_rg_00010241_00010752_0027_0037 30 
170 20071112_00010_002_rg_00010241_00010752_0027_0037 30 
171 20071112_00010_003_rg_00010241_00010752_0027_0037 30 
172 20071112_00010_004_rg_00010241_00010752_0027_0037 30 
173 20071112_00010_005_rg_00010241_00010752_0027_0037 30 
174 20071112_00010_006_rg_00010241_00010752_0027_0037 30 
175 20071112_00011_001_rg_00010241_00010752_0027_0037 31 
176 20071112_00011_002_rg_00010241_00010752_0027_0037 31 
177 20071112_00011_003_rg_00010241_00010752_0027_0037 31 
178 20071112_00011_004_rg_00010241_00010752_0027_0037 31 
179 20071112_00011_005_rg_00010241_00010752_0027_0037 31 
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180 20071112_00011_006_rg_00010241_00010752_0027_0037 31 
181 20071019_00002_001_rg_00010241_00010752_0050_0040 45 
182 20071019_00002_002_rg_00010241_00010752_0050_0040 45 
183 20071019_00002_003_rg_00010241_00010752_0050_0040 45 
184 20071019_00002_004_rg_00010241_00010752_0050_0040 45 
185 20071019_00002_005_rg_00010241_00010752_0050_0040 45 
186 20071019_00002_006_rg_00010241_00010752_0050_0040 45 
187 20071019_00003_001_rg_00010241_00010752_0050_0040 45.5 
188 20071019_00003_002_rg_00010241_00010752_0050_0040 45 
189 20071019_00003_003_rg_00010241_00010752_0050_0040 45 
190 20071019_00003_004_rg_00010241_00010752_0050_0040 45 
191 20071019_00003_005_rg_00010241_00010752_0050_0040 45 
192 20071019_00003_006_rg_00010241_00010752_0050_0040 45 
193 20071025_00004_001_rg_00010241_00010752_0050_0040 44 
194 20071025_00004_002_rg_00010241_00010752_0050_0040 44 
195 20071025_00004_003_rg_00010241_00010752_0050_0040 44 
196 20071025_00004_004_rg_00010241_00010752_0050_0040 44 
197 20071025_00004_005_rg_00010241_00010752_0050_0040 44 
198 20071025_00004_006_rg_00010241_00010752_0050_0040 44 
199 20071026_00005_001_rg_00010241_00010752_0050_0040 46 
200 20071026_00005_002_rg_00010241_00010752_0050_0040 46 
201 20071026_00005_003_rg_00010241_00010752_0050_0040 46 
202 20071026_00005_004_rg_00010241_00010752_0050_0040 46 
203 20071026_00005_005_rg_00010241_00010752_0050_0040 46 
204 20071026_00005_006_rg_00010241_00010752_0050_0040 46 
205 20071026_00006_001_rg_00010241_00010752_0050_0040 45.5 
206 20071026_00006_002_rg_00010241_00010752_0050_0040 46 
207 20071026_00006_003_rg_00010241_00010752_0050_0040 45.5 
208 20071026_00006_004_rg_00010241_00010752_0050_0040 46 
209 20071026_00006_005_rg_00010241_00010752_0050_0040 46 
210 20071026_00006_006_rg_00010241_00010752_0050_0040 46 
211 20071026_00007_001_rg_00010241_00010752_0050_0040 46 
212 20071026_00007_002_rg_00010241_00010752_0050_0040 46 
213 20071026_00007_003_rg_00010241_00010752_0050_0040 46 
214 20071026_00007_004_rg_00010241_00010752_0050_0040 46 
215 20071026_00007_005_rg_00010241_00010752_0050_0040 46 
216 20071026_00007_006_rg_00010241_00010752_0050_0040 46 
217 20071026_00008_001_rg_00010241_00010752_0050_0040 45 
218 20071026_00008_002_rg_00010241_00010752_0050_0040 45 
219 20071026_00008_003_rg_00010241_00010752_0050_0040 45 
220 20071026_00008_004_rg_00010241_00010752_0050_0040 45 
221 20071026_00008_005_rg_00010241_00010752_0050_0040 45 
222 20071026_00008_006_rg_00010241_00010752_0050_0040 45 
223 20071026_00009_001_rg_00010241_00010752_0050_0040 46 
224 20071026_00009_002_rg_00010241_00010752_0050_0040 46 
225 20071026_00009_003_rg_00010241_00010752_0050_0040 46 
226 20071026_00009_004_rg_00010241_00010752_0050_0040 46 
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227 20071026_00009_005_rg_00010241_00010752_0050_0040 46 
228 20071026_00009_006_rg_00010241_00010752_0050_0040 46 
229 20071112_00010_001_rg_00010241_00010752_0050_0040 47 
230 20071112_00010_002_rg_00010241_00010752_0050_0040 47 
231 20071112_00010_003_rg_00010241_00010752_0050_0040 47 
232 20071112_00010_004_rg_00010241_00010752_0050_0040 47 
233 20071112_00010_005_rg_00010241_00010752_0050_0040 47 
234 20071112_00010_006_rg_00010241_00010752_0050_0040 47 
235 20071112_00011_001_rg_00010241_00010752_0050_0040 45 
236 20071112_00011_002_rg_00010241_00010752_0050_0040 45.5 
237 20071112_00011_003_rg_00010241_00010752_0050_0040 45.5 
238 20071112_00011_004_rg_00010241_00010752_0050_0040 45.5 
239 20071112_00011_005_rg_00010241_00010752_0050_0040 45 
240 20071112_00011_006_rg_00010241_00010752_0050_0040 45 
241 20071019_00002_001_rg_00010241_00010752_0053_0063 56.5 
242 20071019_00002_002_rg_00010241_00010752_0053_0063 56 
243 20071019_00002_003_rg_00010241_00010752_0053_0063 56 
244 20071019_00002_004_rg_00010241_00010752_0053_0063 56 
245 20071019_00002_005_rg_00010241_00010752_0053_0063 56 
246 20071019_00002_006_rg_00010241_00010752_0053_0063 57 
247 20071019_00003_001_rg_00010241_00010752_0053_0063 56 
248 20071019_00003_002_rg_00010241_00010752_0053_0063 56 
249 20071019_00003_003_rg_00010241_00010752_0053_0063 56 
250 20071019_00003_004_rg_00010241_00010752_0053_0063 56 
251 20071019_00003_005_rg_00010241_00010752_0053_0063 56.5 
252 20071019_00003_006_rg_00010241_00010752_0053_0063 56 
253 20071025_00004_001_rg_00010241_00010752_0053_0063 58 
254 20071025_00004_002_rg_00010241_00010752_0053_0063 58 
255 20071025_00004_003_rg_00010241_00010752_0053_0063 58 
256 20071025_00004_004_rg_00010241_00010752_0053_0063 58 
257 20071025_00004_005_rg_00010241_00010752_0053_0063 58 
258 20071025_00004_006_rg_00010241_00010752_0053_0063 58 
259 20071026_00005_001_rg_00010241_00010752_0053_0063 56 
260 20071026_00005_002_rg_00010241_00010752_0053_0063 55.5 
261 20071026_00005_003_rg_00010241_00010752_0053_0063 56 
262 20071026_00005_004_rg_00010241_00010752_0053_0063 55.5 
263 20071026_00005_005_rg_00010241_00010752_0053_0063 56 
264 20071026_00005_006_rg_00010241_00010752_0053_0063 55.5 
265 20071026_00006_001_rg_00010241_00010752_0053_0063 56 
266 20071026_00006_002_rg_00010241_00010752_0053_0063 56 
267 20071026_00006_003_rg_00010241_00010752_0053_0063 56 
268 20071026_00006_004_rg_00010241_00010752_0053_0063 56 
269 20071026_00006_005_rg_00010241_00010752_0053_0063 56 
270 20071026_00006_006_rg_00010241_00010752_0053_0063 56 
271 20071026_00007_001_rg_00010241_00010752_0053_0063 56 
272 20071026_00007_002_rg_00010241_00010752_0053_0063 56 
273 20071026_00007_003_rg_00010241_00010752_0053_0063 56 
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274 20071026_00007_004_rg_00010241_00010752_0053_0063 56 
275 20071026_00007_005_rg_00010241_00010752_0053_0063 56 
276 20071026_00007_006_rg_00010241_00010752_0053_0063 56 
277 20071026_00008_001_rg_00010241_00010752_0053_0063 56 
278 20071026_00008_002_rg_00010241_00010752_0053_0063 56.5 
279 20071026_00008_003_rg_00010241_00010752_0053_0063 56.5 
280 20071026_00008_004_rg_00010241_00010752_0053_0063 56.5 
281 20071026_00008_005_rg_00010241_00010752_0053_0063 56.5 
282 20071026_00008_006_rg_00010241_00010752_0053_0063 56.5 
283 20071026_00009_001_rg_00010241_00010752_0053_0063 56 
284 20071026_00009_002_rg_00010241_00010752_0053_0063 56 
285 20071026_00009_003_rg_00010241_00010752_0053_0063 56 
286 20071026_00009_004_rg_00010241_00010752_0053_0063 56 
287 20071026_00009_005_rg_00010241_00010752_0053_0063 56 
288 20071026_00009_006_rg_00010241_00010752_0053_0063 56 
289 20071112_00010_001_rg_00010241_00010752_0053_0063 54.5 
290 20071112_00010_002_rg_00010241_00010752_0053_0063 54.5 
291 20071112_00010_003_rg_00010241_00010752_0053_0063 54.5 
292 20071112_00010_004_rg_00010241_00010752_0053_0063 54.5 
293 20071112_00010_005_rg_00010241_00010752_0053_0063 54.5 
294 20071112_00010_006_rg_00010241_00010752_0053_0063 54.5 
295 20071112_00011_001_rg_00010241_00010752_0053_0063 56.5 
296 20071112_00011_002_rg_00010241_00010752_0053_0063 56 
297 20071112_00011_003_rg_00010241_00010752_0053_0063 56 
298 20071112_00011_004_rg_00010241_00010752_0053_0063 56 
299 20071112_00011_005_rg_00010241_00010752_0053_0063 56 
300 20071112_00011_006_rg_00010241_00010752_0053_0063 56.5 
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Appendix V: List number 5. part one. Epochs’ list extracted using customized 
software. Matrix was positioned by operator A. Each epoch is identified by a 
code containing the following details: date of acquisition, subject ID, 
contraction number, operator code, signal epoch, matrix column. Operator A 
collected all epochs included in this list. A1, 1st estimate by operator A. 
 
n Epochs_ID A1 
1 20071019_00002_002_mb_00010241_00010752_0001_0011 6 
2 20071019_00002_002_mb_00010241_00010752_0024_0014 18 
3 20071019_00002_002_mb_00010241_00010752_0027_0037 31.5 
4 20071019_00002_002_mb_00010241_00010752_0050_0040 45 
5 20071019_00002_002_mb_00010241_00010752_0053_0063 57 
6 20071019_00003_003_mb_00010241_00010752_0001_0011 6 
7 20071019_00003_003_mb_00010241_00010752_0024_0014 18.5 
8 20071019_00003_003_mb_00010241_00010752_0027_0037 31 
9 20071019_00003_003_mb_00010241_00010752_0050_0040 46 
10 20071019_00003_003_mb_00010241_00010752_0053_0063 56 
11 20071025_00004_001_mb_00010241_00010752_0001_0011 4.5 
12 20071025_00004_001_mb_00010241_00010752_0024_0014 19 
13 20071025_00004_001_mb_00010241_00010752_0027_0037 31.5 
14 20071025_00004_001_mb_00010241_00010752_0050_0040 44 
15 20071025_00004_001_mb_00010241_00010752_0053_0063 57.5 
16 20071026_00005_001_mb_00010241_00010752_0001_0011 5 
17 20071026_00005_001_mb_00010241_00010752_0024_0014 18.5 
18 20071026_00005_001_mb_00010241_00010752_0027_0037 31.5 
19 20071026_00005_001_mb_00010241_00010752_0050_0040 45 
20 20071026_00005_001_mb_00010241_00010752_0053_0063 57 
21 20071026_00006_003_mb_00010241_00010752_0001_0011 5 
22 20071026_00006_003_mb_00010241_00010752_0024_0014 19 
23 20071026_00006_003_mb_00010241_00010752_0027_0037 30 
24 20071026_00006_003_mb_00010241_00010752_0050_0040 46 
25 20071026_00006_003_mb_00010241_00010752_0053_0063 56 
26 20071026_00007_001_mb_00010241_00010752_0001_0011 4 
27 20071026_00007_001_mb_00010241_00010752_0024_0014 19.5 
28 20071026_00007_001_mb_00010241_00010752_0027_0037 30.5 
29 20071026_00007_001_mb_00010241_00010752_0050_0040 46 
30 20071026_00007_001_mb_00010241_00010752_0053_0063 56 
31 20071026_00008_001_mb_00010241_00010752_0001_0011 5 
32 20071026_00008_001_mb_00010241_00010752_0024_0014 19 
33 20071026_00008_001_mb_00010241_00010752_0027_0037 30 
34 20071026_00008_001_mb_00010241_00010752_0050_0040 46 
35 20071026_00008_001_mb_00010241_00010752_0053_0063 56 
36 20071026_00009_001_mb_00010241_00010752_0001_0011 6 
37 20071026_00009_001_mb_00010241_00010752_0024_0014 18 
38 20071026_00009_001_mb_00010241_00010752_0027_0037 32 
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39 20071026_00009_001_mb_00010241_00010752_0050_0040 45 
40 20071026_00009_001_mb_00010241_00010752_0053_0063 57 
41 20071112_00010_002_mb_00010241_00010752_0001_0011 4.5 
42 20071112_00010_002_mb_00010241_00010752_0024_0014 19.5 
43 20071112_00010_002_mb_00010241_00010752_0027_0037 30.5 
44 20071112_00010_002_mb_00010241_00010752_0050_0040 47 
45 20071112_00010_002_mb_00010241_00010752_0053_0063 55 
46 20071112_00011_001_mb_00010241_00010752_0001_0011 5 
47 20071112_00011_001_mb_00010241_00010752_0024_0014 19 
48 20071112_00011_001_mb_00010241_00010752_0027_0037 31 
49 20071112_00011_001_mb_00010241_00010752_0050_0040 45.5 
50 20071112_00011_001_mb_00010241_00010752_0053_0063 56 
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Appendix VI: List number 5, part two. Epochs’ list extracted using customized 
software. Matrix was positioned by operator B. Each epoch is identified by a 
code containing the following details: date of acquisition, subject ID, 
contraction number, operator code, signal epoch, matrix column. Operator B 
collected all epochs included in this list. B1, 1st estimate by operator B. 
 
 
n Epochs_ID B1 
1 20071019_00002_002_rg_00010241_00010752_0001_0011 5.5 
2 20071019_00002_002_rg_00010241_00010752_0024_0014 18.5 
3 20071019_00002_002_rg_00010241_00010752_0027_0037 31 
4 20071019_00002_002_rg_00010241_00010752_0050_0040 45 
5 20071019_00002_002_rg_00010241_00010752_0053_0063 56 
6 20071019_00003_001_rg_00010241_00010752_0001_0011 5 
7 20071019_00003_001_rg_00010241_00010752_0024_0014 19 
8 20071019_00003_001_rg_00010241_00010752_0027_0037 31 
9 20071019_00003_001_rg_00010241_00010752_0050_0040 45.5 
10 20071019_00003_001_rg_00010241_00010752_0053_0063 56 
11 20071025_00004_001_rg_00010241_00010752_0001_0011 5 
12 20071025_00004_001_rg_00010241_00010752_0024_0014 18 
13 20071025_00004_001_rg_00010241_00010752_0027_0037 32 
14 20071025_00004_001_rg_00010241_00010752_0050_0040 44 
15 20071025_00004_001_rg_00010241_00010752_0053_0063 58 
16 20071026_00005_001_rg_00010241_00010752_0001_0011 4.5 
17 20071026_00005_001_rg_00010241_00010752_0024_0014 19.5 
18 20071026_00005_001_rg_00010241_00010752_0027_0037 30 
19 20071026_00005_001_rg_00010241_00010752_0050_0040 46 
20 20071026_00005_001_rg_00010241_00010752_0053_0063 56 
21 20071026_00006_002_rg_00010241_00010752_0001_0011 5 
22 20071026_00006_002_rg_00010241_00010752_0024_0014 19 
23 20071026_00006_002_rg_00010241_00010752_0027_0037 30.5 
24 20071026_00006_002_rg_00010241_00010752_0050_0040 46 
25 20071026_00006_002_rg_00010241_00010752_0053_0063 56 
26 20071026_00007_001_rg_00010241_00010752_0001_0011 4 
27 20071026_00007_001_rg_00010241_00010752_0024_0014 20 
28 20071026_00007_001_rg_00010241_00010752_0027_0037 30 
29 20071026_00007_001_rg_00010241_00010752_0050_0040 46 
30 20071026_00007_001_rg_00010241_00010752_0053_0063 56 
31 20071026_00008_002_rg_00010241_00010752_0001_0011 5.5 
32 20071026_00008_002_rg_00010241_00010752_0024_0014 18.5 
33 20071026_00008_002_rg_00010241_00010752_0027_0037 31 
34 20071026_00008_002_rg_00010241_00010752_0050_0040 45 
35 20071026_00008_002_rg_00010241_00010752_0053_0063 56.5 
36 20071026_00009_001_rg_00010241_00010752_0001_0011 5.5 
37 20071026_00009_001_rg_00010241_00010752_0024_0014 19 
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38 20071026_00009_001_rg_00010241_00010752_0027_0037 31 
39 20071026_00009_001_rg_00010241_00010752_0050_0040 46 
40 20071026_00009_001_rg_00010241_00010752_0053_0063 56 
41 20071112_00010_001_rg_00010241_00010752_0001_0011 4 
42 20071112_00010_001_rg_00010241_00010752_0024_0014 19.5 
43 20071112_00010_001_rg_00010241_00010752_0027_0037 30 
44 20071112_00010_001_rg_00010241_00010752_0050_0040 47 
45 20071112_00010_001_rg_00010241_00010752_0053_0063 54.5 
46 20071112_00011_002_rg_00010241_00010752_0001_0011 5.5 
47 20071112_00011_002_rg_00010241_00010752_0024_0014 19 
48 20071112_00011_002_rg_00010241_00010752_0027_0037 31 
49 20071112_00011_002_rg_00010241_00010752_0050_0040 45.5 
50 20071112_00011_002_rg_00010241_00010752_0053_0063 56 
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Appendix VII: Sample size table for Cohen’s Kappa statistic. Minimum 
number of estimates required to detect a kappa coefficient as statistically 
significant (p < 0.05) in a 2-rater study.  
 
 
  
1-Tailed Test Null Value=.00  
 
2-Tailed Test Null Value=.00 
Proportion 
of positive 
ratings 
Kappa 
to 
detect 
n at 80% 
power 
n at 90% 
power  
n at 80% 
power 
n at 90%  
power 
.10 .40 39 54 
 
50 66 
.30 .40 39 54 
 
50 66 
.50 .40 39 54 
 
50 66 
.70 .40 39 54 
 
50 66 
.90 .40 39 54 
 
50 66 
.10 .50 25 35 
 
32 43 
.30 .50 25 35 
 
32 43 
.50 .50 25 35 
 
32 43 
.70 .50 25 35 
 
32 43 
.90 .50 25 35 
 
32 43 
.10 .60 18 24 
 
22 30 
.30 .60 18 24 
 
22 30 
.50 .60 18 24 
 
22 30 
.70 .60 18 24 
 
22 30 
.90 .60 13 18 
 
17 22 
.10 .70 13 18 
 
17 22 
.30 .70 13 18 
 
17 22 
.50 .70 13 18 
 
17 22 
.70 .70 13 18 
 
17 22 
.90 .70 13 18 
 
17 22 
.10 .80 10 14 
 
13 17 
.30 .80 10 14 
 
13 17 
.50 .80 10 14 
 
13 17 
.70 .80 10 14 
 
13 17 
.90 .80 10 14 
 
13 17 
.10 .90 8 11 
 
10 13 
.30 .90 8 11 
 
10 13 
.50 .90 8 11 
 
10 13 
.70 .90 8 11 
 
10 13 
.90 .90 8 11 
 
10 13 
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Appendix VIII:  Operators’ and contractions’ order during the data collecting. Randomization has been performed prior to the 
experimental sessions. 
Subject_ID Operator Contraction order (%MVC) Operator Contraction order (%MVC) 
1 A 40 20 20 20 40 40 B 40 20 40 20 40 20 
2 A 40 40 20 40 20 20 B 20 40 20 40 40 20 
3 A 20 40 20 20 40 40 B 20 40 20 40 20 40 
4 A 20 20 40 40 20 40 B 20 20 40 20 40 40 
5 B 40 20 40 20 20 40 A 40 40 20 40 20 20 
6 A 20 20 20 40 40 40 B 20 20 40 20 40 40 
7 A 20 20 40 40 40 20 B 40 20 40 40 20 20 
8 B 20 40 20 20 40 40 A 20 40 20 20 40 40 
9 A 40 20 20 40 20 40 B 20 20 40 20 40 40 
10 B 40 20 20 20 40 40 A 20 20 40 40 40 20 
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Appendix IX: Checklist for reliability studies. 
 
 
Items Item description (abbreviated) 
1 Was the sample of subjects representative?  
2 Were raters blinded to the findings of other raters?  
3 Were raters blinded to the findings of other raters?  
4 Were raters blinded to their own prior findings?  
5 Were raters blinded to the accepted reference standard?  
6 Were raters blinded to clinical information not part of test  
7 Were raters blinded to additional non-clinical cues?  
8 Was the order of examination varied?  
9 
Was the time interval between repeated measures 
appropriate?  
10 Was the test applied correctly and interpreted appropriately?  
11 Were appropriate statistical measures of agreement used?  
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Appendix X: Pre-set answers for MTrP’ palpation.  The following questions 
was asked: is this spot unusually painful?; I will compress two spots, a first 
one and second one. Please tell me which is the most painful; do you 
recognize this pain as a familiar complaint?; Does the pain occurs anywhere 
from the spot that I am compressing? If yes, indicate where according to the 
anatomical regions reported on the sheet. 
 
 
 
  
YES NO 
1st 2nd 
Head 
Neck 
Shoulder 
Arm 
Elbow 
Forearm 
Hand 
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Appendix XI Table for sample size’ computation.  
 
 
ρo 
 
 
n=2 
ρ1 
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 
0.1 
 
591.2 142.8 60.6 32.2 19.1 12 7.7 4.8 
0.2 
  
543.7 128.2 53 27.2 15.5 9.2 5.3 
0.3 
   
476.2 109 43.5 21.4 11.4 6.1 
0.4 
    
393 86.6 32.9 15.1 7.1 
0.5 
     
300.3 62.6 22 8.8 
0.6 
      
205.4 39.1 11.7 
0.7 
       
117.1 18.4 
0.8 
        
45.8 
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Appendix XII: Results of the normality for tests Chapter 4. X1, X value measured 
during the first palpatory examination; X2, X value measured during the second 
palpatory examination. Y1, Y value measured during the first palpatory 
examination; Y2, Y value measured during the second palpatory examination; 
MTrP, distance between MTrP_1 and MTrP_2, L, left; R, right. 
 
 
Shapiro-Wilk 
Statistic df Sig. 
X1 .963 24 .494 
Y1 .928 24 .089 
X2 .958 24 .401 
Y2 .931 24 .103 
 
 
SIDE 
Shapiro-Wilk 
Statistic df Sig. 
MTrP_d L .910 12 .212 
R .908 12 .203 
X1 L .938 12 .471 
R .980 12 .983 
Y1 L .839 12 .027 
R .832 12 .022 
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Appendix XIII: Results of the palpation’ procedures for the enrolled subjects. 
 
 
Subjects 
MTrP Diagnostic criteria 
 
Taut 
band 
Spot 
tenderness 
Pain 
recognition 
Referred 
pain 
Referral 
zone 
1 x x x 
  
2 x x x x Head 
3 x x x 
  
4 x x x x Neck 
5 x x x x Shoulder 
6 x x x x Neck 
7 x x x 
  
8 x x x x Neck 
9 x x x x Head 
10 x x x 
  
11 x x x 
  
12 x x x 
  
13 x x x 
  
14 x x x x Head 
15 x x x 
  
16 x x x x Arm/elbow 
17 x x x 
  
18 x x x 
  
19 x x x x Head 
20 x x x 
  
21 x x x x Shoulder 
22 x x x x Neck 
23 x x x x Neck 
24 x x x 
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Appendix XIV: The distance between MTrP_1 and MTrP_2 for each subject. 
MTrP_1, myofascial trigger point detected during the first palpatory 
examination; MTrP_2, myofascial trigger point detected during the second 
palpatory examination. 
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Appendix XV: NDI – Italian version. 
 
Neck Disability Index – Versione Italiana (Monticone at al. 2012). 
 
ISTRUZIONI: Il presente questionario è stato creato per permetterci di capire 
in che modo il dolore che prova al collo abbia condizionato la Sua capacità di 
gestire le attività della vita quotidiana. Per cortesia, risponda ad ogni sezione 
barrando LA RISPOSTA che giudica più pertinente. Ci rendiamo conto che si 
possa trovare d’accordo con più di una affermazione, ma PROVI 
GENTILMENTE A CERCHIARE SOLO LA RISPOSTA CHE DESCRIVE 
MAGGIORMENTE IL SUO PROBLEMA PROPRIO ADESSO. 
 
Sezione 1 - Intensità del dolore 
□ Al momento non ho dolore cervicale.  
□ Al momento il dolore cervicale è molto lieve.  
□ Al momento il dolore cervicale è di media intensità.  
□ Al momento il dolore cervicale è abbastanza forte.  
□ Al momento il dolore cervicale è molto forte.  
□ Al momento il dolore cervicale è il massimo immaginabile. 
 
Sezione 2 - Cura personale (lavarsi, vestirsi, ecc.) 
□ Riesco a prendermi cura di me stesso/a normalmente senza sentire più 
dolore cervicale del solito.  
□ Riesco a prendermi cura di me stesso/a normalmente ma mi causa più 
dolore cervicale del solito.  
□ Mi fa male prendermi cura di me stesso/a e sono lento/a e prudente.  
□ Ho bisogno di un po' di aiuto ma riesco per lo più a prendermi cura di 
me stesso/a.  
□ Ho bisogno di aiuto ogni giorno in quasi tutti gli aspetti della cura di 
me stesso/a. 
□ Non mi vesto, mi lavo con difficoltà e sto a letto. 
 
Sezione 3 - Alzare pesi 
□ Riesco a sollevare oggetti pesanti senza sentire più dolore cervicale 
del solito.  
□ Riesco a sollevare oggetti pesanti ma sentendo più dolore cervicale 
del solito.  
□ Il dolore cervicale mi impedisce di sollevare oggetti pesanti da terra, ma ci 
riesco se     sono posizionati in maniera opportuna, per esempio su un 
tavolo.  
□ Il dolore cervicale mi impedisce di sollevare oggetti pesanti, ma riesco a 
sollevare  oggetti leggeri o di medio peso se sono posizionati in maniera 
opportuna.  
□ Riesco a sollevare solo oggetti molto leggeri. 
□ Non riesco a sollevare o trasportare assolutamente niente. 
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Sezione 4 – Leggere 
□ Riesco a leggere quanto voglio senza provare alcun dolore al collo. 
□ Riesco a leggere quanto voglio avvertendo un dolore al collo lieve. 
□ Riesco a leggere quanto voglio avvertendo un dolore al collo di media 
intensità. 
□ Non riesco a leggere quanto voglio a causa di un dolore al collo di media 
intensità. 
□ Non riesco a leggere quanto voglio a causa di un dolore al collo molto 
forte. 
□ Non riesco a leggere del tutto. 
 
Sezione 5 – Mal di testa 
□ Non provo mal di testa per nulla.  
□ Provo un mal di testa lieve che insorge raramente. 
□ Provo un mal di testa di media intensità che insorge raramente. 
□ Provo un mal di testa di media intensità che insorge frequentemente. 
□ Provo un mal di testa molto forte che insorge frequentemente. 
□ Provo quasi sempre mal di testa. 
 
Sezione 6 – Concentrarsi 
□ Riesco a concentrarmi perfettamente quando lo desidero senza 
difficoltà. 
□ Riesco a concentrarmi perfettamente quando lo desidero con leggera 
difficoltà. 
□ Avverto una difficoltà intermedia a concentrarmi quando lo desidero. 
□ Avverto molta difficoltà a concentrarmi quando lo desidero. 
□ Avverto moltissima difficoltà a concentrarmi quando lo desidero. 
□ Non riesco a concentrarmi del tutto. 
 
Sezione 7 – Lavorare 
□ Riesco a svolgere tutto il lavoro che voglio. 
□ Riesco a svolgere solo il mio lavoro abituale, ma nulla di più. 
□ Riesco a svolgere parte del mio lavoro abituale, ma nulla di più. 
□ Non riesco a svolgere il mio lavoro abituale. 
□ Svolgo ogni lavoro con molta difficoltà. 
□ Non riesco più a svolgere alcun lavoro. 
 
Sezione 8 - Guidare 
□ Riesco a guidare la mia macchina senza alcun dolore al collo. 
□ Riesco a guidare la mia macchina fin quando voglio provando un lieve 
dolore al collo. 
□ Riesco a guidare la mia macchina fin quando voglio provando un dolore 
al collo di media intensità. 
□ Non riesco a guidare la mia macchina fin quando voglio a causa di un 
dolore al collo di media intensità. 
□ Riesco a guidare proprio con molta difficoltà a causa di un forte dolore 
al collo. 
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□ Non riesco più a guidare la mia macchina a causa del dolore 
cervicale. 
 
Sezione 9 – Dormire 
□ Non ho problemi per dormire. 
□ Il mio riposo è scarsamente disturbato (meno di un’ora di insonnia). 
□ Il mio riposo è leggermente disturbato (1-2 ore di insonnia). 
□ Il mio riposo è moderatamente disturbato (2-3 ore di insonnia). 
□ Il mio riposo è disturbato moltissimo (3-5 ore di insonnia). 
□ Il mio riposo è completamente disturbato (5-7 ore di insonnia). 
 
Sezione 10 – Svagarsi  
□ Posso dedicarmi a tutti i miei passatempi senza alcun dolore al collo. 
□ Posso dedicarmi a tutti i miei passatempi con un po’ di dolore al mio 
collo. 
□ Posso dedicarmi a molti, ma non a tutti i miei passatempi a causa del 
dolore al mio collo. 
□ Posso dedicarmi solo ad alcuni dei miei passatempi a causa del 
dolore al mio collo. 
□ Posso dedicarmi con difficoltà ai miei passatempi a causa del dolore 
al mio collo. 
□ Non riesco più a dedicarmi a nessun passatempo. 
 
Commenti:……………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
……………………………………………… 
Nominativo: 
…………………………………………………………………………………………
. 
Data di compilazione: 
……………………………………………………………………………… 
Punteggio: 
…………………………………………………………………………………………
… 
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Calcolo del Punteggio per il Neck Disability Index. 
 
1. Ognuna delle 10 sezioni ottiene un punteggio separato (da 0 a 5) che è 
poi sommato (totale max. = 50). 
 
ESEMPIO: 
 
Sezione 1 - Intensità del dolore      
 Punteggio 
A. Al momento non ho dolore cervicale.      0 
B. Al momento il dolore cervicale è molto lieve.     1
  
C. Al momento il dolore cervicale è di media intensità.   2 
D. Al momento il dolore cervicale è abbastanza forte.    3 
E. Al momento il dolore cervicale è molto forte.     4 
F. Al momento il dolore cervicale è il massimo immaginabile.  5 
 
2. Se tutte le sezioni sono state compilate, raddoppiare semplicemente il 
punteggio ottenuto. 
 
3. Se una sezione è stata tralasciata, dividere il punteggio totale per il 
numero delle sezioni compilate, moltiplicando per 5. 
 
 
FORMULA:  Punteggio totale 
   ---------------------------------- X 100 = ______ Disabilità 
   # di sezioni riempite X 5 
 
 
ESEMPIO: 
Se 9 delle 10 sezioni sono state riempite, dividere il punteggio totale per 9 X 
5 = 45. 
Punteggio totale: 22  
Numero delle sezioni riempite: 9 (9X5=45) 
 22/45X100=48% di disabilità 
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Appendix XVI: Histograms and results of the normality tests in Chapter 5. 
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Test for normality. 
 
 
Shapiro-Wilk 
Statistic df Sig. 
X .992 24 .999 
Y .932 24 .107 
TrP_IZ .971 24 .682 
PTT .951 24 .287 
NDI .924 24 .070 
VAS .951 24 .280 
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Appendix XVII: IZ’ and MTrP’ location with respect to the ARS for each 
subject. 
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